c5-6	JJ	B-PROBLEM
disc	NN	I-PROBLEM
herniation	NN	I-PROBLEM
with	IN	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
and	CC	O
myelopathy	NN	B-PROBLEM
.	.	O

microscopic	NN	B-TREATMENT
anterior	JJ	I-TREATMENT
cervical	JJ	I-TREATMENT
diskectomy	NN	I-TREATMENT
at	IN	I-TREATMENT
c5-6	NN	I-TREATMENT
and	CC	O
fusion	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
63-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
three-year	JJ	O
history	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
hand	NN	I-PROBLEM
numbness	NN	I-PROBLEM
and	CC	O
occasional	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

within	IN	O
the	DT	O
past	JJ	O
year	NN	O
,	,	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
have	VBP	O
progressively	RB	O
gotten	VBN	O
worse	JJR	O
,	,	O
to	TO	O
encompass	VB	O
also	RB	O
her	PRP$	O
feet	NNS	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
workup	NN	I-TEST
by	IN	O
her	PRP$	O
neurologist	NN	O
and	CC	O
an	DT	B-TEST
mri	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
c5-6	JJ	I-PROBLEM
disc	NN	I-PROBLEM
herniation	NN	I-PROBLEM
with	IN	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
t2	JJ	I-PROBLEM
signal	JJ	I-PROBLEM
change	NN	I-PROBLEM
at	IN	O
that	DT	O
level	NN	O
.	.	O

significant	JJ	O
for	IN	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
.	.	O

lipitor	NN	B-TREATMENT
,	,	O
flexeril	NN	B-TREATMENT
,	,	O
hydrochlorothiazide	NN	B-TREATMENT
and	CC	O
norvasc	NN	B-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergy	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
hoffman	JJ	I-TEST
&apos;s	NN	I-TEST
sign	NN	I-TEST
greater	JJR	O
on	IN	O
the	DT	O
right	NN	O
than	IN	O
the	DT	O
left	NN	O
and	CC	O
she	PRP	O
had	VBD	O
10	CD	B-PROBLEM
beats	NNS	I-PROBLEM
of	IN	I-PROBLEM
clonus	NN	I-PROBLEM
in	IN	O
the	DT	O
right	JJ	O
foot	NN	O
and	CC	O
3-5	JJ	B-PROBLEM
beats	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
foot	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
hyperreflexia	VBN	B-PROBLEM
in	IN	O
both	DT	O
the	DT	O
bilateral	JJ	O
upper	NN	O
and	CC	O
lower	JJR	O
extremities	NNS	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
a	DT	B-TREATMENT
c5-6	JJ	I-TREATMENT
acdf	NN	I-TREATMENT
by	IN	O
dr.	NN	O
miezetri	NN	O
gach	NN	O
quite	RB	O
well	RB	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
postoperative	JJ	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
that	WDT	O
revealed	VBD	O
partial	JJ	B-PROBLEM
decompression	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
spinal	JJ	I-PROBLEM
canal	NN	I-PROBLEM
and	CC	O
good	JJ	O
placement	NN	O
of	IN	O
her	PRP$	B-TREATMENT
hardware	NN	I-TREATMENT
.	.	O

immediately	RB	O
postop	NN	O
,	,	O
her	PRP$	B-TEST
exam	NN	I-TEST
only	RB	O
improved	VBD	O
slightly	RB	O
in	IN	O
her	PRP$	B-PROBLEM
hyperreflexia	NN	I-PROBLEM
.	.	O

her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
under	IN	O
good	JJ	O
control	NN	O
with	IN	O
po	NN	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
she	PRP	O
was	VBD	O
deemed	VBN	O
suitable	JJ	O
for	IN	O
discharge	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
asked	VBN	O
to	TO	O
call	VB	O
dr.	NN	O
miezetri	NN	O
gach	NN	O
&apos;s	NNP	O
office	NN	O
for	IN	O
a	DT	O
follow-up	JJ	O
appointment	NN	O
and	CC	O
wound	NN	B-TEST
check	NN	I-TEST
.	.	O

she	PRP	O
is	VBZ	O
asked	VBN	O
to	TO	O
call	VB	O
with	IN	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
weakness	NN	I-PROBLEM
or	CC	O
numbness	NN	B-PROBLEM
or	CC	O
any	DT	O
bowel	NN	B-PROBLEM
and	CC	I-PROBLEM
bladder	NN	I-PROBLEM
disruption	NN	I-PROBLEM
.	.	O

1.	CD	O
colace	NN	B-TREATMENT
,	,	O
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

2.	CD	O
zantac	NN	B-TREATMENT
,	,	O
150	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

3.	CD	O
percocet	NN	B-TREATMENT
,	,	O
5/325	CD	O
,	,	O
1-2	JJ	O
tabs	NN	O
po	IN	O
q4-6h	JJ	O
prn	NN	O
pain	NN	B-PROBLEM
.	.	O

4.	CD	O
lipitor	NN	B-TREATMENT
,	,	O
10	CD	O
mg	NN	O
po	JJ	O
daily	RB	O
.	.	O

5.	CD	O
hydrochlorothiazide	NN	B-TREATMENT
,	,	O
25	CD	O
mg	NN	O
po	JJ	O
daily	RB	O
.	.	O

6.	CD	O
norvasc	NN	B-TREATMENT
,	,	O
5	CD	O
mg	NN	O
po	JJ	O
daily	RB	O
.	.	O

l	NN	B-PROBLEM
shoulder	NN	I-PROBLEM
inj	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
neck	NN	B-PROBLEM
strains	NNS	I-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

left	VBN	B-PROBLEM
shoulder	NN	I-PROBLEM
/	NNP	I-PROBLEM
neck	NN	I-PROBLEM
strain	NN	I-PROBLEM
/	NN	I-PROBLEM
sprain	NN	I-PROBLEM
.	.	O

dilaudid	RB	B-TREATMENT
2mg	CD	O
po	NN	O
x	VBD	O
1	CD	O
flexeril	JJ	B-TREATMENT
10	CD	O
mg	NN	O
x	CD	O
1	CD	O

flexeril	RB	B-TREATMENT
10mg	CD	O
tid	NN	O

take	VB	O
codeine	NN	B-TREATMENT
prescribed	VBN	O
by	IN	O
pcp	NN	O
with	IN	O
food	NN	O
and	CC	O
water	NN	O
to	TO	O
prevent	VB	O
nausea	NN	B-PROBLEM
and	CC	O
constipation	NN	B-PROBLEM
.	.	O

do	VB	O
not	RB	O
drive	VB	O
if	IN	O
taking	VBG	O
flexeril	NN	B-TREATMENT
and	CC	O
codeine	NN	B-TREATMENT
.	.	O

near	IN	B-PROBLEM
syncope	NN	I-PROBLEM
standardized	VBN	O
discharge	NN	O
instructions	NNS	O
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
dizziness	NN	B-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

near	IN	B-PROBLEM
syncope	NN	I-PROBLEM
,	,	O
dehydration	NN	B-PROBLEM
vs	NN	O
cardiogenic	NN	B-PROBLEM

ivf	NN	B-TREATMENT
,	,	O
cbc	NN	B-TEST
(	(	O
hct	JJ	B-TEST
36	CD	O
)	)	O
,	,	O
normal	JJ	O
chem	NN	O
7	CD	O
,	,	O
negative	JJ	O
cardiac	JJ	O
enzymes	NNS	O
,	,	O
negative	JJ	O
stool	NN	O
guaiac	NN	O
,	,	O
normal	JJ	O
cxr	NN	O

dr.	NN	O
foutchner	NN	O
will	MD	O
arrange	VB	O
for	IN	O
an	DT	B-TEST
outpatient	JJ	I-TEST
holter	NN	I-TEST
monitor	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
ed	NN	O
for	IN	O
recurrent	NN	B-PROBLEM
dizziness	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
.	.	O

copd	NN	B-PROBLEM
flare	NN	I-PROBLEM

acetylsalicylic	JJ	B-TREATMENT
acid	VBZ	I-TREATMENT
81	CD	O
mg	NN	O
po	JJ	O
daily	JJ	O
albuterol	NN	B-TREATMENT
nebulizer	NN	I-TREATMENT
2.5	CD	O
mg	NN	O
neb	NN	O
q4h	NN	O
starting	VBG	O
today	NN	O
(	(	O
03/17	CD	O
)	)	O
prn	NN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
lisinopril	NN	B-TREATMENT
10	CD	O
mg	NN	O
po	JJ	O
daily	JJ	O
niferex-150	JJ	B-TREATMENT
150	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
prednisone	NN	B-TREATMENT
taper	NN	I-TREATMENT
po	NN	I-TREATMENT
give	VBP	O
50	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
x	$	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
give	VB	O
40	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
x	$	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
give	VB	O
30	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
x	$	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
give	VB	O
20	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
x	$	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
give	VB	O
10	CD	O
mg	NN	O
q	NN	O
24	CD	O
h	NN	O
x	$	O
1	CD	O
dose	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
then	RB	O
starting	VBG	O
today	NN	O
(	(	O
03/17	CD	O
)	)	O
claritin	NN	B-TREATMENT
(	(	I-TREATMENT
loratadine	NN	I-TREATMENT
)	)	I-TREATMENT
10	CD	O
mg	JJ	O
po	NNS	O
daily	RB	O

give	VB	O
on	IN	O
an	DT	O
empty	JJ	O
stomach	NN	O
(	(	O
give	JJ	O
1hr	CD	O
before	IN	O
or	CC	O
2hr	CD	O
after	IN	O
food	NN	O
)	)	O
singulair	NN	B-TREATMENT
(	(	I-TREATMENT
montelukast	NN	I-TREATMENT
)	)	I-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
bedtime	NN	O
advair	NN	B-TREATMENT
diskus	VBZ	I-TREATMENT
500/50	CD	I-TREATMENT
(	(	I-TREATMENT
fluticasone	NN	I-TREATMENT
propionate/...	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
puff	JJ	O
inh	NN	O
bid	NN	O
caltrate	NN	B-TREATMENT
+	NNP	I-TREATMENT
d	VBZ	I-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
bid	NN	O
lantus	NN	B-TREATMENT
(	(	I-TREATMENT
insulin	JJ	I-TREATMENT
glargine	NN	I-TREATMENT
)	)	I-TREATMENT
35	CD	O
units	NNS	O
sc	VBP	O
qam	JJ	O
duoneb	NN	B-TREATMENT
(	(	I-TREATMENT
albuterol	NN	I-TREATMENT
and	CC	I-TREATMENT
ipratropium	NN	I-TREATMENT
nebulizer	NN	I-TREATMENT
)	)	I-TREATMENT
3/0.5	CD	O
mg	NN	O
neb	NN	O
q6h	NN	O
starting	VBG	O
today	NN	O
(	(	O
03/17	CD	O
)	)	O
prn	NN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
wheezing	VBG	B-PROBLEM
novolog	NN	B-TREATMENT
(	(	I-TREATMENT
insulin	JJ	I-TREATMENT
aspart	NN	I-TREATMENT
)	)	I-TREATMENT
4	CD	O
units	NNS	O
sc	VBP	O
ac	NN	O

standing	VBG	B-TREATMENT
pre-meal	JJ	I-TREATMENT
novolog	NN	I-TREATMENT
.	.	O

novolog	NN	B-TREATMENT
(	(	I-TREATMENT
insulin	JJ	I-TREATMENT
aspart	NN	I-TREATMENT
)	)	I-TREATMENT
sliding	VBG	O
scale	NN	O
(	(	O
subcutaneously	RB	O
)	)	O
sc	NN	O
ac	NN	O

give	VB	O
in	IN	O
addition	NN	O
to	TO	O
standing	VBG	B-TREATMENT
pre-meal	JJ	I-TREATMENT
novolog	NN	I-TREATMENT
when	WRB	O
patient	NN	O
will	MD	O
eat	VB	O
and	CC	O
food	NN	O
is	VBZ	O
in	IN	O
the	DT	O
room	NN	O
.	.	O

if	IN	O
bs	VBN	B-TEST
is	VBZ	O
less	JJR	O
than	IN	O
125	CD	O
,	,	O
then	RB	O
give	VB	O
0	CD	O
units	NNS	O
subcutaneously	RB	O
if	IN	O
bs	VBN	B-TEST
is	VBZ	O
125-150	JJ	O
,	,	O
then	RB	O
give	VB	O
2	CD	O
units	NNS	O
subcutaneously	RB	O
if	IN	O
bs	VBN	B-TEST
is	VBZ	O
151-200	CD	O
,	,	O
then	RB	O
give	VB	O
3	CD	O
units	NNS	O
subcutaneously	RB	O
if	IN	O
bs	VBN	B-TEST
is	VBZ	O
201-250	JJ	O
,	,	O
then	RB	O
give	VB	O
4	CD	O
units	NNS	O
subcutaneously	RB	O
if	IN	O
bs	VBN	B-TEST
is	VBZ	O
251-300	JJ	O
,	,	O
then	RB	O
give	VB	O
6	CD	O
units	NNS	O
subcutaneously	RB	O
if	IN	O
bs	VBN	B-TEST
is	VBZ	O
301-350	JJ	O
,	,	O
then	RB	O
give	VB	O
8	CD	O
units	NNS	O
subcutaneously	RB	O
if	IN	O
bs	VBN	B-TEST
is	VBZ	O
351-400	JJ	O
,	,	O
then	RB	O
give	VB	O
10	CD	O
units	NNS	O
subcutaneously	RB	O
and	CC	O
call	VB	O
ho	NN	O
call	NN	O
ho	NN	O
if	IN	O
bs	NN	B-TEST
is	VBZ	O
greater	JJR	O
than	IN	O
400	CD	O
protonix	NN	B-TREATMENT
(	(	I-TREATMENT
pantoprazole	NN	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
mg	JJ	O
po	JJ	O
daily	JJ	O
combivent	NN	B-TREATMENT
(	(	I-TREATMENT
ipratropium	NN	I-TREATMENT
and	CC	I-TREATMENT
albuterol	VB	I-TREATMENT
sulfate	NN	I-TREATMENT
)	)	I-TREATMENT
2	CD	O
puff	NN	O
inh	NN	O
qid	NN	O
fosamax	NN	B-TREATMENT
(	(	I-TREATMENT
alendronate	NN	I-TREATMENT
)	)	I-TREATMENT
70	CD	O
mg	NN	O
po	NN	O
qweek	NN	O

take	VB	O
with	IN	O
8	CD	O
oz	NN	O
of	IN	O
plain	JJ	O
water	NN	O
spiriva	NN	B-TREATMENT
(	(	I-TREATMENT
tiotropium	NN	I-TREATMENT
)	)	I-TREATMENT
18	CD	O

walk	NN	O
with	IN	O
assist	JJ	O
per	IN	O
pt	NN	B-TEST
eval	NN	I-TEST

copd	NN	B-PROBLEM
flare	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
copd	NN	B-PROBLEM
flare	NN	I-PROBLEM

copd	NN	B-PROBLEM
(	(	I-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	VBP	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
)	)	I-PROBLEM
dm	VBZ	B-PROBLEM
cervical	JJ	B-PROBLEM
djd	NN	I-PROBLEM
(	(	O
)	)	O
iron	NN	B-PROBLEM
deficiency	NN	I-PROBLEM
anemia	NN	I-PROBLEM
(	(	I-PROBLEM
iron	JJ	I-PROBLEM
deficiency	NN	I-PROBLEM
anemia	NN	I-PROBLEM
)	)	I-PROBLEM
cervical	NN	B-PROBLEM
and	CC	I-PROBLEM
lumbar	NN	I-PROBLEM
djd	NN	I-PROBLEM
(	(	O
12	CD	O
)	)	O
osa	NN	B-PROBLEM
(	(	I-PROBLEM
sleep	JJ	I-PROBLEM
apnea	NN	I-PROBLEM
)	)	I-PROBLEM
s	NN	O
/	NNP	O
p	NN	O
tb	NN	B-TREATMENT
treatment	NN	I-TREATMENT
(	(	O
5	CD	O
)	)	O

weakness	NN	B-PROBLEM

75	CD	O
y	JJ	O
/	NNP	O
o	MD	O
f	VB	O
with	IN	O
dm	NN	B-PROBLEM
,	,	O
copd	NN	B-PROBLEM
on	IN	O
2l	CD	B-TREATMENT
nc	NNS	I-TREATMENT
and	CC	O
bipap	NN	B-TREATMENT
at	IN	O
night	NN	O
p	NN	O
/	NNP	O
w	VBZ	O
generalized	VBN	B-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
,	,	O
urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
and	CC	O
shaking	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
increased	VBN	B-PROBLEM
sputum	NN	I-PROBLEM
production	NN	I-PROBLEM
.	.	O

per	IN	O
daughter	NN	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
are	VBP	O
typical	JJ	O
of	IN	O
copd	NN	B-PROBLEM
flare	NN	I-PROBLEM
.	.	O

rec&apos;d	NN	O
duonebs	NN	B-TREATMENT
,	,	O
solumedrol	NN	B-TREATMENT
125	CD	O

t97.5	NN	O
,	,	O
hr	NN	B-TEST
117	CD	O
,	,	O
bp156/81	NN	O
,	,	O
rr28	NN	O
,	,	O
o2	JJ	B-TEST
sats	NNS	I-TEST
87%	CD	O
ra	NN	O
;	:	O
95%	CD	O
4l	CD	O

nad	RB	B-PROBLEM
,	,	O
pleasant	JJ	O
,	,	O
speaking	VBG	O
in	IN	O
complete	JJ	O
sentences	NNS	O
,	,	O
poor	JJ	B-PROBLEM
air	NN	I-PROBLEM
movement	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
l	NN	O
&gt;	NNP	O
r	NN	O
,	,	O
no	DT	O
wheezes	NN	B-PROBLEM
or	CC	O
rales	NNS	B-PROBLEM
,	,	O
rrr	NN	O
,	,	O
distant	NN	O
,	,	O
abd	JJ	O
benign	NN	O
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
alert	NN	O
and	CC	O
oriented	VBN	O
times	NNS	O
three	CD	O
,	,	O
no	DT	O
focal	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
,	,	O
conversant	JJ	O
studies	NNS	O
:	:	O

-	:	O
ekg	NN	B-TEST
sinus	NN	O
92	CD	O
,	,	O
no	DT	O
st	NN	B-PROBLEM
changes	NNS	I-PROBLEM

-	:	O
cxr	NN	B-TEST
no	DT	O
focal	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
,	,	O
old	JJ	B-PROBLEM
biapical	JJ	I-PROBLEM
scarring	NN	I-PROBLEM
abg	NN	B-TEST
7.34/79/74	CD	O
u	JJ	B-TEST
/	FW	I-TEST
a	DT	I-TEST
negative	JJ	O

improving	NN	O
,	,	O
but	CC	O
still	RB	B-PROBLEM
poor	JJ	I-PROBLEM
air	NN	I-PROBLEM
movement	NN	I-PROBLEM
,	,	O
diffusely	RB	B-PROBLEM
wheezy	VBP	I-PROBLEM
on	IN	O
exam	NN	B-TEST
,	,	O
at	IN	O
baseline	NN	O
2l	CD	B-TREATMENT
o2	NN	I-TREATMENT
requirement	NN	I-TREATMENT

75	CD	O
y	JJ	O
/	NNP	O
o	MD	O
f	VB	O
with	IN	O
h	JJ	O
/	JJ	O
o	NN	O
copd	NN	B-PROBLEM
c	NN	O
/	NN	O
b	NN	O
frequent	JJ	B-PROBLEM
exacerbations	NNS	I-PROBLEM
p	VBP	O
/	JJ	O
w	JJ	O
typical	JJ	B-PROBLEM
flare	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

cv	SYM	O
-	:	O
ischemia	NN	B-PROBLEM
asa	NN	B-TREATMENT
,	,	O
lisinopril	JJ	B-TREATMENT
pump	NN	I-TREATMENT
no	DT	O
evidence	NN	O
of	IN	O
failure	NN	B-PROBLEM

rhythm	NN	O
resp	SYM	O
-	:	O
copd	NN	B-PROBLEM

flare	NN	B-PROBLEM
-	:	O
steroids	NNS	B-TREATMENT
,	,	O
cont	VBP	O
prednisone	NN	B-TREATMENT
60	CD	O
,	,	O
taper	JJR	O
slowly	RB	O
as	IN	O
tolerated	VBN	O
,	,	O
duonebs	NN	B-TREATMENT
,	,	O
advair	NN	B-TREATMENT
,	,	O
singulair	NN	B-TREATMENT
,	,	O
spiriva	NN	B-TREATMENT
,	,	O
claritin	NN	B-TREATMENT
azithromycin	NN	B-TREATMENT
for	IN	O
atypical	JJ	B-PROBLEM
bronchitis	NN	I-PROBLEM
to	TO	O
complete	VB	O
a	DT	O
5	CD	O
day	NN	O
course	NN	O
,	,	O
keep	VB	O
o2	JJ	B-TEST
sat	JJ	I-TEST
90-94	CD	O
,	,	O
home	NN	B-TREATMENT
nocturnal	JJ	I-TREATMENT
cpap	NN	I-TREATMENT
not	RB	O
tolerated	VBN	O
in	IN	O
house	NN	O
,	,	O
does	VBZ	O
well	RB	O
on	IN	O
nc	NNS	B-TREATMENT
,	,	O
appears	VBZ	O
ato	RB	O
be	VB	O
at	IN	O
baseline	NN	O

cr	NN	B-TEST
0.8	CD	O
,	,	O
stress	NN	B-PROBLEM
incontinence	NN	I-PROBLEM
by	IN	O
symptoms	NNS	B-PROBLEM
with	IN	O
increased	JJ	B-PROBLEM
cough	NN	I-PROBLEM
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
uti	JJ	B-PROBLEM
,	,	O
cont	NN	O
to	TO	O
closely	RB	O
monitor	VB	O

gi	SYM	O
-	:	O
bowel	NN	B-TREATMENT
regimen	NNS	I-TREATMENT

heme	NN	O
-	:	O
chronic	JJ	B-PROBLEM
fe	NN	I-PROBLEM
deficiency	NN	I-PROBLEM
anemia	NN	I-PROBLEM
,	,	O
cont	NN	O
iron	NN	B-TREATMENT

endo	SYM	O
-	:	O
dm	NN	B-PROBLEM
on	IN	O
insulin	NN	B-TREATMENT
with	IN	O
steroids	NNS	B-TREATMENT

id	SYM	O
-	:	O
afebrile	NN	B-PROBLEM
,	,	O
no	DT	O
wbc	NN	B-TEST
,	,	O
started	VBD	O
on	IN	O
azithromycin	NN	B-TREATMENT
for	IN	O
copd	NN	B-PROBLEM
flare	NN	I-PROBLEM

ppx	SYM	O
-	:	O
lovenox	NN	B-TREATMENT
,	,	O
ppi	NN	B-TREATMENT

dispo	SYM	O
-	:	O
to	TO	O
rehab	VB	O
when	WRB	O
resp	NN	B-PROBLEM
status	NN	I-PROBLEM
improved	VBN	O
,	,	O
pt	NN	O
consulted	VBD	O

f	JJ	O
/	NNP	O
u	NN	O
with	IN	O
pcp	NN	O
and	CC	O
dr.	JJ	O
pump	NN	O
as	IN	O
scheduled	VBN	O
,	,	O
return	VB	O
to	TO	O
ed	VB	O
with	IN	O
worsening	VBG	B-PROBLEM
sob	NN	I-PROBLEM
or	CC	O
increased	JJ	B-PROBLEM
cough	NN	I-PROBLEM
or	CC	O
sputum	NN	B-PROBLEM
production	NN	I-PROBLEM

dizziness	NN	B-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
dizziness	NN	B-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

benign	JJ	B-PROBLEM
positional	JJ	I-PROBLEM
vertigo	NN	I-PROBLEM
vs	NN	O
labyrinthitis	NN	B-PROBLEM

head	NN	B-TEST
ct	NN	I-TEST
negative	JJ	O
.	.	O

meclizine	NN	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

return	NN	O
to	TO	O
ed	VB	O
or	CC	O
call	VB	O
pcp	NN	O
if	IN	O
symptoms	NNS	B-PROBLEM
worsen	VBP	O
or	CC	O
if	IN	O
fever	VBN	B-PROBLEM
with	IN	O
headache	NN	B-PROBLEM
.	.	O

swollen	VBN	B-PROBLEM
painful	JJ	I-PROBLEM
l	JJ	I-PROBLEM
side	NN	I-PROBLEM
fc	NN	I-PROBLEM

l	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lip	NN	I-PROBLEM
/	NNP	I-PROBLEM
l	NN	I-PROBLEM
nostril	NN	I-PROBLEM
abscess	NN	I-PROBLEM

5	CD	O
cc	NN	O
of	IN	O
purulent	JJ	B-PROBLEM
material	NN	I-PROBLEM
drained	VBN	O
by	IN	O
needle	JJ	B-TREATMENT
aspiration	NN	I-TREATMENT

augmentin	RB	B-TREATMENT
875	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
for	IN	O
10	CD	O
days	NNS	O
.	.	O

return	NN	O
immediately	RB	O
for	IN	O
worsening	VBG	O
signs	NNS	O
of	IN	O
infection	NN	B-PROBLEM
(	(	O
increased	JJ	B-PROBLEM
swelling	NN	I-PROBLEM
,	,	O
pain	NN	B-PROBLEM
,	,	O
redness	NN	B-PROBLEM
)	)	O
or	CC	O
for	IN	O
any	DT	B-PROBLEM
neurologic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
(	(	O
blurry	NN	B-PROBLEM
or	CC	I-PROBLEM
double	JJ	I-PROBLEM
vision	NN	I-PROBLEM
,	,	O
headaches	NNS	B-PROBLEM
,	,	O
trouble	NN	B-PROBLEM
walking	NN	I-PROBLEM
,	,	O
etc	NN	O
)	)	O
.	.	O

right	JJ	B-PROBLEM
parietal	NN	I-PROBLEM
occipital	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

5/5/05	CD	O
right	JJ	B-TREATMENT
parietal	NN	I-TREATMENT
occipital	JJ	I-TREATMENT
craniotomy	NN	I-TREATMENT
and	CC	O
debulking	NN	B-TREATMENT
of	IN	I-TREATMENT
tumor	NN	I-TREATMENT
using	VBG	O
stulz	JJ	B-TREATMENT
neuro	JJ	I-TREATMENT
navigation	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
83-year-old	JJ	O
retired	JJ	O
psychiatrist	NN	O
who	WP	O
presents	VBZ	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
gait	NN	B-PROBLEM
difficulty	NN	I-PROBLEM
for	IN	O
the	DT	O
last	JJ	O
five	CD	O
to	TO	O
six	CD	O
months	NNS	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
laryngeal	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
2000	CD	O
and	CC	O
2001	CD	O
,	,	O
cva	NN	B-PROBLEM
in	IN	O
2001	CD	O
to	TO	O
2002	CD	O
and	CC	O
hypertension	NN	B-PROBLEM
,	,	O
who	WP	O
has	VBZ	O
a	DT	O
six	CD	O
month	NN	O
history	NN	O
of	IN	O
progressive	JJ	B-PROBLEM
difficulty	NN	I-PROBLEM
in	IN	I-PROBLEM
ambulation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
previously	RB	O
good	JJ	O
health	NN	O
when	WRB	O
he	PRP	O
reports	VBZ	O
starting	VBG	O
to	TO	O
notice	VB	O
problems	NNS	B-PROBLEM
ambulating	VBG	I-PROBLEM
about	IN	O
six	CD	O
months	NNS	O
ago	RB	O
.	.	O

his	PRP$	O
partner	NN	O
also	RB	O
reports	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
been	VBN	O
having	VBG	O
more	RBR	B-PROBLEM
difficulty	NN	I-PROBLEM
with	IN	I-PROBLEM
adls	NN	I-PROBLEM
.	.	O

he	PRP	O
reported	VBD	O
that	IN	O
he	PRP	O
began	VBD	O
with	IN	O
difficulty	NN	B-PROBLEM
buttoning	VBG	I-PROBLEM
his	PRP$	I-PROBLEM
shirt	NN	I-PROBLEM
for	IN	O
many	JJ	O
years	NNS	O
since	IN	O
after	IN	O
a	DT	B-PROBLEM
stroke	NN	I-PROBLEM
but	CC	O
now	RB	O
reports	VBZ	O
that	IN	O
on	IN	O
occasion	NN	O
she	PRP	O
would	MD	O
ask	VB	O
him	PRP	O
why	WRB	O
he	PRP	O
was	VBD	O
doing	VBG	O
certain	JJ	O
things	NNS	O
and	CC	O
he	PRP	O
could	MD	O
not	RB	O
give	VB	O
a	DT	O
concrete	JJ	O
example	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
having	VBG	O
a	DT	B-PROBLEM
hard	JJ	I-PROBLEM
time	NN	I-PROBLEM
walking	VBG	I-PROBLEM
and	CC	O
reports	NNS	O
that	IN	O
he	PRP	O
has	VBZ	O
felt	VBN	O
weaker	NN	O
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
uncoordination	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
feet	NNS	I-PROBLEM
and	CC	O
began	VBD	O
having	VBG	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
four	CD	O
to	TO	O
five	CD	O
months	NNS	O
ago	RB	O
with	IN	O
the	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
seen	VBN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
who	WP	O
referred	VBD	O
him	PRP	O
to	TO	O
physical	JJ	O
therapy	NN	O
for	IN	O
his	PRP$	B-PROBLEM
gait	NN	I-PROBLEM
weakness	NN	I-PROBLEM
but	CC	O
his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
failed	VBD	O
to	TO	O
improve	VB	O
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
progress	VB	O
until	IN	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
he	PRP	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
bathtub	NN	O
,	,	O
unsteady	JJ	B-PROBLEM
and	CC	O
fell	VBD	O
trying	VBG	O
to	TO	O
steady	VB	O
himself	PRP	O
.	.	O

since	IN	O
that	DT	O
time	NN	O
he	PRP	O
had	VBD	O
been	VBN	O
ambulating	VBG	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
and	CC	O
has	VBZ	O
had	VBN	O
increasing	VBG	B-PROBLEM
difficulty	NN	I-PROBLEM
with	IN	I-PROBLEM
falls	NNS	I-PROBLEM
in	IN	O
the	DT	O
last	JJ	O
two	CD	O
weeks	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
again	RB	O
seen	VBN	O
by	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
and	CC	O
a	DT	B-TEST
cg	JJ	I-TEST
scan	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
the	DT	O
neurology	NN	O
service	NN	O
for	IN	O
further	JJ	B-TEST
workup	NN	I-TEST
of	IN	O
the	DT	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
denied	VBD	O
blurry	JJ	B-PROBLEM
vision	NN	I-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
paresthesias	NN	B-PROBLEM
,	,	O
pain	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
or	CC	O
seizures	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
resection	NN	B-TREATMENT
and	CC	O
reconstruction	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
laryngeal	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

positive	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
otherwise	RB	O
negative	JJ	O
.	.	O

hypertension	NN	B-PROBLEM
,	,	O
cva	NN	B-PROBLEM
2001	CD	O
,	,	O
2002	CD	O
diabetes	NNS	B-PROBLEM
,	,	O
laryngeal	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
right	JJ	B-TREATMENT
cea	NN	I-TREATMENT
,	,	O
prostatectomy	NN	B-TREATMENT
for	IN	O
bph	NN	B-PROBLEM
,	,	O
total	JJ	B-TREATMENT
knee	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
.	.	O

plavix	NN	B-TREATMENT
75	CD	O
mg	NN	O
every	DT	O
day	NN	O
,	,	O
lipitor	NN	B-TREATMENT
40	CD	O
mg	NN	O
every	DT	O
day	NN	O
,	,	O
hctz	VBD	B-TREATMENT
50	CD	O
mg	NN	O
,	,	O
monopril	FW	B-TREATMENT
10	CD	O
mg	NN	O
every	DT	O
day	NN	O
,	,	O
viagra	FW	B-TREATMENT
100	CD	O
mg	NN	O
prn	NN	O
.	.	O

nkda	NN	B-PROBLEM
.	.	O

father	NN	O
with	IN	O
cad	NN	B-PROBLEM
at	IN	O
90	CD	O
,	,	O
diabetes	NNS	B-PROBLEM
,	,	O
cva	NN	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

afebrile	NN	B-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
stable	JJ	O
but	CC	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
164/80	CD	O
.	.	O

generally	RB	O
a	DT	O
well	NN	O
developed	VBD	O
elderly	JJ	O
man	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
sitting	VBG	O
in	IN	O
bed	NN	O
.	.	O

no	DT	O
nystagmus	NN	B-PROBLEM
.	.	O

no	DT	O
retinal	JJ	B-PROBLEM
hemorrhages	NNS	I-PROBLEM
.	.	O

moist	JJ	O
buccal	JJ	O
mucosa	NN	O
,	,	O
poor	JJ	B-PROBLEM
dentition	NN	I-PROBLEM
,	,	O
no	DT	O
erythema	NN	B-PROBLEM
or	CC	I-PROBLEM
exudates	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
posterior	JJ	I-PROBLEM
pharynx	NN	I-PROBLEM
.	.	O

prominent	JJ	B-PROBLEM
salivary	JJ	I-PROBLEM
glands	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

no	DT	O
other	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
noted	VBN	O
.	.	O

no	DT	O
cervical	JJ	B-PROBLEM
,	,	I-PROBLEM
para-auricular	JJ	I-PROBLEM
or	CC	I-PROBLEM
clavicular	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

crackles	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lung	NN	I-PROBLEM
field	NN	I-PROBLEM
.	.	O

no	DT	O
egophony	NN	B-PROBLEM
.	.	O

no	DT	O
palpable	JJ	B-PROBLEM
thrill	NN	I-PROBLEM
or	CC	O
heave	NN	B-PROBLEM
.	.	O

3/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	FW	I-PROBLEM
heard	NN	O
best	JJS	O
at	IN	O
the	DT	O
apex	NN	O
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

no	DT	O
hepato	NN	B-PROBLEM
or	CC	O
splenomegaly	NN	B-PROBLEM
.	.	O

right	RB	B-PROBLEM
lower	JJR	I-PROBLEM
quadrant	JJ	I-PROBLEM
scar	NN	I-PROBLEM
and	CC	O
inferior	JJ	B-PROBLEM
midline	NN	I-PROBLEM
scar	NN	I-PROBLEM
that	WDT	O
are	VBP	O
well	RB	O
healed	VBN	O
.	.	O

no	DT	O
cva	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

no	DT	O
petechiae	NN	B-PROBLEM
.	.	O

cranial	JJ	O
nerves	NNS	O
ii	VBP	O
through	IN	O
xii	NNP	O
grossly	RB	O
intact	JJ	O
with	IN	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
uvula	NN	I-PROBLEM
and	CC	I-PROBLEM
tongue	NN	I-PROBLEM
to	TO	O
the	DT	O
right	NN	O
.	.	O

there	EX	O
is	VBZ	O
increased	JJ	B-PROBLEM
tone	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
left	NN	I-PROBLEM
pronator	NN	I-PROBLEM
drift	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
an	DT	B-PROBLEM
intention	NN	I-PROBLEM
tremor	NN	I-PROBLEM
with	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
hand	NN	I-PROBLEM
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
on	IN	O
admission	NN	O
6.1	CD	O
,	,	O
inr	NN	B-TEST
on	IN	O
admission	NN	O
1.0	CD	O
,	,	O
relevant	JJ	B-TEST
imaging	NN	I-TEST
.	.	O

echocardiogram	NN	B-TEST
june	NN	O
2004	CD	O
showed	VBD	O
an	DT	B-TEST
ef	NN	I-TEST
of	IN	O
77%	CD	O
.	.	O

chest	NN	B-TEST
xray	NN	I-TEST
reveals	VBZ	O
no	DT	O
consolidation	NN	B-PROBLEM
or	CC	O
signs	NNS	B-PROBLEM
of	IN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

ct	NN	B-TEST
shows	VBZ	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
hyperdense	NN	I-PROBLEM
and	CC	I-PROBLEM
heterogenously	RB	I-PROBLEM
enhancing	VBG	I-PROBLEM
mass	NN	I-PROBLEM
measuring	VBG	O
6.5	CD	O
x	JJ	O
5	CD	O
cm	NN	O
with	IN	O
the	DT	B-PROBLEM
surrounding	VBG	I-PROBLEM
vasogenic	JJ	I-PROBLEM
edema	NN	I-PROBLEM
in	IN	O
effacement	NN	O
of	IN	O
the	DT	O
right	JJ	O
lateral	JJ	O
ventricle	NN	O
.	.	O

the	DT	O
finding	NN	O
was	VBD	O
most	RBS	O
consistent	JJ	O
with	IN	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
less	RBR	O
likely	JJ	O
primary	JJ	B-PROBLEM
cns	NNS	I-PROBLEM
neoplasm	RB	I-PROBLEM
such	JJ	O
as	IN	O
glioblastoma	NN	B-PROBLEM
.	.	O

mri	NN	B-TEST
showed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
heterogenous	JJ	I-PROBLEM
enhancing	VBG	I-PROBLEM
right	JJ	I-PROBLEM
parietal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
a	DT	O
possible	JJ	O
ependymal	JJ	B-PROBLEM
spread	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
neurologic	JJ	O
service	NN	O
for	IN	O
workup	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

the	DT	O
neuro-oncologist	JJ	O
felt	NN	O
that	IN	O
because	IN	O
of	IN	O
the	DT	B-PROBLEM
tremendous	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
burden	NN	I-PROBLEM
that	WDT	O
was	VBD	O
likely	JJ	O
causing	VBG	O
his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
the	DT	O
patient	NN	O
will	MD	O
require	VB	O
open	JJ	B-TREATMENT
debulking	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
obtaining	VBG	O
issue	NN	O
for	IN	O
a	DT	B-TEST
pathologic	JJ	I-TEST
diagnosis	NN	I-TEST
.	.	O

on	IN	O
may	MD	O
5	CD	O
,	,	O
2005	CD	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
parietal	NN	I-TREATMENT
occipital	JJ	I-TREATMENT
craniotomy	NN	I-TREATMENT
and	CC	O
debulking	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
tumor	NN	I-PROBLEM
using	VBG	O
stulz	JJ	B-TREATMENT
neuro	JJ	I-TREATMENT
navigation	NN	I-TREATMENT
.	.	O

please	VB	O
see	VB	O
the	DT	O
separately	RB	O
dictated	JJ	O
operative	JJ	O
report	NN	O
for	IN	O
further	JJ	O
details	NNS	O
of	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

of	IN	O
note	PDT	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
cardiology	NN	O
for	IN	O
preoperative	JJ	B-TEST
assessment	NN	I-TEST
.	.	O

a	DT	B-TEST
postoperative	JJ	I-TEST
mri	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
revealed	VBD	O
no	DT	O
remarkable	JJ	B-PROBLEM
findings	NNS	I-PROBLEM
but	CC	O
only	RB	O
post	RB	B-PROBLEM
surgical	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

transcranial	JJ	B-TEST
dopplers	NNS	I-TEST
were	VBD	O
checked	VBN	O
following	VBG	O
surgery	NN	B-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
decadron	NN	B-TREATMENT
4	CD	O
mg	NN	O
q6	NN	O
to	TO	O
prevent	VB	O
swelling	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
fragmin	NN	B-TREATMENT
for	IN	O
dvt	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
dilantin	NN	B-TEST
levels	NNS	I-TEST
.	.	O

of	IN	O
note	NN	O
on	IN	O
5/9/05	CD	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
urology	NN	O
due	JJ	O
to	TO	O
an	DT	B-PROBLEM
inability	NN	I-PROBLEM
to	TO	I-PROBLEM
void	VB	I-PROBLEM
and	CC	O
a	DT	B-TREATMENT
16	CD	I-TREATMENT
french	JJ	I-TREATMENT
coude	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

the	DT	O
patient	NN	O
then	RB	O
was	VBD	O
given	VBN	O
voiding	VBG	B-TREATMENT
trials	NNS	I-TREATMENT
but	CC	O
eventually	RB	O
he	PRP	O
needed	VBD	O
to	TO	O
be	VB	O
straight	VBN	O
cathed	JJ	O
prn	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
a	DT	B-TREATMENT
16	CD	I-TREATMENT
coude	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
in	IN	O
place	NN	O
and	CC	O
draining	VBG	O
well	RB	O
.	.	O

the	DT	O
patient	NN	O
can	MD	O
have	VB	O
voiding	VBG	B-TREATMENT
trials	NNS	I-TREATMENT
at	IN	O
rehab	NN	O
and	CC	O
he	PRP	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
on	IN	O
flomax	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
relatively	RB	O
unremarkable	JJ	O
course	NN	O
and	CC	O
his	PRP$	O
neurologic	JJ	O
status	NN	O
continued	VBD	O
to	TO	O
improve	VB	O
following	VBG	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
.	.	O

on	IN	O
5/11/05	CD	O
repeat	NN	B-TEST
imaging	NN	I-TEST
revealed	VBD	O
some	DT	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
mass	NN	B-PROBLEM
affect	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
an	DT	B-TREATMENT
iv	JJ	I-TREATMENT
load	NN	I-TREATMENT
of	IN	I-TREATMENT
decadron	NN	I-TREATMENT
and	CC	O
restarted	VBN	O
on	IN	O
iv	NN	B-TREATMENT
decadron	NN	I-TREATMENT
which	WDT	O
was	VBD	O
eventually	RB	O
transferred	VBN	O
to	TO	O
po	VB	B-TREATMENT
decadron	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
mannitol	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
pathology	NN	I-TEST
came	VBD	O
back	RB	O
as	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
grade	NN	I-PROBLEM
iv	NN	I-PROBLEM
glioma	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
initially	RB	O
controlled	VBN	O
with	IN	O
iv	NN	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
but	CC	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
to	TO	O
the	DT	O
rehab	NN	O
facility	NN	O
he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
control	VB	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
po	NN	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
a	DT	B-TEST
postoperative	JJ	I-TEST
serum	NN	I-TEST
sodium	NN	I-TEST
in	IN	O
the	DT	O
120s	CD	O
from	IN	O
the	DT	O
130s	CD	O
three	CD	O
days	NNS	O
postoperatively	RB	O
.	.	O

an	DT	O
endocrine	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
to	TO	O
help	VB	O
manage	VB	O
his	PRP$	B-TEST
serum	NN	I-TEST
electrolytes	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
three	CD	O
grams	NNS	O
of	IN	O
sodium	NN	B-TREATMENT
,	,	O
3x	CD	O
a	DT	O
day	NN	O
with	IN	O
fluid	JJ	B-TREATMENT
restriction	NN	I-TREATMENT
.	.	O

over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
his	PRP$	B-TEST
sodium	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
followed	VBN	O
and	CC	O
by	IN	O
5/12/05	CD	O
his	PRP$	B-TEST
plasma	NN	I-TEST
sodium	NN	I-TEST
was	VBD	O
back	RB	O
to	TO	O
136	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
off	RP	O
fluid	JJ	B-TREATMENT
restriction	NN	I-TREATMENT
.	.	O

on	IN	O
5/14/05	CD	O
mannitol	NN	B-TREATMENT
was	VBD	O
tapered	VBN	O
and	CC	O
then	RB	O
d	VB	O
/	NNP	O
c&apos;d.	NN	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
and	CC	O
needed	VBN	O
only	RB	O
physical	JJ	B-TREATMENT
and	CC	I-TREATMENT
occupational	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
hard	JJ	B-PROBLEM
of	IN	I-PROBLEM
hearing	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
complaints	NNS	B-PROBLEM
of	IN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

1.	CD	O
lipitor	NN	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
every	DT	O
day	NN	O
.	.	O

2.	CD	O
captopril	NN	B-TREATMENT
12.5	CD	O
mg	NN	O
po	NN	O
tid	NN	O
.	.	O

3.	CD	O
nexium	JJ	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
every	DT	O
day	NN	O
.	.	O

4.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

5.	CD	O
ativan	JJ	B-TREATMENT
0.5	CD	O
mg	NN	O
po	NN	O
q4	NN	O
hours	NNS	O
prn	VBP	O
for	IN	O
anxiety	NN	B-PROBLEM
.	.	O

6.	CD	O
allegra	JJ	B-TREATMENT
60	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

7.	CD	O
dilantin	NN	B-TREATMENT
100	CD	O
mg	NN	O
iv	NN	O
tid	NN	O
which	WDT	O
can	MD	O
be	VB	O
changed	VBN	O
to	TO	O
a	DT	B-TREATMENT
po	JJ	I-TREATMENT
regimen	NN	I-TREATMENT
in	IN	O
seven	CD	O
days	NNS	O
.	.	O

8.	CD	O
zinc	NN	B-TREATMENT
220	CD	O
mg	NN	O
po	NN	O
every	DT	O
day	NN	O
.	.	O

9.	CD	O
vitamin	JJ	B-TREATMENT
c	NN	I-TREATMENT
500	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

10.	CD	O
flomax	JJ	B-TREATMENT
0.4	CD	O
mg	NN	O
po	NN	O
every	DT	O
day	NN	O
.	.	O

11.	CD	O
fragmin	JJ	B-TREATMENT
2500	CD	O
units	NNS	O
subcut	VBD	O
every	DT	O
day	NN	O
.	.	O

12.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
q	JJ	O
daily	JJ	O
x10	NNP	O
days	NNS	O
.	.	O

13.	CD	O
dexamethasone	NN	B-TREATMENT
4	CD	O
mg	NN	O
po	NN	O
q6	NN	O
hours	NNS	O
.	.	O

14.	CD	O
the	DT	B-TREATMENT
steroid	NN	I-TREATMENT
will	MD	O
be	VB	O
kept	VBN	O
for	IN	O
now	RB	O
and	CC	O
tapered	VBN	O
at	IN	O
a	DT	O
later	JJ	O
date	NN	O
on	IN	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
coma	NN	O
.	.	O

15.	CD	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
with	IN	O
finger	NN	O
sticks	NNS	O
qac	NN	O
and	CC	O
qhs	NN	O
.	.	O

16.	CD	O
neutra-phos	JJ	B-TREATMENT
1.25	CD	O
grams	NNS	O
po	VBP	O
as	IN	O
needed	VBN	O
.	.	O

the	DT	B-TREATMENT
staples	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
asked	VBN	O
to	TO	O
see	VB	O
a	DT	O
physician	JJ	O
immediately	RB	O
or	CC	O
go	VB	O
to	TO	O
the	DT	O
nearest	JJS	O
emergency	NN	O
room	NN	O
if	IN	O
any	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
wound	JJ	B-PROBLEM
infection	NN	I-PROBLEM
,	,	O
fever	RB	B-PROBLEM
greater	JJR	O
than	IN	O
100.8	CD	O
,	,	O
intractable	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
and	CC	I-PROBLEM
vomiting	NN	I-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
numbness	NN	B-PROBLEM
,	,	O
pain	NN	B-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
occurs	NNS	O
.	.	O

the	DT	O
patient	NN	O
instructed	VBD	O
to	TO	O
call	VB	O
dr.	JJ	O
coma	NN	O
&apos;s	NNP	O
office	NN	O
at	IN	O
496-260-3297	JJ	O
to	TO	O
arrange	VB	O
for	IN	O
a	DT	O
follow	JJ	O
up	RP	O
appointment	NN	O
in	IN	O
the	DT	O
saintaelfoote	JJ	O
hospital	NN	O
at	IN	O
the	DT	O
first	JJ	O
available	JJ	O
time	NN	O
,	,	O
one	CD	O
to	TO	O
two	CD	O
months	NNS	O
after	IN	O
surgery	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
asked	VBN	O
to	TO	O
take	VB	O
a	DT	O
course	NN	O
of	IN	O
dilantin	NN	B-TREATMENT
for	IN	O
ten	RB	O
more	JJR	O
days	NNS	O
.	.	O

pancreatic	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

laparoscopy	NN	B-TEST
with	IN	O
biopsy	NN	B-TEST
for	IN	O
diagnosis	NN	O
.	.	O

ms.	NN	O
sterpkoteneish	NN	O
is	VBZ	O
a	DT	O
69-year-old	JJ	O
woman	NN	O
,	,	O
who	WP	O
over	IN	O
the	DT	O
past	JJ	O
six	CD	O
months	NNS	O
has	VBZ	O
noted	VBN	O
increasing	VBG	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
radiating	VBG	O
to	TO	O
the	DT	O
back	NN	O
.	.	O

she	PRP	O
described	VBD	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
as	IN	O
being	VBG	O
exacerbated	VBN	O
by	IN	O
eating	VBG	O
and	CC	O
described	VBD	O
an	DT	B-PROBLEM
associated	JJ	I-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

she	PRP	O
presented	VBD	O
to	TO	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	NN	O
tlandtaze	NN	O
,	,	O
in	IN	O
aersing	VBG	O
rocuch	JJ	O
sun	NN	O
,	,	O
who	WP	O
obtained	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
,	,	O
which	WDT	O
demonstrated	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	O
the	DT	O
tail	NN	O
of	IN	O
the	DT	O
pancreas	NNS	O
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
referred	VBN	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
under	IN	O
the	DT	O
el	JJ	O
memorial	NN	O
and	CC	O
was	VBD	O
seen	VBN	O
by	IN	O
dr.	JJ	O
blinjesc	NN	O
,	,	O
who	WP	O
scheduled	VBD	O
her	PRP	O
for	IN	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparoscopy	NN	I-TEST
.	.	O

is	VBZ	O
significant	JJ	O
for	IN	O
spinal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	O
series	NN	O
of	IN	O
operations	NNS	B-TREATMENT
including	VBG	O
repair	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
ureteral	JJ	I-PROBLEM
stricture	NN	I-PROBLEM
;	:	O
cataract	JJ	B-TREATMENT
implants	NNS	I-TREATMENT
;	:	O
two	CD	B-TREATMENT
partial	JJ	I-TREATMENT
hysterectomies	NNS	I-TREATMENT
;	:	O
and	CC	O
an	DT	B-TREATMENT
appendectomy	NN	I-TREATMENT
.	.	O

oxycontin	RB	B-TREATMENT
10	CD	O
mg	NNS	O
po	JJ	O
q.day	NN	O
.	.	O

darvocet	NN	B-TREATMENT
.	.	O

estratab	NN	B-TREATMENT
.	.	O

aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
po	JJ	O
q.day	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
150/86	CD	O
;	:	O
pulse	JJ	B-TEST
82	CD	O
;	:	O
respirations	NNS	B-TEST
16	CD	O
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

regular	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
;	:	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

soft	JJ	O
;	:	O
nontender	CC	O
;	:	O
no	DT	O
palpable	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
through	IN	O
same	JJ	O
day	NN	O
surgery	NN	O
and	CC	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
dr.	NN	O
blinjesc	NN	O
,	,	O
assisted	VBN	O
by	IN	O
dr.	NN	O
zockbeathe	NN	O
,	,	O
performed	VBD	O
a	DT	B-TEST
diagnostic	JJ	I-TEST
laparoscopy	NN	I-TEST
with	IN	O
peritoneal	JJ	B-TREATMENT
washings	NNS	I-TREATMENT
.	.	O

findings	NNS	O
included	VBD	O
no	DT	B-PROBLEM
gross	JJ	I-PROBLEM
evidence	NN	I-PROBLEM
seating	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
abdominal	JJ	I-PROBLEM
wall	NN	I-PROBLEM
;	:	O
one	CD	B-PROBLEM
nodule	NN	I-PROBLEM
on	IN	O
the	DT	O
posterior	JJ	O
surface	NN	O
of	IN	O
the	DT	O
right	JJ	O
lobe	NN	O
of	IN	O
the	DT	O
liver	NN	O
;	:	O
one	CD	B-PROBLEM
nodule	NN	I-PROBLEM
in	IN	O
the	DT	O
inferior	JJ	O
edge	NN	O
of	IN	O
the	DT	O
falciform	NN	O
ligament	NN	O
.	.	O

specimens	NNS	B-TEST
sent	VBD	O
to	TO	O
pathology	VB	O
included	JJ	O
peritoneal	JJ	B-TEST
washings	NNS	I-TEST
and	CC	O
permanent	JJ	B-TEST
specimens	NNS	I-TEST
from	IN	I-TEST
the	DT	I-TEST
liver	NN	I-TEST
and	CC	O
falciform	NN	B-PROBLEM
nodules	NNS	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
,	,	O
and	CC	O
the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

postoperatively	RB	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
some	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
bloating	NN	I-PROBLEM
with	IN	O
evidence	NN	O
of	IN	O
subcutaneous	JJ	B-PROBLEM
emphysema	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
uncomfortable	JJ	B-PROBLEM
and	CC	O
slow	JJ	O
to	TO	O
have	VB	O
bowel	NN	O
movements	NNS	O
,	,	O
although	IN	O
she	PRP	O
did	VBD	O
have	VB	O
flatus	NN	O
.	.	O

she	PRP	O
tolerated	VBD	O
a	DT	O
full	JJ	O
diet	NN	O
well	RB	O
,	,	O
but	CC	O
continued	VBD	O
to	TO	O
have	VB	O
abdominal	JJ	B-PROBLEM
cramping	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
ileus	NN	I-PROBLEM
for	IN	O
the	DT	O
following	JJ	O
three	CD	O
days	NNS	O
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
repeated	VBN	B-TREATMENT
fleet	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
enemas	NN	I-TREATMENT
,	,	O
and	CC	O
on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	O
number	NN	O
of	IN	O
bowel	NN	O
movements	NNS	O
,	,	O
was	VBD	O
considerably	RB	O
more	RBR	O
comfortable	JJ	O
,	,	O
and	CC	O
deemed	VBD	O
ready	JJ	O
for	IN	O
discharge	NN	O
.	.	O

included	VBN	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
.	.	O

percocet	RB	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
whenever	WRB	O
necessary	JJ	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

estratab	VB	B-TREATMENT
one	CD	O
po	NN	O
q.day	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
cytopathology	NN	B-TEST
specimens	NNS	I-TEST
had	VBD	O
been	VBN	O
negative	JJ	O
,	,	O
and	CC	O
surgical	JJ	B-TEST
pathology	NN	I-TEST
specimens	NNS	I-TEST
were	VBD	O
still	RB	O
pending	VBG	O
.	.	O

she	PRP	O
was	VBD	O
instructed	VBN	O
to	TO	O
call	VB	O
dr.	NN	O
blinjesc	NN	O
for	IN	O
the	DT	O
results	NNS	O
of	IN	O
these	DT	B-TEST
tests	NNS	I-TEST
and	CC	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
him	PRP	O
for	IN	O
further	JJ	O
management	NN	O
if	IN	O
necessary	JJ	O
.	.	O

ho	NN	B-TEST
evaluation	NN	I-TEST

docusate	NN	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
prn	VBZ	O
ibuprofen	JJ	B-TREATMENT
200-600	JJ	O
mg	NN	O
po	IN	O
q4-6h	JJ	O
prn	NN	O
pain	NN	B-PROBLEM

ob	NN	O
clinic	JJ	O
2	CD	O
weeks	NNS	O
and	CC	O
6	CD	O
weeks	NNS	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

postdates	NNS	B-PROBLEM
pregnancy	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
s	NN	O
/	NNP	O
p	NN	O
nsvd	NN	B-PROBLEM

post	NN	B-PROBLEM
dates	NNS	I-PROBLEM

initial	JJ	B-TEST
newborn	JJ	I-TEST
exam	NN	I-TEST
:	:	O

no	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

apgars	NNS	B-TEST
8,9	CD	O

weight	NN	B-TEST
:	:	O

nothing	NN	O
in	IN	O
the	DT	O
vagina	NN	O
for	IN	O
6	CD	O
weeks	NNS	O
-	:	O
no	DT	O
tampons	NNS	B-TREATMENT
,	,	O
no	DT	O
douching	NN	B-TREATMENT
,	,	O
no	DT	O
intercourse	NN	O
.	.	O

if	IN	O
you	PRP	O
experience	VBP	O
fever	RB	B-PROBLEM
&gt;	RB	O
100.4	CD	O
,	,	O
bleeding	VBG	B-PROBLEM
&gt;	JJ	O
1	CD	O
pad	NN	O
/	FW	O
hour	NN	O
,	,	O
foul	JJ	B-PROBLEM
smelling	VBG	I-PROBLEM
discharge	NN	I-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
other	JJ	B-PROBLEM
worrisome	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
please	VB	O
call	VB	O
your	PRP$	O
doctor	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
.	.	O

right	JJ	B-PROBLEM
occipital	JJ	I-PROBLEM
hemorrhagic	NN	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

right	JJ	B-PROBLEM
occipital	JJ	I-PROBLEM
hemorrhagic	NN	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

ms.	JJ	O
tlandkotesmitskote	NN	O
is	VBZ	O
a	DT	O
patient	NN	O
who	WP	O
came	VBD	O
complaining	NN	O
of	IN	O
feeling	VBG	O
dizzy	NN	B-PROBLEM
and	CC	O
bumping	VBG	O
into	IN	O
objects	NNS	O
on	IN	O
her	PRP$	O
left	JJ	O
side	NN	O
.	.	O

she	PRP	O
is	VBZ	O
a	DT	O
seventy-one	JJ	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
who	WP	O
is	VBZ	O
in	IN	O
otherwise	RB	O
good	JJ	O
health	NN	O
.	.	O

she	PRP	O
also	RB	O
felt	VBD	O
dizzy	JJ	B-PROBLEM
and	CC	O
the	DT	O
room	NN	O
was	VBD	O
spinning	VBG	O
.	.	O

she	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
a	DT	B-PROBLEM
dull	NN	I-PROBLEM
,	,	I-PROBLEM
right	RB	I-PROBLEM
sided	VBD	I-PROBLEM
headache	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
eyebrow	NN	I-PROBLEM
.	.	O

symptoms	NNS	B-PROBLEM
lasted	VBD	O
about	IN	O
five	CD	O
hours	NNS	O
and	CC	O
then	RB	O
gradually	RB	O
resolved	VBN	O
except	IN	O
for	IN	O
the	DT	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
vision	NN	I-PROBLEM
.	.	O

she	PRP	O
denied	VBD	O
having	VBG	O
any	DT	O
weakness	NN	B-PROBLEM
,	,	O
numbness	NN	B-PROBLEM
,	,	O
or	CC	O
pain	NN	B-PROBLEM
.	.	O

she	PRP	O
also	RB	O
denies	VBZ	O
having	VBG	O
hoarseness	NN	B-PROBLEM
,	,	O
difficulties	NNS	B-PROBLEM
in	IN	I-PROBLEM
finding	VBG	I-PROBLEM
words	NNS	I-PROBLEM
,	,	O
speaking	NN	O
,	,	O
hiccups	NNS	B-PROBLEM
,	,	O
or	CC	O
diplopia	NN	B-PROBLEM
.	.	O

the	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
significant	JJ	O
for	IN	O
hypertension	NN	B-PROBLEM
.	.	O

atenolol	NN	B-TREATMENT
,	,	O
25	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

on	IN	O
review	NN	O
of	IN	O
systems	NNS	O
,	,	O
the	DT	O
patient	NN	O
denied	VBD	O
any	DT	O
history	NN	O
of	IN	O
transient	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
attacks	NNS	I-PROBLEM
.	.	O

father	NN	O
and	CC	O
mother	NN	O
died	VBD	O
in	IN	O
their	PRP$	O
eighties	NNS	O
of	IN	O
heart	NN	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
she	PRP	O
was	VBD	O
a	DT	O
very	RB	O
pleasant	JJ	O
,	,	O
moderately	RB	O
obese	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

the	DT	O
head	NN	O
was	VBD	O
normocephalic	JJ	O
and	CC	O
atraumatic	JJ	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
,	,	O
without	IN	O
rales	NNS	B-PROBLEM
or	CC	O
wheezes	NNS	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

extremities	NNS	O
revealed	VBD	O
2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
knees	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
and	CC	O
oriented	VBN	O
to	TO	O
person	NN	O
,	,	O
place	NN	O
and	CC	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
subtract	VB	O
serial	JJ	O
sevens	NNS	O
,	,	O
remember	VB	O
three	CD	O
out	IN	O
of	IN	O
three	CD	O
objects	NNS	O
after	IN	O
five	CD	O
minutes	NNS	O
,	,	O
and	CC	O
there	RB	O
was	VBD	O
notable	JJ	B-PROBLEM
aphasia	NN	I-PROBLEM
or	CC	O
word	NN	B-PROBLEM
finding	NN	I-PROBLEM
difficulty	NN	I-PROBLEM
.	.	I-PROBLEM

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
dense	JJ	I-PROBLEM
hemianopsia	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

sensation	NN	O
was	VBD	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
and	CC	O
pin	NN	B-TEST
prick	NN	I-TEST
bilaterally	RB	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
pronator	NN	B-PROBLEM
drift	NN	I-PROBLEM
.	.	O

sensation	NN	O
was	VBD	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
,	,	O
pin	NN	B-TEST
prick	NN	I-TEST
,	,	O
and	CC	O
proprioception	NN	B-TEST
.	.	O

cerebellar	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
in	IN	O
intention	NN	B-PROBLEM
tremor	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
considerable	JJ	B-PROBLEM
difficulty	NN	I-PROBLEM
with	IN	I-PROBLEM
left	JJ	I-PROBLEM
finger-to-nose	JJ	I-PROBLEM
movement	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
hemianopsia	VB	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
nystagmus	NN	B-PROBLEM
,	,	O
except	IN	O
for	IN	O
some	DT	B-PROBLEM
fine	JJ	I-PROBLEM
fast	JJ	I-PROBLEM
beat	NN	I-PROBLEM
nystagmus	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
extremes	NNS	I-PROBLEM
of	IN	I-PROBLEM
abduction	NN	I-PROBLEM
.	.	O

patient	NN	O
had	VBD	O
difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
tandem	JJ	I-PROBLEM
gait	NN	I-PROBLEM
and	CC	O
fell	VBD	O
forward	RB	O
while	IN	O
standing	VBG	O
on	IN	O
his	PRP$	O
his	PRP$	O
toes	NNS	O
.	.	O

laboratory	NN	O
studies	NNS	O
on	IN	O
admission	NN	O
demonstrated	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
144	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
106	CD	O
,	,	O
bicarbonate	NN	B-TEST
20.0	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
12/0.7	CD	O
,	,	O
glucose	RB	B-TEST
99	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
5.7	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
40.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
226	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
was	VBD	O
9.4	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
was	VBD	O
29	CD	O
.	.	O

the	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
performed	VBN	O
and	CC	O
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
seventy-one	JJ	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
who	WP	O
now	RB	O
presents	VBZ	O
with	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
occipital	NN	I-PROBLEM
hemorrhagic	JJ	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
and	CC	O
work	NN	B-TEST
up	RB	I-TEST
.	.	O

however	RB	O
,	,	O
she	PRP	O
was	VBD	O
soon	RB	O
moved	VBN	O
out	IN	O
of	IN	O
there	EX	O
as	IN	O
her	PRP$	B-TEST
examination	NN	I-TEST
appeared	VBD	O
to	TO	O
be	VB	O
stable	JJ	O
.	.	O

a	DT	O
neurosurgery	JJ	O
service	NN	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
they	PRP	O
felt	VBD	O
that	IN	O
no	DT	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
was	VBD	O
required	VBN	O
.	.	O

the	DT	O
patient	NN	O
underwent	NN	O
a	DT	O
number	NN	O
of	IN	O
tests	NNS	B-TEST
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
and	CC	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
angiogram	NN	I-TEST
performed	VBD	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
hemorrhagic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
occipital	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
clear	JJ	B-PROBLEM
enhancing	VBG	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
but	CC	O
follow	VBP	O
up	RP	O
was	VBD	O
suggested	VBN	O
.	.	O

so	RB	O
an	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
angiogram	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
showed	VBD	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
occipital	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
mra	NN	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
narrowing	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
ica	NN	I-PROBLEM
just	RB	O
distal	JJ	O
to	TO	O
the	DT	O
bifurcation	NN	O
.	.	O

there	EX	O
was	VBD	O
also	RB	O
scattered	VBN	B-PROBLEM
t2	NN	I-PROBLEM
hyperintense	NN	I-PROBLEM
foci	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	NN	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
frontal	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
consistent	NN	O
with	IN	O
small	JJ	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
gliosis	NN	B-PROBLEM
or	CC	O
demyelination	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
holter	NN	I-TEST
monitor	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
showed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

the	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
53	CD	O
to	TO	O
106	CD	O
.	.	O

there	EX	O
were	VBD	O
some	DT	B-PROBLEM
very	RB	I-PROBLEM
rare	JJ	I-PROBLEM
atrial	JJ	I-PROBLEM
premature	NN	I-PROBLEM
contractions	NNS	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
ventricular	JJ	B-PROBLEM
premature	NN	I-PROBLEM
contractions	NNS	I-PROBLEM
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
showed	VBD	O
that	IN	O
the	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
was	VBD	O
60%	CD	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
thrombus	NN	B-PROBLEM
.	.	O

over	IN	O
the	DT	O
ensuing	JJ	O
days	NNS	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
several	JJ	O
episodes	NNS	O
of	IN	O
confusion	NN	B-PROBLEM
at	IN	O
night	NN	O
.	.	O

she	PRP	O
also	RB	O
developed	VBD	O
what	WP	O
appeared	VBD	O
to	TO	O
be	VB	O
urinary	JJ	B-PROBLEM
tract	JJ	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
was	VBD	O
placed	VBN	O
on	IN	O
po	NN	B-TREATMENT
bactrim	NN	I-TREATMENT
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
dense	NN	I-PROBLEM
left	VBD	I-PROBLEM
hemianopsia	NN	I-PROBLEM
,	,	O
but	CC	O
otherwise	RB	O
was	VBD	O
neurologically	RB	O
intact	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
on	IN	O
tenormin	NN	B-TREATMENT
,	,	O
25	CD	O
mg	NN	O
po	NN	O
qd	NN	O
;	:	O
bactrim	JJ	B-TREATMENT
ds	NN	I-TREATMENT
,	,	O
one	CD	O
po	NN	O
bid	NN	O
x5	NNP	O
days	NNS	O
.	.	O

deep	RB	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
of	IN	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

deep	RB	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
of	IN	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

metastatic	JJ	B-PROBLEM
melanoma	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
the	DT	O
second	JJ	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
admission	NN	O
for	IN	O
taroby	JJ	O
patient	NN	O
,	,	O
a	DT	O
70	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
melanoma	NN	I-PROBLEM
.	.	O

his	PRP$	B-PROBLEM
melanoma	NN	I-PROBLEM
was	VBD	O
originally	RB	O
diagnosed	VBN	O
last	JJ	O
fall	NN	O
when	WRB	O
he	PRP	O
presented	VBD	O
with	IN	O
lesions	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
and	CC	I-PROBLEM
spleen	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-TEST
chest	NN	I-TEST
ct	NN	I-TEST
showed	VBD	O
left	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
nodules	NNS	I-PROBLEM
.	.	O

a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
negative	JJ	O
,	,	O
but	CC	O
an	DT	B-TEST
mri	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
spine	NN	I-TEST
showed	VBD	O
an	DT	O
l5	JJ	B-PROBLEM
metastasis	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
fracture	NN	I-PROBLEM
and	CC	O
had	VBD	O
with	IN	O
epidural	JJ	B-PROBLEM
and	CC	I-PROBLEM
paraspinal	JJ	I-PROBLEM
extension	NN	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
t11	JJ	I-PROBLEM
metastasis	NN	I-PROBLEM
with	IN	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
.	.	O

approximately	RB	O
one	CD	O
week	NN	O
ago	RB	O
,	,	O
he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
for	IN	O
chemotherapy	NN	B-TREATMENT
with	IN	O
dtic	JJ	B-TREATMENT
and	CC	O
tamoxifen	NN	B-TREATMENT
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
he	PRP	O
also	RB	O
began	VBD	O
radiation	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
his	PRP$	O
lumbosacral	JJ	O
spine	NN	O
.	.	O

he	PRP	O
is	VBZ	O
continuing	VBG	O
on	IN	O
the	DT	B-TREATMENT
radiation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
date	NN	O
.	.	O

on	IN	O
february	JJ	O
23	CD	O
,	,	O
mr.	FW	O
patient	NN	O
presented	VBD	O
to	TO	O
dr.	VB	O
patient	JJ	O
&apos;s	NNP	O
office	NN	O
with	IN	O
two	CD	B-PROBLEM
major	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

first	RB	O
,	,	O
he	PRP	O
had	VBD	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
and	CC	O
lower	JJR	B-TEST
extremity	NN	I-TEST
noninvasives	NNS	I-TEST
confirmed	VBD	O
the	DT	O
diagnosis	NN	O
of	IN	O
a	DT	B-PROBLEM
femoral	JJ	I-PROBLEM
deep	JJ	I-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

second	JJ	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
witnessed	JJ	I-PROBLEM
episode	NN	I-PROBLEM
in	IN	O
which	WDT	O
his	PRP$	O
eyes	NNS	O
rolled	VBD	O
to	TO	O
the	DT	O
back	NN	O
of	IN	O
his	PRP$	O
head	NN	O
and	CC	O
there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
some	DT	B-PROBLEM
seizure	NN	I-PROBLEM
activity	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
past	NN	O
,	,	O
he	PRP	O
has	VBZ	O
not	RB	O
been	VBN	O
known	VBN	O
to	TO	O
have	VB	O
a	DT	O
history	NN	O
of	IN	O
cns	NN	B-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

the	DT	O
episode	NN	O
of	IN	O
potential	JJ	B-PROBLEM
seizure	NN	I-PROBLEM
activity	NN	I-PROBLEM
occurred	VBD	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
a	DT	O
bowel	NN	O
movement	NN	O
and	CC	O
may	MD	O
have	VB	O
been	VBN	O
associated	VBN	O
with	IN	O
vasovagal	JJ	B-PROBLEM
activity	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
review	NN	I-TEST
of	IN	I-TEST
systems	NNS	I-TEST
is	VBZ	O
negative	JJ	O
,	,	O
except	IN	O
as	IN	O
above	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
reveals	VBZ	O
a	DT	O
pleasant	NN	O
70	CD	O
year	NN	O
old	JJ	O
male	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
113/70	CD	O
,	,	O
pulse	RB	B-TEST
66	CD	O
,	,	O
respirations	NNS	B-TEST
20	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
96.8	CD	O
.	.	O

heent	NN	B-TEST
showed	VBD	O
pupils	NNS	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
,	,	O
and	CC	O
extra	JJ	O
ocular	JJ	O
movements	NNS	O
intact	JJ	O
.	.	O

the	DT	O
neck	NN	O
was	VBD	O
supple	JJ	O
,	,	O
without	IN	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
or	CC	O
increased	VBN	B-PROBLEM
thyroid	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
appreciable	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
,	,	I-PROBLEM
supraclavicular	JJ	I-PROBLEM
,	,	I-PROBLEM
axillary	JJ	I-PROBLEM
,	,	I-PROBLEM
or	CC	I-PROBLEM
inguinal	JJ	I-PROBLEM
adenopathy	NN	I-PROBLEM
.	.	O

the	DT	O
chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
i	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
extremity	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
extending	VBG	O
to	TO	O
the	DT	O
knee	NN	O
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

mr.	JJ	O
patient	JJ	O
underwent	JJ	O
venogram	NN	B-TEST
and	CC	O
inferior	JJ	B-TREATMENT
vena	NN	I-TREATMENT
cava	NN	I-TREATMENT
filter	NN	I-TREATMENT
placement	NN	I-TREATMENT
on	IN	O
february	JJ	O
23	CD	O
,	,	O
1993	CD	O
and	CC	O
was	VBD	O
then	RB	O
he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
for	IN	O
postoperative	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

he	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
second	JJ	O
major	JJ	O
event	NN	O
that	WDT	O
had	VBD	O
occurred	VBN	O
yesterday	NN	O
was	VBD	O
a	DT	B-PROBLEM
neurologic	JJ	I-PROBLEM
event	NN	I-PROBLEM
of	IN	O
some	DT	O
kind	NN	O
.	.	O

over	IN	O
the	DT	O
24	CD	O
hours	NNS	O
of	IN	O
in	IN	O
house	NN	O
hospitalization	NN	O
,	,	O
he	PRP	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
neurologic	JJ	I-PROBLEM
activity	NN	I-PROBLEM
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
ambulate	VB	O
without	IN	O
assistance	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

he	PRP	O
will	MD	O
be	VB	O
scheduled	VBN	O
for	IN	O
an	DT	B-TEST
mri	JJ	I-TEST
scan	NN	I-TEST
,	,	O
neurology	NN	B-TEST
consult	NN	I-TEST
,	,	O
and	CC	O
an	DT	B-TEST
eeg	NN	I-TEST
next	JJ	O
week	NN	O
as	IN	O
an	DT	O
out	IN	O
patient	NN	O
.	.	O

mr.	NN	O
patient	NN	O
was	VBD	O
a	DT	O
poor	JJ	O
candidate	NN	O
for	IN	O
anticoagulation	NN	B-TREATMENT
because	IN	O
of	IN	O
his	PRP$	O
history	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
melanoma	NN	I-PROBLEM
and	CC	O
the	DT	O
question	NN	O
of	IN	O
cns	NN	B-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

an	DT	B-TREATMENT
ivc	JJ	I-TREATMENT
filter	NN	I-TREATMENT
placement	NN	I-TREATMENT
was	VBD	O
accomplished	VBN	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

ivc	JJ	B-TREATMENT
filter	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

decadron	NN	B-TREATMENT
4	CD	O
mg	NN	O
po	NN	O
bid	NN	O
,	,	O
dilantin	VBZ	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
tid	NN	O
.	.	O

atypical	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM

albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
2	CD	O
puff	NN	O
inh	NN	O
qid	NN	O

please	NN	O
use	NN	O
with	IN	O
spacer	NN	B-TREATMENT
(	(	O
please	JJ	O
instruct	NN	O
patient	NN	O
)	)	O
ecasa	NN	B-TREATMENT
(	(	I-TREATMENT
aspirin	JJ	I-TREATMENT
enteric	RB	I-TREATMENT
coated	VBN	I-TREATMENT
)	)	I-TREATMENT
325	CD	O
mg	NN	O
po	NN	O
qd	NN	O
wellbutrin	NN	B-TREATMENT
(	(	I-TREATMENT
bupropion	NN	I-TREATMENT
hcl	NN	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
gemfibrozil	VBZ	B-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
bid	NN	O
zestril	NN	B-TREATMENT
(	(	I-TREATMENT
lisinopril	NN	I-TREATMENT
)	)	I-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O
zantac	NN	B-TREATMENT
(	(	I-TREATMENT
ranitidine	JJ	I-TREATMENT
hcl	NN	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
serzone	NN	B-TREATMENT
(	(	I-TREATMENT
nefazodone	NN	I-TREATMENT
)	)	I-TREATMENT
300	CD	O
mg	NN	O
po	NN	O
qhs	NN	O
zyprexa	NN	B-TREATMENT
(	(	I-TREATMENT
olanzapine	NN	I-TREATMENT
)	)	I-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

glucophage	NN	B-TREATMENT
(	(	I-TREATMENT
metformin	NN	I-TREATMENT
)	)	I-TREATMENT
850	CD	O
mg	NN	O
po	NN	O
tid	NN	O
starting	VBG	O
on	IN	O
10/03/00	CD	O
(	(	O
10/03	CD	O
)	)	O
actos	NN	B-TREATMENT
30	CD	O
mg	NN	O
po	NN	O
qd	NN	O

penicillins	NNS	B-TREATMENT

atypical	JJ	B-PROBLEM
cp	NN	I-PROBLEM

principal	JJ	O
discharge	NN	O
diagnosis	NN	O
;	:	O
responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
atypical	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM

other	JJ	O
diagnosis	NN	O
;	:	O
conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
dm	NN	B-PROBLEM
(	(	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NN	I-PROBLEM
)	)	I-PROBLEM
anxiety	NN	B-PROBLEM
(	(	I-PROBLEM
anxiety	NN	I-PROBLEM
)	)	I-PROBLEM
htn	NN	B-PROBLEM
(	(	I-PROBLEM
hypertension	NN	I-PROBLEM
)	)	I-PROBLEM
gerd	NN	B-PROBLEM
(	(	I-PROBLEM
esophageal	JJ	I-PROBLEM
reflux	NN	I-PROBLEM
)	)	I-PROBLEM

41	CD	O
yo	JJ	O
man	NN	O
with	IN	O
crfs	NN	B-PROBLEM
of	IN	O
dm	NN	B-PROBLEM
type	NN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
smoking	VBG	O
history	NN	O
,	,	O
family	NN	O
hx	NN	O
,	,	O
htn	NN	B-PROBLEM
p	NN	O
/	NNP	O
w	VBZ	O
episodes	NNS	B-PROBLEM
of	IN	I-PROBLEM
atypical	JJ	I-PROBLEM
cp	NN	I-PROBLEM
x	VBD	I-PROBLEM
1	CD	I-PROBLEM
week	NN	I-PROBLEM
,	,	O
with	IN	O
rest	NN	O
and	CC	O
exertion	NN	O
.	.	O

also	RB	O
has	VBZ	O
h	VBN	O
/	NNP	O
o	JJ	O
anxiety	NN	B-PROBLEM
and	CC	O
gerd	NN	B-PROBLEM
.	.	O

no	DT	O
assoicated	JJ	B-PROBLEM
sx	NN	I-PROBLEM
.	.	O

here	RB	O
,	,	O
had	VBD	O
t	VBN	B-PROBLEM
wave	VBP	I-PROBLEM
flattening	VBG	I-PROBLEM
laterally	RB	I-PROBLEM
and	CC	I-PROBLEM
inferiorly	RB	I-PROBLEM
with	IN	O
pain	NN	B-PROBLEM
that	WDT	O
resolved	VBD	O
pain	RB	B-PROBLEM
free	JJ	O
,	,	O
but	CC	O
not	RB	O
clear	JJ	O
that	IN	O
lead	JJ	B-TEST
placement	NN	I-TEST
is	VBZ	O
the	DT	O
same	JJ	O
.	.	O

had	VBD	O
chest	JJS	B-TEST
ct	NN	I-TEST
to	TO	O
r	VB	O
/	NNP	O
o	JJ	O
dissection	NN	B-PROBLEM
(	(	O
due	JJ	O
to	TO	O
back	VB	B-PROBLEM
pain	NN	I-PROBLEM
)	)	O
which	WDT	O
was	VBD	O
neg.	NN	O

ruled	VBN	O
out	RP	O
for	IN	O
mi	NN	B-PROBLEM
.	.	O

will	MD	O
plan	VB	O
on	IN	O
ett	NN	B-TEST
.	.	O

holding	VBG	O
metformin	NN	B-TREATMENT
until	IN	O
friday	JJ	O
due	JJ	O
to	TO	O
ct	VB	B-TEST
with	IN	I-TEST
contrast	NN	I-TEST
.	.	O

prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

radical	JJ	B-TREATMENT
retropubic	NN	I-TREATMENT
prostatectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	DT	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
67	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
recent	JJ	O
history	NN	O
of	IN	O
urinary	JJ	B-PROBLEM
frequency	NN	I-PROBLEM
q2-3h	NN	O
,	,	O
stranguria	NN	B-PROBLEM
,	,	O
nocturia	JJ	B-PROBLEM
x	JJ	O
3-4	JJ	O
per	IN	O
night	NN	O
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
on	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
to	TO	O
have	VB	O
an	DT	B-PROBLEM
asymmetric	JJ	I-PROBLEM
prostate	NN	I-PROBLEM
with	IN	O
prominence	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

repeat	NN	B-TEST
exam	CC	I-TEST
one	CD	O
month	NN	O
later	RB	O
showed	VBD	O
a	DT	B-PROBLEM
firm	JJ	I-PROBLEM
left-sided	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

transrectal	NN	B-TEST
ultrasound	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
hypoechoic	JJ	I-PROBLEM
left-sided	JJ	I-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
peripheral	JJ	I-PROBLEM
zone	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
biopsy	NN	I-TEST
showed	VBD	O
moderately	RB	B-PROBLEM
to	TO	I-PROBLEM
poorly	RB	I-PROBLEM
differentiated	VBN	I-PROBLEM
grade	JJ	I-PROBLEM
iii-iv	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
a	DT	O
3-4	JJ	O
year	NN	O
history	NN	O
of	IN	O
impotence	NN	B-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
non-insulin	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
takes	VBZ	O
diabeta	NN	B-TREATMENT
,	,	O
one	CD	O
qd	NN	O
;	:	O
right	JJ	B-PROBLEM
eye	NN	I-PROBLEM
cataract	NN	I-PROBLEM
,	,	O
operated	VBN	O
on	IN	O
three	CD	O
years	NNS	O
ago	RB	O
.	.	O

he	PRP	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
motrin	VB	B-TREATMENT
.	.	O

diabeta	NN	B-TREATMENT
,	,	O
one	CD	O
qd	NN	O
.	.	O

his	PRP$	O
neck	NN	O
was	VBD	O
supple	JJ	O
with	IN	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
percussion	NN	B-TEST
and	CC	O
auscultation	NN	B-TEST
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
normal	JJ	O
s1	NNS	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	I-PROBLEM

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
non-tender	JJ	B-PROBLEM
with	IN	O
no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
organomegaly	NN	B-PROBLEM
.	.	O

no	DT	O
costovertebral	JJ	B-PROBLEM
angle	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
genitourinary	JJ	I-TEST
exam	NN	I-TEST
showed	VBD	O
an	DT	O
uncircumcised	JJ	O
male	NN	O
with	IN	O
normal	JJ	O
scrotal	JJ	O
contents	NNS	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
firm	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
in	IN	O
the	DT	O
left	JJ	O
lobe	NN	O
of	IN	O
the	DT	O
prostate	NN	O
in	IN	O
the	DT	O
lateral	JJ	O
aspect	NN	O
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
,	,	I-PROBLEM
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

pulses	NNS	B-TEST
2+	CD	O
.	.	O

sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
104	CD	O
,	,	O
bicarbonate	NN	B-TEST
28.8	CD	O
,	,	O
bun	NN	B-TEST
17	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
,	,	O
glucose	VBD	B-TEST
118	CD	O
.	.	O

his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
7100	CD	O
,	,	O
hematocrit	VBD	B-TEST
35.9	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
258,000	CD	O
.	.	O

pt	NN	B-TEST
9.4/10.3	CD	O
,	,	O
ptt	RB	B-TEST
27	CD	O
.	.	O

his	PRP$	B-TEST
urinalysis	NN	I-TEST
showed	VBD	O
marked	JJ	B-PROBLEM
occult	NN	I-PROBLEM
blood	NN	I-PROBLEM
and	CC	O
positive	JJ	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cell	NN	I-PROBLEM
screen	NN	I-PROBLEM
but	CC	O
was	VBD	O
otherwise	RB	O
negative	JJ	O
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

ekg	NN	B-TEST
:	:	O

a	DT	B-TREATMENT
radical	JJ	I-TREATMENT
retropubic	NN	I-TREATMENT
prostatectomy	NN	I-TREATMENT
with	IN	O
bilateral	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	JJ	I-TREATMENT
dissection	NN	I-TREATMENT
was	VBD	O
done	VBN	O
.	.	O

he	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
postoperatively	RB	O
with	IN	O
vital	JJ	B-TEST
signs	NNS	I-TEST
stable	JJ	O
.	.	O

his	PRP$	B-TEST
potassium	NN	I-TEST
was	VBD	O
3.7	CD	O
and	CC	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
33	CD	O
.	.	O

his	PRP$	O
postoperative	JJ	O
course	NN	O
was	VBD	O
remarkable	JJ	O
for	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
grade	NN	I-PROBLEM
temperature	NN	I-PROBLEM
to	TO	O
101.7	CD	O
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
and	CC	O
chest	JJS	B-TEST
x-ray	JJ	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

his	PRP$	B-TREATMENT
jackson-pratt	NN	I-TREATMENT
drained	VBD	O
about	IN	O
35-40	JJ	O
cc	NNS	O
per	IN	O
day	NN	O
and	CC	O
was	VBD	O
discontinued	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
3	CD	O
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
on	IN	O
07/03	CD	O
was	VBD	O
28.1	CD	O
.	.	O

on	IN	O
that	DT	O
day	NN	O
he	PRP	O
was	VBD	O
slightly	RB	B-PROBLEM
diaphoretic	JJ	I-PROBLEM
with	IN	O
some	DT	B-PROBLEM
tachycardia	NN	I-PROBLEM
to	TO	O
100	CD	O
.	.	O

the	DT	O
remaining	VBG	O
unit	NN	O
of	IN	O
autologous	JJ	B-TREATMENT
packed	NNS	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
was	VBD	O
transfused	VBN	O
.	.	O

a	DT	B-TEST
cardiology	NN	I-TEST
consult	NN	I-TEST
was	VBD	O
obtained	VBN	O
for	IN	O
this	DT	O
episode	NN	O
of	IN	O
diaphoresis	NN	B-PROBLEM
with	IN	O
tachycardia	NN	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
for	IN	O
an	DT	B-TEST
ekg	NN	I-TEST
being	VBG	O
read	VBN	O
as	IN	O
having	VBG	O
anterolateral	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
symptoms	NNS	B-PROBLEM
of	IN	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
myocardial	JJ	B-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
ekg	NN	I-TEST
showed	VBD	O
no	DT	O
changes	NNS	B-PROBLEM
.	.	O

he	PRP	O
subsequently	RB	O
did	VBD	O
well	RB	O
,	,	O
with	IN	O
a	DT	B-TEST
repeat	NN	I-TEST
hematocrit	NN	I-TEST
of	IN	O
34.3	CD	O
after	IN	O
the	DT	B-TEST
transfusion	NN	I-TEST
.	.	O

his	PRP$	B-TEST
creatinine	NN	I-TEST
was	VBD	O
1.2	CD	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
5	CD	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
6	CD	O
his	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
grade	NN	I-PROBLEM
temperature	NN	I-PROBLEM
resolved	VBN	O
.	.	O

his	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

he	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
percocet	NN	B-TREATMENT
and	CC	O
keflex	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
58	CD	O
year	NN	O
old	JJ	O
right	JJ	O
hand	NN	O
dominant	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
long	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
changed	VBD	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
from	IN	O
aldomet	NN	B-TREATMENT
to	TO	O
clonidine	VB	B-TREATMENT
six	CD	O
weeks	NNS	O
ago	RB	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
adult	NN	B-PROBLEM
onset	VBN	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	RBR	I-PROBLEM
,	,	O
ankylosing	VBG	B-PROBLEM
spondylitis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
&apos;96	NNP	O
(	(	O
?	.	O
)	)	O
now	RB	O
with	IN	O
acute	JJ	O
onset	NN	O
of	IN	O
left	JJ	B-PROBLEM
face	NN	I-PROBLEM
and	CC	I-PROBLEM
arm	NN	I-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
leg	JJR	I-PROBLEM
hemiplegia	NN	I-PROBLEM
and	CC	O
primary	JJ	B-PROBLEM
hemisensory	JJ	I-PROBLEM
loss	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

his	PRP$	O
voice	NN	O
became	VBD	O
slurred	JJ	B-PROBLEM
and	CC	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
central	JJ	I-PROBLEM
dull	NN	I-PROBLEM
headache	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
unable	JJ	O
to	TO	O
move	VB	O
the	DT	O
left	JJ	O
side	NN	O
of	IN	O
his	PRP$	O
body	NN	O
and	CC	O
felt	VBD	O
numb	NNS	B-PROBLEM
on	IN	I-PROBLEM
that	DT	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
wayskemedcalltown	VB	O
talmi	NN	O
and	CC	O
transferred	VBD	O
to	TO	O
heaonboburg	VB	O
linpack	NN	O
grant	JJ	O
medical	JJ	O
center	NN	O
with	IN	O
a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	JJ	I-TEST
showing	VBG	O
a	DT	B-PROBLEM
1x2	CD	I-PROBLEM
thalamic	JJ	I-PROBLEM
capsular	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
without	IN	O
superficial	JJ	B-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
220/110	CD	O
there	RB	O
.	.	O

he	PRP	O
denies	VBZ	O
any	DT	O
visual	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
or	CC	O
cortical-type	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

vasotec	JJ	B-TREATMENT
40	CD	O
mg	NN	O
q.day	NN	O
,	,	O
soma	VBD	B-TREATMENT
1	CD	O
tablet	NN	O
q.day	NN	O
,	,	O
demerolprn	NN	B-TREATMENT
,	,	O
clonidine	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
family	NN	O
history	NN	O
is	VBZ	O
positive	JJ	O
for	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
positive	JJ	O
for	IN	O
cancer	NN	B-PROBLEM
.	.	O

on	IN	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
,	,	O
patient	NN	O
is	VBZ	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
afebrile	RB	B-PROBLEM
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
134/80	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
and	CC	O
regular	JJ	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

cardiovascular	JJ	B-TEST
exam	NN	I-TEST
:	:	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
i/vi	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

his	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
non-tender	JJ	B-PROBLEM
,	,	O
obese	JJ	B-PROBLEM
,	,	O
with	IN	O
normal	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

back	RB	O
and	CC	O
neck	NN	O
were	VBD	O
stiff	JJ	B-PROBLEM
and	CC	O
sore	NN	B-PROBLEM
,	,	O
without	IN	O
localizing	VBG	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

on	IN	O
neurological	JJ	B-TEST
examination	NN	I-TEST
,	,	O
mental	JJ	O
status	NN	O
alert	NN	O
and	CC	O
oriented	VBD	O
x	NNP	O
three	CD	O
,	,	O
good	JJ	O
memory	NN	O
,	,	O
fluent	JJ	O
speech	NN	O
,	,	O
good	JJ	O
repetition	NN	O
and	CC	O
naming	NN	O
.	.	O

the	DT	O
cranial	JJ	O
nerves	NNS	O
showed	VBD	O
full	JJ	O
visual	JJ	O
fields	NNS	O
without	IN	O
extinction	NN	B-PROBLEM
,	,	O
pupils	VBZ	O
5	CD	O
to	TO	O
3	CD	O
bilaterally	RB	O
and	CC	O
equal	JJ	O
,	,	O
disks	NNS	O
flat	JJ	O
,	,	O
lower	JJR	B-PROBLEM
left	VBD	I-PROBLEM
facial	JJ	I-PROBLEM
decreased	JJ	I-PROBLEM
sensation	NN	I-PROBLEM
to	TO	I-PROBLEM
temperature	NN	I-PROBLEM
,	,	O
pin	NN	B-TEST
prick	NN	I-TEST
on	IN	O
the	DT	O
left	NN	O
v1	NN	O
through	IN	O
v3	NN	O
,	,	O
tongue	NN	O
deviates	NNS	O
to	TO	O
the	DT	O
left	NN	O
,	,	O
good	JJ	O
gag	NN	O
,	,	O
decreased	VBN	B-PROBLEM
shrug	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

motor	NN	B-TEST
examination	NN	I-TEST
showed	VBD	O
full	JJ	O
power	NN	O
on	IN	O
the	DT	O
right	JJ	O
arm	NN	O
and	CC	O
leg	NN	O
,	,	O
could	MD	O
barely	RB	O
flex	JJ	O
fingers	NNS	O
of	IN	O
the	DT	O
left	JJ	O
hand	NN	O
,	,	O
pulls	NNS	O
left	VBD	O
arm	NN	O
medially	RB	O
only	RB	O
.	.	O

on	IN	O
sensory	JJ	B-TEST
examination	NN	I-TEST
,	,	O
had	VBD	O
decreased	VBN	O
pin	NN	O
prick	NN	O
,	,	O
temperature	NN	O
,	,	O
vibration	NN	O
in	IN	O
the	DT	O
left	JJ	O
side	NN	O
of	IN	O
the	DT	O
body	NN	O
.	.	O

the	DT	B-TEST
finger-to-nose	NN	I-TEST
was	VBD	O
okay	VBN	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

on	IN	O
reflex	JJ	B-TEST
examination	NN	I-TEST
,	,	O
2	CD	O
on	IN	O
the	DT	O
right	JJ	O
upper	JJ	O
extremity	NN	O
,	,	O
2+	CD	O
on	IN	O
the	DT	O
left	JJ	O
upper	JJ	O
extremity	NN	O
,	,	O
2	CD	O
on	IN	O
the	DT	O
right	JJ	O
knee	NN	O
,	,	O
0	CD	O
on	IN	O
the	DT	O
right	JJ	O
ankle	NN	O
,	,	O
with	IN	O
down	RP	O
going	VBG	O
toe	NN	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

three	CD	O
on	IN	O
the	DT	O
left	NN	O
knee	NN	O
,	,	O
4	CD	O
on	IN	O
the	DT	O
left	NN	O
ankle	NN	O
with	IN	O
upgoing	JJ	O
toe	NN	O
and	CC	O
clonus	NN	B-PROBLEM
on	IN	O
the	DT	O
left	NN	O
.	.	O

electrolytes	NNS	B-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
glucose	JJ	B-TEST
192	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
9/0.7	CD	O
,	,	O
hematocrit	NN	B-TEST
49.5	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
7.9	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
166,000	CD	O
,	,	O
65%	CD	O
polys	NN	B-TEST
,	,	O
3	CD	O
bands	NNS	B-TEST
,	,	O
24%	CD	O
lymphs	NN	B-TEST
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
with	IN	O
old	JJ	B-PROBLEM
q	NNS	I-PROBLEM
wave	VBP	I-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
computerized	VBD	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
showed	VBD	O
1.5	CD	B-PROBLEM
to	TO	I-PROBLEM
2	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
bleed	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
thalamus	NN	I-PROBLEM
extending	VBG	O
to	TO	O
the	DT	O
internal	JJ	O
capsule	NN	O
with	IN	O
mild	JJ	B-PROBLEM
distortion	NN	I-PROBLEM
only	RB	O
,	,	O
no	DT	O
shift	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
was	VBD	O
clear	JJ	O
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
on	IN	O
discharge	NN	O
was	VBD	O
no	DT	O
movement	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
hand	NN	I-PROBLEM
on	IN	O
the	DT	O
left	NN	O
or	CC	O
arm	NN	O
.	.	O

on	IN	O
the	DT	O
lower	JJR	O
extremity	NN	O
,	,	O
could	MD	O
wiggle	VB	B-TEST
toes	NNS	I-TEST
,	,	O
flexor	NN	B-TEST
and	CC	O
plantar	NN	B-TEST
,	,	O
3+/5	CD	O
,	,	O
quadriceps	VBZ	O
4/5	CD	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
managed	VBN	O
with	IN	O
vasotec	NN	B-TREATMENT
,	,	O
nifedipine	NN	B-TREATMENT
and	CC	O
clonidine	NN	B-TREATMENT
with	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
under	IN	O
good	JJ	O
control	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
average	JJ	O
125	CD	O
systolic	JJ	B-TEST
,	,	O
70	CD	O
diastolic	NN	B-TEST
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
72	CD	O
.	.	O

also	RB	O
managed	VBN	O
with	IN	O
valium	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O

muscle	NN	B-PROBLEM
spasms	NNS	I-PROBLEM
were	VBD	O
managed	VBN	O
with	IN	O
flexeril	JJ	B-TREATMENT
10	CD	O
po	NN	O
t.i.d.	NN	O

3.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
2.5	CD	O
of	IN	O
micronase	NN	B-TREATMENT
with	IN	O
resulting	VBG	B-TEST
sugars	NNS	I-TEST
as	RB	O
low	JJ	O
as	IN	O
63	CD	O
,	,	O
decreased	VBD	O
to	TO	O
1.25	CD	O
mg	NNS	O
q.day	RB	O
.	.	O

vasotec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
clonidine	VBP	B-TREATMENT
0.2	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
nifedipine	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
flexeril	VBP	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
valium	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
micronase	NN	B-TREATMENT
1.25	CD	O
mg	NN	O
q.day	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
allergic	JJ	B-PROBLEM
to	TO	O
percocet	VB	B-TREATMENT
and	CC	O
percodan	VB	B-TREATMENT
during	IN	O
his	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

right	JJ	B-PROBLEM
thalamic	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

mitral	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

mitral	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

tricuspid	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
ectopy	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

epistaxis	NN	B-PROBLEM
to	TO	O
coumadin	VB	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
11/03	CD	O
.	.	O

pulmonary	JJ	B-TEST
function	NN	I-TEST
test	NN	I-TEST
11/04	CD	O
.	.	O

this	DT	O
68-year-old	JJ	O
patient	NN	O
of	IN	O
dr.	NN	O
naka	NN	O
jesc	NN	O
had	VBD	O
two	CD	O
episodes	NNS	O
of	IN	O
rheumatic	JJ	B-PROBLEM
fever	NN	I-PROBLEM
as	IN	O
a	DT	O
teenager	NN	O
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
chronic	VBN	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

coumadin	NN	B-TREATMENT
has	VBZ	O
caused	VBN	O
bleeding	VBG	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
mouth	NN	I-PROBLEM
and	CC	I-PROBLEM
nose	VB	I-PROBLEM
on	IN	O
two	CD	O
occasions	NNS	O
,	,	O
on	IN	O
one	CD	O
occasion	NN	O
with	IN	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
13	CD	O
,	,	O
and	CC	O
has	VBZ	O
been	VBN	O
replaced	VBN	O
by	IN	O
anti-platelet	JJ	B-TREATMENT
agents	NNS	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
recurrent	VBN	B-PROBLEM
syncope	NN	I-PROBLEM
since	IN	O
age	NN	O
6	CD	O
.	.	O

she	PRP	O
has	VBZ	O
now	RB	O
had	VBN	O
progressive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
holter	NN	I-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
period	NN	O
of	IN	O
ventricular	JJ	B-PROBLEM
bigemini	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
hypertension	NN	B-PROBLEM
or	CC	O
diabetes	NNS	B-PROBLEM
,	,	O
and	CC	O
says	VBZ	O
he	PRP	O
has	VBZ	O
lowered	VBN	O
her	PRP$	B-TEST
cholesterol	NN	I-TEST
from	IN	O
333	CD	O
to	TO	O
197	CD	O
by	IN	O
changing	VBG	O
her	PRP$	O
diet	NN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
heart	NN	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
treated	VBN	O
with	IN	O
vanceril	NN	B-TREATMENT
for	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
one	CD	O
gram	NN	O
per	IN	O
day	NN	O
proteinuria	NN	B-TREATMENT
with	IN	O
normal	JJ	O
creatinine	NN	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
partial	JJ	I-TREATMENT
gastrectomy	NN	I-TREATMENT
in	IN	O
1972	CD	O
for	IN	O
a	DT	B-PROBLEM
&quot;	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
&quot;	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
an	DT	B-TREATMENT
appendectomy	NN	I-TREATMENT
and	CC	O
cholecystectomy	NN	B-TREATMENT
.	.	O

digoxin	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
po	NN	O
q.d.	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
40	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
aspirin	JJ	B-TREATMENT
held	NN	O
,	,	O
and	CC	O
vanceril	NNS	B-TREATMENT
three	CD	O
puffs	NNS	O
b.i.d.	VBP	O

transdermal	JJ	B-TREATMENT
nitroglycerin	NNS	I-TREATMENT
caused	VBD	O
headache	NN	B-PROBLEM
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
86	CD	O
,	,	O
irregularly	RB	O
irregular	JJ	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
142/86	CD	O
.	.	O

neck	NN	B-PROBLEM
veins	NNS	I-PROBLEM
distended	VBD	I-PROBLEM
.	.	O

apical	JJ	B-TEST
impulse	NN	I-TEST
not	RB	O
palpable	JJ	O
.	.	O

right	RB	B-PROBLEM
ventricular	JJ	I-PROBLEM
heave	NN	I-PROBLEM
.	.	O

s2	NN	O
narrowly	RB	B-PROBLEM
physiologically	RB	I-PROBLEM
split	VBN	I-PROBLEM
with	IN	O
accentuation	NN	B-PROBLEM
of	IN	O
p2	NN	O
.	.	O

no	DT	O
s3	NN	B-PROBLEM
or	CC	O
opening	NN	B-PROBLEM
snap	NN	I-PROBLEM
.	.	O

grade	NN	B-PROBLEM
ii	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

grade	NN	B-PROBLEM
ii	NN	I-PROBLEM
decrescendo	VBZ	I-PROBLEM
diastolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

diastolic	JJ	B-PROBLEM
rumble	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

liver	RB	B-PROBLEM
slightly	RB	I-PROBLEM
pulsatile	JJ	I-PROBLEM
but	CC	O
no	DT	O
enlarged	NN	B-PROBLEM
.	.	O

pulses	NNS	B-TEST
normal	JJ	O
to	TO	O
the	DT	O
femorals	NNS	O
with	IN	O
weak	JJ	B-PROBLEM
dorsalis	NN	I-PROBLEM
pedis	NN	I-PROBLEM
pulses	NNS	I-PROBLEM
.	.	O

superficial	JJ	B-PROBLEM
varicose	NN	I-PROBLEM
veins	NNS	I-PROBLEM
.	.	O

no	DT	O
edema	NN	B-PROBLEM
.	.	O

hematocrit	NN	B-TEST
44	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
bun	NN	B-TEST
23	CD	O
,	,	O
creatinine	NN	B-TEST
1.2	CD	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
115	CD	O
,	,	O
digoxin	NN	B-TEST
1.4	CD	O
.	.	O

electrocardiogram	NN	B-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
moderate	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
response	NN	I-PROBLEM
,	,	O
incomplete	JJ	B-PROBLEM
right	NN	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
axis	NN	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
hypertrophy	NN	I-PROBLEM
and	CC	O
possible	JJ	O
apical	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
left	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
,	,	I-PROBLEM
right	JJ	I-PROBLEM
ventricular	NN	I-PROBLEM
and	CC	I-PROBLEM
pulmonary	JJ	I-PROBLEM
arterial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
and	CC	O
interstitial	JJ	B-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
small	JJ	B-PROBLEM
,	,	I-PROBLEM
bilateral	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

cardiac	JJ	B-TREATMENT
catheterization	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
without	IN	O
complication	NN	B-PROBLEM
from	IN	O
the	DT	O
right	JJ	O
neck	NN	O
and	CC	O
right	JJ	O
groin	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

right	JJ	B-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
12	CD	O
with	IN	O
a	DT	O
wave	NN	O
form	NN	O
consistent	NN	O
with	IN	O
tricuspid	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
tricuspid	JJ	B-PROBLEM
valve	NN	I-PROBLEM
gradient	NN	I-PROBLEM
.	.	O

pulmonary	JJ	B-TEST
artery	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
markedly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
at	IN	O
120/60	CD	O
.	.	O

pulmonary	JJ	B-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
markedly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
at	IN	O
38	CD	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
large	JJ	I-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
gradient	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
little	JJ	O
or	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
gradient	NN	I-PROBLEM
.	.	O

fich	JJ	B-TEST
cardiac	NN	I-TEST
output	NN	I-TEST
was	VBD	O
3.0	CD	O
and	CC	O
indexed	JJ	O
2.0	CD	O
.	.	O

arterial	JJ	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
85	CD	O
percent	NN	O
.	.	O

there	EX	O
was	VBD	O
minimal	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
calcification	NN	I-PROBLEM
,	,	O
normal	JJ	O
left	VBD	O
ventricular	JJ	O
contraction	NN	O
,	,	O
and	CC	O
2+	CD	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
into	IN	I-PROBLEM
a	DT	I-PROBLEM
large	JJ	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
minimal	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
calcification	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
______________	NNP	I-PROBLEM
thickening	NN	I-PROBLEM
,	,	O
normal	JJ	O
open	JJ	O
,	,	O
and	CC	O
mild	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
atherosclerosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
.	.	O

fvc	NN	B-TEST
was	VBD	O
1.6	CD	O
or	CC	O
58	CD	O
percent	NN	O
of	IN	O
predicted	VBN	O
and	CC	O
fev1	JJ	B-TEST
0.95	CD	O
or	CC	O
45	CD	O
percent	NN	O
of	IN	O
predicted	VBN	O
.	.	O

room	NN	B-TEST
air	NN	I-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
was	VBD	O
56/40/7.45	CD	O
.	.	O

because	IN	O
it	PRP	O
would	MD	O
be	VB	O
ideal	JJ	O
to	TO	O
place	VB	O
a	DT	B-TREATMENT
mechanical	JJ	I-TREATMENT
valve	NN	I-TREATMENT
if	IN	O
valve	JJ	B-TREATMENT
replacement	NN	I-TREATMENT
rather	RB	O
that	IN	O
commissurotomy	NN	B-TREATMENT
is	VBZ	O
needed	VBN	O
,	,	O
she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
dr.	NN	O
ca	MD	O
shuff	VB	O
of	IN	O
ent	NN	O
for	IN	O
her	PRP$	O
history	NN	O
of	IN	O
epistaxis	NN	B-PROBLEM
.	.	O

he	PRP	O
identified	VBD	O
no	DT	O
bleeding	NN	B-PROBLEM
source	NN	I-PROBLEM
,	,	O
but	CC	O
felt	VBD	O
that	IN	O
the	DT	O
risk	NN	O
of	IN	O
nasal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT
could	MD	O
be	VB	O
minimized	VBN	O
interventional	JJ	B-TREATMENT
neuroradiology	NN	I-TREATMENT
occlusion	NN	I-TREATMENT
of	IN	O
the	DT	O
arteries	NNS	O
to	TO	O
the	DT	O
nose	JJ	O
bilaterally	RB	O
.	.	O

the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
could	MD	O
not	RB	O
be	VB	O
scheduled	VBN	O
during	IN	O
this	DT	O
admission	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
,	,	O
therefore	RB	O
,	,	O
discharged	VBD	O
after	IN	O
a	DT	O
three	CD	O
day	NN	O
hospitalization	NN	O
,	,	O
with	IN	O
plans	NNS	O
for	IN	O
re-admission	NN	O
for	IN	O
the	DT	B-TREATMENT
neuroradiology	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

this	DT	O
will	MD	O
be	VB	O
followed	VBN	O
by	IN	O
a	DT	O
trial	NN	O
of	IN	O
coumadin	NN	B-TREATMENT
,	,	O
and	CC	O
then	RB	O
by	IN	O
mitral	JJ	B-TREATMENT
commissurotomy	NN	I-TREATMENT
or	CC	O
replacement	NN	B-TREATMENT
and	CC	O
probable	JJ	O
tricuspid	JJ	B-TREATMENT
annuloplasty	NN	I-TREATMENT
by	IN	O
dr.	NN	O
riemund	NN	O
c.	NN	O
wave	NN	O
.	.	O

in	IN	O
the	DT	O
meantime	NN	O
,	,	O
lasix	JJ	B-TREATMENT
dosage	NN	O
is	VBZ	O
increased	VBN	O
.	.	O

potassium	NN	B-TREATMENT
replacement	NN	I-TREATMENT
has	VBZ	O
caused	VBN	O
,	,	O
according	VBG	O
to	TO	O
the	DT	O
patient	NN	O
,	,	O
marked	VBD	B-PROBLEM
hyperkalemia	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

digoxin	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
80	CD	O
mg	NN	O
q.a.m.	NN	O
and	CC	O
40	CD	O
mg	NN	O
q.p.m.	NN	O
aspirin	VBD	B-TREATMENT
1	CD	O
q.d.	NN	O
,	,	O
and	CC	O
vanceril	NNS	B-TREATMENT
three	CD	O
puffs	NNS	O
b.i.d.	VBP	O

flank	NN	B-PROBLEM
pain	NN	I-PROBLEM
uri	NN	B-PROBLEM
?	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
(	(	O
portugese	JJ	O
)	)	O
.	.	O

urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM

exam	NN	B-TEST
,	,	O
urinalysis	NN	B-TEST
,	,	O
medication	NN	B-TREATMENT

levofloxacin	RB	B-TREATMENT
500	CD	O
mg	JJ	O
every	DT	O
day	NN	O
for	IN	O
7	CD	O
days	NNS	O

return	NN	O
to	TO	O
the	DT	O
er	NN	O
for	IN	O
high	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
uncontrolled	JJ	B-PROBLEM
pains	NNS	I-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
concerns	NNS	I-PROBLEM
as	IN	O
needed	VBN	O
.	.	O

chronic	JJ	B-PROBLEM
myelogenous	JJ	I-PROBLEM
leukemia	NN	I-PROBLEM

cml	NN	B-PROBLEM
.	.	O

1.	CD	O
status	NN	O
post	NN	O
bone	NN	B-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

2.	CD	O
intraparenchymal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

mr.	NN	O
larsen	NN	O
was	VBD	O
a	DT	O
50-year-old	JJ	O
salesman	NN	O
who	WP	O
in	IN	O
12/26	CD	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
platelet	NN	I-PROBLEM
count	NN	I-PROBLEM
of	IN	O
778,000	CD	O
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
cml	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
06/07/00	CD	O
for	IN	O
a	DT	B-TREATMENT
matched	VBN	I-TREATMENT
,	,	I-TREATMENT
unrelated	JJ	I-TREATMENT
donor	NN	I-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
24.409	CD	O
and	CC	O
platelets	NNS	B-TEST
of	IN	O
956,000	CD	O
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
his	PRP$	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
on	IN	O
06/12/00	CD	O
.	.	O

his	PRP$	O
course	NN	O
was	VBD	O
then	RB	O
complicated	VBN	O
by	IN	O
fevers	NNS	B-PROBLEM
and	CC	O
neutropenia	NN	B-PROBLEM
which	WDT	O
were	VBD	O
treated	VBN	O
with	IN	O
antibiotics	NNS	B-TREATMENT
and	CC	O
a	DT	B-PROBLEM
diffuse	NN	I-PROBLEM
erythroderm	NN	I-PROBLEM
felt	VBD	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
drug	NN	I-PROBLEM
reaction	NN	I-PROBLEM
.	.	O

on	IN	O
06/24/00	CD	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
pulmonary	JJ	B-PROBLEM
infiltrates	NNS	I-PROBLEM
and	CC	O
some	DT	B-PROBLEM
hemoptysis	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
bronchoscopy	NN	I-TEST
was	VBD	O
done	VBN	O
and	CC	O
there	EX	O
was	VBD	O
blood	NN	B-PROBLEM
found	VBN	O
in	IN	O
the	DT	O
upper	JJ	O
airways	NNS	O
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
blood	NN	B-PROBLEM
in	IN	I-PROBLEM
alveoli	NNS	I-PROBLEM
so	IN	O
it	PRP	O
was	VBD	O
not	RB	O
felt	VBN	O
to	TO	O
be	VB	O
dah	VBN	B-PROBLEM
.	.	O

on	IN	O
06/26/00	CD	O
due	JJ	O
to	TO	O
agitation	NN	B-PROBLEM
,	,	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
increased	VBD	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
intubated	VBN	B-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
at	IN	O
that	DT	O
time	NN	O
that	IN	O
the	DT	B-PROBLEM
changing	VBG	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
might	MD	O
be	VB	O
due	JJ	O
to	TO	O
a	DT	O
combination	NN	O
of	IN	O
medication	NN	B-TREATMENT
and	CC	O
worsening	VBG	B-PROBLEM
mucositis	NN	I-PROBLEM
.	.	O

although	IN	O
the	DT	B-TREATMENT
patient	JJ	I-TREATMENT
&apos;s	NN	I-TREATMENT
pain	NN	I-TREATMENT
and	CC	I-TREATMENT
sedation	NN	I-TREATMENT
meds	NNS	I-TREATMENT
were	VBD	O
adjusted	VBN	O
he	PRP	O
continued	VBD	O
to	TO	O
be	VB	O
agitated	VBN	B-PROBLEM
and	CC	O
there	EX	O
was	VBD	O
difficulty	NN	O
weaning	VBG	O
him	PRP	O
off	RP	O
the	DT	B-TREATMENT
vent	NN	I-TREATMENT
.	.	O

because	IN	O
of	IN	O
this	DT	B-PROBLEM
continued	JJ	I-PROBLEM
agitation	NN	I-PROBLEM
,	,	O
a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
07/01/00	CD	O
and	CC	O
it	PRP	O
revealed	VBD	O
an	DT	B-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

neurosurgery	NN	O
was	VBD	O
consulted	VBN	O
but	CC	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
severity	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
bleed	NN	I-PROBLEM
surgery	NN	B-TREATMENT
was	VBD	O
not	RB	O
considered	VBN	O
an	DT	O
option	NN	O
.	.	O

the	DT	O
patient	NN	O
gradually	RB	O
lost	VBD	O
brain	NN	O
systolic	JJ	O
ejection	NN	O
murmur	NN	O
function	NN	O
and	CC	O
was	VBD	O
pronounced	VBN	O
dead	JJ	B-PROBLEM
on	IN	O
07/02/00	CD	O
.	.	O

right	RB	B-PROBLEM
capsular	JJ	I-PROBLEM
putamenal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

right	RB	B-PROBLEM
capsular	JJ	I-PROBLEM
putamenal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

mrs.	NN	O
dua	NN	O
is	VBZ	O
a	DT	O
34	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
an	DT	O
unclear	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
for	IN	O
at	IN	O
least	JJS	O
five	CD	O
years	NNS	O
.	.	O

she	PRP	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
around	IN	O
12:40	CD	O
on	IN	O
october	NN	O
19	CD	O
,	,	O
when	WRB	O
while	NN	O
on	IN	O
the	DT	O
phone	NN	O
,	,	O
started	VBD	O
to	TO	O
have	VB	O
difficulty	NN	B-PROBLEM
in	IN	I-PROBLEM
talking	VBG	I-PROBLEM
.	.	O

her	PRP$	O
speech	NN	O
became	VBD	O
slurred	JJ	B-PROBLEM
,	,	O
this	DT	O
was	VBD	O
followed	VBN	O
a	DT	O
few	JJ	O
seconds	NNS	O
after	IN	O
by	IN	O
weakness	NN	B-PROBLEM
and	CC	I-PROBLEM
numbness	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

she	PRP	O
did	VBD	O
not	RB	O
complain	VB	O
of	IN	O
headache	NN	B-PROBLEM
,	,	O
diplopia	NN	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
neurological	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
seen	VBN	O
at	IN	O
a	DT	O
memorial	JJ	O
hospital	NN	O
where	WRB	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
measured	VBN	O
at	IN	O
240/120	CD	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
left	JJ	I-PROBLEM
hemiparesis	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
ro	VB	O
woodma	NN	O
healthcare	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

she	PRP	O
does	VBZ	O
not	RB	O
smoke	VB	O
,	,	O
does	VBZ	O
not	RB	O
use	VB	O
birth	NN	B-TREATMENT
control	NN	I-TREATMENT
pills	NNS	I-TREATMENT
,	,	O
does	VBZ	O
not	RB	O
use	VB	O
drugs	NNS	O
.	.	O

father	NN	O
and	CC	O
brother	NN	O
died	VBD	O
of	IN	O
pe	NN	B-PROBLEM
.	.	O

a	DT	O
34	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
lying	NN	O
in	IN	O
bed	NN	O
,	,	O
anxious	JJ	B-PROBLEM
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
220/120	CD	O
,	,	O
afebrile	NN	B-PROBLEM
.	.	O

no	DT	O
lesions	NNS	B-PROBLEM
.	.	O

normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
,	,	O
anicteric	JJ	B-PROBLEM
.	.	O

supple	NN	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

regular	JJ	O
rhythm	NN	O
with	IN	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

bowel	NN	O
sounds	VBZ	O
present	JJ	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
guaiac	JJ	O
negative	JJ	O
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
,	,	I-PROBLEM
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

her	PRP$	O
speech	NN	O
was	VBD	O
fluent	JJ	O
with	IN	O
no	DT	O
phasic	NN	B-PROBLEM
or	CC	I-PROBLEM
praxic	NN	I-PROBLEM
problems	NNS	I-PROBLEM
,	,	O
dysarthric	NN	B-PROBLEM
.	.	O

visual	JJ	O
fields	NNS	O
were	VBD	O
full	JJ	O
to	TO	O
confrontation	NN	B-TEST
.	.	O

pupils	NNS	O
were	VBD	O
2	CD	O
millimeters	NNS	O
down	RB	O
to	TO	O
1	CD	O
millimeter	NN	O
by	IN	O
direct	JJ	B-TEST
and	CC	I-TEST
consensual	JJ	I-TEST
stimuli	NN	I-TEST
.	.	O

v1	NN	O
through	IN	O
v3	NN	O
,	,	O
diminished	VBD	O
light	JJ	B-TEST
touch	NN	I-TEST
and	CC	O
pinprick	NN	B-TEST
in	IN	O
the	DT	O
left	JJ	O
side	NN	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
central	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
paresis	NN	I-PROBLEM
.	.	O

gag	NN	B-TEST
was	VBD	O
symmetric	JJ	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
pronator	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
deep	JJ	I-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
2+	CD	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
,	,	O
1+	CD	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
.	.	O

on	IN	O
sensory	JJ	B-TEST
exam	NN	I-TEST
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
diminution	NN	I-PROBLEM
of	IN	I-PROBLEM
light	JJ	I-PROBLEM
touch	NN	I-PROBLEM
,	,	I-PROBLEM
pinprick	NN	I-PROBLEM
,	,	I-PROBLEM
position	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
vibration	NN	I-PROBLEM
sense	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

the	DT	O
fine	JJ	O
motor	NN	O
movements	NNS	O
of	IN	O
the	DT	O
left	JJ	O
hand	NN	O
were	VBD	O
diminished	VBN	B-PROBLEM
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
dysmetria	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
to	TO	O
finger	VB	B-TEST
/	NNP	I-TEST
nose	JJ	I-TEST
and	CC	O
heel	JJ	B-TEST
/	NNP	I-TEST
shin	NN	I-TEST
.	.	O

the	DT	B-PROBLEM
walk	NN	I-PROBLEM
was	VBD	I-PROBLEM
paretic	JJ	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
4	CD	O
,	,	O
chloride	RB	B-TEST
107	CD	O
,	,	O
co2	NN	B-TEST
25.4	CD	O
,	,	O
bun	NN	B-TEST
9	CD	O
,	,	O
creatinine	NN	B-TEST
.8	NNP	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
130	CD	O
.	.	O

uric	JJ	B-TEST
acid	NN	I-TEST
4.7	CD	O
,	,	O
cholesterol	NN	B-TEST
150	CD	O
,	,	O
triglycerides	NNS	B-TEST
74	CD	O
,	,	O
hdl	NN	B-TEST
44	CD	O
,	,	O
ldl	VBD	B-TEST
91	CD	O
.	.	O

urine	NN	B-TEST
and	CC	I-TEST
serum	NN	I-TEST
toxicology	NN	I-TEST
screen	JJ	I-TEST
negative	JJ	O
.	.	O

thyroid	JJ	B-TEST
stimulation	NN	I-TEST
hormone	NN	I-TEST
1.9	CD	O
.	.	O

dexamethasone	NN	B-TEST
suppression	NN	I-TEST
test	NN	I-TEST
negative	JJ	O
with	IN	O
a	DT	B-TEST
cortisol	JJ	I-TEST
level	NN	I-TEST
at	IN	O
8	CD	O
a.m.	NN	O
of	IN	O
1.7	CD	O
.	.	O

twenty-four	JJ	B-TEST
urine	NN	I-TEST
for	IN	O
catecholamine	NN	B-TEST
,	,	O
metanephrines	NNS	B-TEST
,	,	O
and	CC	O
vma	JJ	B-TEST
pending	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
9.8	CD	O
,	,	O
hematocrit	NN	B-TEST
44.1	CD	O
,	,	O
platelets	NNS	B-TEST
262	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
10.4/	CD	O
10.3	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
25.9	CD	O
.	.	O

urinalysis	NN	B-TEST
:	:	O

specific	JJ	B-TEST
gravity	NN	I-TEST
125	CD	O
,	,	O
ph	RB	O
6	CD	O
.	.	O

urine	JJ	B-TEST
culture	NN	I-TEST
negative	JJ	O
.	.	O

sedimentation	NN	B-TEST
rate	NN	I-TEST
2	CD	O
,	,	O
antithrombin	RB	B-TEST
3	CD	O
.	.	O

protein	NN	B-TEST
c	NN	I-TEST
,	,	O
protein	NN	B-TEST
s	NN	I-TEST
and	CC	O
plasminogen	NN	B-TEST
level	NN	I-TEST
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

electrocardiogram	NN	B-TEST
:	:	O

sinus	NN	B-TEST
rhythm	NN	I-TEST
at	IN	O
116	CD	O
,	,	O
axis	NN	B-TEST
of	IN	O
23	CD	O
,	,	O
intervals	NNS	B-TEST
of	IN	O
.14/	NNP	O
.07/	NNP	O
.42	NNP	O
,	,	O
no	DT	O
st-segment	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
negative	JJ	O
.	.	O

head	NN	B-TEST
computerized	VBD	I-TEST
tomography	JJ	I-TEST
scan	JJ	I-TEST
on	IN	O
10/19	CD	O
:	:	O
3	CD	B-PROBLEM
centimeter	NN	I-PROBLEM
hyperdensity	NN	I-PROBLEM
within	IN	O
the	DT	O
right	JJ	O
putamenal	JJ	O
area	NN	O
in	IN	O
the	DT	O
right	JJ	O
external	JJ	O
capsusle	NN	O
consistent	JJ	O
with	IN	O
intra-parenchymal	JJ	B-PROBLEM
hematoma	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
local	JJ	I-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
and	CC	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

no	DT	O
other	JJ	O
areas	NNS	O
of	IN	O
hemorrhage	NN	B-PROBLEM
identified	VBN	O
.	.	O

head	NN	B-TEST
computerized	VBD	I-TEST
tomography	JJ	I-TEST
scan	NN	I-TEST
of	IN	O
10/23	CD	O
:	:	O

the	DT	O
area	NN	O
of	IN	O
hemorrhage	NN	B-PROBLEM
the	DT	O
same	JJ	O
,	,	O
slightly	RB	B-PROBLEM
more	RBR	I-PROBLEM
edema	JJ	I-PROBLEM
and	CC	I-PROBLEM
mass	JJ	I-PROBLEM
effect	NN	I-PROBLEM
.	.	O

pulmonary	JJ	B-TEST
angiogram	NN	I-TEST
:	:	O

no	DT	O
evidence	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	O
localization	NN	O
of	IN	O
the	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
the	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
the	DT	O
most	RBS	O
likely	JJ	O
cause	NN	O
for	IN	O
mrs.	NN	O
dua	NN	O
&apos;s	NNP	O
cerebellar	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
is	VBZ	O
hypertension	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
will	MD	O
be	VB	O
scheduled	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
in	IN	O
three	CD	O
months	NNS	O
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
if	IN	O
responsible	JJ	O
for	IN	O
the	DT	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
now	RB	O
able	JJ	O
to	TO	O
walk	VB	O
fitfully	RB	O
and	CC	O
use	VB	O
her	PRP$	O
left	JJ	O
hand	NN	O
with	IN	O
no	DT	O
problem	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
exam	NN	I-TEST
is	VBZ	O
remarkable	JJ	O
for	IN	O
a	DT	B-PROBLEM
mild	NN	I-PROBLEM
leftsided	VBD	I-PROBLEM
face	NN	I-PROBLEM
,	,	O
arm	NN	B-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
sensory	JJ	B-PROBLEM
deficit	NN	I-PROBLEM
that	WDT	O
should	MD	O
further	RB	O
improve	VB	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
help	NN	O
.	.	O

her	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
difficult	JJ	O
to	TO	O
manage	VB	O
initially	RB	O
and	CC	O
required	VBD	O
three	CD	O
days	NNS	O
of	IN	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
a-line	JJ	B-TREATMENT
and	CC	O
nipride	JJ	B-TREATMENT
intravenously	RB	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
finally	RB	O
under	IN	O
control	NN	O
with	IN	O
high	JJ	O
doses	NNS	O
of	IN	O
captopril	NN	B-TREATMENT
,	,	O
nifedipine	NN	B-TREATMENT
,	,	O
and	CC	O
hydrochlorothiazide	NN	B-TREATMENT
.	.	O

the	DT	B-TEST
workup	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
secondary	JJ	B-PROBLEM
cause	NN	I-PROBLEM
of	IN	O
hypertension	NN	B-PROBLEM
given	VBN	O
the	DT	O
patient	NN	O
&apos;s	NN	O
young	JJ	O
age	NN	O
and	CC	O
the	DT	O
difficulty	NN	O
controlling	VBG	O
the	DT	O
blood	NN	O
pressure	NN	O
was	VBD	O
started	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
and	CC	O
will	MD	O
be	VB	O
completed	VBN	O
by	IN	O
dr.	NN	O
______________as	NNP	O
an	DT	O
outpatient	NN	O
.	.	O

so	RB	O
far	RB	O
no	DT	O
secondary	JJ	B-PROBLEM
causes	NNS	I-PROBLEM
of	IN	O
hypertension	NN	B-PROBLEM
were	VBD	O
identified	VBN	O
but	CC	O
causes	VBZ	O
like	IN	O
lymphocytic	JJ	B-PROBLEM
?	.	I-PROBLEM
chromocytoma	NN	I-PROBLEM
or	CC	O
renal	JJ	B-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
have	VBP	O
not	RB	O
been	VBN	O
ruled	VBN	O
out	RP	O
yet	RB	O
.	.	O

hydrochlorothiazide	RB	B-TREATMENT
25	CD	O
mg.	NNS	O
po	JJ	O
q.day	NN	O
,	,	O
captopril	VBP	B-TREATMENT
75	CD	O
mg.	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
nifedipine	JJ	B-TREATMENT
40	CD	O
mg.	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

will	MD	O
be	VB	O
reassessed	VBN	O
after	IN	O
a	DT	O
month	NN	O
of	IN	O
intensive	JJ	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

vaginal	JJ	B-TREATMENT
delivery	NN	I-TREATMENT
with	IN	O
second	JJ	B-PROBLEM
degree	NN	I-PROBLEM
laceration	NN	I-PROBLEM

abnormal	JJ	B-PROBLEM
laboratory	NN	I-PROBLEM
result	NN	I-PROBLEM
;	:	O
abnormal	JJ	B-PROBLEM
pap	JJ	I-PROBLEM
test	NN	I-PROBLEM
;	:	O
monilial	JJ	B-PROBLEM
vaginitis	NN	I-PROBLEM

spontaneous	JJ	B-TREATMENT
vertex	NNS	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT

routine	JJ	B-TREATMENT
post	NN	I-TREATMENT
partum	NN	I-TREATMENT
care	NN	I-TREATMENT

premature	JJ	B-PROBLEM
rupture	NN	I-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM

height	RB	O
63	CD	O
heent	NN	B-TEST
normal	JJ	O
mouth	NN	O
normal	JJ	O
neck	NN	O
normal	JJ	O
breasts	NNS	O
normal	JJ	O
no	DT	O
masses	NNS	B-PROBLEM
nipples	VBZ	O
normal	JJ	O
chest	NN	O
normal	JJ	O
cta	NN	B-TEST
bilat	NN	O
,	,	O
neg	JJ	O
wheezing	VBG	B-PROBLEM
cor	NN	O
normal	JJ	O
nsr	NN	O
,	,	O
no	DT	O
murmur	JJ	B-PROBLEM
abdomen	NNS	O
gravid	VBP	B-PROBLEM
,	,	O
vtx	NN	O
.	.	O

efw	NN	B-TEST
=	$	O
7#	CD	O
.	.	O

fhts	NNS	B-TEST
140s	CD	O
w/	JJ	O
reactivity	NN	O
.	.	O

mild	JJ	B-PROBLEM
irreg.	JJ	I-PROBLEM
ctx	NN	I-PROBLEM
.	.	O

extrem	NN	B-TEST
normal	JJ	O
skin	NN	O
normal	JJ	O
nodes	NNS	O
normal	JJ	O
vulva	NN	O
normal	JJ	O
vagina	NN	O
leaking	VBG	O
copious	JJ	B-PROBLEM
amounts	NNS	I-PROBLEM
clear	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

fluid	NN	B-TEST
amnioswab	NN	I-TEST
and	CC	O
fern	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
.	.	O

sse	NN	B-TEST
and	CC	O
digital	JJ	B-TEST
exam	NN	I-TEST
deferred	VBD	O
cervix	JJ	B-TEST
digital	JJ	I-TEST
exam	NN	I-TEST
deferred	VBN	O
at	IN	O
time	NN	O
of	IN	O
admission	NN	O
os	NN	B-TEST
normal	JJ	O
see	VBP	O
above	IN	O
adnexae	NNS	B-TEST
normal	JJ	O
non-palp	JJ	O
d	NN	O
/	NNP	O
t	NN	O
advanced	VBD	B-PROBLEM
gest	JJS	I-PROBLEM
uterus	NN	I-PROBLEM
gravid	NN	I-PROBLEM
,	,	O
vtx	NN	O
.	.	O

efw	NN	B-TEST
=	$	O
7#	CD	O
.	.	O

fhts	NNS	B-TEST
140s	CD	O
w/	JJ	O
reactivity	NN	O
.	.	O

ctx	NN	B-TEST
q	VBZ	O
6	CD	O
&apos;	NN	O
.	.	O

uterine	JJ	B-TEST
size	NN	I-TEST
in	IN	O
weeks	NNS	O
38	CD	O

premature	JJ	B-PROBLEM
rupture	NN	I-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
.	.	O

she	PRP	O
delivered	VBD	O
a	DT	O
3235	CD	O
gram	NN	O
male	NN	O
infant	NN	O
on	IN	O
11/01/2004	CD	O
at	IN	O
09:31	CD	O
am	VBP	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
9	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
39.0	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

multivitamins	NNS	B-TREATMENT
and	CC	O
folate	NN	B-TREATMENT

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
fever	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
ph	VB	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
.	.	O

your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
aner	NN	O
,	,	O
aea	JJ	O
m	NN	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
line	NN	B-PROBLEM
sepsis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
68	CD	O
year	NN	O
old	JJ	O
,	,	O
right	RB	O
handed	VBN	O
caucasian	JJ	O
female	NN	O
,	,	O
former	JJ	O
r.n.	NN	O
who	WP	O
complained	VBD	O
of	IN	O
several	JJ	O
days	NNS	O
of	IN	O
vertigo	NN	B-PROBLEM
,	,	O
one	CD	O
day	NN	O
of	IN	O
double	JJ	B-PROBLEM
vision	NN	I-PROBLEM
,	,	O
dysarthria	NN	B-PROBLEM
and	CC	O
worsening	NN	O
of	IN	O
vertigo	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
seen	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
and	CC	O
put	VB	O
on	IN	O
aspirin	NN	B-TREATMENT
for	IN	O
two	CD	O
days	NNS	O
.	.	O

an	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
showed	VBD	O
basilar	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
questionable	JJ	O
aneurysm	NN	B-PROBLEM
.	.	O

an	DT	B-TEST
angiogram	NN	I-TEST
on	IN	O
11/3	CD	O
was	VBD	O
consistent	JJ	O
with	IN	O
thrombosis	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
basilar	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
put	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
and	CC	O
was	VBD	O
stable	JJ	O
since	IN	O
.	.	O

hypertension	NN	B-PROBLEM
for	IN	O
20	CD	O
years	NNS	O
,	,	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
episodes	NNS	O
of	IN	O
angina	NN	B-PROBLEM
,	,	O
no	DT	O
history	NN	O
of	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
exercise	NN	B-TEST
treadmill	NN	I-TEST
or	CC	O
evaluation	NN	B-TEST
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
an	DT	B-TREATMENT
inguinal	JJ	I-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

a	DT	B-TREATMENT
left	JJ	I-TREATMENT
breast	NN	I-TREATMENT
lumpectomy	NN	I-TREATMENT
was	VBD	O
reportedly	RB	O
benign	JJ	B-TEST
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

mevicor	NN	B-TREATMENT
60	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O
,	,	O
cardizem	VBP	B-TREATMENT
90	CD	O
mg.	NN	O
w	NN	O
release	NN	O
po	NN	O
q.d.	NN	O
,	,	O
questran	VBD	B-TREATMENT
one	CD	O
pack	NN	O
q.i.d.	NN	O
,	,	O
niacin	RB	B-TREATMENT
500	CD	O
mg.	NNS	O
po	JJ	O
b.i.d.	NN	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
190/90	CD	O
when	WRB	O
i	NN	O
first	RB	O
saw	VBD	O
her	PRP	O
on	IN	O
her	PRP$	O
second	JJ	O
hospital	JJ	O
day	NN	O
.	.	O

she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
in	IN	O
sinus	NN	O
rhythm	NN	O
,	,	O
pulse	RB	O
60	CD	O
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
without	IN	O
ectopy	NN	B-PROBLEM
.	.	O

a	DT	B-PROBLEM
ii	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
is	VBZ	O
at	IN	O
the	DT	O
base	NN	O
,	,	O
minimal	JJ	B-PROBLEM
radiation	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
carotids	NNS	I-PROBLEM
.	.	O

soft	JJ	O
,	,	O
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

normal	JJ	O
pulses	NNS	O
,	,	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
:	:	O

post	NN	O
angiogram	IN	B-TEST
her	PRP$	O
eyes	NNS	O
were	VBD	O
closed	VBN	O
.	.	O

she	PRP	O
was	VBD	O
very	RB	O
responsive	JJ	O
,	,	O
somewhat	RB	O
sleepy	JJ	O
,	,	O
she	PRP	O
complained	VBD	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
diffuse	NN	O
,	,	O
non-localizing	JJ	O
without	IN	O
electrocardiogram	JJ	O
changes	NNS	O
and	CC	O
persisted	VBN	O
for	IN	O
several	JJ	O
days	NNS	O
and	CC	O
then	RB	O
went	VBD	O
away	RB	O
completely	RB	O
.	.	O

the	DT	B-TEST
cranial	JJ	I-TEST
nerve	NN	I-TEST
exam	NN	I-TEST
:	:	O

pupils	NNS	O
reactive	VBP	O
to	TO	O
light	NN	O
,	,	O
extra	JJ	B-TEST
ocular	JJ	I-TEST
movements	NNS	I-TEST
show	VBP	O
good	JJ	O
upgaze	NN	O
up	RB	O
to	TO	O
3	CD	O
mm.	NNS	O
,	,	O
good	JJ	O
down	RP	O
gaze	NN	O
.	.	O

right	JJ	B-TEST
lateral	NN	I-TEST
gaze	NN	I-TEST
,	,	O
the	DT	O
right	NN	O
eye	NN	O
had	VBD	O
2	CD	O
mm.	NN	O
of	IN	O
sclera	NN	O
showing	NN	O
,	,	O
the	DT	O
left	NN	O
eye	NN	O
was	VBD	O
normal	JJ	O
,	,	O
and	CC	O
there	EX	O
are	VBP	O
a	DT	O
few	JJ	O
beats	NNS	O
of	IN	O
right	JJ	B-PROBLEM
beading	VBG	I-PROBLEM
nystagmus	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
left	JJ	I-TEST
lateral	JJ	I-TEST
gaze	NN	I-TEST
,	,	O
the	DT	O
left	NN	O
eye	NN	O
had	VBD	O
1	CD	O
mm.	NN	O
of	IN	O
lateral	JJ	O
sclera	NN	O
showing	NN	O
.	.	O

sensory	JJ	O
limb	NN	O
of	IN	O
the	DT	O
right	JJ	O
eye	NN	O
corneal	NN	B-TEST
reflex	NN	I-TEST
is	VBZ	O
slowed	VBN	O
,	,	O
otherwise	RB	O
normal	JJ	O
.	.	O

seventh	JJ	B-PROBLEM
nerve	NN	I-PROBLEM
weakness	NN	I-PROBLEM
on	IN	O
the	DT	O
right	NN	O
in	IN	O
a	DT	O
central	JJ	O
pattern	NN	O
is	VBZ	O
present	JJ	O
.	.	O

sensory	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
not	RB	O
remarkable	JJ	O
,	,	O
cerebellar	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
not	RB	O
possible	JJ	O
.	.	O

motor	NN	B-TEST
exam	NN	I-TEST
showed	VBD	O
greater	JJR	O
than	IN	O
4+	CD	O
strength	NN	O
bilateral	JJ	O
upper	JJ	O
extremities	NNS	O
and	CC	O
psoas	NN	O
unable	JJ	O
to	TO	O
lift	VB	O
off	RP	O
bed	NN	O
.	.	O

quadraceps	NNS	B-TEST
2+	CD	O
on	IN	O
the	DT	O
left	NN	O
and	CC	O
3+	CD	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

gastroc.	NN	B-TEST
3	CD	O
on	IN	O
the	DT	O
left	NN	O
and	CC	O
4+	CD	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

tibialis	RB	B-TEST
3	CD	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
5+	CD	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

reflexes	NNS	B-TEST
were	VBD	O
diffuse	RB	O
3+	CD	O
,	,	O
toes	NNS	O
upgoing	VBG	O
bilaterally	RB	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
electrocardiogram	NN	B-TEST
showed	VBD	O
less	JJR	O
than	IN	O
1	CD	O
mm.	NN	O
of	IN	O
st	JJ	B-PROBLEM
depression	NN	I-PROBLEM
in	IN	I-PROBLEM
v4	NN	I-PROBLEM
to	TO	I-PROBLEM
v6	VB	I-PROBLEM
,	,	O
which	WDT	O
is	VBZ	O
likely	JJ	O
the	DT	O
patient	JJ	O
&apos;s	NNP	O
baseline	NN	O
.	.	O

ck	NN	B-TEST
&apos;s	NNS	I-TEST
were	VBD	O
mildly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
but	CC	O
the	DT	B-TEST
mb	JJ	I-TEST
fractions	NNS	I-TEST
were	VBD	O
not	RB	O
remarkable	JJ	O
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
some	DT	B-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

admitting	VBG	B-TEST
creatinine	NN	I-TEST
was	VBD	O
.7	NNP	O
,	,	O
glucose	VBD	B-TEST
131	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
10,000	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
40	CD	O
,	,	O
liver	RB	B-TEST
enzymes	VBZ	I-TEST
normal	JJ	O
range	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
after	IN	O
her	PRP$	B-TEST
angiogram	NN	I-TEST
.	.	O

she	PRP	O
was	VBD	O
aggressively	RB	O
anticoagulated	VBN	O
with	IN	O
heparin	NN	B-TREATMENT
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
intimal	JJ	I-PROBLEM
tear	NN	I-PROBLEM
in	IN	O
the	DT	O
arch	NN	O
of	IN	O
the	DT	O
aorta	NN	O
during	IN	O
the	DT	B-TEST
angiogram	NN	I-TEST
,	,	O
was	VBD	O
without	IN	O
sequelae	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
doing	VBG	O
well	RB	O
with	IN	O
at	IN	O
least	JJS	O
4+	CD	O
strength	NN	O
in	IN	O
all	DT	O
of	IN	O
her	PRP$	O
extremities	NNS	O
,	,	O
when	WRB	O
on	IN	O
11/13	CD	O
,	,	O
she	PRP	O
had	VBD	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
drop	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
to	TO	O
70	CD	O
for	IN	O
unclear	JJ	O
reasons	NNS	O
and	CC	O
without	IN	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
accompanied	VBN	O
by	IN	O
substantial	JJ	B-PROBLEM
decrement	NN	I-PROBLEM
in	IN	I-PROBLEM
neurologic	JJ	I-PROBLEM
function	NN	I-PROBLEM
.	.	O

for	IN	O
a	DT	O
short	JJ	O
time	NN	O
,	,	O
she	PRP	O
seemed	VBD	O
&quot;	JJ	B-PROBLEM
locked	VBN	I-PROBLEM
in	IN	I-PROBLEM
&quot;	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
drowsy	VBN	B-PROBLEM
at	IN	O
times	NNS	O
,	,	O
but	CC	O
generally	RB	O
alert	JJ	O
,	,	O
responsive	JJ	O
,	,	O
interactive	JJ	O
,	,	O
able	JJ	O
to	TO	O
talk	VB	O
in	IN	O
two	CD	O
to	TO	O
three	CD	O
word	NN	O
sentences	NNS	O
when	WRB	O
she	PRP	O
wants	VBZ	O
to	TO	O
.	.	O

she	PRP	O
has	VBZ	O
severe	JJ	B-PROBLEM
memory	NN	I-PROBLEM
deficits	NNS	I-PROBLEM
,	,	O
but	CC	O
nevertheless	RB	O
,	,	O
is	VBZ	O
able	JJ	O
to	TO	O
engage	VB	O
in	IN	O
conversation	NN	O
,	,	O
answers	NNS	O
questions	NNS	O
,	,	O
names	NNS	O
things	NNS	O
well	RB	O
,	,	O
does	VBZ	O
calculations	NNS	O
and	CC	O
recognizes	VBZ	O
family	NN	O
members	NNS	O
and	CC	O
states	NNS	O
preferences	NNS	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
working	VBG	O
with	IN	O
speech	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
closely	RB	O
and	CC	O
should	MD	O
continue	VB	O
to	TO	O
show	VB	O
improvement	NN	O
.	.	O

she	PRP	O
is	VBZ	O
anticoagulated	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
and	CC	O
this	DT	O
has	VBZ	O
been	VBN	O
stable	JJ	O
.	.	O

follow	VB	O
up	RP	O
computerized	JJ	B-TEST
tomography	NN	I-TEST
scans	NNS	I-TEST
and	CC	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
studies	NNS	I-TEST
have	VBP	O
shown	VBN	O
infarction	NN	B-PROBLEM
in	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
basis	NN	I-PROBLEM
pontis	NN	I-PROBLEM
,	,	I-PROBLEM
mid	NN	I-PROBLEM
brain	NN	I-PROBLEM
,	,	I-PROBLEM
the	DT	I-PROBLEM
superior	JJ	I-PROBLEM
cerebellar	JJ	I-PROBLEM
areas	NNS	I-PROBLEM
,	,	I-PROBLEM
left	VBD	I-PROBLEM
thalamus	NN	I-PROBLEM
,	,	I-PROBLEM
bilateral	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
lobes	NNS	I-PROBLEM
medially	RB	I-PROBLEM
and	CC	I-PROBLEM
inferiorly	RB	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
posterior	JJ	I-PROBLEM
communicating	VBG	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
fevers	NNS	B-PROBLEM
sporadically	RB	O
during	IN	O
this	DT	O
hospitalization	NN	O
with	IN	O
rising	VBG	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
counts	NNS	I-PROBLEM
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
documented	VBD	O
a	DT	B-PROBLEM
progressing	NN	I-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

initially	RB	O
this	DT	O
improved	VBN	O
on	IN	O
clindamycin	NN	B-TREATMENT
and	CC	O
cefotetan	NN	B-TREATMENT
,	,	O
but	CC	O
fevers	NNS	B-PROBLEM
recurred	VBD	O
on	IN	O
this	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

sputum	NN	B-TEST
grew	VBD	O
out	RP	O
klebsiella	NN	B-PROBLEM
pneumoniae	NN	I-PROBLEM
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
gentamicin	NN	B-TREATMENT
and	CC	O
ancef	NN	B-TREATMENT
for	IN	O
14	CD	O
days	NNS	O
intravenous	JJ	O
(	(	O
bug	JJ	B-PROBLEM
being	VBG	O
sensitive	JJ	O
to	TO	O
these	DT	B-TREATMENT
two	CD	I-TREATMENT
drugs	NNS	I-TREATMENT
)	)	O
.	.	O

a	DT	B-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
developed	VBD	O
and	CC	O
this	DT	O
was	VBD	O
tapped	VBN	O
with	IN	O
ultrasound	JJ	B-TEST
guidance	NN	I-TEST
,	,	O
and	CC	O
found	VBD	O
to	TO	O
be	VB	O
sterile	JJ	O
,	,	O
and	CC	O
without	IN	O
evidence	NN	O
of	IN	O
empyema	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
on	IN	O
ciprofloxacin	NN	B-TREATMENT
.	.	O

the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
is	VBZ	O
day	NN	O
#3	NNP	O
of	IN	O
7	CD	O
,	,	O
after	IN	O
which	WDT	O
antibiotics	NNS	B-TREATMENT
should	MD	O
be	VB	O
totally	RB	O
discontinued	VBN	O
.	.	O

she	PRP	O
has	VBZ	O
developed	VBN	O
bad	JJ	B-PROBLEM
thrush	NN	I-PROBLEM
in	IN	O
this	DT	O
setting	NN	O
,	,	O
she	PRP	O
is	VBZ	O
not	RB	O
yet	RB	O
able	JJ	O
to	TO	O
swallow	VB	O
and	CC	O
so	RB	O
she	PRP	O
is	VBZ	O
on	IN	O
nystatin	JJ	B-TREATMENT
swish	JJ	I-TREATMENT
and	CC	I-TREATMENT
spit	JJ	I-TREATMENT
five	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

she	PRP	O
also	RB	O
gets	VBZ	O
peridex	NN	B-TREATMENT
to	TO	O
clean	VB	O
out	RP	O
her	PRP$	O
mouth	NN	O
.	.	O

once	RB	O
her	PRP$	B-TEST
liver	NN	I-TEST
enzymes	NNS	I-TEST
are	VBP	O
completely	RB	O
normal	JJ	O
,	,	O
a	DT	O
seven	CD	O
day	NN	O
course	NN	O
of	IN	O
fluconazol	NN	B-TREATMENT
may	MD	O
be	VB	O
helpful	JJ	O
if	IN	O
the	DT	B-PROBLEM
thrush	NN	I-PROBLEM
is	VBZ	O
not	RB	O
spontaneously	RB	O
resolving	VBG	O
off	IN	O
of	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
afebrile	RB	B-PROBLEM
for	IN	O
greater	JJR	O
than	IN	O
10	CD	O
days	NNS	O
,	,	O
including	VBG	O
several	JJ	O
days	NNS	O
on	IN	O
oral	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
liver	NN	I-TEST
enzymes	NNS	I-TEST
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
elevated	VBN	O
mid	JJ	O
way	NN	O
through	IN	O
her	PRP$	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
,	,	O
to	TO	O
about	IN	O
three	CD	O
times	NNS	O
normal	JJ	O
,	,	O
especially	RB	O
the	DT	O
sgot	NN	B-TEST
and	CC	O
sgpt	NN	B-TEST
.	.	O

a	DT	B-TEST
right	JJ	I-TEST
upper	NN	I-TEST
quadrant	NN	I-TEST
ultrasound	NN	I-TEST
documented	VBD	O
gallstones	NNS	B-PROBLEM
,	,	O
without	IN	O
evidence	NN	O
of	IN	O
common	JJ	B-PROBLEM
bile	JJ	I-PROBLEM
duct	NN	I-PROBLEM
dilatation	NN	I-PROBLEM
or	CC	O
active	JJ	B-PROBLEM
cholecystitis	NN	I-PROBLEM
.	.	O

the	DT	O
exact	JJ	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
liver	NN	I-PROBLEM
enzyme	DT	I-PROBLEM
elevation	NN	I-PROBLEM
is	VBZ	O
unclear	JJ	O
,	,	O
but	CC	O
we	PRP	O
are	VBP	O
being	VBG	O
careful	JJ	O
about	IN	O
administering	VBG	O
drugs	NNS	B-TREATMENT
,	,	O
which	WDT	O
might	MD	O
irritate	VB	O
the	DT	O
liver	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
steady	JJ	I-PROBLEM
decline	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
during	IN	O
this	DT	B-TREATMENT
hospitalization	NN	I-TREATMENT
.	.	O

iron	NN	B-TEST
studies	NNS	I-TEST
are	VBP	O
all	DT	O
entirely	RB	O
normal	JJ	O
,	,	O
her	PRP$	B-PROBLEM
anemia	NN	I-PROBLEM
is	VBZ	O
attributed	VBN	O
to	TO	O
anemia	VB	B-PROBLEM
or	CC	O
chronic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
hypoproliferation	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
multiple	JJ	B-TEST
phlebotomies	NNS	I-TEST
.	.	O

the	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
give	VB	O
her	PRP$	O
folic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
,	,	O
but	CC	O
not	RB	O
iron	NN	B-TREATMENT
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
potassiums	NNS	I-TEST
have	VBP	O
been	VBN	O
repeatedly	RB	O
low	JJ	O
and	CC	O
require	JJ	O
daily	JJ	B-TEST
checks	NNS	I-TEST
and	CC	O
repletion	NN	B-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
thought	VBN	O
due	RB	O
to	TO	O
the	DT	O
extensive	JJ	O
course	NN	O
of	IN	O
gentamicin	NN	B-TREATMENT
which	WDT	O
she	PRP	O
received	VBD	O
.	.	O

this	DT	O
must	MD	O
be	VB	O
carefully	RB	O
checked	VBN	O
despite	IN	O
the	DT	O
standing	VBG	O
order	NN	O
for	IN	O
potassium	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
low	JJ	B-PROBLEM
sodiums	NNS	I-PROBLEM
during	IN	O
this	DT	B-TREATMENT
hospitalization	NN	I-TREATMENT
.	.	O

this	DT	O
may	MD	O
due	VB	O
to	TO	O
her	PRP$	B-PROBLEM
central	JJ	I-PROBLEM
nervous	JJ	I-PROBLEM
system	NN	I-PROBLEM
process	NN	I-PROBLEM
or	CC	O
her	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
process	NN	I-PROBLEM
,	,	O
with	IN	O
fluids	NNS	B-TREATMENT
administered	VBN	I-TREATMENT
as	IN	O
described	NN	O
,	,	O
she	PRP	O
should	MD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
problems	NNS	I-PROBLEM
from	IN	O
this	DT	O
.	.	O

her	PRP$	B-TEST
sodiums	NNS	I-TEST
were	VBD	O
never	RB	O
below	IN	O
130	CD	O
.	.	O

she	PRP	O
does	VBZ	O
well	RB	O
with	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
orders	NNS	O
are	VBP	O
as	IN	O
follow	NN	O
:	:	O

full	JJ	O
strength	NN	O
replete	NN	O
with	IN	O
fiber	NN	B-TREATMENT
at	IN	O
70	CD	O
cc.	NNS	O
per	IN	O
hour	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	JJ	O
gets	VBZ	O
250	CD	O
cc.	NN	O
of	IN	O
juice	NN	B-TREATMENT
(	(	O
not	RB	O
water	NN	O
)	)	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

she	PRP	O
also	RB	O
gets	VBZ	O
lactinex	JJ	B-TREATMENT
granules	NNS	I-TREATMENT
three	CD	O
packages	NNS	O
in	IN	O
each	DT	O
bottle	NN	O
of	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

she	PRP	O
also	RB	O
gets	VBZ	O
metamucil	JJ	B-TREATMENT
one	CD	O
teaspoon	NN	O
with	IN	O
the	DT	O
first	JJ	O
bolus	NN	O
of	IN	O
juice	NN	B-TREATMENT
each	DT	O
day	NN	O
.	.	O

please	VB	O
note	NN	O
that	IN	O
evaluation	NN	B-TEST
by	IN	I-TEST
the	DT	I-TEST
swallowing	VBG	I-TEST
therapist	NN	I-TEST
,	,	O
showed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
is	VBZ	O
aspirating	VBG	O
at	IN	O
this	DT	O
time	NN	O
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
great	JJ	O
hope	NN	O
from	IN	O
the	DT	O
nature	NN	O
of	IN	O
her	PRP$	B-PROBLEM
deficit	NN	I-PROBLEM
and	CC	O
the	DT	O
good	JJ	O
movements	NNS	O
of	IN	O
her	PRP$	O
tongue	NN	O
that	IN	O
normal	JJ	O
swallowing	NN	O
should	MD	O
return	VB	O
soon	RB	O
.	.	O

it	PRP	O
is	VBZ	O
for	IN	O
this	DT	O
reason	NN	O
that	IN	O
she	PRP	O
is	VBZ	O
discharged	VBN	O
with	IN	O
an	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
that	IN	O
no	DT	O
plans	NNS	O
for	IN	O
g	NN	B-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
are	VBP	O
made	VBN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
of	IN	O
angina	NN	B-PROBLEM
without	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
that	WDT	O
has	VBZ	O
not	RB	O
been	VBN	O
worked	VBN	O
up	RP	O
.	.	O

she	PRP	O
did	VBD	O
have	VB	O
brief	NN	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
twice	RB	O
during	IN	O
this	DT	O
admission	NN	O
that	WDT	O
did	VBD	O
not	RB	O
correlate	VB	O
with	IN	O
electrocardiogram	JJ	O
changes	NNS	O
.	.	O

in	IN	O
the	DT	O
first	JJ	O
week	NN	O
of	IN	O
november	NN	O
,	,	O
her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
t	JJ	B-PROBLEM
wave	NN	I-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
leads	NNS	I-PROBLEM
,	,	O
correlating	VBG	O
with	IN	O
an	DT	B-PROBLEM
increase	NN	I-PROBLEM
in	IN	O
the	DT	B-TEST
ldh	NN	I-TEST
,	,	O
but	CC	O
not	RB	O
ck	NNS	B-TEST
.	.	O

this	DT	O
did	VBD	O
not	RB	O
normalize	VB	O
with	IN	O
administration	NN	O
of	IN	O
isordil	NN	B-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
denied	VBD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
.	.	O

as	IN	O
of	IN	O
4/7	CD	O
,	,	O
her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
had	VBD	O
reverted	VBN	O
back	RB	O
to	TO	O
normal	JJ	O
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
or	CC	O
continued	VBN	O
electrocardiogram	JJ	O
changes	NNS	O
,	,	O
and	CC	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
is	VBZ	O
absent	JJ	O
.	.	O

her	PRP$	B-TEST
cholesterol	NN	I-TEST
was	VBD	O
350	CD	O
here	RB	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
off	IN	O
of	IN	O
her	PRP$	B-TREATMENT
hypercholesterol	NN	I-TREATMENT
medicines	NNS	I-TREATMENT
.	.	O

these	DT	O
can	MD	O
be	VB	O
restarted	VBN	O
when	WRB	O
it	PRP	O
is	VBZ	O
deemed	VBN	O
reasonable	JJ	O
,	,	O
in	IN	O
view	NN	O
of	IN	O
her	PRP$	B-PROBLEM
acute	JJ	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
recently	RB	B-PROBLEM
elevated	VBD	I-PROBLEM
liver	JJ	I-PROBLEM
enzymes	NNS	I-PROBLEM
.	.	O

note	NN	O
that	IN	O
the	DT	B-TEST
liver	NN	I-TEST
enzymes	NNS	I-TEST
were	VBD	O
normal	JJ	O
on	IN	O
admission	NN	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
was	VBD	O
taking	VBG	O
all	DT	O
of	IN	O
the	DT	B-TREATMENT
above	JJ	I-TREATMENT
cholesterol	NN	I-TREATMENT
medicines	NNS	I-TREATMENT
.	.	O

metamucil	NN	B-TREATMENT
1	CD	O
teaspoon	NN	O
q.d.	NN	O
,	,	O
with	IN	O
first	JJ	O
bolus	NN	O
of	IN	O
juice	NN	B-TREATMENT
,	,	O
juice	NN	B-TREATMENT
250	CD	O
cc.	NN	O
down	RB	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
t.i.d.	NN	O
,	,	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
as	IN	O
above	IN	O
,	,	O
lactinex	NN	B-TREATMENT
as	IN	O
above	IN	O
,	,	O
tagamet	VBD	B-TREATMENT
800	CD	O
mg.	NN	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
qhs	NN	O
,	,	O
nystatin	JJ	B-TREATMENT
swish	JJ	I-TREATMENT
and	CC	I-TREATMENT
spit	JJ	I-TREATMENT
10	CD	O
cc.	NN	O
five	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
cardizem	NN	B-TREATMENT
slow	JJ	I-TREATMENT
release	NN	I-TREATMENT
90	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O
,	,	O
folic	JJ	B-TREATMENT
acid	VBP	I-TREATMENT
1	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O
,	,	O
ciprofloxacin	VBP	B-TREATMENT
500	CD	O
mg.	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
discontinue	NN	O
on	IN	O
12/10/92	CD	O
kayciel	NNS	B-TREATMENT
30	CD	O
meq.	NNS	O
down	RB	O
nasogastric	RB	B-TREATMENT
tube	JJ	I-TREATMENT
q.d.	NN	O
,	,	O
peridex	NN	B-TREATMENT
10	CD	O
cc.	NN	O
swish	NN	O
and	CC	O
spit	NN	O
q.i.d.	NN	O
,	,	O
coumadin	VBP	B-TREATMENT
4	CD	O
mg.	NNS	O
nasogastric	JJ	O
tube	NN	O
on	IN	O
odd	JJ	O
days	NNS	O
,	,	O
alternating	VBG	O
with	IN	O
5	CD	O
mg.	NNS	O
nasogastric	JJ	O
tube	NN	O
on	IN	O
even	JJ	O
days	NNS	O
,	,	O
once	RB	O
daily	JJ	O
,	,	O
tylenol	JJ	B-TREATMENT
650	CD	O
mg.	NN	O
po	NN	O
and	CC	O
pr	NN	O
q6hours	NNS	O
prn	VBP	O
pain	NN	B-PROBLEM
,	,	O
nystatin	JJ	B-TREATMENT
powder	NN	I-TREATMENT
to	TO	O
axilla	VB	O
and	CC	O
groin	VB	O
as	IN	O
needed	VBN	O
.	.	O

basilar	JJ	B-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
basilar	JJ	B-PROBLEM
thrombosis	NN	I-PROBLEM
and	CC	O
&quot;	NNP	B-PROBLEM
top	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
basilar	JJ	I-PROBLEM
&quot;	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

includes	VBZ	O
recent	JJ	B-PROBLEM
infarct	NN	I-PROBLEM
to	TO	I-PROBLEM
pons	NNS	I-PROBLEM
,	,	I-PROBLEM
mid	NN	I-PROBLEM
brain	NN	I-PROBLEM
,	,	I-PROBLEM
left	VBD	I-PROBLEM
thalamus	NN	I-PROBLEM
,	,	I-PROBLEM
bilateral	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
lobes	NNS	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
visual	JJ	I-PROBLEM
cortex	NN	I-PROBLEM
,	,	O
on	IN	O
coumadin	NN	B-TREATMENT
.	.	O

left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
resolving	VBG	O
now	RB	O
on	IN	O
oral	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

gallstones	NNS	B-PROBLEM
,	,	O
thought	VBN	O
to	TO	O
be	VB	O
inactive	JJ	O
.	.	O

improving	VBG	O
liver	NN	B-PROBLEM
enzyme	DT	I-PROBLEM
elevation	NN	I-PROBLEM
.	.	O

anemia	NN	B-PROBLEM
,	,	O
discharge	NN	B-TEST
hematocrit	NN	I-TEST
28	CD	O
,	,	O
not	RB	O
iron	VB	B-PROBLEM
deficient	NN	I-PROBLEM
.	.	O

low	JJ	B-PROBLEM
potassium	NN	I-PROBLEM
,	,	O
thought	VBD	O
due	JJ	O
to	TO	O
gentamicin	VB	B-TREATMENT
.	.	O

low	JJ	B-PROBLEM
sodium	NN	I-PROBLEM
,	,	O
responsive	JJ	O
to	TO	O
fluid	VB	B-TREATMENT
restriction	NN	I-TREATMENT
.	.	O

history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

thrush	NN	B-PROBLEM
.	.	O

high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
needs	VBZ	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
checked	VBD	O
daily	RB	O
,	,	O
patient	JJ	O
needs	NNS	O
potassium	NN	B-TEST
checked	VBD	O
daily	RB	O
,	,	O
patient	JJ	O
needs	NNS	O
sodium	NN	B-TEST
checked	VBN	O
at	IN	O
least	JJS	O
every	DT	O
other	JJ	O
day	NN	O
.	.	O

rlq	NN	B-PROBLEM
pain	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
kidney	NN	B-PROBLEM
stones	NNS	I-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

likely	RB	O
recently	RB	B-PROBLEM
passed	VBN	I-PROBLEM
kidney	NN	I-PROBLEM
stone	NN	I-PROBLEM

history	NN	O
,	,	O
physical	JJ	B-TEST
,	,	O
lab	NN	B-TEST
,	,	O
abdominal	JJ	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST

motrin	NN	B-TREATMENT
as	IN	O
needed	VBN	O

also	RB	O
please	NN	O
follow	VB	O
up	RP	O
with	IN	O
urology	NN	O
regarding	VBG	O
management	NN	B-TREATMENT
of	IN	O
your	PRP$	B-PROBLEM
kidney	NN	I-PROBLEM
stones	NNS	I-PROBLEM
.	.	O

please	VB	O
return	VB	O
if	IN	O
your	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
return	VBP	O
,	,	O
you	PRP	O
develop	VBP	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

following	VBG	O
triage	NN	B-TEST
,	,	O
the	DT	O
patient	NN	O
left	VBD	O
without	IN	O
treatment	NN	B-TREATMENT
.	.	O

left	VBN	B-PROBLEM
knee	NN	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
.	.	O

left	JJ	B-TREATMENT
total	JJ	I-TREATMENT
knee	NN	I-TREATMENT
arthroplasty	NN	I-TREATMENT
on	IN	O
6/26/90	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
78-year-old	JJ	O
female	NN	O
who	WP	O
has	VBZ	O
had	VBN	O
osteoarthritis	VBN	B-PROBLEM
and	CC	O
noted	VBD	O
the	DT	O
sudden	JJ	O
onset	NN	O
of	IN	O
left	JJ	B-PROBLEM
knee	NN	I-PROBLEM
pain	NN	I-PROBLEM
in	IN	O
09/89	CD	O
.	.	O

since	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
has	VBZ	O
used	VBN	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
and	CC	O
she	PRP	O
was	VBD	O
referred	VBN	O
to	TO	O
dr.	VB	O
koors	NNS	O
.	.	O

mri	NN	B-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
condyle	NN	I-PROBLEM
osteonecrotic	JJ	I-PROBLEM
defect	NN	I-PROBLEM
and	CC	O
degenerative	JJ	B-PROBLEM
meniscus	NN	I-PROBLEM
.	.	O

she	PRP	O
climbs	VBZ	O
stairs	JJ	O
one	CD	O
at	IN	O
a	DT	O
time	NN	O
and	CC	O
denied	VBD	O
rest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
can	MD	O
one	CD	O
walk	NN	O
without	IN	O
difficulties	NNS	B-PROBLEM
.	.	O

she	PRP	O
presented	VBD	O
for	IN	O
an	DT	B-TREATMENT
elective	JJ	I-TREATMENT
left	NN	I-TREATMENT
total	JJ	I-TREATMENT
knee	NN	I-TREATMENT
arthroplasty	NN	I-TREATMENT
.	.	O

pneumonia	NN	B-PROBLEM
one	CD	O
and	CC	O
a	DT	O
half	JJ	O
years	NNS	O
ago	RB	O
.	.	O

hepatitis	NN	B-PROBLEM
35	CD	O
years	NNS	O
ago	RB	O
.	.	O

anxiety	NN	B-PROBLEM
neurosis	NN	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
has	VBZ	O
received	VBN	O
shock	NN	B-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O
.	.	O

total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
.	.	O

on	IN	O
admission	NN	O
included	VBD	O
tylenol	NN	B-TREATMENT
.	.	O

doxepin	NN	B-TREATMENT
causes	VBZ	O
itching	VBG	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
was	VBD	O
only	RB	O
significant	JJ	O
for	IN	O
her	PRP$	B-TEST
orthopaedic	JJ	I-TEST
exam	NN	I-TEST
.	.	O

her	PRP$	O
left	JJ	O
knee	NN	O
had	VBD	O
5	CD	O
degrees	NNS	O
of	IN	O
valgus	NN	B-PROBLEM
,	,	O
120	CD	O
degrees	NNS	O
of	IN	O
flexion	NN	O
,	,	O
full	JJ	O
extension	NN	O
and	CC	O
slight	JJ	B-PROBLEM
valgus	NN	I-PROBLEM
instability	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
lachmann	NN	O
or	CC	O
anterior	JJ	O
drawer	NN	O
,	,	O
she	PRP	O
did	VBD	O
have	VB	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
included	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
34.2	CD	O
.	.	O

potassium	NN	B-TEST
4.4	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
cleared	VBN	O
for	IN	O
surgery	NN	B-TREATMENT
by	IN	O
dr.	NN	O
lupevickette	NN	O
ca	MD	O
.	.	O

her	PRP$	B-TEST
ekg	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

she	PRP	O
was	VBD	O
therefore	RB	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
6/26	CD	O
and	CC	O
underwent	VB	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
total	JJ	I-TREATMENT
knee	NN	I-TREATMENT
arthroplasty	NN	I-TREATMENT
losing	VBG	O
200	CD	O
cc	NN	O
of	IN	O
blood	NN	O
in	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
with	IN	O
two	CD	B-TREATMENT
drains	NNS	I-TREATMENT
left	VBN	O
in	IN	O
which	WDT	O
were	VBD	O
removed	VBN	O
on	IN	O
the	DT	O
first	JJ	O
postoperative	JJ	O
day	NN	O
.	.	O

she	PRP	O
was	VBD	O
slightly	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
on	IN	O
the	DT	O
first	JJ	O
postoperative	JJ	O
day	NN	O
but	CC	O
this	DT	O
resolved	VBN	O
by	IN	O
the	DT	O
second	JJ	O
postoperative	JJ	O
day	NN	O
.	.	O

her	PRP$	B-TREATMENT
epidural	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
6/29	CD	O
.	.	O

the	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
6/29	CD	O
and	CC	O
she	PRP	O
had	VBD	O
no	DT	O
difficulties	NNS	B-PROBLEM
voiding	VBG	I-PROBLEM
.	.	O

psychiatry	NN	O
service	NN	O
saw	VBD	O
her	PRP$	O
on	IN	O
6/28	CD	O
and	CC	O
recommended	VBD	O
avoiding	VBG	O
benzodiazepines	NNS	B-TREATMENT
and	CC	O
haldol	NN	B-TREATMENT
for	IN	O
agitation	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
prophylaxed	VBN	O
with	IN	O
kefzol	NN	B-TREATMENT
perioperatively	RB	O
and	CC	O
with	IN	O
coumadin	NN	B-TREATMENT
postoperatively	RB	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
given	VBN	O
whiskey	JJ	B-TREATMENT
spirits	NNS	I-TREATMENT
because	IN	O
of	IN	O
the	DT	O
fact	NN	O
that	IN	O
she	PRP	O
drank	VBD	O
one	CD	O
to	TO	O
two	CD	O
drinks	NNS	O
of	IN	O
scotch	NN	O
per	IN	O
day	NN	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
31.4	CD	O
on	IN	O
6/29	CD	O
with	IN	O
a	DT	B-TEST
pt	NN	I-TEST
of	IN	O
18.2	CD	O

her	PRP$	B-TEST
pt	NN	I-TEST
drifted	VBD	O
down	RB	O
to	TO	O
a	DT	O
level	NN	O
of	IN	O
12.9	CD	O
by	IN	O
7/3	CD	O
and	CC	O
therefore	JJR	O
she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
with	IN	O
4	CD	O
mg	NNS	O
of	IN	O
coumadin	JJ	B-TREATMENT
per	IN	O
day	NN	O
to	TO	O
be	VB	O
followed	VBN	O
by	IN	O
the	DT	O
coumadin	NN	O
clinic	NN	O
at	IN	O
cowerin	NN	O
tonli	RB	O
medical	JJ	O
center	NN	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
with	IN	O
a	DT	O
prescription	NN	O
for	IN	O
tylenol	JJ	B-TREATMENT
#3	NN	I-TREATMENT
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
quite	RB	O
well	RB	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
was	VBD	O
ambulating	VBG	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
and	CC	O
crutches	NNS	B-TREATMENT
by	IN	O
7/3/90	CD	O
.	.	O

she	PRP	O
developed	VBD	O
no	DT	O
problems	NNS	O
with	IN	O
edema	NN	B-PROBLEM
or	CC	O
with	IN	O
her	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
during	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

left	VBN	B-PROBLEM
proximal	JJ	I-PROBLEM
humerus	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

left	VBN	B-PROBLEM
proximal	JJ	I-PROBLEM
humerus	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

adult-onset	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
x	JJ	O
40	CD	O
years	NNS	O
,	,	O
history	NN	O
of	IN	O
silent	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
(	(	O
three	CD	O
vessels	NNS	O
in	IN	O
1987	CD	O
)	)	O
,	,	O
history	NN	O
of	IN	O
chronic	NN	B-PROBLEM
,	,	I-PROBLEM
stable	JJ	I-PROBLEM
angina	NN	I-PROBLEM
pectoris	NN	I-PROBLEM
,	,	O
fournier	JJR	B-PROBLEM
&apos;s	JJ	I-PROBLEM
gangrene	NN	I-PROBLEM
versus	IN	O
necrotizing	VBG	B-PROBLEM
fasciitis	NN	I-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
in	IN	O
03/97	CD	O
while	IN	O
in	IN	O
the	DT	O
hospital	NN	O
for	IN	O
a	DT	B-PROBLEM
rib	NN	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
glaucoma	NN	B-PROBLEM
,	,	O
diabetic	JJ	B-PROBLEM
retinopathy	NN	I-PROBLEM
with	IN	O
blindness	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
eye	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
gastric	JJ	B-TREATMENT
stapling	NN	I-TREATMENT
,	,	O
left	VBD	B-PROBLEM
rib	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
right	JJ	B-TREATMENT
femur	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

left	VBN	B-TREATMENT
shoulder	NN	I-TREATMENT
hemiarthroplasty	NN	I-TREATMENT
.	.	O

upper	JJ	B-TREATMENT
endoscopy	NN	I-TREATMENT
x	VBD	O
2	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
65-year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
three-vessel	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypassgraft	NN	I-TREATMENT
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
a	DT	B-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
admitted	VBN	O
for	IN	O
preoperative	JJ	B-TEST
and	CC	I-TEST
orthopedic	JJ	I-TEST
evaluations	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	B-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	NN	I-PROBLEM
humerus	NN	I-PROBLEM
when	WRB	O
he	PRP	O
slipped	VBD	O
over	IN	O
the	DT	O
stairs	NNS	O
,	,	O
about	IN	O
to	TO	O
board	NN	O
an	DT	O
airplane	NN	O
back	RB	O
to	TO	O
jeglas	NNS	O
blvd.	NN	O
,	,	O
jolouisrowarlihis	NN	O
,	,	O
alabama	RB	O
86071	CD	O
.	.	O

the	DT	B-PROBLEM
fracture	NN	I-PROBLEM
was	VBD	O
seen	VBN	O
by	IN	O
orthopedics	NNS	O
and	CC	O
was	VBD	O
reduced	VBN	O
.	.	O

during	IN	O
conscious	JJ	B-TREATMENT
sedation	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
bigeminy	NN	B-PROBLEM
(	(	O
the	DT	O
patient	NN	O
was	VBD	O
sedated	VBN	O
,	,	O
did	VBD	O
not	RB	O
feel	VB	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
)	)	O
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
bri	VB	O
health	NN	O
in	IN	O
order	NN	O
to	TO	O
be	VB	O
evaluated	VBN	O
for	IN	O
preoperative	JJ	B-TEST
clearance	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
reported	VBN	O
to	TO	O
have	VB	O
had	VBN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
(	(	O
ekg	JJ	B-TEST
positive	JJ	O
for	IN	O
ischemia	NN	B-PROBLEM
,	,	O
exercise	NN	B-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
positive	JJ	O
,	,	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
positive	JJ	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
now	RB	O
status	NN	O
posta	JJ	O
three-vessel	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
1987	CD	O
)	)	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
hada	JJ	O
history	NN	O
of	IN	O
arrhythmia	NN	B-PROBLEM
,	,	O
found	VBD	O
approximately	RB	O
ten	JJ	O
years	NNS	O
ago	RB	O
,	,	O
unknown	RP	O
what	WP	O
type	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
coumadin	NN	B-TREATMENT
recently	RB	O
,	,	O
?	.	O
whether	IN	O
for	IN	O
the	DT	O
arrhythmia	NN	B-PROBLEM
.	.	O

coumadin	NN	B-TREATMENT
was	VBD	O
reportedly	RB	O
discontinued	VBN	O
approximately	RB	O
six	CD	O
months	NNS	O
ago	RB	O
secondary	JJ	O
to	TO	O
planned	VBN	O
surgery	NN	B-TREATMENT
for	IN	O
diabetic	JJ	B-PROBLEM
retinopathy	NN	I-PROBLEM
and	CC	O
glaucoma	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
until	IN	O
approximately	RB	O
1-1/2	CD	O
years	NNS	O
ago	RB	O
,	,	O
when	WRB	O
he	PRP	O
began	VBD	O
to	TO	O
have	VB	O
chest	JJS	B-PROBLEM
tightness	NN	I-PROBLEM
(	(	I-PROBLEM
pressure	NN	I-PROBLEM
)	)	I-PROBLEM
approximately	RB	O
every	DT	O
three	CD	O
months	NNS	O
with	IN	O
stress	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
when	WRB	O
walking	VBG	O
slowly	RB	O
and	CC	O
can	MD	O
walk	VB	O
approximately	RB	O
1.5	CD	O
miles	NNS	O
.	.	O

he	PRP	O
can	MD	O
climb	VB	O
approximately	RB	O
three	CD	O
flights	NNS	O
of	IN	O
stairs	NNS	O
before	IN	O
becoming	VBG	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

he	PRP	O
does	VBZ	O
become	VB	O
slightly	RB	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
when	WRB	O
lifting	VBG	O
furniture	NN	O
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
when	WRB	O
he	PRP	O
fell	VBD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
experiencing	VBG	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
and	CC	O
had	VBD	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
,	,	O
no	DT	O
head	NN	B-PROBLEM
trauma	NN	I-PROBLEM
with	IN	I-PROBLEM
fall	NN	I-PROBLEM
.	.	O

no	DT	O
fevers	NNS	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
,	,	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
stable	JJ	B-PROBLEM
three-pillow	JJ	I-PROBLEM
orthopnea	NN	I-PROBLEM
and	CC	O
occasional	JJ	B-PROBLEM
paroxysmal	JJ	I-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
cough	NN	I-PROBLEM
with	IN	O
clear	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
.	.	O

no	DT	O
hemoptysis	NN	B-PROBLEM
,	,	O
hematemesis	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
black	JJ	B-PROBLEM
or	CC	I-PROBLEM
tarry	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
dysuria	NNS	B-PROBLEM
/	VBP	O
frequency/urgency	NN	B-PROBLEM
.	.	O

some	DT	O
type	NN	O
of	IN	O
cardiac	JJ	B-PROBLEM
arrhythmia	NN	I-PROBLEM
,	,	O
diagnosed	VBD	O
approximately	RB	O
ten	JJ	O
years	NNS	O
ago	RB	O
.	.	O

history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
silent	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
and	CC	O
three-vessel	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
1987	CD	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
experiencing	VBG	O
chronic	JJ	B-PROBLEM
,	,	I-PROBLEM
stable	JJ	I-PROBLEM
angina	NN	I-PROBLEM
pectoris	NN	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
one	CD	O
to	TO	O
one	CD	O
and	CC	O
a	DT	O
half	JJ	O
years	NNS	O
approximately	RB	O
once	RB	O
every	DT	O
three	CD	O
months	NNS	O
.	.	O

history	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
diagnosed	VBD	O
approximately	RB	O
eight	CD	O
years	NNS	O
ago	RB	O
.	.	O

diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
for	IN	O
approximately	RB	O
40	CD	O
years	NNS	O
.	.	O

fournier	JJR	B-PROBLEM
&apos;s	JJ	I-PROBLEM
gangrene	NN	I-PROBLEM
versus	IN	O
necrotizing	VBG	B-PROBLEM
fasciitis	NN	I-PROBLEM
.	.	O

glaucoma	NN	B-PROBLEM
.	.	O

diabetic	JJ	B-PROBLEM
retinopathy	NN	I-PROBLEM
with	IN	O
the	DT	O
patient	NN	O
blind	NN	B-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
eye	NN	I-PROBLEM
.	.	O

cholecystectomy	NN	B-TREATMENT
.	.	O

status	NN	O
post	NN	O
gastric	JJ	B-TREATMENT
stapling	NN	I-TREATMENT
.	.	O

left	VBN	B-PROBLEM
rib	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

right	RB	B-TREATMENT
femur	NN	I-TREATMENT
surgery	NN	I-TREATMENT
approximately	RB	O
two	CD	O
years	NNS	O
ago	RB	O
.	.	O

righteye	NN	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
glaucoma	NN	B-PROBLEM
in	IN	O
05/97	CD	O
.	.	O

laser	NN	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
retinopathy	NN	B-PROBLEM
.	.	O

humulin	NN	B-TREATMENT
70/30	CD	O
with	IN	O
30	CD	O
units	NNS	O
subq.q.a.m.	RB	O
and	CC	O
20	CD	O
units	NNS	O
subq.q.p.m.	RB	O
vasotec	VBP	B-TREATMENT
20	CD	O
mg.	NN	O
q.	NN	O
a.m.	RB	O
prozac	VBD	B-TREATMENT
40	CD	O
mg.	NN	O
q.d.	NN	O
lasix	VBD	B-TREATMENT
40	CD	O
mg.	JJ	O
q.d.	JJ	O
k-dur	NN	B-TREATMENT
approximately	RB	O
28	CD	O
?	.	O
meq	NN	O
q.d.	NN	O
atropine	VBP	B-TREATMENT
1%	CD	O
1	CD	O
gtt	NN	O
od	NN	O
b.i.d.	NN	O
ocufen	VBD	B-TREATMENT
0.03%	CD	O
1	CD	O
gtt	NN	O
od	NN	O
t.i.d.	JJ	O
ventolin	NN	B-TREATMENT
metered-dose	JJ	O
inhaler	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
retired	VBN	O
,	,	O
lives	VBZ	O
with	IN	O
his	PRP$	O
wife	NN	O
and	CC	O
one	CD	O
son	NN	O
,	,	O
who	WP	O
is	VBZ	O
47	CD	O
years	NNS	O
old	JJ	O
and	CC	O
had	VBD	O
multiple	VBN	B-PROBLEM
myeloma	NN	I-PROBLEM
and	CC	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
alert	JJ	O
and	CC	O
oriented	VBN	O
and	CC	O
has	VBZ	O
a	DT	B-TREATMENT
sling	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
120/70	CD	O
,	,	O
temperature	NN	B-TEST
97.8	CD	O
f	NN	O
,	,	O
pulse	RB	B-TEST
68	CD	O
,	,	O
respirations	NNS	B-TEST
22	CD	O
,	,	O
sa02	NN	B-TEST
on	IN	O
2	CD	O
l	NN	O
94%	CD	O
.	.	O

right-sided	JJ	B-PROBLEM
ptosis	NN	I-PROBLEM
,	,	O
right	RB	O
eye	NN	O
not	RB	O
reactive	JJ	O
to	TO	O
light	JJ	O
,	,	O
cataract	JJ	B-PROBLEM
present	JJ	O
,	,	O
patient	JJ	O
blind	NN	B-PROBLEM
in	IN	I-PROBLEM
that	DT	I-PROBLEM
eye	NN	I-PROBLEM
,	,	O
left	VBD	O
eye	NN	O
reactive	NN	O
to	TO	O
light	NN	O
,	,	O
cataract	NN	B-PROBLEM
also	RB	O
present	JJ	O
in	IN	O
that	DT	O
eye	NN	O
.	.	O

extraocular	JJ	B-TEST
movements	NNS	I-TEST
-	:	O
conjugated	VBN	O
eye	NN	O
movement	NN	O
intact	JJ	O
.	.	O

oropharynx	JJ	O
moist	NN	O
,	,	O
without	IN	O
lesions	NNS	B-PROBLEM
.	.	O

mild	RB	B-PROBLEM
right	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
.	.	O

no	DT	O
slurred	JJ	B-PROBLEM
speech	NN	I-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
appreciated	VBD	O
,	,	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
diffusely	RB	B-PROBLEM
wheezy	JJ	I-PROBLEM
upon	IN	O
presentation	NN	O
.	.	O

abdomen	NNS	B-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
,	,	O
bowel	VB	B-TEST
sounds	NNS	I-TEST
present	JJ	O
,	,	O
nohepatosplenomegaly	JJ	B-PROBLEM
.	.	O

1+	CD	B-PROBLEM
edema	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
ankles	NNS	I-PROBLEM
,	,	O
pulses	NNS	B-TEST
present	VBP	O
bilaterally	RB	O
.	.	O

no	DT	O
calf	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

guaiac	JJ	B-TEST
negative	NN	O
.	.	O

non-focal	JJ	O
,	,	O
except	IN	O
unable	JJ	O
to	TO	O
assess	VB	O
left	JJ	O
upper	JJ	O
extremity	NN	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
broken	VBZ	I-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

sodium	NN	B-TEST
135	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
101	CD	O
,	,	O
c02	NN	B-TEST
28.4	CD	O
,	,	O
bun	NN	B-TEST
17	CD	O
,	,	O
creatinine	NN	B-TEST
1.0	CD	O
,	,	O
glucose	RB	B-TEST
302	CD	O
,	,	O
calcium	NN	B-TEST
8.6	CD	O
,	,	O
phosphorus	NN	B-TEST
2.5	CD	O
,	,	O
magnesium	NN	B-TEST
1.6	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
6.7	CD	O
,	,	O
albumin	RB	B-TEST
3.3	CD	O
,	,	O
globulin	NN	B-TEST
3.4	CD	O
,	,	O
uric	JJ	B-TEST
acid	NN	I-TEST
6.3	CD	O
,	,	O
totalbilirubin	NN	B-TEST
.7	NNP	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
93	CD	O
,	,	O
sgot	VBD	B-TEST
20	CD	O
,	,	O
ldh	VBD	B-TEST
258	CD	O
,	,	O
cpk	NN	B-TEST
95	CD	O
,	,	O
whiteblood	NN	B-TEST
count	NN	I-TEST
15.3	CD	O
,	,	O
hematocrit	NN	B-TEST
49.7	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
159	CD	O
,	,	O
mcv	VBD	B-TEST
98	CD	O
.	.	O

chest	VB	B-TEST
x-ray	JJ	I-TEST
10/10/97	CD	O
:	:	O

elevated	VBN	B-PROBLEM
left	VBD	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM
of	IN	O
uncertain	JJ	O
etiology	NN	O
or	CC	O
duration	NN	O
.	.	O

postoperative	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
sternum	NN	I-PROBLEM
and	CC	I-PROBLEM
media	NNS	I-PROBLEM
stinum	NN	I-PROBLEM
were	VBD	O
seen	VBN	O
and	CC	O
no	DT	O
acute	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
was	VBD	O
visualized	VBN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
a	DT	B-TEST
shoulder	NN	I-TEST
film	NN	I-TEST
done	VBN	O
on	IN	O
10/10/97	CD	O
that	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
severely	RB	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
humerus	NN	I-PROBLEM
with	IN	O
proximal	JJ	B-PROBLEM
distraction	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
lucency	NN	I-PROBLEM
and	CC	I-PROBLEM
irregularity	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
glenoid	NN	I-PROBLEM
,	,	O
possibly	RB	O
representing	VBG	O
a	DT	B-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
was	VBD	O
also	RB	O
seen	VBN	O
,	,	O
and	CC	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
was	VBD	O
therefore	RB	O
obtained	VBN	O
in	IN	O
order	NN	O
to	TO	O
evaluate	VB	O
this	DT	O
area	NN	O
.	.	O

this	DT	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
,	,	O
done	VBN	O
also	RB	O
on	IN	O
10/10/97	CD	O
,	,	O
again	RB	O
showed	VBD	O
the	DT	B-PROBLEM
severely	RB	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
humerus	NN	I-PROBLEM
.	.	O

two	CD	B-PROBLEM
major	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
fragments	NNS	I-PROBLEM
were	VBD	O
seen	VBN	O
at	IN	O
the	DT	O
humeral	JJ	O
head	NN	O
,	,	O
articulating	VBG	O
with	IN	O
the	DT	O
glenoid	NN	O
fossa	NN	O
.	.	O

the	DT	B-PROBLEM
fracture	NN	I-PROBLEM
fragments	NNS	I-PROBLEM
retained	VBD	O
their	PRP$	O
proper	JJ	O
site	NN	O
of	IN	O
articulation	NN	O
with	IN	O
the	DT	O
glenoid	NN	O
fossa	NN	O
.	.	O

innumerable	JJ	B-PROBLEM
smaller	JJR	I-PROBLEM
fracture	NN	I-PROBLEM
fragments	NNS	I-PROBLEM
were	VBD	O
interposed	VBN	O
between	IN	O
the	DT	B-PROBLEM
fracture	NN	I-PROBLEM
fragment	NN	I-PROBLEM
and	CC	O
the	DT	O
distal	JJ	O
humeral	JJ	O
shaft	NN	O
.	.	O

no	DT	O
scapular	JJ	B-PROBLEM
fractures	NNS	I-PROBLEM
were	VBD	O
present	JJ	O
.	.	O

ekg	NN	B-TEST
:	:	O

normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
72	CD	O
beats	NNS	B-TEST
/	VBP	I-TEST
minute	NN	I-TEST
,	,	O
intraventricular	JJ	B-PROBLEM
conduction	NN	I-PROBLEM
delay	NN	I-PROBLEM
,	,	O
q	SYM	O
-	:	O
waves	NNS	O
seen	VBN	O
in	IN	O
ii	NN	O
,	,	O
iii	NN	O
,	,	O
and	CC	O
avf	NN	O
with	IN	O
probable	JJ	O
old	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

ventricular	JJ	B-PROBLEM
bigeminy	NN	I-PROBLEM
was	VBD	O
also	RB	O
seen	VBN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
severely	RB	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
humerus	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
a	DT	B-TREATMENT
hemiarthroplasty	NN	I-TREATMENT
on	IN	O
10/17/97	CD	O
.	.	O

he	PRP	O
received	VBD	O
ancef	RB	B-TREATMENT
preoperatively	RB	O
.	.	O

physical	JJ	O
therapy	NN	O
has	VBZ	O
been	VBN	O
seeing	VBG	O
the	DT	O
patient	NN	O
and	CC	O
putting	VBG	O
him	PRP	O
through	IN	O
passive	JJ	B-TREATMENT
external	JJ	I-TREATMENT
rotation	NN	I-TREATMENT
to	TO	O
the	DT	O
neutral	JJ	O
position	NN	O
of	IN	O
the	DT	O
left	JJ	O
shoulder	NN	O
and	CC	O
forward	JJ	O
flexion	NN	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
assistance	NN	I-TREATMENT
.	.	O

brittle	JJ	B-PROBLEM
bones	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
during	IN	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
.	.	O

a	DT	B-TEST
bone	NN	I-TEST
density	NN	I-TEST
scan	NN	I-TEST
would	MD	O
be	VB	O
recommended	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
evaluate	VB	O
this	DT	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
right	JJ	B-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
ptosis	NN	I-PROBLEM
,	,	O
stable	JJ	O
and	CC	O
present	JJ	O
for	IN	O
greater	JJR	O
than	IN	O
one	CD	O
year	NN	O
.	.	O

no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
1+	CD	B-PROBLEM
ankle	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
given	VBN	O
his	PRP$	B-PROBLEM
fall	NN	I-PROBLEM
at	IN	O
the	DT	O
airport	NN	O
and	CC	O
bigeminy	NN	B-PROBLEM
seen	VBN	O
on	IN	O
electrocardiogram	NN	B-TEST
that	IN	O
he	PRP	O
developed	VBD	O
during	IN	O
conscious	JJ	B-TREATMENT
sedation	NN	I-TREATMENT
during	IN	O
reduction	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
fracture	NN	I-TREATMENT
.	.	O

cardiology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
aspirin	JJ	B-TREATMENT
and	CC	O
beta	JJ	B-TREATMENT
blocker	NN	I-TREATMENT
added	VBD	O
to	TO	O
his	PRP$	B-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
chest	JJS	B-TREATMENT
wall	NN	I-TREATMENT
nitroglycerin	NN	I-TREATMENT
around	IN	O
the	DT	O
time	NN	O
of	IN	O
surgery	NN	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
subsequently	RB	O
discontinued	VBN	O
.	.	O

an	DT	B-TEST
adenosine	NN	I-TEST
sestamibi	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
10/12/97	CD	O
,	,	O
which	WDT	O
showed	VBD	O
a	DT	O
negative	JJ	O
electrocardiogram	NN	O
for	IN	O
ischemia	NN	B-PROBLEM
and	CC	O
cardiac	JJ	B-TEST
perfusion	NN	I-TEST
scans	NNS	I-TEST
,	,	O
with	IN	O
a	DT	B-PROBLEM
moderate-sized	JJ	I-PROBLEM
,	,	I-PROBLEM
dense	NN	I-PROBLEM
,	,	I-PROBLEM
fixed	VBN	I-PROBLEM
inferior	JJ	I-PROBLEM
defect	JJ	I-PROBLEM
indicative	NN	O
of	IN	O
scar	NN	B-PROBLEM
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
/	JJ	I-PROBLEM
moderate-sized	JJ	I-PROBLEM
,	,	I-PROBLEM
mild-intensity	NN	I-PROBLEM
,	,	I-PROBLEM
reversible	JJ	I-PROBLEM
posterior	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
defect	NN	I-PROBLEM
was	VBD	O
also	RB	O
seen	VBN	O
,	,	O
indicative	JJ	O
of	IN	O
mild	JJ	B-PROBLEM
/	NNP	I-PROBLEM
moderate	NN	I-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
columbus	NN	O
day	NN	O
which	WDT	O
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
50%	CD	O
,	,	O
left	VBD	B-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
,	,	O
thickening	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
aortic	JJ	I-PROBLEM
wall	NN	I-PROBLEM
consistent	NN	O
with	IN	O
atherosclerotic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
left	VBD	O
ventricle	NN	O
size	NN	O
,	,	O
and	CC	O
systolic	JJ	O
function	NN	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

cardiac	JJ	B-TEST
monitor	NN	I-TEST
was	VBD	O
placed	VBN	O
on	IN	O
the	DT	O
patient	NN	O
,	,	O
given	VBN	O
the	DT	B-PROBLEM
bigeminy	NN	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
did	VBD	O
rule	VB	O
out	IN	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

cardiology	NN	O
recommended	VBD	O
that	IN	O
in	IN	O
addition	NN	O
to	TO	O
the	DT	B-TREATMENT
medications	NNS	I-TREATMENT
already	RB	O
stated	VBN	O
above	IN	O
,	,	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
be	VB	O
kept	VBN	O
greater	JJR	O
than	IN	O
30	CD	O
.	.	O

after	IN	O
his	PRP$	B-TREATMENT
procedure	NN	I-TREATMENT
on	IN	O
10/17/97	CD	O
,	,	O
elevated	VBN	B-PROBLEM
cpks	NN	I-PROBLEM
were	VBD	O
noted	VBN	O
on	IN	O
10/19/97	CD	O
to	TO	O
10/20/97	CD	O
,	,	O
and	CC	O
the	DT	O
first	JJ	O
level	NN	O
was	VBD	O
744	CD	O
,	,	O
cpk	NN	B-TEST
#	#	O
2	CD	O
635	CD	O
,	,	O
and	CC	O
cpk	RB	B-TEST
#	#	O
3	CD	O
461	CD	O
.	.	O

mb	JJ	B-PROBLEM
fractionations	NNS	I-PROBLEM
of	IN	O
the	DT	B-TEST
cpks	NN	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
and	CC	O
were	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
the	DT	O
patient	NN	O
&apos;s	NN	O
beginning	VBG	O
physical	JJ	O
therapy	NN	O
on	IN	O
10/19/97	CD	O
,	,	O
and	CC	O
all	DT	O
muscular	NN	O
in	IN	O
origin	NN	O
.	.	O

gi	NN	O
was	VBD	O
consulted	VBN	O
on	IN	O
10/15/97	CD	O
for	IN	O
melena	NN	B-PROBLEM
,	,	O
decreased	VBD	B-PROBLEM
hematocrit	NN	I-PROBLEM
prior	RB	O
to	TO	O
his	PRP$	B-TREATMENT
humeral	JJ	I-TREATMENT
fixation	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

upper	JJ	B-TEST
endoscopy	NN	I-TEST
x	$	I-TEST
2	CD	I-TEST
were	VBD	O
done	VBN	O
.	.	O

the	DT	O
first	JJ	O
was	VBD	O
on	IN	O
10/15/97	CD	O
,	,	O
which	WDT	O
showed	VBD	O
clotted	VBD	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
esophagus	NN	I-PROBLEM
.	.	O

the	DT	O
stomach	NN	O
had	VBD	O
evidence	NN	O
of	IN	O
prior	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
old	JJ	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
thought	VBN	O
that	IN	O
the	DT	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
esophagus	NN	I-PROBLEM
was	VBD	O
secondary	JJ	O
to	TO	O
a	DT	O
possible	JJ	O
mallory-weiss	JJ	B-PROBLEM
tear	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
second	JJ	I-TEST
endoscopy	NN	I-TEST
was	VBD	O
also	RB	O
performed	VBN	O
several	JJ	O
days	NNS	O
later	RB	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
,	,	O
and	CC	O
also	RB	O
because	IN	O
the	DT	O
patient	NN	O
had	VBD	O
had	VBN	O
another	DT	O
episode	NN	O
of	IN	O
melena	NN	B-PROBLEM
.	.	O

a	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
found	VBN	O
and	CC	O
this	DT	O
was	VBD	O
biopsied	VBN	O
and	CC	O
pathology	NN	B-TEST
is	VBZ	O
pending	VBG	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
needs	VBZ	O
a	DT	B-TEST
repeat	NN	I-TEST
endoscopy	NN	I-TEST
and	CC	O
a	DT	B-TEST
gi	JJ	I-TEST
follow-up	JJ	I-TEST
appointment	NN	O
inapproximately	RB	O
two	CD	O
months	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
on	IN	O
cimetidine	NN	B-TREATMENT
and	CC	O
carafate	NN	B-TREATMENT
here	RB	O
at	IN	O
bri	JJ	O
health	NN	O
,	,	O
and	CC	O
then	RB	O
switched	VBD	O
to	TO	O
prilosec	VB	B-TREATMENT
20	CD	O
mg	JJ	O
bid	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
admitting	VBG	I-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
left	NN	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM
consistent	JJ	O
with	IN	O
atelectasis	NN	B-PROBLEM
versus	NN	O
splinting	VBG	B-PROBLEM
on	IN	I-PROBLEM
that	DT	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

incentive	JJ	B-TREATMENT
spirometry	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

albuterol	NN	B-TREATMENT
and	CC	I-TREATMENT
atrovent	JJ	I-TREATMENT
nebulizers	NNS	I-TREATMENT
were	VBD	O
done	VBN	O
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
chest	JJ	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
bid	NN	O
.	.	O

the	DT	O
patient	NN	O
needs	VBZ	O
still	RB	O
better	RBR	O
diabetes	NNS	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
nph	NN	I-TREATMENT
was	VBD	O
recently	RB	O
increased	VBN	O
today	NN	O
(	(	O
10/23/97	CD	O
)	)	O
to	TO	O
24	CD	O
units	NNS	O
in	IN	O
the	DT	O
a.m.	NN	O
and	CC	O
14	CD	O
units	NNS	O
in	IN	O
the	DT	O
p.m.	NN	O
with	IN	O
czi	JJ	B-TREATMENT
sliding-scale	JJ	I-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
patient	JJ	I-TEST
urinalysis	NN	I-TEST
on	IN	O
10/19/97	CD	O
showed	VBD	O
moderate	JJ	B-PROBLEM
occult	NN	I-PROBLEM
blood	NN	I-PROBLEM
,	,	O
ph	NN	B-TEST
5	CD	O
,	,	O
albumin	RB	B-TEST
1+	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
present	JJ	O
,	,	O
2-50	JJ	O
red	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
,	,	O
10-20	JJ	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
,	,	O
few	JJ	B-PROBLEM
bacteria	NNS	I-PROBLEM
,	,	O
and	CC	O
moderate	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
epithelial	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

floxin	NN	B-TREATMENT
200	CD	O
mg	NN	O
po	NN	O
bid	NN	O
was	VBD	O
begun	VBN	O
.	.	O

however	RB	O
,	,	O
his	PRP$	B-TEST
urine	JJ	I-TEST
culture	NN	I-TEST
from	IN	O
the	DT	O
same	JJ	O
day	NN	O
remained	VBD	O
negative	JJ	O
,	,	O
and	CC	O
this	DT	O
was	VBD	O
discontinued	VBN	O
two	CD	O
days	NNS	O
later	RB	O
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
urinalysis	NN	I-TEST
on	IN	O
10/22/97	CD	O
was	VBD	O
negative	JJ	O
.	.	O

after	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
,	,	O
he	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
volume	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
iv	NN	O
x	$	O
1	CD	O
and	CC	O
also	RB	O
had	VBD	O
nitro	JJ	B-TREATMENT
paste	NN	I-TREATMENT
around	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
became	VBD	O
slightly	RB	B-PROBLEM
hypotensive	JJ	I-PROBLEM
on	IN	O
the	DT	O
night	NN	O
of	IN	O
10/18/97	CD	O
with	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
80s	CD	O
to	TO	O
90s.	CD	O

his	PRP$	B-TEST
bun/	NN	I-TEST
creatinine	NN	I-TEST
rose	VBD	O
from	IN	O
16/1.2	CD	O
on	IN	O
10/18/97	CD	O
to	TO	O
25/1.9	CD	O
on	IN	O
10/18/97	CD	O
to	TO	O
22/9.1	CD	O
to	TO	O
today	NN	O
&apos;s	NNP	O
labs	NN	O
,	,	O
which	WDT	O
are	VBP	O
15/0.7	CD	O
on	IN	O
10/23/97	CD	O
.	.	O

the	DT	O
patient	NN	O
transfused	VBD	O
2	CD	O
units	NNS	O
on	IN	O
10/15/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
27.6	CD	O
.	.	O

the	DT	O
patient	NN	O
transfused	VBD	O
2	CD	O
units	NNS	O
of	IN	O
10/16/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
30.03	CD	O
.	.	O

the	DT	O
patient	NN	O
transfused	VBD	O
1	CD	O
unit	NN	O
on	IN	O
10/18/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
29.4	CD	O
.	.	O

the	DT	O
patient	NN	O
transfused	VBD	O
1	CD	O
unit	NN	O
on	IN	O
10/19/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
27.9	CD	O
.	.	O

the	DT	O
patient	NN	O
transfused	VBD	O
2	CD	O
units	NNS	O
on	IN	O
10/20/97	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
28.2.10	CD	O
.	.	O

repleting	VBG	O
potassium	NN	B-TREATMENT
,	,	O
magnesium	NN	B-TREATMENT
,	,	O
phosphorus	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
slightly	RB	B-PROBLEM
hyponatremic	JJ	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
few	JJ	O
days	NNS	O
,	,	O
with	IN	O
sodiums	NNS	B-TEST
in	IN	O
the	DT	O
128-132	JJ	O
range	NN	O
,	,	O
but	CC	O
this	DT	O
was	VBD	O
secondary	JJ	O
to	TO	O
elevated	VBN	B-PROBLEM
glucose	JJ	I-PROBLEM
fingerstick	JJ	I-PROBLEM
blood	NN	I-PROBLEM
sugars	NNS	I-PROBLEM
.	.	O

nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
24	CD	O
units	NNS	O
subq.	VBP	O
q.	JJ	O
a.m.	RB	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
14	CD	O
units	NNS	O
subq.	VBP	O
q.	JJ	O
p.m.	NN	O
czi	NN	B-TREATMENT
sliding	VBG	O
scale	NN	O
on	IN	O
a	DT	O
q.	JJ	O
a.c.	NN	O
and	CC	O
q.	JJ	O
h.s.	NN	O
fingerstick	JJ	O
basis	NN	O
with	IN	O
the	DT	O
following	VBG	O
scale	NN	O
:	:	O

fbs	RB	B-TEST
less	JJR	O
than	IN	O
200	CD	O
=	JJ	O
0	CD	O
units	NNS	O
of	IN	O
czi	JJ	B-TREATMENT
fbs	JJ	B-TEST
201-250	JJ	O
=	NN	O
2	CD	O
units	NNS	O
of	IN	O
czi	JJ	B-TREATMENT
fbs	JJ	B-TEST
251-300	JJ	O
=	NN	O
4	CD	O
units	NNS	O
of	IN	O
czi	JJ	B-TREATMENT
fbs	JJ	B-TEST
301-350	JJ	O
=	NN	O
6	CD	O
units	NNS	O
of	IN	O
czi	JJ	B-TREATMENT
fbs	JJ	B-TEST
351-400	JJ	O
=	NN	O
8	CD	O
units	NNS	O
of	IN	O
czi	NN	B-TREATMENT
fbs	NN	B-TEST
greater	JJR	O
than	IN	O
400	CD	O
=	JJ	O
10	CD	O
units	NNS	O
of	IN	O
czi	NN	B-TREATMENT
.	.	O

atropine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
1	CD	O
gtt	NN	O
1%	CD	O
od	NN	O
b.i.d.	NN	O

ocufen	RB	B-TREATMENT
0.03%	CD	O
1	CD	O
gtt	NN	O
od	NN	O
t.i.d.	NN	O
vasotec	JJ	B-TREATMENT
20	CD	O
mg.	NN	O
p.o.q.	NN	O
a.m.	RB	O
prozac	VBD	B-TREATMENT
40	CD	O
mg.p.o.q.	NNS	O
a.m.	RB	O

oxygen	NN	B-TREATMENT
2-4	JJ	O
l	NN	O
to	TO	O
keep	VB	O
sa02	NN	B-TEST
greater	JJR	O
than	IN	O
or	CC	O
equal	JJ	O
to	TO	O
94-95%	CD	O
and	CC	O
wean	JJ	O
as	IN	O
tolerated	VBN	O
.	.	O

colace	NN	B-TREATMENT
100	CD	O
mg.	NN	O
p.o.	NN	O
t.i.d.	NN	O
senokot	VBD	B-TREATMENT
1	CD	O
p.o.	NN	O
q.	JJ	O
h.s.	NN	O
nystatin	JJ	B-TREATMENT
powder	NN	O
to	TO	O
affected	JJ	B-PROBLEM
area	NN	I-PROBLEM
t.i.d.	NN	O
lopressor	VBD	B-TREATMENT
25	CD	O
mg.	NN	O
p.o.	NN	O
b.i.d.	NN	O
atrovent	NN	B-TREATMENT
0.8/2.5	CD	O
c.c.	NN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
nebulizers	NNS	I-TREATMENT
q.	VBP	O
8	CD	O
h.	NNS	O
albuterol	VBP	B-TREATMENT
2.5/5	CD	O
c.c.	NN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
nebulizers	NNS	I-TREATMENT
q.	VBP	O
4	CD	O
h.	NN	O
with	IN	O
q.	JJ	O
2	CD	O
h.	JJ	O
p.r.n.	NN	O
percocet	IN	B-TREATMENT
1-2	JJ	O
p.o.	NN	O
q.	NN	O
4	CD	O
h.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

prilosec	NN	B-TREATMENT
20	CD	O
mg.	NN	O
p.o.	NN	O
b.i.d.	NN	O
vexol	VBD	B-TREATMENT
1%	CD	O
1	CD	O
gtt	NN	O
od	NN	O
b.i.d.	NN	O
lasix	VBD	B-TREATMENT
40	CD	O
mg.	NN	O
p.o.	NN	O
q.d.	NN	O
kcl	VBD	B-TREATMENT
20	CD	O
meq	NN	O
p.o.	NN	O
q.d.	NN	O
tylenol	VBD	B-TREATMENT
650	CD	O
mg.	NN	O
p.o.	NN	O
q.	VBD	O
12	CD	O
h.	NN	O
p.r.n.	NN	O
ativan	VBD	B-TREATMENT
1	CD	O
mg.	NN	O
p.o.	NN	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O

left	JJ	B-PROBLEM
rotator	NN	I-PROBLEM
cuff	NN	I-PROBLEM
tear	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
52-year-old	JJ	O
right	NN	O
handed	VBN	O
male	NN	O
with	IN	O
a	DT	O
many	JJ	O
year	NN	O
history	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
shoulder	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	NN	O
.	.	O

he	PRP	O
has	VBZ	O
steroid	JJ	B-TREATMENT
injections	NNS	I-TREATMENT
in	IN	O
the	DT	O
right	NN	O
and	CC	O
in	IN	O
the	DT	O
left	NN	O
four	CD	O
times	NNS	O
.	.	O

arthrogram	NN	B-TEST
in	IN	O
the	DT	O
distant	JJ	O
past	NN	O
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
rotator	NN	I-PROBLEM
cuff	NN	I-PROBLEM
tear	NN	I-PROBLEM
and	CC	O
he	PRP	O
now	RB	O
has	VBZ	O
increased	VBN	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
shoulder	NN	I-PROBLEM
.	.	O

mri	NN	B-TEST
by	IN	O
report	NN	O
showed	VBD	O
bilateral	JJ	B-TREATMENT
rotator	NN	I-TREATMENT
cuff	NN	I-TREATMENT
repairs	NNS	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
repair	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
rotator	NN	I-TREATMENT
cuff	NN	I-TREATMENT
.	.	O

back	RB	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

ankle	NN	B-TREATMENT
surgery	NN	I-TREATMENT
times	RB	O
two	CD	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

pilonidal	JJ	B-TREATMENT
cyst	NN	I-TREATMENT
removal	NN	I-TREATMENT
.	.	O

on	IN	O
admission	NN	O
included	VBD	O
naprosyn	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
revealed	VBD	O
a	DT	O
white	JJ	O
male	NN	O
with	IN	O
no	DT	O
palpable	JJ	B-PROBLEM
adenopathy	NN	I-PROBLEM
.	.	O

heent	NN	B-TEST
exam	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

lungs	NNS	O
revealed	VBD	O
occasional	JJ	B-PROBLEM
wheezing	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
at	IN	O
both	DT	O
bases	NNS	O
.	.	O

heart	NN	O
was	VBD	O
regular	JJ	O
with	IN	O
a	DT	B-PROBLEM
i	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
without	IN	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
.	.	O

abdomen	NNS	O
was	VBD	O
obese	JJ	B-PROBLEM
with	IN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

examination	NN	B-TEST
of	IN	I-TEST
his	PRP$	I-TEST
shoulder	NN	I-TEST
revealed	VBD	O
the	DT	O
patient	NN	O
to	TO	O
be	VB	O
able	JJ	O
to	TO	O
flex	VB	O
his	PRP$	O
right	JJ	O
arm	NN	O
to	TO	O
170	CD	O
degrees	NNS	O
,	,	O
internally	RB	O
rotate	VB	O
to	TO	O
10	CD	O
degrees	NNS	O
and	CC	O
externally	RB	O
rotate	VB	O
to	TO	O
40	CD	O
degrees	NNS	O
with	IN	O
positive	JJ	B-PROBLEM
joint	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
the	DT	B-TEST
assessment	NN	I-TEST
of	IN	O
left	JJ	B-TREATMENT
rotator	NN	I-TREATMENT
cuff	NN	I-TREATMENT
repair	NN	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
where	WRB	O
he	PRP	O
underwent	JJ	O
left	VBD	B-TREATMENT
rotator	NN	I-TREATMENT
cuff	NN	I-TREATMENT
repair	NN	I-TREATMENT
under	IN	O
general	JJ	B-TREATMENT
endotracheal	NN	I-TREATMENT
tube	NN	I-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

there	EX	O
were	VBD	O
no	DT	O
intraoperative	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

occupational	JJ	O
therapy	NN	O
became	VBD	O
involved	VBN	O
initially	RB	O
and	CC	O
he	PRP	O
remained	VBD	O
on	IN	O
patient	NN	B-TREATMENT
controlled	VBN	I-TREATMENT
analgesia	RB	I-TREATMENT
secondary	JJ	O
to	TO	O
problems	NNS	O
with	IN	O
left	JJ	B-PROBLEM
shoulder	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
remained	VBD	O
clean	JJ	O
and	CC	O
dry	JJ	O
and	CC	O
showed	VBD	O
no	DT	O
signs	NNS	B-PROBLEM
of	IN	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
healed	VBN	O
well	RB	O
.	.	O

however	RB	O
,	,	O
his	PRP$	O
course	NN	O
was	VBD	O
otherwise	RB	O
complicated	VBN	O
by	IN	O
discovery	NN	O
of	IN	O
persistently	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
sugars	NNS	I-PROBLEM
and	CC	O
endocrinology	NN	O
was	VBD	O
consulted	VBN	O
to	TO	O
rule	VB	O
out	IN	O
possible	JJ	O
newly	RB	B-PROBLEM
diagnosed	VBN	I-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TEST
hemoglobin	NN	I-TEST
a1c	NN	I-TEST
levels	NNS	I-TEST
actually	RB	O
came	VBD	O
back	RB	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
however	RB	O
,	,	O
the	DT	B-PROBLEM
wide	JJ	I-PROBLEM
excursions	NNS	I-PROBLEM
of	IN	O
his	PRP$	B-TEST
sugars	NNS	I-TEST
were	VBD	O
consistent	JJ	O
with	IN	O
possible	JJ	O
diabetes	NNS	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
diabetic	JJ	I-TREATMENT
diet	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TEST
sugars	NNS	I-TEST
did	VBD	O
show	VB	O
some	DT	O
improvement	NN	O
.	.	O

it	PRP	O
was	VBD	O
not	RB	O
necessary	JJ	O
to	TO	O
start	VB	O
him	PRP	O
on	IN	O
oral	JJ	B-TREATMENT
hypoglycemics	NNS	I-TREATMENT
or	CC	O
insulin	NN	B-TREATMENT
.	.	O

he	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
occasional	JJ	B-PROBLEM
spells	NNS	I-PROBLEM
and	CC	O
jitteriness	NN	B-PROBLEM
and	CC	O
some	DT	B-PROBLEM
orthostatic	JJ	I-PROBLEM
dizziness	NN	I-PROBLEM
and	CC	O
thus	RB	O
neurology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
emg	JJ	B-TEST
&apos;s	NN	I-TEST
were	VBD	O
performed	VBN	O
which	WDT	O
were	VBD	O
normal	JJ	O
.	.	O

his	PRP$	O
neurologist	NN	O
was	VBD	O
contacted	VBN	O
,	,	O
dr.	JJ	O
cap	NN	O
,	,	O
and	CC	O
the	DT	O
exact	NN	O
of	IN	O
his	PRP$	O
problems	NNS	O
was	VBD	O
not	RB	O
demonstrated	VBN	O
during	IN	O
this	DT	O
hospitalization	NN	O
,	,	O
however	RB	O
,	,	O
they	PRP	O
felt	VBD	O
that	IN	O
this	DT	O
could	MD	O
possibly	RB	O
be	VB	O
an	DT	B-PROBLEM
autonomic	JJ	I-PROBLEM
type	NN	I-PROBLEM
neuropathy	JJ	I-PROBLEM
maybe	RB	O
secondary	JJ	O
to	TO	O
some	DT	B-PROBLEM
underlying	JJ	I-PROBLEM
diabetic	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

further	JJ	B-TEST
work-up	NN	I-TEST
of	IN	O
his	PRP$	B-PROBLEM
neurologic	JJ	I-PROBLEM
conditions	NNS	I-PROBLEM
were	VBD	O
planned	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

thus	RB	O
,	,	O
he	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
eight	CD	O
in	IN	O
good	JJ	O
condition	NN	O
with	IN	O
a	DT	B-PROBLEM
well	NN	I-PROBLEM
healed	VBN	I-PROBLEM
left	VBD	I-PROBLEM
shoulder	NN	I-PROBLEM
wound	NN	I-PROBLEM
and	CC	O
doing	VBG	O
well	RB	O
with	IN	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
with	IN	O
plans	NNS	O
for	IN	O
him	PRP	O
to	TO	O
follow-up	NN	O
with	IN	O
dr.	JJ	O
necessary	JJ	O
.	.	O

on	IN	O
discharge	NN	O
included	VBD	O
valium	NN	B-TREATMENT
,	,	O
2	CD	O
mg	NN	O
po	NN	O
t.i.d.;	NN	O
naprosyn	NN	B-TREATMENT
,	,	O
500	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
________________________________	NNP	O
zv061/6138	NNP	O
ticena	NN	O
necessary	JJ	O
,	,	O
m.d.	JJ	O
wo00	NN	O

1.	CD	O
insulin	NN	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM

2.	CD	O
prior	JJ	O
history	NN	O
of	IN	O
anterior	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM

3.	CD	O
episode	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM

4.	CD	O
hypercholesterolemia	NN	B-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
40	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
prior	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
insulin	NN	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
after	IN	O
an	DT	O
episode	NN	O
of	IN	O
acute	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
four	CD	O
years	NNS	O
ago	RB	O
of	IN	O
being	VBG	O
admitted	VBN	O
to	TO	O
the	DT	O
etearal	JJ	O
etsystems/	NN	O
hospital	NN	O
after	IN	O
suffering	VBG	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
course	NN	O
had	VBD	O
multiple	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
requiring	VBG	O
pressors	NNS	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
performed	VBD	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
three	CD	I-PROBLEM
vessel	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
an	DT	B-PROBLEM
occluded	JJ	I-PROBLEM
rca	NN	I-PROBLEM
,	,	O
70%-80%	JJ	B-PROBLEM
proximal	NN	I-PROBLEM
lad	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
grade	NN	I-PROBLEM
left	VBD	I-PROBLEM
circumflex	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
after	IN	I-PROBLEM
the	DT	I-PROBLEM
om	NN	I-PROBLEM
with	IN	O
distal	JJ	B-PROBLEM
left	VBD	I-PROBLEM
circumflex	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
subsequently	RB	O
medically	RB	O
management	NN	O
after	IN	O
this	DT	B-TREATMENT
hospitalization	NN	I-TREATMENT
and	CC	O
has	VBZ	O
done	VBN	O
very	RB	O
well	RB	O
.	.	O

his	PRP$	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
echocardiogram	NN	I-TEST
in	IN	O
april	NN	O
of	IN	O
1996	CD	O
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
20%	CD	O
with	IN	O
a	DT	B-PROBLEM
thin	JJ	I-PROBLEM
fibrotic	JJ	I-PROBLEM
septum	NN	I-PROBLEM
with	IN	O
akinesis	NN	B-PROBLEM
and	CC	O
moderately	RB	B-PROBLEM
severe	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
in	IN	I-PROBLEM
all	DT	I-PROBLEM
other	JJ	I-PROBLEM
regions	NNS	I-PROBLEM
except	IN	O
for	IN	O
the	DT	O
lateral	JJ	O
wall	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
an	DT	B-TEST
electrocardiogram	NN	I-TEST
in	IN	O
april	NN	O
of	IN	O
1996	CD	O
which	WDT	O
was	VBD	O
negative	JJ	O
following	NN	O
,	,	O
however	RB	O
was	VBD	O
at	IN	O
a	DT	O
low	JJ	O
workload	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NN	O
was	VBD	O
most	RBS	O
recently	RB	O
admitted	VBN	O
to	TO	O
centdick	VB	O
naco	JJ	O
hospital	NN	O
medical	JJ	O
center	NN	O
on	IN	O
martin	NN	O
luther	NN	O
king	VBG	O
day	NN	O
after	IN	O
becoming	VBG	O
acutely	RB	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
after	IN	O
a	DT	O
five	CD	O
minute	NN	O
walk	NN	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
,	,	O
or	CC	O
nausea	NN	B-PROBLEM
.	.	O

he	PRP	O
called	VBD	O
the	DT	O
emt	NN	O
&apos;s	NN	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
in	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
by	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
at	IN	O
centdick	NN	O
naco	FW	O
hospital	JJ	O
medical	JJ	O
center	NN	O
.	.	O

he	PRP	O
was	VBD	O
diuresed	VBN	B-TREATMENT
and	CC	O
ruled	VBN	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
ecg	NN	I-TEST
showed	VBD	O
no	DT	O
ischemic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

(1)	JJ	O
insulin	NN	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	RBS	I-PROBLEM
x	JJ	O
15	CD	O
years	NNS	O
with	IN	O
no	DT	O
retinopathy	NN	B-PROBLEM
or	CC	O
foot	NN	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

(2)	JJ	O
bilateral	JJ	B-PROBLEM
cataracts	NNS	I-PROBLEM
.	.	O

(3)	NN	O
in	IN	O
1967	CD	O
he	PRP	O
had	VBD	O
an	DT	B-TREATMENT
orchiopexy	NN	I-TREATMENT
for	IN	O
undescended	JJ	B-PROBLEM
testicle	NN	I-PROBLEM
.	.	O

(4)	JJ	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
as	IN	O
above	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
p.o.	JJ	O
q.	JJ	O
day	NN	O
,	,	O
capoten	VB	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.8h.	NN	O
,	,	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
28	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
10	CD	O
units	NNS	O
q.p.m.	RB	O
,	,	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
4	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
4	CD	O
units	NNS	O
q.p.m.	RB	O
,	,	O
simvastatin	VBD	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mg.	NN	O

his	PRP$	O
mother	NN	O
and	CC	O
father	NN	O
both	DT	O
died	VBD	O
secondary	JJ	O
to	TO	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

one	CD	O
of	IN	O
his	PRP$	O
brothers	NNS	O
has	VBZ	O
had	VBD	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
100.3	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
76	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
100/78	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
16	CD	O
,	,	O
and	CC	O
an	DT	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
of	IN	O
96%	CD	O
on	IN	O
two	CD	O
liters	NNS	O
.	.	O

no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
with	IN	O
no	DT	O
wheezes	NN	B-PROBLEM
or	CC	O
rales	NNS	B-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
extra	JJ	B-PROBLEM
heart	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
and	CC	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

no	DT	O
edema	NN	B-PROBLEM
with	IN	O
2+	CD	O
pulses	NNS	O
.	.	O

bun	NN	B-TEST
25	CD	O
and	CC	O
creatinine	VB	B-TEST
1.4	CD	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
6	CD	O
and	CC	O
hematocrit	$	B-TEST
41.5	CD	O
.	.	O

pt	NN	B-TEST
14.1	CD	O
with	IN	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
1.4	CD	O
,	,	O
ptt	RB	B-TEST
36.7	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
no	DT	O
infiltrates	NNS	B-PROBLEM
and	CC	O
no	DT	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

urinalysis	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

electrocardiogram	RB	B-TEST
showed	VBN	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
63	CD	O
with	IN	O
normal	JJ	O
intervals	NNS	O
.	.	O

he	PRP	O
had	VBD	O
flat	JJ	B-PROBLEM
t	NN	I-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
i	NN	I-PROBLEM
and	CC	I-PROBLEM
avl	NN	I-PROBLEM
,	,	O
which	WDT	O
were	VBD	O
unchanged	JJ	O
from	IN	O
previous	JJ	B-TEST
ecg	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
possibly	RB	O
had	VBD	O
a	DT	O
worsening	NN	O
of	IN	O
his	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
therefore	RB	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
on	IN	O
01/17/96	CD	O
.	.	O

at	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
he	PRP	O
had	VBD	O
an	DT	B-TEST
ra	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
8	CD	O
,	,	O
an	DT	B-TEST
rv	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
52/10	CD	O
,	,	O
pa	JJ	B-TEST
pressure	NN	I-TEST
of	IN	O
60/25	CD	O
,	,	O
and	CC	O
wedge	NN	B-TEST
of	IN	O
26	CD	O
.	.	O

his	PRP$	O
coronary	JJ	O
arteries	NNS	O
revealed	VBD	O
an	DT	B-PROBLEM
80%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
om	NN	I-PROBLEM
.	.	O

the	DT	O
dominant	JJ	O
left	VBD	O
circumflex	NN	O
was	VBD	O
occluded	VBN	B-PROBLEM
with	IN	O
left-to-left	JJ	B-PROBLEM
filling	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
50%	CD	I-PROBLEM
lad	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
100%	CD	I-PROBLEM
large	JJ	I-PROBLEM
dt	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	O
nondominant	JJ	O
rca	NN	O
with	IN	O
left	JJ	O
rca	NN	O
collaterals	NNS	O
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
this	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
was	VBD	O
not	RB	O
significantly	RB	O
changed	VBN	O
from	IN	O
his	PRP$	B-TEST
previous	JJ	I-TEST
catheterization	NN	I-TEST
.	.	O

given	VBN	O
his	PRP$	B-PROBLEM
high	JJ	I-PROBLEM
right-sided	JJ	I-PROBLEM
filling	NN	I-PROBLEM
pressure	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
lasix	NN	B-TREATMENT
for	IN	O
diuresis	NN	B-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
captopril	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
for	IN	O
greater	JJR	B-TREATMENT
afterload	NN	I-TREATMENT
reduction	NN	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
should	MD	O
have	VB	O
an	DT	B-TREATMENT
augmented	JJ	I-TREATMENT
medical	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
and	CC	O
as	IN	O
an	DT	O
outpatient	NN	O
undergo	NN	O
an	DT	B-TEST
exercise	NN	I-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
with	IN	O
viability	NN	B-TEST
evaluation	NN	I-TEST
to	TO	O
determine	VB	O
whether	IN	O
he	PRP	O
would	MD	O
benefit	VB	O
from	IN	O
revascularization	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
fraction	NN	I-PROBLEM
and	CC	O
started	VBD	O
on	IN	O
diuresis	NN	B-TREATMENT
with	IN	O
iv	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
for	IN	O
two	CD	O
days	NNS	O
and	CC	O
then	RB	O
switched	VBD	O
to	TO	O
an	DT	B-TREATMENT
oral	JJ	I-TREATMENT
lasix	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

insulin	NN	B-TREATMENT
nph	CC	I-TREATMENT
10	CD	O
units	NNS	O
q.p.m.	RB	O
and	CC	O
28	CD	O
units	NNS	O
q.a.m.	RB	O
,	,	O
insulin	NN	B-TREATMENT
regular	JJ	I-TREATMENT
4	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
4	CD	O
units	NNS	O
q.p.m.	RB	O
,	,	O
aspirin	VBZ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
simvastatin	VBD	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
,	,	O
captopril	VBP	B-TREATMENT
37.5	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
coumadin	VBP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

he	PRP	O
is	VBZ	O
to	TO	O
see	VB	O
dr.	JJ	O
ench	NN	O
in	IN	O
two	CD	O
weeks	NNS	O
to	TO	O
check	VB	O
his	PRP$	B-TEST
pt	NN	I-TEST
and	CC	O
inr	NN	B-TEST
,	,	O
also	RB	O
to	TO	O
check	VB	O
for	IN	O
potassium	NN	B-TEST
.	.	O

right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
,	,	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
.	.	O

right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
,	,	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
generally	RB	O
healthy	JJ	O
85	CD	O
year	NN	O
old	JJ	O
female	NN	O
,	,	O
who	WP	O
has	VBZ	O
had	VBD	O
a	DT	O
five	CD	O
year	NN	O
history	NN	O
of	IN	O
right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
worsening	VBG	O
over	IN	O
the	DT	O
past	JJ	O
several	JJ	O
months	NNS	O
.	.	O

her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
is	VBZ	O
located	VBN	O
in	IN	O
the	DT	O
groin	NN	O
and	CC	O
thigh	NN	O
.	.	O

it	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
rest	NN	B-PROBLEM
pain	NN	I-PROBLEM
as	IN	O
well	RB	O
.	.	O

she	PRP	O
uses	VBZ	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
or	CC	O
walker	NN	B-TREATMENT
for	IN	O
ambulation	NN	O
,	,	O
and	CC	O
is	VBZ	O
limited	VBN	O
to	TO	O
one	CD	O
to	TO	O
two	CD	O
blocks	NNS	O
.	.	O

she	PRP	O
has	VBZ	O
difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
shoes	NNS	I-PROBLEM
and	CC	I-PROBLEM
socks	NNS	I-PROBLEM
and	CC	I-PROBLEM
foot	NN	I-PROBLEM
care	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
pain	NN	I-PROBLEM
has	VBZ	O
not	RB	O
been	VBN	O
relieved	VBN	O
by	IN	O
darvocet	NN	B-TREATMENT
and	CC	O
advil	NN	B-TREATMENT
.	.	O

radiographs	NN	B-TEST
demonstrate	NN	O
right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
.	.	O

having	VBG	O
failed	VBD	O
conservative	JJ	B-TREATMENT
management	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
presented	VBD	O
for	IN	O
elective	JJ	B-TREATMENT
right	JJ	I-TREATMENT
total	NN	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

hypertension	NN	B-PROBLEM
,	,	O
possible	JJ	O
peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
1959	CD	O
,	,	O
history	NN	O
of	IN	O
left	JJ	B-PROBLEM
ankle	NN	I-PROBLEM
and	CC	I-PROBLEM
knee	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
,	,	O
1980	CD	O
.	.	O

recent	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
e.	VBP	B-PROBLEM
coli	JJ	I-PROBLEM
03/93	CD	O
.	.	O

recent	JJ	B-PROBLEM
herpes	NNS	I-PROBLEM
zoster	NN	I-PROBLEM
.	.	O

cholecystectomy	NN	B-TREATMENT
,	,	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
cataract	JJ	B-TREATMENT
excision	NN	I-TREATMENT
.	.	O

medications	NNS	B-TREATMENT
on	IN	I-TREATMENT
admission	NN	I-TREATMENT
:	:	O

hydrochlorothiazide	RB	B-TREATMENT
50	CD	O
mg.	NNS	O
po	JJ	O
qday	NN	O
,	,	O
kayciel	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
an	DT	O
elderly	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
head	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

left	VBD	O
hip	NN	O
110	CD	O
degrees	NNS	O
of	IN	O
flexion	NN	B-TEST
,	,	O
0	CD	O
degrees	NNS	O
of	IN	O
extension	NN	B-TEST
,	,	O
30	CD	O
degrees	NNS	O
of	IN	O
abduction	NN	B-TEST
,	,	O
45	CD	O
degrees	NNS	O
of	IN	O
adduction	NN	B-TEST
,	,	O
10	CD	O
degrees	NNS	O
of	IN	O
internal	JJ	B-TEST
rotation	NN	I-TEST
and	CC	I-TEST
flexion	NN	I-TEST
,	,	O
45	CD	O
degrees	NNS	O
of	IN	O
external	JJ	B-TEST
rotation	NN	I-TEST
and	CC	I-TEST
flexion	NN	I-TEST
.	.	O

right	JJ	O
hip	NN	O
90	CD	O
degrees	NNS	O
of	IN	O
flexion	NN	B-TEST
,	,	O
minus	CC	O
30	CD	O
degrees	NNS	O
of	IN	O
extension	NN	B-TEST
,	,	O
20	CD	O
degrees	NNS	O
of	IN	O
abduction	NN	B-TEST
,	,	O
30	CD	O
degrees	NNS	O
of	IN	O
adduction	NN	B-TEST
,	,	O
less	JJR	O
than	IN	O
5	CD	O
degrees	NNS	O
of	IN	O
internal	JJ	B-TEST
rotation	NN	I-TEST
and	CC	I-TEST
flexion	NN	I-TEST
and	CC	O
less	JJR	O
than	IN	O
5	CD	O
degrees	NNS	O
of	IN	O
external	JJ	B-TEST
rotation	NN	I-TEST
and	CC	I-TEST
flexion	NN	I-TEST
.	.	O

there	EX	O
was	VBD	O
no	DT	O
leg	JJ	B-PROBLEM
length	NN	I-PROBLEM
discrepancy	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
used	VBD	O
the	DT	B-TREATMENT
cane	NN	I-TREATMENT
in	IN	O
her	PRP$	O
left	JJ	O
hand	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
neurovascular	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
intact	JJ	O
.	.	O

the	DT	B-TEST
sodium	NN	I-TEST
was	VBD	O
140	CD	O
,	,	O
potassium	NN	B-TEST
3.7	CD	O
,	,	O
chloride	RB	B-TEST
96	CD	O
,	,	O
bicarbonate	NN	B-TEST
30	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
14/0.9	CD	O
,	,	O
glucose	RB	B-TEST
105	CD	O
,	,	O
hematocrit	NN	B-TEST
42	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
8.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
644,000	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
10.4	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
28.7	CD	O
,	,	O
urinalysis	JJ	B-TEST
trace	NN	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
slight	JJ	B-PROBLEM
occult	NN	I-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
a	DT	B-TEST
rate	NN	I-TEST
of	IN	O
80	CD	O
with	IN	O
intraventricular	JJ	B-PROBLEM
conduction	NN	I-PROBLEM
delay	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
r	NN	I-PROBLEM
wave	NN	I-PROBLEM
progression	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
acute	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
borderline	JJ	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
but	CC	O
no	DT	O
acute	JJ	B-PROBLEM
cardiac	NN	I-PROBLEM
or	CC	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
his	PRP$	O
impression	NN	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
on	IN	O
hydrochlorothiazide	NN	B-TREATMENT
.	.	O

given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
low	JJ	I-PROBLEM
potassium	NN	I-PROBLEM
level	NN	I-PROBLEM
of	IN	O
2.4	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
he	PRP	O
suggested	VBD	O
supplementation	NN	O
with	IN	O
potassium	NN	B-TREATMENT
.	.	O

on	IN	O
the	DT	O
following	JJ	O
morning	NN	O
4/17/93	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
total	NN	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
using	VBG	O
a	DT	B-TREATMENT
hybrid	JJ	I-TREATMENT
s-rom	JJ	I-TREATMENT
system	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
with	IN	O
the	DT	O
physical	JJ	O
therapy	NN	O
service	NN	O
initially	RB	O
for	IN	O
routine	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
after	IN	O
a	DT	B-TREATMENT
total	JJ	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
hemovac	NN	I-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
2	CD	O
as	IN	O
was	VBD	O
her	PRP$	B-TREATMENT
foley	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
in	IN	O
the	DT	O
low	JJ	O
to	TO	O
mid	VB	O
30	CD	O
&apos;s	NN	O
and	CC	O
she	PRP	O
did	VBD	O
not	RB	O
require	VB	O
a	DT	B-TREATMENT
transfusion	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
postoperatively	RB	B-PROBLEM
hypokalemia	VBN	I-PROBLEM
to	TO	O
a	DT	O
level	NN	O
of	IN	O
2.7	CD	O
and	CC	O
subsequently	RB	O
was	VBD	O
corrected	VBN	O
with	IN	O
oral	JJ	B-TREATMENT
and	CC	I-TREATMENT
intravenous	JJ	I-TREATMENT
potassium	NN	I-TREATMENT
on	IN	O
4/22/93	CD	O
,	,	O
the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TEST
duplex	JJ	I-TEST
ultrasound	NN	I-TEST
examination	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
of	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
thus	RB	O
stopped	VBN	O
and	CC	O
she	PRP	O
was	VBD	O
switched	VBN	O
to	TO	O
bufferin	VB	B-TREATMENT
.	.	O

right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
right	RB	B-TREATMENT
total	JJ	I-TREATMENT
hip	JJ	I-TREATMENT
replacement	NN	I-TREATMENT
on	IN	O
4/17/93	CD	O
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

postoperative	JJ	B-PROBLEM
hypokalemia	NN	I-PROBLEM
,	,	O
resolved	VBN	O
.	.	O

postoperative	JJ	B-PROBLEM
confusion	NN	I-PROBLEM
,	,	O
transient	NN	O
and	CC	O
resolved	VBD	O
spontaneously	RB	O
.	.	O

hydrochlorothiazide	RB	B-TREATMENT
50	CD	O
mg.	NNS	O
po	JJ	O
qday	NN	O
,	,	O
kayciel	VB	B-TREATMENT
40	CD	O
meq.	NN	O
b.i.d.	NN	O
,	,	O
ecotrin	VBZ	B-TREATMENT
1	CD	O
tablet	NN	O
qday	NN	O
,	,	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
mg.	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
folate	VBP	B-TREATMENT
1	CD	O
mg.	NN	O
po	NN	O
qday	NN	O
,	,	O
multivitamins	VBZ	B-TREATMENT
one	CD	O
tablet	NN	O
qday	NN	O
,	,	O
tylenol	JJ	B-TREATMENT
#	#	I-TREATMENT
3	CD	I-TREATMENT
1	CD	O
to	TO	O
2	CD	O
po	NN	O
q3hours	NNS	O
prn	VBP	O
.	.	O

there	EX	O
she	PRP	O
should	MD	O
received	VB	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
consist	VB	O
of	IN	O
a	DT	B-TREATMENT
routine	JJ	I-TREATMENT
post	NN	I-TREATMENT
total	JJ	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
rehabilitation	NN	I-TREATMENT
protocol	NN	I-TREATMENT
,	,	O
with	IN	O
emphasis	NN	O
on	IN	O
gait	NN	B-TREATMENT
training	NN	I-TREATMENT
,	,	O
partial	JJ	O
weight	NN	O
bearing	NN	O
on	IN	O
the	DT	O
right	NN	O
lower	JJR	O
extremity	NN	O
,	,	O
using	VBG	O
a	DT	O
walker	NN	B-TREATMENT
or	CC	O
crutches	NNS	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
should	MD	O
also	RB	O
have	VB	O
her	PRP$	B-TEST
potassium	NN	I-TEST
levels	NNS	I-TEST
checked	VBD	O
two	CD	O
times	NNS	O
per	IN	O
week	NN	O
to	TO	O
insure	VB	O
that	IN	O
she	PRP	O
is	VBZ	O
not	RB	O
becoming	VBG	O
hypokalemic	NN	B-PROBLEM
.	.	O

vag	NN	B-PROBLEM
bleeding	NN	I-PROBLEM

dysfunctional	JJ	B-PROBLEM
uterine	NN	I-PROBLEM
bleeding	NN	I-PROBLEM

pelvic	NN	B-TEST
ultrasound	SYM	I-TEST
-	:	O
normal	JJ	O
ovaries	NNS	O
,	,	O
thickened	VBD	B-PROBLEM
endometrium	NN	I-PROBLEM
hematocrit	NN	B-TEST
-	:	O
33	CD	O

percocet	NN	B-TREATMENT
as	IN	O
directed	VBN	O
for	IN	O
pain	NN	B-PROBLEM

please	NN	O
follow	VB	O
up	RP	O
with	IN	O
gynecology	NN	O
-	:	O
you	PRP	O
will	MD	O
need	VB	O
to	TO	O
have	VB	O
your	PRP$	B-PROBLEM
uterine	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
evaluted	VBD	O

please	VB	O
return	NN	O
to	TO	O
the	DT	O
ed	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
any	DT	B-PROBLEM
worsening	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
fevers	NNS	B-PROBLEM
&gt;	VBP	O
101	CD	O
.	.	O

if	IN	O
you	PRP	O
are	VBP	O
unable	JJ	O
to	TO	O
keep	VB	O
down	RP	O
liquids	NNS	O
or	CC	O
have	VBP	O
any	DT	B-PROBLEM
fainting	JJ	I-PROBLEM
episodes	NNS	I-PROBLEM
we	PRP	O
should	MD	O
see	VB	O
you	PRP	O
again	RB	O
as	RB	O
well	RB	O
.	.	O

otherwise	RB	O
you	PRP	O
need	VBP	O
to	TO	O
see	VB	O
a	DT	O
gynecologist	NN	O
to	TO	O
evaluate	VB	O
this	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

attending	VBG	B-TEST
evaluation	NN	I-TEST

tylenol	NN	B-TREATMENT
(	(	I-TREATMENT
acetaminophen	NN	I-TREATMENT
)	)	I-TREATMENT
650	CD	O
mg	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
colace	NN	B-TREATMENT
(	(	I-TREATMENT
docusate	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
prn	VBZ	O
constipation	NN	B-PROBLEM
ibuprofen	NN	B-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
q4-6h	JJ	O
prn	NN	O
pain	NN	B-PROBLEM
milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
(	(	I-TREATMENT
magnesium	JJ	I-TREATMENT
hydroxide	NN	I-TREATMENT
)	)	I-TREATMENT
30	CD	O
milliliters	NNS	O
po	VBP	O
qd	JJ	O
prn	NN	O
constipation	NN	B-PROBLEM
percocet	IN	B-TREATMENT
1-2	JJ	O
tab	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

houghtbreun	RB	O
6	CD	O
weeks	NNS	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

repeat	NN	B-PROBLEM
c	NNS	I-PROBLEM
/	VBP	I-PROBLEM
s	JJ	I-PROBLEM
pps	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
iup	NN	B-PROBLEM
at	IN	O
36	CD	O
weeks	NNS	O
,	,	O
delivered	VBD	O

conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
iup	NN	B-PROBLEM
at	IN	O
36	CD	O
weeks	NNS	O
.	.	O

insulin	NN	B-PROBLEM
dependent	JJ	I-PROBLEM
gestational	JJ	I-PROBLEM
diabetic	NN	I-PROBLEM
,	,	O
prior	JJ	B-PROBLEM
c	NN	I-PROBLEM
/	NNP	I-PROBLEM
s	NN	I-PROBLEM
,	,	O
rsap	NN	B-PROBLEM

apgars	NNS	B-TEST
9,9	CD	O

weight	NN	B-TEST
:	:	O

biliary	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM

1.	CD	O
rectal	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
partial	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
.	.	O

2.	CD	O
metastatic	JJ	B-PROBLEM
colon	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

3.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

4.	CD	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
porcine	JJ	B-TREATMENT
valve	NN	I-TREATMENT
.	.	O

5.	CD	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

6.	CD	O
cholangitis	NN	B-PROBLEM
.	.	O

7.	CD	O
anemia	NN	B-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
70	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
rectal	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
biliary	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
past	NN	O
,	,	O
he	PRP	O
had	VBD	O
biliary	JJ	B-TREATMENT
stents	NNS	I-TREATMENT
placed	VBD	O
which	WDT	O
clotted	VBD	O
off	RP	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
short	JJ	O
stay	NN	O
unit	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

the	DT	O
day	NN	O
prior	RB	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
endoscopic	VBN	B-TEST
retrograde	NN	I-TEST
cholangiopancreatography	NN	I-TEST
done	VBN	O
with	IN	O
dilated	JJ	B-PROBLEM
ducts	NNS	I-PROBLEM
times	NNS	O
two	CD	O
and	CC	O
eventually	RB	O
had	VBD	O
interventional	JJ	B-TREATMENT
radiology	NN	I-TREATMENT
attempt	NN	O
to	TO	O
place	NN	O
percutaneous	JJ	B-TREATMENT
drains	NNS	I-TREATMENT
to	TO	O
decompress	VB	O
his	PRP$	B-PROBLEM
biliary	JJ	I-PROBLEM
tree	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
two	CD	B-TREATMENT
drains	NNS	I-TREATMENT
placed	VBN	O
after	IN	O
a	DT	B-TREATMENT
prolonged	JJ	I-TREATMENT
course	NN	I-TREATMENT
and	CC	O
difficult	JJ	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

after	IN	O
being	VBG	O
transferred	VBN	O
from	IN	O
the	DT	O
interventional	JJ	O
radiology	NN	O
table	NN	O
to	TO	O
the	DT	O
stretcher	NN	O
,	,	O
one	CD	O
of	IN	O
his	PRP$	B-TREATMENT
lateral	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
drains	NNS	I-TREATMENT
had	VBD	O
been	VBN	O
pulled	VBN	O
out	RP	O
inadvertently	RB	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
short	JJ	O
stay	NN	O
unit	NN	O
,	,	O
given	VBN	O
ancef	NNS	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
per	IN	O
the	DT	O
team	NN	O
for	IN	O
antibiotic	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
and	CC	O
observed	VBD	O
overnight	RB	O
.	.	O

cipro	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
vasotec	JJ	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

significant	JJ	O
for	IN	O
colon	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
was	VBD	O
99.1	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
132/74	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
,	,	O
02	CD	B-TEST
sat	VBD	I-TEST
99%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
an	DT	O
alert	NN	O
,	,	O
jaundiced	VBD	O
gentleman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

had	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
ii	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
with	IN	O
good	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

he	PRP	O
had	VBD	O
midline	NN	B-TREATMENT
catheter	NN	I-TREATMENT
that	WDT	O
was	VBD	O
still	RB	O
in	IN	O
place	NN	O
and	CC	O
was	VBD	O
draining	VBG	O
bile	NN	O
.	.	O

were	VBD	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

exam	RB	B-TEST
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
8.2	CD	O
,	,	O
hematocrit	NN	B-TEST
35	CD	O
.	.	O

ast	NN	B-TEST
was	VBD	O
175	CD	O
,	,	O
alt	RB	B-TEST
76	CD	O
,	,	O
ldh	VBD	B-TEST
454	CD	O
.	.	O

total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
12	CD	O
and	CC	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
8	CD	O
.	.	O

alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
372	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
short	JJ	O
stay	NN	O
unit	NN	O
and	CC	O
continued	VBN	O
to	TO	O
receive	VB	O
antibiotics	NNS	B-TREATMENT
overnight	JJ	O
.	.	O

the	DT	O
next	JJ	O
morning	NN	O
,	,	O
he	PRP	O
was	VBD	O
doing	VBG	O
well	RB	O
with	IN	O
the	DT	B-TREATMENT
intact	JJ	I-TREATMENT
drain	NN	I-TREATMENT
draining	VBG	O
bilious	JJ	B-PROBLEM
material	NN	I-PROBLEM
without	IN	O
any	DT	O
difficulty	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
doing	VBG	O
well	RB	O
with	IN	O
minimal	JJ	O
to	TO	O
no	DT	O
belly	RB	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
back	RB	O
to	TO	O
surgery	NN	O
by	IN	O
the	DT	O
interventional	JJ	O
radiology	NN	O
team	NN	O
and	CC	O
had	VBD	O
a	DT	B-TREATMENT
second	JJ	I-TREATMENT
drain	NN	I-TREATMENT
placed	VBD	O
without	IN	O
any	DT	O
difficulty	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
short	JJ	O
stay	NN	O
unit	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
observed	VBN	O
overnight	RB	O
without	IN	O
any	DT	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

he	PRP	O
will	MD	O
continue	VB	O
cipro	JJ	B-TREATMENT
p.o.	NN	I-TREATMENT
for	IN	O
prophylaxis	NN	B-TREATMENT
.	.	O

he	PRP	O
is	VBZ	O
also	RB	O
to	TO	O
have	VB	O
ah	NN	B-TREATMENT
for	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
stent	NN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM

chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM

steroid	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
,	,	O
including	VBG	O
cataract	NN	B-PROBLEM
,	,	O
osteoporosis	NN	B-PROBLEM
,	,	O
diffuse	NN	B-PROBLEM
fibrocystic	JJ	I-PROBLEM
breast	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
trigeminal	JJ	B-PROBLEM
neuralgia	NN	I-PROBLEM
.	.	O

mrs.	NN	O
cast	NN	O
is	VBZ	O
a	DT	O
50	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
evidence	NN	O
of	IN	O
severe	JJ	B-PROBLEM
lobular	JJ	I-PROBLEM
emphysema	NN	I-PROBLEM
,	,	O
who	WP	O
has	VBZ	O
progressive	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
inability	NN	O
to	TO	O
carry	VB	O
on	IN	O
with	IN	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
without	IN	O
assistance	NN	O
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
a	DT	B-TEST
pre	NN	I-TEST
lung	NN	I-TEST
transplant	JJ	I-TEST
evaluation	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
steroid	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
for	IN	O
two	CD	O
years	NNS	O
and	CC	O
has	VBZ	O
been	VBN	O
intubated	VBN	B-TREATMENT
in	IN	O
the	DT	O
past	JJ	O
only	RB	O
once	RB	O
for	IN	O
a	DT	B-TREATMENT
surgical	JJ	I-TREATMENT
repair	NN	I-TREATMENT
of	IN	I-TREATMENT
trigeminal	JJ	I-TREATMENT
neuralgia	NN	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
history	NN	O
of	IN	O
asbestos	NN	B-PROBLEM
exposure	NN	I-PROBLEM
or	CC	O
tuberculosis	NN	B-PROBLEM
exposure	NN	I-PROBLEM
.	.	O

notable	JJ	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
trigeminal	JJ	B-PROBLEM
neuralgia	NN	I-PROBLEM
,	,	O
left	VBD	B-TREATMENT
shoulder	NN	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
fibrocystic	JJ	B-PROBLEM
breast	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
endometriosis	NN	B-PROBLEM
and	CC	O
status	NN	O
post	NN	O
total	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
hysterectomy	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
gastrointestinal	JJ	B-PROBLEM
intolerance	NN	I-PROBLEM
to	TO	O
tetracycline	VB	B-TREATMENT
,	,	O
erythromycin	FW	B-TREATMENT
,	,	O
declomycin	RB	B-TREATMENT
associated	VBN	O
with	IN	O
edema	NN	B-PROBLEM
and	CC	O
rash	NN	B-PROBLEM
,	,	O
talwin	NN	B-TREATMENT
associated	VBN	O
with	IN	O
disorientation	NN	B-PROBLEM
and	CC	O
gastrointestinal	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
dilantin	NN	B-TREATMENT
has	VBZ	O
caused	VBN	O
rash	NN	B-PROBLEM
and	CC	O
edema	NN	B-PROBLEM
,	,	O
morphine	NN	B-TREATMENT
associated	VBN	O
with	IN	O
itching	NN	B-PROBLEM
and	CC	O
gastrointestinal	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
demerol	NN	B-TREATMENT
unclear	JJ	O
.	.	O

notable	JJ	O
for	IN	O
her	PRP$	B-PROBLEM
diffuse	NN	I-PROBLEM
expiratory	NN	I-PROBLEM
wheezes	NNS	I-PROBLEM
and	CC	O
scattered	JJ	B-PROBLEM
expiratory	NN	I-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

cranial	JJ	O
nerves	NNS	O
were	VBD	O
intact	JJ	O
except	IN	O
for	IN	O
paresthesias	NN	B-PROBLEM
on	IN	O
the	DT	O
left	NN	O
in	IN	O
the	DT	O
vii	NN	O
and	CC	O
viii	JJ	O
distribution	NN	O
.	.	O

the	DT	O
breasts	NNS	O
were	VBD	O
notable	JJ	O
for	IN	O
fibrocystic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

serum	NN	B-TEST
sodium	NN	I-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
106	CD	O
,	,	O
c02	NN	B-TEST
29.6	CD	O
,	,	O
calcium	NN	B-TEST
9.2	CD	O
,	,	O
phosphorus	NN	B-TEST
3.6	CD	O
.	.	O

magnesium	NN	B-TEST
1.7	CD	O
.	.	O

bun	NN	B-TEST
12	CD	O
,	,	O
creatinine	NN	B-TEST
0.6	CD	O
,	,	O
glucose	RB	B-TEST
92	CD	O
,	,	O
uric	JJ	B-TEST
acid	NN	I-TEST
3.3.	CD	O
cholesterol	NN	B-TEST
236	CD	O
,	,	O
triglycerides	NNS	B-TEST
115	CD	O
,	,	O
hdl	NN	B-TEST
99	CD	O
,	,	O
ldl	VBD	B-TEST
114	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
6.2	CD	O
,	,	O
globulin	NN	B-TEST
2.6	CD	O
,	,	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
0	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.2	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
59	CD	O
,	,	O
amylase	NN	B-TEST
64	CD	O
,	,	O
sgot	VBD	B-TEST
16	CD	I-TEST
,	,	O
ldh	VBD	B-TEST
141	CD	I-TEST
,	,	O
cpk	NN	B-TEST
57	CD	O
.	.	O

the	DT	B-TEST
lh	NN	I-TEST
was	VBD	O
4.9	CD	O
,	,	O
fsh	RB	B-TEST
3.3	CD	O
.	.	O

tsh	NN	B-TEST
was	VBD	O
124	CD	O
,	,	O
cortisol	NN	B-TEST
2.1	CD	O
,	,	O
25	CD	B-TEST
hydroxy	NN	I-TEST
vitamin	NN	I-TEST
d	NN	I-TEST
,	,	I-TEST
and	CC	I-TEST
125	CD	I-TEST
dihydroxy	JJ	I-TEST
vitamin	NN	I-TEST
d	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
pending	VBG	O
.	.	O

urine	JJ	B-TEST
cotenine	NN	I-TEST
level	NN	O
none	NN	O
detected	VBN	O
.	.	O

estradialol	NN	B-TEST
pending	VBG	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
9.6	CD	O
,	,	O
hematocrit	NN	B-TEST
38.8	CD	O
,	,	O
platelet	NN	B-TEST
348,000	CD	O
,	,	O
mean	JJ	B-TEST
corpuscular	JJ	I-TEST
volume	NN	I-TEST
85	CD	O
and	CC	O
86	CD	O
,	,	O
mch	FW	B-TEST
29	CD	O
,	,	O
mchc	VBD	B-TEST
34	CD	O
.	.	O

pt	NN	B-TEST
9.5/10.0	CD	O
,	,	O
ptt	RB	B-TEST
23.9	CD	O
.	.	O

urinalysis	NN	B-TEST
was	VBD	O
normal	JJ	O
.	.	O

sed	VBN	B-TEST
rate	NN	I-TEST
6	CD	O
.	.	O

varicella	NN	B-TEST
antibody	NN	I-TEST
positive	JJ	O
,	,	O
cmv	JJ	B-TEST
antibody	NN	I-TEST
positive	JJ	O
,	,	O
toxo	JJ	B-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
non	RB	O
reactive	JJ	O
.	.	O

fev1	RB	B-TEST
0.78	CD	O
liters	NNS	O
,	,	O
vital	JJ	B-TEST
capacity	NN	I-TEST
2.12	CD	O
liters	NNS	O
,	,	O
total	JJ	B-TEST
lung	NN	I-TEST
capacity	NN	I-TEST
5.51	CD	O
liters	NNS	O
,	,	O
single	JJ	B-TEST
breath	NN	I-TEST
dlco	NN	I-TEST
5.3	CD	O
(	(	O
25%	CD	O
predicted	VBN	O
)	)	O
.	.	O

cardiopulmonary	JJ	B-TEST
exercise	NN	I-TEST
study	NN	I-TEST
results	NNS	O
are	VBP	O
pending	VBG	O
.	.	O

echocardiogram	RB	B-TEST
showed	VBD	O
normal	JJ	O
right	JJ	O
ventricular	NN	O
and	CC	O
left	VBD	O
ventricular	JJ	O
size	NN	O
and	CC	O
systolic	JJ	O
function	NN	O
.	.	O

a	DT	B-TEST
left	NN	I-TEST
and	CC	I-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
and	CC	O
coronary	JJ	B-TEST
angiogram	NN	I-TEST
revealed	VBD	O
aortic	JJ	B-TEST
120/70	CD	O
,	,	O
mean	JJ	B-TEST
95	CD	O
,	,	O
pa	NN	B-TEST
26/10	CD	O
,	,	O
mean	JJ	B-TEST
17	CD	O
,	,	O
pc	NN	B-TEST
7	CD	O
,	,	O
rv	NN	B-TEST
26/6	CD	O
,	,	O
ra	NN	B-TEST
4	CD	O
,	,	O
cardiac	JJ	B-TEST
output	NN	I-TEST
5.7	CD	O
,	,	O
index	NN	B-TEST
3.8	CD	O
.	.	O

systemic	JJ	B-TEST
arterial	JJ	I-TEST
resistance	NN	I-TEST
12/81	CD	O
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
short	JJ	I-PROBLEM
pr	NN	I-PROBLEM
interval	NN	I-PROBLEM
with	IN	O
no	DT	O
delta	NN	B-PROBLEM
wave	NN	I-PROBLEM
,	,	O
clockwise	NN	B-PROBLEM
rotation	NN	I-PROBLEM
present	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
quantitative	JJ	I-TEST
vq	NN	I-TEST
scan	NN	I-TEST
of	IN	O
the	DT	O
lung	NN	O
showed	VBD	O
42%	CD	O
ventilation	NN	B-TEST
to	TO	I-TEST
the	DT	I-TEST
left	NN	I-TEST
,	,	O
57%	CD	O
ventilation	NN	B-TEST
to	TO	I-TEST
the	DT	I-TEST
right	NN	I-TEST
,	,	O
42%	CD	O
perfusion	NN	B-TEST
to	TO	I-TEST
the	DT	I-TEST
left	NN	I-TEST
,	,	O
57%	CD	O
perfusion	NN	B-TEST
to	TO	I-TEST
the	DT	I-TEST
right	NN	I-TEST
.	.	O

abdominal	JJ	B-TEST
ultrasound	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

hiv	NN	B-TEST
testing	VBG	I-TEST
results	NNS	O
pending	VBG	O
.	.	O

hepatitis	NN	B-TEST
serologies	NNS	I-TEST
pending	VBG	O
.	.	O

she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
mild	JJ	B-PROBLEM
cataracts	NNS	I-PROBLEM
,	,	O
possibly	RB	O
due	JJ	O
to	TO	O
chronic	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
subtle	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
disc	NN	I-PROBLEM
pallor	NN	I-PROBLEM
od	NN	I-PROBLEM
,	,	O
possibly	RB	O
due	JJ	O
to	TO	O
previous	JJ	O
episode	NN	O
of	IN	O
optic	JJ	B-PROBLEM
neuritis	NN	I-PROBLEM
.	.	O

no	DT	O
acute	JJ	B-PROBLEM
pathology	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
and	CC	O
no	DT	O
treatment	NN	B-PROBLEM
was	VBD	O
necessary	JJ	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

dr.	NN	O
koteelks	NNS	O
indicated	VBD	O
that	IN	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
sinus	VBN	B-PROBLEM
problems	NNS	I-PROBLEM
currently	RB	O
but	CC	O
thought	VBD	O
that	IN	O
the	DT	B-PROBLEM
trigeminal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
might	MD	O
be	VB	O
investigated	VBN	O
further	RBR	O
and	CC	O
that	IN	O
the	DT	B-PROBLEM
sphenoid	NN	I-PROBLEM
might	MD	O
account	VB	O
for	IN	O
some	DT	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
discomfort	NN	I-PROBLEM
.	.	O

dr.	JJ	O
tikkerth	NN	O
felt	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
mild	JJ	B-PROBLEM
adjustment	NN	I-PROBLEM
related	VBN	I-PROBLEM
anxiety	NN	I-PROBLEM
under	IN	O
good	JJ	O
control	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
tobacco	NN	O
abuse	NN	O
in	IN	O
the	DT	O
past	NN	O
.	.	O

the	DT	O
patient	NN	O
completed	VBD	O
the	DT	B-TEST
studies	NNS	I-TEST
and	CC	O
to	TO	O
be	VB	O
informed	VBN	O
of	IN	O
the	DT	O
results	NNS	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

she	PRP	O
knows	VBZ	O
to	TO	O
return	VB	O
to	TO	O
her	PRP$	O
local	JJ	O
physician	NN	O
for	IN	O
her	PRP$	B-TREATMENT
routine	JJ	I-TREATMENT
care	NN	I-TREATMENT
with	IN	O
her	PRP$	B-PROBLEM
condition	NN	I-PROBLEM
unchanged	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
sob	NN	B-PROBLEM

r	NN	B-PROBLEM
lung	NN	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
likely	JJ	O
cancer	NN	B-PROBLEM

physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
laboratory	JJ	B-TEST
evaluation	NN	I-TEST
,	,	O
cxr	NN	B-TEST
,	,	O
chest	VBP	B-TEST
ct	NN	I-TEST

vicodin	JJ	B-TREATMENT
1-2	JJ	O
tabs	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
,	,	O
#	#	O
50	CD	O
,	,	O
no	DT	O
refills	NNS	O

we	PRP	O
are	VBP	O
scheduling	VBG	O
you	PRP	O
for	IN	O
a	DT	B-TEST
needle	JJ	I-TEST
biopsy	NN	I-TEST
by	IN	O
interventional	JJ	O
radiology	NN	O
for	IN	O
some	DT	O
time	NN	O
in	IN	O
the	DT	O
next	JJ	O
week	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
on	IN	O
july	NN	O
12th	CD	O
for	IN	O
a	DT	B-TREATMENT
chole	NN	I-TREATMENT
with	IN	O
a	DT	O
principle	JJ	O
diagnosis	NN	O
of	IN	O
recurrent	NN	B-PROBLEM
biliary	JJ	I-PROBLEM
colic	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
42	CD	O
year	NN	O
old	JJ	O
with	IN	O
recurrent	JJ	B-PROBLEM
biliary	JJ	I-PROBLEM
colic	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
ultrasound	VBN	B-PROBLEM
proven	RB	I-PROBLEM
gallstones	NNS	I-PROBLEM
for	IN	O
ten	JJ	O
years	NNS	O
,	,	O
seen	VBN	O
on	IN	O
an	DT	B-TEST
earlier	JJR	I-TEST
obstetric	JJ	I-TEST
ultrasound	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
no	DT	O
symptoms	NNS	B-PROBLEM
until	IN	O
approximately	RB	O
two	CD	O
years	NNS	O
ago	RB	O
when	WRB	O
she	PRP	O
began	VBD	O
having	VBG	O
classic	JJ	B-PROBLEM
biliary	JJ	I-PROBLEM
colic	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
epigastric	JJ	I-PROBLEM
pain	NN	I-PROBLEM
radiating	VBG	O
to	TO	O
midback	VB	O
with	IN	O
nausea	NN	B-PROBLEM
,	,	O
but	CC	O
without	IN	O
vomiting	VBG	B-PROBLEM
.	.	O

episodes	NNS	B-PROBLEM
have	VBP	O
been	VBN	O
increasing	VBG	O
in	IN	O
frequency	NN	O
over	IN	O
the	DT	O
last	JJ	O
few	JJ	O
months	NNS	O
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
respiratory	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
or	CC	O
melena	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
found	VBN	O
any	DT	O
relieve	NN	O
with	IN	O
any	DT	O
over	IN	B-TREATMENT
the	DT	I-TREATMENT
counter	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
gallbladder	NN	B-PROBLEM
or	CC	O
pancreatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
significant	JJ	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
.	.	O

no	DT	O
anorexia	NN	B-PROBLEM
.	.	O

an	DT	B-TEST
ultrasound	NN	I-TEST
on	IN	O
1/25/00	CD	O
showed	VBD	O
six	CD	B-PROBLEM
gallstones	NNS	I-PROBLEM
without	IN	O
cholecystitis	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
history	NN	O
of	IN	O
liver	NN	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
hepatitis	NN	B-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
ear	NN	I-TREATMENT
operation	NN	I-TREATMENT
approximately	RB	O
30	CD	O
years	NNS	O
ago	RB	O
with	IN	O
left	JJ	B-TREATMENT
tm	JJ	I-TREATMENT
reconstruction	NN	I-TREATMENT
in	IN	O
december	NN	O
1999	CD	O
at	IN	O
hitch	NN	O
hospital	NN	O
.	.	O

only	RB	O
multivitamins	NNS	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
healthy	JJ	O
appearing	VBG	O
female	JJ	O
looking	VBG	O
her	PRP$	O
stated	JJ	O
age	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
anicteric	JJ	B-PROBLEM
without	IN	O
rash	NN	B-PROBLEM
or	CC	O
heent	NN	O
.	.	O

significant	JJ	O
for	IN	O
left	JJ	B-PROBLEM
tm	NN	I-PROBLEM
scarring	VBG	I-PROBLEM
without	IN	O
acute	JJ	B-PROBLEM
inflammation	NN	I-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
.	.	O

no	DT	O
lymphadenopathy	NN	B-PROBLEM
is	VBZ	O
noted	VBN	O
.	.	O

she	PRP	O
is	VBZ	O
without	IN	O
bruits	NNS	B-PROBLEM
or	CC	O
jvd	NN	B-PROBLEM
.	.	O

lungs	NNS	O
are	VBP	O
bilaterally	RB	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

cardiac	JJ	B-TEST
exam	NN	I-TEST
;	:	O
she	PRP	O
has	VBZ	O
positive	JJ	O
s1	NN	O
,	,	O
s2	NN	O
without	IN	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
.	.	O

rate	NN	B-TEST
was	VBD	O
75	CD	O
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
or	CC	O
mass	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
rectal	JJ	I-TEST
exam	NN	I-TEST
is	VBZ	O
guaiac	JJ	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
the	DT	B-TREATMENT
lap	NN	I-TREATMENT
coli	NN	I-TREATMENT
with	IN	O
an	DT	B-TEST
intraoperative	JJ	I-TEST
cholangiogram	NN	I-TEST
by	IN	O
dr.	JJ	O
sterp	NN	O
under	IN	O
general	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

operative	JJ	O
course	NN	O
and	CC	O
recovery	NN	O
were	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

percocet	NN	B-TREATMENT
5	CD	O
mg	NN	O
in	IN	O
325	CD	O
mg	NN	O
one	CD	O
to	TO	O
two	CD	O
tabs	NNS	O
po	VBP	O
q4	NN	O
to	TO	O
6	CD	O
prn	NN	O
pain	NN	B-PROBLEM
.	.	O

dermoplast	RB	B-TREATMENT
topical	JJ	I-TREATMENT
tp	NN	O
q12h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
docusate	NN	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
prn	VBZ	O
constipation	NN	B-PROBLEM
ibuprofen	JJ	B-TREATMENT
400-600	JJ	O
mg	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

take	VB	O
with	IN	O
food	NN	O
prenatal	NN	B-TREATMENT
multivitamins	NNS	I-TREATMENT
(	(	I-TREATMENT
stuartnatal	JJ	I-TREATMENT
1+1	CD	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
qd	NN	O
tucks	NNS	B-TREATMENT
(	(	I-TREATMENT
witch	VB	I-TREATMENT
hazel	NN	I-TREATMENT
)	)	I-TREATMENT
topical	JJ	O
tp	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

nka	NN	B-PROBLEM

labor	NN	B-PROBLEM
at	IN	I-PROBLEM
term	NN	I-PROBLEM

initial	JJ	B-TEST
newborn	JJ	I-TEST
exam	NN	I-TEST
:	:	O

no	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

endometrial	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingo	NN	I-TREATMENT
oophorectomy	IN	I-TREATMENT
2-19-91	JJ	O
by	IN	O
dr.	NN	O
lako	NN	O
coma	NN	O
.	.	O

this	DT	O
is	VBZ	O
an	DT	O
81-year-old	JJ	O
who	WP	O
presented	VBD	O
with	IN	O
postmenopausal	NN	B-PROBLEM
spotting	NN	I-PROBLEM
and	CC	O
had	VBD	O
an	DT	B-TEST
endometrial	JJ	I-TEST
biopsy	NN	I-TEST
which	WDT	O
was	VBD	O
read	VBN	O
at	IN	O
the	DT	O
etearal	JJ	O
etsystems/	JJ	O
hospital	NN	O
as	IN	O
showing	VBG	O
grade	NN	B-PROBLEM
i	NN	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
.	.	O

accordingly	RB	O
she	PRP	O
presents	VBZ	O
for	IN	O
operative	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

abdomen	NNS	B-PROBLEM
obese	JJ	I-PROBLEM
,	,	O
no	DT	O
scars	NNS	B-PROBLEM
.	.	O

pelvic	JJ	B-TEST
exam	NN	I-TEST
showed	VBD	O
a	DT	O
small	JJ	O
mobile	JJ	O
uterus	NN	O
.	.	O

extremities	NNS	O
show	VBP	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2-19-91	JJ	O
where	WRB	O
she	PRP	O
had	VBD	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
,	,	O
tah	NN	B-TREATMENT
/	NNP	I-TREATMENT
bso	NN	I-TREATMENT
,	,	O
and	CC	O
omental	JJ	B-TEST
biopsy	NN	I-TEST
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
normal	JJ	I-TEST
abdominal	JJ	I-TEST
exploration	NN	I-TEST
of	IN	O
a	DT	O
small	JJ	O
uterus	NN	O
with	IN	O
superficial	JJ	B-PROBLEM
invasion	NN	I-PROBLEM
on	IN	O
gross	JJ	B-TEST
examination	NN	I-TEST
,	,	O
normal	JJ	O
ovaries	NNS	O
.	.	O

washings	NNS	B-TEST
were	VBD	O
sent	VBN	O
.	.	O

a	DT	B-TREATMENT
subfascial	JJ	I-TREATMENT
j-p	NN	I-TREATMENT
was	VBD	O
left	VBN	O
.	.	O

subfascia	NN	B-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
postoperative	JJ	B-TEST
hct	NN	I-TEST
was	VBD	O
34	CD	O
.	.	O

gait	NN	B-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

gait	NN	B-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
31-year-old	JJ	O
right-handed	JJ	O
female	NN	O
with	IN	O
right-sided	JJ	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
left-sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
difficulty	NN	B-PROBLEM
walking	VBG	I-PROBLEM
for	IN	O
several	JJ	O
days	NNS	O
.	.	O

she	PRP	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
3/20/97	CD	O
when	WRB	O
she	PRP	O
experienced	VBD	O
the	DT	O
fairly	RB	O
sudden	JJ	O
onset	NN	O
of	IN	O
predominantly	RB	O
right-sided	JJ	B-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
ataxia	NN	B-PROBLEM
.	.	O

she	PRP	O
evidently	RB	O
recovered	VBD	O
from	IN	O
the	DT	B-PROBLEM
episode	NN	I-PROBLEM
after	IN	O
a	DT	O
number	NN	O
of	IN	O
minutes	NNS	O
.	.	O

the	DT	O
following	JJ	O
day	NN	O
,	,	O
she	PRP	O
remained	VBD	O
in	IN	O
bed	NN	O
through	IN	O
essentially	RB	O
all	DT	O
of	IN	O
the	DT	O
day	NN	O
due	JJ	O
to	TO	O
malaise	VB	B-PROBLEM
with	IN	O
no	DT	O
specific	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
being	VBG	O
noted	VBN	O
.	.	O

in	IN	O
the	DT	O
subsequent	JJ	O
two	CD	O
days	NNS	O
,	,	O
she	PRP	O
had	VBD	O
several	JJ	O
small	JJ	B-PROBLEM
spells	NNS	I-PROBLEM
of	IN	I-PROBLEM
&quot;	JJ	I-PROBLEM
imbalance	NN	I-PROBLEM
&quot;	NNP	O
,	,	O
particularly	RB	O
towards	IN	O
the	DT	O
right	NN	O
,	,	O
and	CC	O
other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
included	VBN	O
diffuse	NN	B-PROBLEM
and	CC	I-PROBLEM
mainly	RB	I-PROBLEM
frontal	JJ	I-PROBLEM
headaches	NNS	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
neck	NN	I-PROBLEM
soreness	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
diplopia	NN	B-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
loss	NN	I-PROBLEM
,	,	O
speech	JJ	B-PROBLEM
abnormality	NN	I-PROBLEM
or	CC	O
sensory	JJ	B-PROBLEM
change	NN	I-PROBLEM
in	IN	O
her	PRP$	O
history	NN	O
.	.	O

is	VBZ	O
notable	JJ	O
for	IN	O
depression	NN	B-PROBLEM
,	,	O
and	CC	O
she	PRP	O
has	VBZ	O
been	VBN	O
followed	VBN	O
regularly	RB	O
by	IN	O
dr.	JJ	O
freiermchird	NN	O
of	IN	O
nash	JJ	O
health	NN	O
for	IN	O
several	JJ	O
months	NNS	O
with	IN	O
pharmacologic	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
,	,	O
which	WDT	O
is	VBZ	O
apparently	RB	O
working	VBG	O
well	RB	O
.	.	O

her	PRP$	B-TREATMENT
doxepin	NN	I-TREATMENT
has	VBZ	O
recently	RB	O
been	VBN	O
increased	VBN	O
.	.	O

she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
and	CC	O
otherwise	RB	O
has	VBZ	O
no	DT	O
remarkable	JJ	O
past	JJ	O
medical	JJ	O
history	NN	O
.	.	O

quinine	NN	B-TREATMENT
gives	VBZ	O
her	PRP$	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

the	DT	O
only	JJ	O
medications	NNS	B-TREATMENT
she	PRP	O
is	VBZ	O
on	IN	O
are	VBP	O
paxil	JJ	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
doxepin	VBZ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
and	CC	O
klonopin	VB	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

she	PRP	O
was	VBD	O
pleasant	JJ	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
130/60	CD	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
66	CD	O
;	:	O
respirations	NNS	B-TEST
18	CD	O
;	:	O
temperature	NN	B-TEST
98	CD	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
carotid	NN	B-PROBLEM
or	CC	I-PROBLEM
cervical	JJ	I-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
and	CC	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
.	.	O

her	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

her	PRP$	O
extremities	NNS	O
were	VBD	O
without	IN	O
clubbing	VBG	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
edema	NN	B-PROBLEM
,	,	O
or	CC	O
rash	NN	B-PROBLEM
;	:	O
there	EX	O
were	VBD	O
some	DT	O
older	JJR	O
hematomas	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
bilaterally	RB	I-PROBLEM
shins	VBZ	I-PROBLEM
.	.	O

her	PRP$	O
affect	NN	O
was	VBD	O
slightly	RB	B-PROBLEM
inappropriate	JJ	I-PROBLEM
at	IN	O
times	NNS	O
;	:	O
for	IN	O
example	NN	O
,	,	O
singing	VBG	B-PROBLEM
or	CC	I-PROBLEM
humming	VBG	I-PROBLEM
along	RB	I-PROBLEM
while	IN	O
performing	VBG	O
some	DT	O
of	IN	O
the	DT	B-TEST
motor	NN	I-TEST
tasks	NNS	I-TEST
and	CC	O
giving	VBG	O
the	DT	O
impression	NN	O
of	IN	O
indifference	NN	B-PROBLEM
to	TO	O
the	DT	B-PROBLEM
deficits	NNS	I-PROBLEM
that	WDT	O
were	VBD	O
demonstrated	VBN	O
on	IN	O
the	DT	B-TEST
examination	NN	I-TEST
.	.	O

there	EX	O
was	VBD	O
no	DT	O
nystagmus	NN	B-PROBLEM
and	CC	O
no	DT	O
ptosis	NN	B-PROBLEM
.	.	O

motor	NN	B-TEST
examination	NN	I-TEST
revealed	VBD	O
5/5	CD	O
power	NN	O
in	IN	O
all	DT	O
groups	NNS	O
in	IN	O
the	DT	O
proximal	NN	O
and	CC	O
distal	JJ	O
upper	NN	O
and	CC	O
lower	JJR	O
extremities	NNS	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
drift	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
slightly	RB	B-PROBLEM
slow	JJ	I-PROBLEM
fine	NN	I-PROBLEM
finger	NN	I-PROBLEM
motility	NN	I-PROBLEM
approximately	RB	O
equal	JJ	O
bilaterally	RB	O
,	,	O
although	IN	O
this	DT	O
was	VBD	O
extremely	RB	O
difficult	JJ	O
to	TO	O
reproduce	VB	O
.	.	O

reflexes	NNS	B-TEST
were	VBD	O
2+	CD	O
throughout	IN	O
in	IN	O
the	DT	O
upper	JJ	O
and	CC	O
lower	JJR	O
extremities	NNS	O
,	,	O
and	CC	O
toes	NNS	O
were	VBD	O
downgoing	VBG	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
jaw	NN	B-PROBLEM
jerk	NN	I-PROBLEM
and	CC	O
no	DT	O
hoffman	NN	O
&apos;s	VBZ	O
sign	NN	O
.	.	O

coordination	NN	O
-	:	O
toe	NN	B-TEST
tap	NN	I-TEST
was	VBD	O
slow	JJ	B-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
although	IN	O
difficult	JJ	O
to	TO	O
reproduce	VB	O
,	,	O
and	CC	O
at	IN	O
best	JJS	O
,	,	O
was	VBD	O
essentially	RB	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

on	IN	O
standing	NN	O
,	,	O
she	PRP	O
tended	VBD	O
to	TO	O
fall	VB	O
to	TO	O
the	DT	O
front	NN	O
,	,	O
back	RB	O
or	CC	O
sides	NNS	O
without	IN	O
trying	VBG	O
to	TO	O
stop	VB	O
her	PRP$	O
fall	NN	O
initially	RB	O
,	,	O
and	CC	O
extensive	JJ	B-TEST
gait	NN	I-TEST
testing	NN	I-TEST
was	VBD	O
deferred	VBN	O
due	JJ	O
to	TO	O
concerns	NNS	O
for	IN	O
safety	NN	O
.	.	O

her	PRP$	B-TEST
heel-to-shin	JJ	I-TEST
and	CC	I-TEST
finger-to-nose	JJ	I-TEST
testing	NN	I-TEST
was	VBD	O
fully	RB	O
intact	JJ	O
bilaterally	RB	O
without	IN	O
ataxia	NN	B-PROBLEM
or	CC	O
tremor	NN	B-PROBLEM
.	.	O

were	VBD	O
unremarkable	JJ	O
with	IN	O
normal	JJ	O
electrolytes	NNS	B-TEST
and	CC	O
complete	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
parameters	NNS	I-TEST
.	.	O

her	PRP$	B-TEST
erythrocyte	JJ	I-TEST
sedimentation	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
12	CD	O
.	.	O

her	PRP$	B-TEST
coagulation	NN	I-TEST
parameters	NNS	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
without	IN	I-TEST
contrast	NN	I-TEST
showed	VBD	O
normal	JJ	O
brain	NN	O
parenchyma	NN	O
and	CC	O
no	DT	O
intracranial	JJ	B-PROBLEM
process	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
her	PRP$	B-PROBLEM
gait	NN	I-PROBLEM
disorder	NN	I-PROBLEM
with	IN	O
other	JJ	O
notable	JJ	B-PROBLEM
findings	NNS	I-PROBLEM
on	IN	O
examination	NN	B-TEST
including	VBG	O
anisocoria	NNS	B-PROBLEM
,	,	O
which	WDT	O
,	,	O
by	IN	O
the	DT	O
patient	JJ	O
&apos;s	NNP	O
report	NN	O
,	,	O
had	VBD	O
been	VBN	O
noted	VBN	O
several	JJ	O
months	NNS	O
earlier	RB	O
.	.	O

a	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
and	CC	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
angiogram	NN	I-TEST
study	NN	I-TEST
was	VBD	O
obtained	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
no	DT	O
clear	JJ	O
evidence	NN	O
of	IN	O
arterial	JJ	B-PROBLEM
dissections	NNS	I-PROBLEM
or	CC	O
infarction	NN	B-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
pathologic	JJ	I-PROBLEM
processes	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
been	VBN	O
placed	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
initially	RB	O
,	,	O
but	CC	O
this	DT	O
was	VBD	O
discontinued	VBN	O
after	IN	O
the	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
results	NNS	O
were	VBD	O
obtained	VBN	O
.	.	O

posterior	JJ	B-TEST
transcranial	JJ	I-TEST
doppler	NN	I-TEST
studies	NNS	I-TEST
showed	VBD	O
normal	JJ	O
studies	NNS	O
of	IN	O
both	DT	O
vertebral	JJ	O
arteries	NNS	O
,	,	O
and	CC	O
carotid	VB	B-TEST
non-invasive	JJ	I-TEST
studies	NNS	I-TEST
showed	VBD	O
normal	JJ	O
right	NN	O
and	CC	O
left	VBD	O
carotid	JJ	O
bifurcations	NNS	O
.	.	O

on	IN	O
the	DT	O
second	JJ	O
hospital	NN	O
day	NN	O
,	,	O
her	PRP$	B-PROBLEM
gait	NN	I-PROBLEM
continued	VBD	O
to	TO	O
be	VB	O
markedly	RB	B-PROBLEM
unstable	JJ	I-PROBLEM
,	,	O
although	IN	O
with	IN	O
no	DT	O
consistent	JJ	O
pattern	NN	O
in	IN	O
terms	NNS	O
of	IN	O
weakness	NN	B-PROBLEM
or	CC	O
directionality	NN	O
of	IN	O
falling	VBG	O
,	,	O
and	CC	O
she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
no	DT	O
reproducible	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
or	CC	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
ataxia	NN	I-PROBLEM
or	CC	O
dysmetria	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O
psychiatry	NN	B-TREATMENT
service	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
not	RB	O
felt	VBN	O
to	TO	O
be	VB	O
acutely	RB	B-PROBLEM
suicidal	JJ	I-PROBLEM
or	CC	O
otherwise	RB	O
in	IN	O
need	NN	O
of	IN	O
acute	JJ	B-TREATMENT
psychiatric	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

the	DT	O
psychiatrist	NN	O
also	RB	O
noted	VBD	O
the	DT	O
indifference	NN	O
the	DT	O
patient	NN	O
evinced	VBD	O
regarding	VBG	O
her	PRP$	B-PROBLEM
own	JJ	I-PROBLEM
symptomatology	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
neurology	NN	O
conferences	NNS	O
for	IN	O
several	JJ	O
hours	NNS	O
,	,	O
and	CC	O
during	IN	O
this	DT	O
time	NN	O
,	,	O
showed	VBD	O
significant	JJ	O
improvement	NN	O
while	IN	O
receiving	VBG	O
gait	JJ	B-TREATMENT
training	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
evaluation	NN	B-TEST
;	:	O
in	IN	O
particular	NN	O
,	,	O
she	PRP	O
became	VBD	O
more	RBR	O
stable	JJ	O
with	IN	O
counter-balancing	JJ	B-TREATMENT
methods	NNS	I-TREATMENT
.	.	O

she	PRP	O
will	MD	O
continue	VB	O
on	IN	O
her	PRP	B-TREATMENT
previous	JJ	I-TREATMENT
outpatient	JJ	I-TREATMENT
medical	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

abd	NN	B-PROBLEM
pain/	NN	I-PROBLEM
pelvic	NN	B-PROBLEM
pain	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
treatment	NN	O
rendered	VBD	O
:	:	O

ct	NN	B-TEST
scan	JJ	I-TEST
shows	NNS	O
ovarian	JJ	B-PROBLEM
cyst	NN	I-PROBLEM

vicodin	NN	B-TREATMENT

if	IN	O
you	PRP	O
have	VBP	O
continued	VBN	O
fevers	NNS	B-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
discharge	NN	B-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
worrisome	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
please	VB	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
sdh	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
glyncred	VBN	O
,	,	O
nabeth	JJ	O
n	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
sdh	JJ	B-PROBLEM
.	.	O

s	NN	O
/	NNP	O
p	NN	O
cesarean	NN	B-TREATMENT

attending	VBG	B-TEST
evaluation	NN	I-TEST

colace	NN	B-TREATMENT
(	(	I-TREATMENT
docusate	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
ibuprofen	VBZ	B-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
pain	NN	O
aldomet	NN	B-TREATMENT
(	(	I-TREATMENT
methyldopa	NN	I-TREATMENT
)	)	I-TREATMENT
250	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
percocet	VBZ	B-TREATMENT
1-2	JJ	O
tab	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

your	PRP$	O
obstetrician	JJ	O
6	CD	O
weeks	NNS	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

s	NN	O
/	NNP	O
p	NN	O
cesarean	NN	B-TREATMENT

principal	JJ	O
discharge	NN	O
diagnosis	NN	O
;	:	O
responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
s	NN	O
/	NNP	O
p	NN	O
cesarean	NN	B-TREATMENT

other	JJ	O
diagnosis	NN	O
;	:	O
conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
s	RB	O
/	NNP	O
p	NN	O
cesarean	NN	B-TREATMENT

epidural	JJ	B-TREATMENT
vaginal	JJ	O
delivery	NN	O
:	:	O

non-reassuring	JJ	B-PROBLEM
fetal	JJ	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
uterine	NN	O

iv	NN	B-TREATMENT
abx	NN	I-TREATMENT

post	NN	B-PROBLEM
dates	NNS	I-PROBLEM

,	,	O
other	JJ	O
-	:	O
bradycardia	NN	B-PROBLEM

no	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

12/02/03	CD	O
03:20	CD	O
pm	NN	O
apgars	NNS	B-TEST
7,8	CD	O

weight	NN	B-TEST
:	:	O

no	DT	O
heavy	JJ	O
lifting	NN	O
;	:	O
nothing	NN	O
in	IN	O
the	DT	O
vagina	NN	O
for	IN	O
6	CD	O
weeks	NNS	O
--	:	O
no	DT	O
intercourse	NN	O
,	,	O
no	DT	O
douching	NN	O
,	,	O
no	DT	O
tampons	NNS	O
;	:	O
call	VB	O
for	IN	O
fever	NN	B-PROBLEM
above	IN	I-PROBLEM
100.5	CD	I-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
heavy	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concern	NN	I-PROBLEM
;	:	O
no	DT	O
driving	VBG	O
while	IN	O
taking	VBG	O
percocet	NN	B-TREATMENT

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
-	:	O
trauma	NN	B-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
sprains	NNS	B-PROBLEM
,	,	O
fractures	NNS	B-PROBLEM
and	CC	O
bruises	NNS	B-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

s	NN	O
/	NNP	O
p	NN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
,	,	O
muscle	NN	B-PROBLEM
contusions	NNS	I-PROBLEM

xray	SYM	B-TEST
-	:	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM

motrin	NN	B-TREATMENT
600	CD	O
mg	NN	O
every	DT	O
8	CD	O
hours	NNS	O
for	IN	O
pain	NN	B-PROBLEM
-	:	O
please	NN	O
take	VB	O
with	IN	O
food	NN	O
in	IN	O
your	PRP$	O
stomach	NN	O

please	NN	O
use	NN	O
ice	NN	B-TREATMENT
to	TO	O
sore	VB	B-PROBLEM
areas	NNS	I-PROBLEM
for	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
.	.	O

if	IN	O
you	PRP	O
develop	VBP	O
trouble	NN	B-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerns	NNS	I-PROBLEM
please	VB	O
return	NN	O
to	TO	O
the	DT	O
ed	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

alzheimer	NN	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
secondary	NN	O
to	TO	O
down	VB	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
44	CD	O
year-old	JJ	O
right	NN	O
handed	VBN	O
woman	NN	O
with	IN	O
down	JJ	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
falling	VBG	B-PROBLEM
and	CC	O
a	DT	B-PROBLEM
decrease	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
activities	NNS	I-PROBLEM
of	IN	O
daily	JJ	O
living	NN	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
44	CD	O
year-old	JJ	O
right	NN	O
handed	VBN	O
woman	NN	O
with	IN	O
down	JJ	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
increased	JJ	B-PROBLEM
falling	VBG	I-PROBLEM
and	CC	O
gait	NN	B-PROBLEM
unsteadiness	NN	I-PROBLEM
and	CC	O
an	DT	B-PROBLEM
increased	VBN	I-PROBLEM
inability	NN	I-PROBLEM
to	TO	O
perform	VB	O
her	PRP$	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
over	IN	O
the	DT	O
past	JJ	O
three	CD	O
years	NNS	O
.	.	O

the	DT	O
diagnosis	NN	O
of	IN	O
alzheimer	NN	B-PROBLEM
&apos;s	NN	I-PROBLEM
was	VBD	O
made	VBN	O
in	IN	O
1998	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
mri	NN	I-TEST
at	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
which	WDT	O
showed	VBD	O
enlarged	JJ	B-PROBLEM
lateral	JJ	I-PROBLEM
ventricles	NNS	I-PROBLEM
and	CC	O
the	DT	O
possible	JJ	O
diagnosis	NN	O
of	IN	O
normal	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
hydrocephalus	NN	I-PROBLEM
was	VBD	O
entertained	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
diagnostic	JJ	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
.	.	O

notable	JJ	O
for	IN	O
down	RP	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
altzheimer	JJ	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
secondary	NN	O
to	TO	O
down	VB	B-PROBLEM
&apos;s	NNP	I-PROBLEM
syndrome	NN	I-PROBLEM
diagnosed	VBD	O
in	IN	O
1998	CD	O
,	,	O
status	NN	O
post	NN	O
multiple	NN	B-PROBLEM
falls	VBZ	I-PROBLEM
,	,	O
no	DT	O
heart	NN	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
ankle	NN	B-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
an	DT	B-PROBLEM
abnormal	JJ	I-PROBLEM
eeg	NN	I-PROBLEM
.	.	O

include	VBP	O
lamictal	JJ	B-TREATMENT
50	CD	O
mgs	NN	O
bid	NN	O
,	,	O
aricept	IN	B-TREATMENT
10	CD	O
mgs	NN	O
qhs	NN	O
,	,	O
buspar	NN	B-TREATMENT
15	CD	O
mgs	NN	O
bid	NN	O
,	,	O
trazodone	NN	B-TREATMENT
100	CD	O
mgs	NN	O
qhs	NN	O
.	.	O

there	EX	O
are	VBP	O
no	DT	O
known	JJ	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

notable	JJ	O
for	IN	O
decreased	JJ	B-PROBLEM
ability	NN	I-PROBLEM
to	TO	O
do	VB	O
her	PRP$	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
,	,	O
a	DT	B-PROBLEM
decrease	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
language	NN	I-PROBLEM
,	,	O
some	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
accidents	NNS	I-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
falls	NNS	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
poor	JJ	I-PROBLEM
gait	NN	I-PROBLEM
.	.	O

noted	VBN	O
for	IN	O
friendly	JJ	O
,	,	O
jovial	JJ	O
44	CD	O
year-old	JJ	O
woman	NN	O
with	IN	O
down	JJ	B-PROBLEM
&apos;s	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
150/82	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
88	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
.	.	O

heent	NN	B-TEST
examination	NN	I-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
bilateral	JJ	B-PROBLEM
esotropia	NN	I-PROBLEM
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

cardiac	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

abdominal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

left	VBD	O
ankle	NN	O
was	VBD	O
notable	JJ	O
for	IN	O
swelling	VBG	B-PROBLEM
secondary	JJ	O
to	TO	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
ankle	RP	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
back	RP	B-PROBLEM
folliculitis	NN	I-PROBLEM
.	.	O

neuro	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	O
patient	NN	O
who	WP	O
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
x	$	O
1	CD	O
.	.	O

cranial	JJ	O
nerves	NNS	O
notable	JJ	O
for	IN	O
bilateral	JJ	B-PROBLEM
esotropia	NN	I-PROBLEM
.	.	O

reflexes	NNS	B-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
with	IN	O
down	RP	O
going	VBG	O
toes	NNS	O
.	.	O

the	DT	O
patient	NN	O
walked	VBD	O
with	IN	O
her	PRP$	B-PROBLEM
feet	NNS	I-PROBLEM
externally	RB	I-PROBLEM
rotated	VBN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
wide	JJ	I-PROBLEM
based	VBN	I-PROBLEM
gait	NN	I-PROBLEM
with	IN	O
shuffling	VBG	B-PROBLEM
short	JJ	I-PROBLEM
steps	NNS	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
tendency	NN	I-PROBLEM
to	TO	I-PROBLEM
fall	VB	I-PROBLEM
back	RB	I-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
unable	JJ	O
to	TO	O
walk	VB	O
without	IN	O
assist	NN	O
.	.	O

mri	NN	B-TEST
,	,	O
as	IN	O
discussed	VBN	O
,	,	O
was	VBD	O
done	VBN	O
at	IN	O
outside	JJ	O
hospital	NN	O
and	CC	O
demonstrated	VBD	O
large	JJ	B-PROBLEM
ventricles	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
arkzie-	JJ	O
memorial	NN	O
for	IN	O
lumbar	NN	B-TEST
puncture	NN	I-TEST
.	.	O

on	IN	O
the	DT	O
night	NN	O
of	IN	O
admission	NN	O
lumbar	NN	B-TEST
puncture	NN	I-TEST
was	VBD	O
attempted	VBN	O
on	IN	O
the	DT	O
floor	NN	O
,	,	O
but	CC	O
we	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
get	VB	O
cerebral	JJ	O
spinal	JJ	O
fluid	NN	O
due	JJ	O
to	TO	O
difficulty	NN	O
with	IN	O
compliance	NN	O
with	IN	O
the	DT	O
patient	NN	O
who	WP	O
was	VBD	O
severely	RB	B-PROBLEM
agitated	JJ	I-PROBLEM
and	CC	O
would	MD	O
not	RB	O
comply	VB	O
with	IN	O
the	DT	B-TEST
examination	NN	I-TEST
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
the	DT	O
patient	NN	O
underwent	JJ	O
conscious	JJ	B-TREATMENT
sedation	NN	I-TREATMENT
in	IN	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
lumbar	NN	B-TEST
puncture	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

opening	VBG	B-TEST
pressure	NN	I-TEST
was	VBD	O
17	CD	O
and	CC	O
approximately	RB	O
20-25	JJ	O
cc	NN	O
of	IN	O
csf	NN	O
was	VBD	O
removed	VBN	O
.	.	O

csf	NN	B-TEST
was	VBD	O
notable	JJ	O
for	IN	O
sugar	JJ	B-TEST
level	NN	I-TEST
of	IN	O
65	CD	O
and	CC	O
total	JJ	B-TEST
protein	JJ	I-TEST
level	NN	I-TEST
of	IN	O
56	CD	O
.	.	O

vitamin	NN	B-TEST
b12	NN	I-TEST
of	IN	O
855	CD	O
,	,	O
folic	JJ	B-TEST
acid	NN	I-TEST
of	IN	O
15.4	CD	O
.	.	O

chem-7	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

tube	NN	O
and	CC	O
requisition	NN	O
of	IN	O
the	DT	O
csf	NN	B-TEST
labeled	VBD	I-TEST
tube	RB	I-TEST
#	#	I-TEST
1	CD	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
color	NN	B-TEST
pink	NN	O
,	,	O
turbidity	NN	B-TEST
slight	NN	O
,	,	O
xanthochromia	NNP	B-TEST
yes	UH	O
,	,	O
red	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
3,800	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
3	CD	O
,	,	O
neutrophils	RB	B-TEST
58	CD	O
,	,	O
bands	VBZ	B-TEST
4	CD	O
,	,	O
lymphs	VBD	B-TEST
29	CD	O
,	,	O
monos	FW	B-TEST
6	CD	O
,	,	O
eos	VBD	B-TEST
2	CD	O
and	CC	O
basos	$	B-TEST
1	CD	O
.	.	O

csf	NN	B-TEST
tube	NN	I-TEST
labeled	VBD	I-TEST
#	#	I-TEST
4	CD	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
csf	NN	B-TEST
color	NN	I-TEST
pink	NN	O
,	,	O
csf	JJ	B-TEST
turbidity	NN	I-TEST
slight	NN	O
,	,	O
csf	JJ	B-TEST
xanthochromia	NNP	I-TEST
yes	UH	O
,	,	O
csf	JJ	B-TEST
rbcs	NN	I-TEST
3,900	CD	O
,	,	O
csf	JJ	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
3	CD	O
,	,	O
csf	NN	B-TEST
neutrophils	NNS	I-TEST
61	CD	O
,	,	O
csf	NN	B-TEST
bands	NNS	I-TEST
3	CD	O
,	,	O
csf	NN	B-TEST
lymphs	NN	I-TEST
31	CD	O
,	,	O
csf	NN	B-TEST
monos	NNS	I-TEST
1	CD	O
,	,	O
csf	NN	B-TEST
eos	VBD	I-TEST
3	CD	O
,	,	O
csf	NN	B-TEST
basos	NN	I-TEST
1	CD	O
.	.	O

csf	NN	B-TEST
gram	NN	I-TEST
stain	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
no	DT	O
polys	NN	B-PROBLEM
and	CC	O
no	DT	O
organisms	JJ	B-PROBLEM
seen	VBN	O
.	.	O

the	DT	B-TEST
fluid	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
no	DT	O
growth	NN	O
to	TO	O
date	NN	O
.	.	O

one	CD	O
day	NN	O
prior	RB	O
to	TO	O
lumbar	VB	B-TEST
puncture	NN	I-TEST
,	,	O
an	DT	B-TEST
aerobic	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
similarly	RB	O
pending	JJ	O
.	.	O

lyme	JJ	B-TEST
capture	NN	I-TEST
was	VBD	O
pending	VBG	O
and	CC	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

rpr	VB	B-TEST
card	NN	I-TEST
test	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

because	IN	O
of	IN	O
poor	JJ	O
compliance	NN	O
with	IN	O
the	DT	B-TEST
gait	NN	I-TEST
examination	NN	I-TEST
it	PRP	O
was	VBD	O
very	RB	O
difficult	JJ	O
to	TO	O
assess	VB	O
changing	VBG	B-PROBLEM
gait	JJ	I-PROBLEM
post	NN	O
lumbar	NN	B-TEST
puncture	NN	I-TEST
.	.	O

her	PRP$	O
mental	JJ	O
status	NN	O
remained	VBD	O
similarly	RB	O
to	TO	O
her	PRP$	B-TEST
admission	NN	I-TEST
examination	NN	I-TEST
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
neuro	CC	I-TEST
examination	NN	I-TEST
was	VBD	O
largely	RB	O
unchanged	JJ	O
from	IN	O
the	DT	B-TEST
admission	NN	I-TEST
neuro	DT	I-TEST
examination	NN	I-TEST
.	.	O

cnm	NN	B-TEST
evaluation	NN	I-TEST

docusate	NN	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
prn	VBZ	O
constipation	NN	B-PROBLEM
ibuprofen	JJ	B-TREATMENT
400-600	JJ	O
mg	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

take	VB	O
with	IN	O
food	NN	O
prenatal	NN	B-TREATMENT
multivitamins	NNS	I-TREATMENT
(	(	I-TREATMENT
stuartnatal	JJ	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
qd	JJ	O
maalox-tablets	NNS	B-TREATMENT
quick	JJ	I-TREATMENT
dissolve	NN	I-TREATMENT
/	NNP	I-TREATMENT
chewable	JJ	I-TREATMENT
1-2	JJ	O
tab	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
upset	JJ	B-PROBLEM
stomach	NN	I-PROBLEM

pregnancy	NN	B-PROBLEM
,	,	I-PROBLEM
term	NN	I-PROBLEM

laceration	NN	B-PROBLEM
:	:	O

perineal	NN	B-PROBLEM
,	,	I-PROBLEM
1st	CD	I-PROBLEM
degree	NN	I-PROBLEM

repair	NN	B-TREATMENT
of	IN	O
first	JJ	B-PROBLEM
degree	JJ	I-PROBLEM
perineal	NN	I-PROBLEM
laceration	NN	I-PROBLEM

no	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

apgars	NNS	B-TEST
9,9	CD	O

weight	NN	B-TEST
:	:	O

this	DT	O
85	CD	O
year	NN	O
old	JJ	O
man	NN	O
was	VBD	O
admitted	VBN	O
because	IN	O
of	IN	O
the	DT	O
new	JJ	O
onset	NN	O
of	IN	O
focal	JJ	B-PROBLEM
left-sided	JJ	I-PROBLEM
seizure	NN	I-PROBLEM
and	CC	O
unresponsiveness	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
past	JJ	O
history	NN	O
of	IN	O
ischemic	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
10	CD	O
,	,	O
mild	FW	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
territory	NN	I-PROBLEM
stroke	NN	I-PROBLEM
in	IN	O
07/94	CD	O
.	.	O

he	PRP	O
was	VBD	O
at	IN	O
orlak	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
and	CC	O
was	VBD	O
found	VBN	O
unresponsive	JJ	B-PROBLEM
with	IN	O
left	JJ	B-PROBLEM
tonic-clonic	JJ	I-PROBLEM
movements	NNS	I-PROBLEM
,	,	O
greater	JJR	O
in	IN	O
the	DT	O
arms	NNS	O
than	IN	O
in	IN	O
the	DT	O
legs	NN	O
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
fairm	VB	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
,	,	O
where	WRB	O
seizures	NNS	B-PROBLEM
were	VBD	O
stopped	VBN	O
with	IN	O
2	CD	O
mg	NNS	O
of	IN	O
ativan	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
loaded	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
dilantin	NN	I-TREATMENT
.	.	O

he	PRP	O
remained	VBD	O
unresponsive	JJ	B-PROBLEM
with	IN	O
poor	JJ	B-PROBLEM
airway	NN	I-PROBLEM
protection	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
flaccid	VBN	B-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
oculocephalic	JJ	B-PROBLEM
reflexes	NNS	I-PROBLEM
.	.	O

after	IN	O
one	CD	O
hour	NN	O
his	PRP$	O
eyes	NNS	O
were	VBD	O
midline	JJ	O
and	CC	O
he	PRP	O
remained	VBD	O
unresponsive	JJ	B-PROBLEM
.	.	O

an	DT	B-TEST
electroencephalogram	NN	I-TEST
revealed	VBD	O
generalized	JJ	B-PROBLEM
slowing	NN	I-PROBLEM
without	IN	I-PROBLEM
ictal	JJ	I-PROBLEM
events	NNS	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
stertorous	JJ	B-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
positional	JJ	B-PROBLEM
tremors	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
spastic	JJ	I-PROBLEM
left	NN	I-PROBLEM
hemiparesis	NN	I-PROBLEM
in	IN	I-PROBLEM
flexion	NN	I-PROBLEM
.	.	O

he	PRP	O
withdrew	VBD	O
both	DT	O
legs	NNS	O
to	TO	O
painful	JJ	B-TEST
stimuli	NNS	I-TEST
.	.	O

the	DT	O
right	JJ	O
upper	JJ	O
extremity	NN	O
was	VBD	O
flaccid	JJ	B-PROBLEM
and	CC	O
paresthetic	JJ	B-PROBLEM
.	.	O

at	IN	O
1:15	CD	O
pm	NN	O
on	IN	O
10/06/94	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
unresponsive	JJ	B-PROBLEM
with	IN	O
no	DT	O
heart	NN	B-PROBLEM
sounds	VBZ	I-PROBLEM
,	,	O
carotid	NN	B-PROBLEM
pulse	NN	I-PROBLEM
,	,	O
respiratory	JJ	B-PROBLEM
excursions	NNS	I-PROBLEM
,	,	O
or	CC	O
pupillary	JJ	B-PROBLEM
reactions	NNS	I-PROBLEM
.	.	O

consent	NN	O
for	IN	O
autopsy	NN	B-TEST
was	VBD	O
denied	VBN	O
.	.	O

1.	CD	O
left	VBD	B-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
territory	NN	I-PROBLEM
cerebral	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

2.	CD	O
cardiomyopathy	NN	B-PROBLEM
.	.	O

3.	CD	O
residual	NN	O
of	IN	O
previous	JJ	B-PROBLEM
right	JJ	I-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

abnormal	JJ	B-PROBLEM
fetal	JJ	I-PROBLEM
heart	NN	I-PROBLEM
rate	NN	I-PROBLEM
/	NNP	I-PROBLEM
rhythm	VBZ	I-PROBLEM
-	:	O
delivered	VBN	O

abnormal	JJ	B-PROBLEM
pap	NN	I-PROBLEM
test	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O

vacuum	NN	B-TREATMENT
extraction	NN	I-TREATMENT

routine	JJ	B-TREATMENT
post	NN	I-TREATMENT
partum	NN	I-TREATMENT
care	NN	I-TREATMENT

active	JJ	B-PROBLEM
labor	NN	I-PROBLEM

height	RB	B-TEST
49	CD	O
heent	NN	B-TEST
normal	JJ	O
mouth	NN	O
normal	JJ	O
neck	NN	O
normal	JJ	O
breasts	NNS	O
normal	JJ	O
nipples	NNS	O
normal	JJ	O
chest	JJS	O
normal	JJ	O
cor	NN	O
normal	JJ	O
abdomen	NNS	O
normal	JJ	O
gravid	NN	O
,	,	O
+	NNP	O
fhr	NN	O
,	,	O
nt	JJ	O
extrem	NN	O
normal	JJ	O
skin	NN	O
normal	JJ	O
nodes	NNS	O
normal	JJ	O
vulva	NN	O
normal	JJ	O
vagina	NN	O
normal	JJ	O
cervix	NN	O
normal	JJ	O
4-5/100%	JJ	O
os	NN	O
normal	JJ	O
closed	VBD	O
,	,	O
firm	NN	O
,	,	O
-cmt	NNP	O
adnexae	VBZ	O
normal	JJ	O
uterus	JJ	O
normal	JJ	O
term	NN	O
7-7.5	JJ	O
#	#	O
vtx	JJ	O
uterine	JJ	O
size	NN	O
in	IN	O
weeks	NNS	O
normal	JJ	O
term	NN	O

active	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

she	PRP	O
delivered	VBD	O
a	DT	O
3263	CD	O
gram	NN	O
female	JJ	O
infant	NN	O
at	IN	O
06/14/2001	CD	O
at	IN	O
06:40	CD	O
pm	NN	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
8	CD	O
and	CC	O
8	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
40.3	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
vacuum	NN	B-TREATMENT
extraction	NN	I-TREATMENT
.	.	O

fetal	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
.	.	O

nuchal	JJ	B-PROBLEM
cord	NN	I-PROBLEM
,	,	O
times	CC	O
two	CD	O
.	.	O

this	DT	O
is	VBZ	O
an	DT	O
81	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
breast	NN	I-PROBLEM
mass	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
mammogram	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
breast	NN	I-TEST
with	IN	O
shadow	JJ	B-TEST
biopsy	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

in	IN	O
the	DT	O
fall	NN	O
of	IN	O
1991	CD	O
,	,	O
nipple	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
and	CC	O
discomfort	NN	B-PROBLEM
was	VBD	O
again	RB	O
noted	JJ	O
.	.	O

a	DT	B-TEST
mmamogram	NN	I-TEST
showed	VBD	O
no	DT	O
change	NN	O
on	IN	O
right	NN	O
,	,	O
but	CC	O
new	JJ	B-TEST
biopsy	NN	I-TEST
was	VBD	O
positive	JJ	O
.	.	O

on	IN	O
the	DT	O
left	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
shawdown	NN	I-PROBLEM
but	CC	O
the	DT	B-TEST
biopsy	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	JJ	O
presents	NNS	O
now	RB	O
for	IN	O
right	JJ	B-TREATMENT
modified	JJ	I-TREATMENT
radical	JJ	I-TREATMENT
mastectomy	NN	I-TREATMENT
with	IN	O
impant	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

clear	JJ	O
lungs	NNS	O
,	,	O
normal	JJ	O
heart	NN	O
,	,	O
pagett	NN	B-TEST
&apos;s	NNP	I-TEST
type	NN	O
changes	NNS	O
on	IN	O
the	DT	O
right	JJ	O
breast	NN	O
and	CC	O
left	VBD	O
breast	NN	O
without	IN	O
apparent	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
with	IN	O
scarring	VBG	B-PROBLEM
supra-areolar	JJ	I-PROBLEM
and	CC	I-PROBLEM
infra-areolar	JJ	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
biopsy	NN	I-PROBLEM
scar	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
breast	NN	I-PROBLEM
from	IN	O
1990	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operting	VBG	O
room	NN	O
on	IN	O
8/7/92	CD	O
,	,	O
where	WRB	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
modified	JJ	I-TREATMENT
radical	JJ	I-TREATMENT
mastectomy	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

subsequently	RB	O
a	DT	B-TREATMENT
saline-filled	JJ	I-TREATMENT
right	NN	I-TREATMENT
breast	NN	I-TREATMENT
implant	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
extremely	RB	O
well	RB	O
.	.	O

two	CD	B-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
used	VBN	O
.	.	O

one	CD	B-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
,	,	O
and	CC	O
the	DT	B-TREATMENT
second	JJ	I-TREATMENT
drain	NN	I-TREATMENT
she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
to	TO	O
home	NN	O
with	IN	O
.	.	O

discharge	NN	B-TREATMENT
medications	NNS	I-TREATMENT
include	VBP	O
percocet	NN	B-TREATMENT
and	CC	O
colace	NN	B-TREATMENT
.	.	O

mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
change	NN	I-PROBLEM
,	,	O
cellulitis	NN	B-PROBLEM

mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

1)	CD	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

2)	CD	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

3)	CD	O
status	NN	O
post	NN	O
fall	NN	B-PROBLEM
.	.	O

4)	CD	O
history	NN	O
of	IN	O
transient	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
attack	NN	I-PROBLEM
/	NNP	O
cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
.	.	O

5)	CD	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
wound	NN	I-PROBLEM
.	.	O

6)	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
88	CD	O
year-old	JJ	O
woman	NN	O
undergoing	VBG	O
treatment	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
child	NN	O
for	IN	O
worsening	VBG	B-PROBLEM
cellulitis	NN	I-PROBLEM
and	CC	O
new	JJ	B-PROBLEM
confusion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
severe	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
was	VBD	O
recently	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
for	IN	O
a	DT	O
nafcillin	JJ	B-PROBLEM
sensitive	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
aureus	JJ	I-PROBLEM
cellulitis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
nafcillin	NN	I-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT
.	.	O

there	EX	O
was	VBD	O
also	RB	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
that	WDT	O
was	VBD	O
incised	VBN	O
and	CC	O
drained	VBN	O
on	IN	O
august	NN	O
1	CD	O
,	,	O
1998	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
to	TO	O
rehabilitation	VB	B-TREATMENT
on	IN	O
levofloxacin	NN	B-TREATMENT
orally	RB	O
.	.	O

although	IN	O
details	NNS	O
were	VBD	O
not	RB	O
available	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
,	,	O
apparently	RB	O
,	,	O
she	PRP	O
had	VBD	O
done	VBN	O
well	RB	O
until	IN	O
the	DT	O
24	CD	O
hours	NNS	O
proceeding	VBG	O
admission	NN	O
when	WRB	O
the	DT	B-PROBLEM
cellulitis	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
worsening	VBG	O
.	.	O

she	PRP	O
had	VBD	O
also	RB	O
been	VBN	O
noted	VBN	O
to	TO	O
be	VB	O
confused	VBN	B-PROBLEM
and	CC	O
combative	JJ	B-PROBLEM
during	IN	O
that	DT	O
24	CD	O
hour	NN	O
period	NN	O
.	.	O

1)	CD	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	I-PROBLEM
severe	JJ	I-PROBLEM
,	,	O
echocardiogram	JJ	B-TEST
in	IN	O
july	NN	O
of	IN	O
1998	CD	O
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
6-8	JJ	O
mm	NN	O
of	IN	O
mercury	NN	O
,	,	O
aortic	JJ	B-TEST
valve	NN	I-TEST
area	NN	I-TEST
calculated	VBD	O
to	TO	O
be	VB	O
0.5	CD	O
cm	NN	O
squared	VBN	O
by	IN	O
the	DT	O
continuity	NN	B-TEST
equation	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

calculated	VBN	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
was	VBD	O
45-50%	JJ	O
.	.	O

2)	CD	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
2+	CD	O
on	IN	O
july	NN	O
of	IN	O
1998	CD	O
echocardiogram	NN	B-TEST
.	.	O

3)	CD	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

4)	CD	O
history	NN	O
of	IN	O
cerebrovascular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

5)	CD	O
hypertension	NN	B-PROBLEM
.	.	O

6)	CD	O
history	NN	O
of	IN	O
temporal	JJ	B-PROBLEM
arteritis	NN	I-PROBLEM
on	IN	O
chronic	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
.	.	O

7)	CD	O
history	NN	O
of	IN	O
colitis	NN	B-PROBLEM
.	.	O

8)	CD	O
history	NN	O
of	IN	O
vertebral	JJ	B-PROBLEM
body	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

1)	CD	O
digoxin	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2)	CD	O
lasix	JJ	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

3)	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4)	CD	O
coumadin	NN	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

5)	CD	O
zaroxolyn	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

6)	CD	O
toprol	NN	B-TREATMENT
xl	VBD	I-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

7)	CD	O
potassium	NN	B-TREATMENT
20	CD	O
meq	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

8)	CD	O
prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.o.d.	NN	O

9)	CD	O
fosamax	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

10)	CD	O
levofloxacin	JJ	B-TREATMENT
250	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

11)	CD	O
axid	JJ	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

12)	CD	O
buspar	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

13)	CD	O
zyrtec	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

physical	JJ	B-TEST
examination	NN	I-TEST
on	IN	O
admission	NN	O
revealed	VBD	O
an	DT	O
elderly	JJ	O
woman	NN	O
,	,	O
sleeping	NN	O
,	,	O
responsive	JJ	O
only	RB	O
to	TO	O
noxious	JJ	B-TEST
stimuli	NNS	I-TEST
after	IN	O
having	VBG	O
received	VBD	O
some	DT	B-TREATMENT
sedation	NN	I-TREATMENT
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
:	:	O

heart	NN	B-TEST
rate	NN	I-TEST
60	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
116/80	CD	O
,	,	O
temperature	NN	B-TEST
97.1	CD	O
degrees	NNS	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
93%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

head	NN	B-TEST
and	CC	I-TEST
neck	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
benign	JJ	O
.	.	O

skin	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-PROBLEM
leg	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
cellulitis	NN	B-PROBLEM
to	TO	O
be	VB	O
delineated	VBN	O
below	IN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
spider	NN	B-PROBLEM
angiomata	NN	I-PROBLEM
.	.	O

neck	NN	O
was	VBD	O
supple	JJ	O
with	IN	O
no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

the	DT	B-TEST
heart	NN	I-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
sustained	VBN	I-PROBLEM
pmi	NN	I-PROBLEM
which	WDT	O
was	VBD	O
located	VBN	O
in	IN	O
the	DT	O
left	NN	O
mid	NN	O
clavicular	JJ	O
line	NN	O
,	,	O
s1	NN	O
,	,	O
near	IN	B-PROBLEM
complete	JJ	I-PROBLEM
obliteration	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
second	JJ	I-PROBLEM
heart	NN	I-PROBLEM
sound	NN	I-PROBLEM
by	IN	O
a	DT	B-PROBLEM
two	CD	I-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
six	CD	I-PROBLEM
high	JJ	I-PROBLEM
pitched	VBN	I-PROBLEM
murmur	NN	I-PROBLEM
peaking	VBG	O
at	IN	O
mid	NN	O
to	TO	O
late	VB	O
systole	NN	O
and	CC	O
heard	NN	O
across	IN	O
the	DT	O
precordium	NN	O
.	.	O

there	EX	O
was	VBD	O
also	RB	O
a	DT	B-PROBLEM
blowing	VBG	I-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	FW	I-PROBLEM
heard	NN	O
at	IN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
apex	NN	O
to	TO	O
axilla	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
s3	NN	B-PROBLEM
appreciated	VBD	O
.	.	O

vascular	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
1+	CD	B-PROBLEM
carotid	NN	I-PROBLEM
impulses	NNS	I-PROBLEM
which	WDT	O
were	VBD	O
diminished	VBN	O
and	CC	O
delayed	VBN	O
and	CC	O
the	DT	O
above	NN	O
mentioned	VBD	O
transmitted	JJ	B-PROBLEM
cardiac	JJ	I-PROBLEM
murmurs	NN	I-PROBLEM
.	.	O

abdominal	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
,	,	O
no	DT	O
organomegaly	NN	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
extremity	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
erythema	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
calf	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
a	DT	O
relatively	RB	O
clean	JJ	O
base	NN	O
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
quite	RB	B-PROBLEM
sedated	VBN	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
having	VBG	O
received	VBN	O
some	DT	O
medications	NNS	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
arousable	JJ	O
only	RB	O
to	TO	O
painful	JJ	B-TEST
stimuli	NNS	I-TEST
.	.	O

she	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
move	VB	O
all	DT	O
four	CD	O
of	IN	O
her	PRP$	O
extremities	NNS	O
in	IN	O
response	NN	O
to	TO	O
pain	VB	B-TEST
.	.	O

her	PRP$	B-TEST
deep	JJ	I-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
slightly	RB	O
diminished	VBN	O
at	IN	O
1+	CD	O
bilaterally	RB	O
,	,	O
but	CC	O
symmetric	JJ	O
.	.	O

sodium	NN	B-TEST
was	VBD	O
142	CD	O
,	,	O
potassium	NN	B-TEST
3.3	CD	O
,	,	O
chloride	RB	B-TEST
99	CD	O
,	,	O
bun	NN	B-TEST
23	CD	O
,	,	O
creatinine	NN	B-TEST
1.1	CD	O
.	.	O

ast	NN	B-TEST
was	VBD	O
25	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
130	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
3.2	CD	O
,	,	O
albumin	RB	B-TEST
3.4	CD	O
,	,	O
calcium	NN	B-TEST
8.8	CD	O
.	.	O

digoxin	NN	B-TEST
level	NN	I-TEST
was	VBD	O
0.8	CD	O
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
33.0	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
627	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
10,000	CD	O
,	,	O
mcv	VBD	B-TEST
79.8	CD	O
.	.	O

coagulation	NN	B-TEST
studies	NNS	I-TEST
revealed	VBD	O
a	DT	O
pt	NN	B-TEST
of	IN	O
17.4	CD	O
seconds	NNS	O
with	IN	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
2.1	CD	O
,	,	O
ptt	RB	B-TEST
25.5	CD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
admission	NN	I-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
revealed	VBD	O
no	DT	O
infiltrate	NN	B-PROBLEM
,	,	O
no	DT	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
performed	VBN	O
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
revealed	VBD	O
no	DT	O
bleed	NN	B-PROBLEM
.	.	O

urinalysis	NN	B-TEST
revealed	VBD	O
trace	NN	B-PROBLEM
microscopic	NN	I-PROBLEM
hematuria	NN	I-PROBLEM
with	IN	O
47	CD	O
red	JJ	O
blood	NN	O
cells	NNS	O
per	IN	O
high	JJ	O
powered	JJ	O
field	NN	O
,	,	O
1+	CD	B-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
somewhat	RB	O
argumentative	JJ	B-PROBLEM
and	CC	O
confused	VBD	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
uncooperative	JJ	B-PROBLEM
with	IN	I-PROBLEM
procedures	NNS	I-PROBLEM
.	.	O

a	DT	B-TEST
neurologic	JJ	I-TEST
work-up	NN	I-TEST
was	VBD	O
undertaken	JJ	O
which	WDT	O
included	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
which	WDT	O
revealed	VBD	O
no	DT	O
acute	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
a	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	B-TEST
glucose	NN	I-TEST
of	IN	O
72	CD	O
,	,	O
protein	RB	B-TEST
65	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
19	CD	O
,	,	O
red	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11,500	CD	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
xanthrochromasia	NN	B-PROBLEM
.	.	O

the	DT	O
neurology	NN	O
service	NN	O
evaluated	VBD	O
the	DT	O
patient	NN	O
who	WP	O
felt	VBD	O
that	IN	O
her	PRP$	B-PROBLEM
agitation	NN	I-PROBLEM
was	VBD	O
most	RBS	O
likely	JJ	O
due	JJ	O
to	TO	O
infection	NN	B-PROBLEM
,	,	O
her	PRP$	B-TREATMENT
multiple	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
or	CC	O
her	PRP$	B-PROBLEM
metabolic	JJ	I-PROBLEM
condition	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
revealed	VBD	O
no	DT	O
abnormality	NN	B-PROBLEM
and	CC	O
imaging	NN	B-TEST
included	VBD	O
a	DT	B-TEST
head	NN	I-TEST
scan	JJ	I-TEST
which	WDT	O
revealed	VBD	O
no	DT	O
bleed	NN	B-PROBLEM
and	CC	O
a	DT	B-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
series	NN	I-TEST
which	WDT	O
revealed	VBD	O
degenerative	JJ	B-PROBLEM
joint	JJ	I-PROBLEM
disease	NN	I-PROBLEM
but	CC	O
no	DT	O
obvious	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
decided	VBD	O
not	RB	O
to	TO	O
pursue	VB	O
further	JJ	B-TEST
testing	VBG	I-TEST
with	IN	O
a	DT	B-TEST
neck	NN	I-TEST
ct	NN	I-TEST
scan	NN	I-TEST
.	.	O

2)	CD	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
surgical	JJ	O
service	NN	O
who	WP	O
felt	VBD	O
that	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
clean	JJ	O
with	IN	O
some	DT	B-PROBLEM
erythema	NN	I-PROBLEM
but	CC	O
without	IN	O
evidence	NN	O
of	IN	O
true	JJ	B-PROBLEM
cellulitis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NN	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
with	IN	O
the	DT	O
thought	NN	O
that	WDT	O
prolonged	VBD	B-TREATMENT
antibiotics	NNS	I-TREATMENT
only	RB	O
put	VBD	O
her	PRP	O
at	IN	O
more	JJR	O
risk	NN	O
for	IN	O
infection	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
critical	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

4)	CD	O
status	NN	O
post	NN	O
fall	NN	B-PROBLEM
:	:	O

a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
and	CC	O
cervical	JJ	B-TEST
spine	NN	I-TEST
series	NN	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
have	VB	O
no	DT	O
deficits	NNS	B-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

5)	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
:	:	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
.	.	O

6)	CD	O
abnormal	JJ	B-PROBLEM
liver	NN	I-PROBLEM
function	NN	I-PROBLEM
tests	NNS	I-PROBLEM
:	:	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
elevated	VBN	B-PROBLEM
bilirubins	NNS	I-PROBLEM
in	IN	O
the	DT	O
3	CD	O
range	NN	O
and	CC	O
mildly	RB	B-PROBLEM
elevated	VBD	I-PROBLEM
alkaline	JJ	I-PROBLEM
phosphatase	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	O
cholestatic	JJ	B-PROBLEM
picture	NN	I-PROBLEM
.	.	O

these	DT	B-TEST
liver	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
will	MD	O
be	VB	O
followed	VBN	O
closely	RB	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

1)	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2)	CD	O
digoxin	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
am	VBP	O
.	.	O

3)	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4)	CD	O
zaroxolyn	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5)	CD	O
prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.o.d.	NN	O

6)	CD	O
coumadin	NN	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

7)	CD	O
kay	NN	B-TREATMENT
ciel	NN	I-TREATMENT
20	CD	O
meq	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

8)	CD	O
fosamax	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

9)	CD	O
amitriptyline	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

10)	CD	O
buspar	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

the	DT	O
patient	NN	O
will	MD	O
be	VB	O
followed	VBN	O
at	IN	O
rehabilitation	NN	B-TREATMENT
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	VB	O
both	DT	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
r	NN	B-PROBLEM
thumb	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

following	VBG	O
triage	NN	B-TEST
,	,	O
the	DT	O
patient	NN	O
left	VBD	O
without	IN	O
treatment	NN	B-TREATMENT
.	.	O

acute	NN	B-PROBLEM
leukemia	NN	I-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
68	CD	O
year	NN	O
old	JJ	O
with	IN	O
acute	JJ	B-PROBLEM
leukemia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
about	IN	O
three	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
began	VBD	O
to	TO	O
notice	VB	O
increased	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
bruising	NN	B-PROBLEM
.	.	O

platelets	NNS	B-TEST
were	VBD	O
9,000	CD	O
,	,	O
hemoglobin	NN	B-TEST
9.5	CD	O
,	,	O
temperature	NN	B-TEST
was	VBD	O
100.4	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
smear	NN	I-TEST
there	RB	O
consistent	JJ	O
with	IN	O
all	DT	B-PROBLEM
.	.	O

no	DT	O
headache	NN	B-PROBLEM
,	,	O
no	DT	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

some	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
allergies	NNS	B-PROBLEM
,	,	O
particularly	RB	O
cats	NNS	O
.	.	O

no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
significant	JJ	O
for	IN	O
allergies	NNS	B-PROBLEM
,	,	O
depression	NN	B-PROBLEM
and	CC	O
anxiety	NN	B-PROBLEM
,	,	O
pleural	JJ	B-PROBLEM
thickening	VBG	I-PROBLEM
/	JJ	O
asbestosis	NN	B-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
left	VBD	I-PROBLEM
bundle	JJ	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
tonsillectomy	NN	B-TREATMENT
,	,	O
adenoidectomy	NN	B-TREATMENT
,	,	O
vein	NN	B-TREATMENT
stripping	NN	I-TREATMENT
(	(	O
1968	CD	O
)	)	O
,	,	O
left	VBD	B-PROBLEM
wrist	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
(	(	O
1994	CD	O
)	)	O
,	,	O
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
include	VBP	O
a	DT	O
questionable	JJ	O
penicillin	NN	B-PROBLEM
reaction	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
the	DT	O
patient	NN	O
tolerated	VBD	O
ampicillin	RB	B-TREATMENT
well	RB	O
.	.	O

the	DT	O
patient	NN	O
does	VBZ	O
not	RB	O
recollect	VB	O
what	WP	O
her	PRP$	B-PROBLEM
reaction	NN	I-PROBLEM
to	TO	O
penicillin	NN	B-TREATMENT
was	VBD	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
platelet	NN	B-PROBLEM
reaction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	JJ	O
family	NN	O
history	NN	O
was	VBD	O
significant	JJ	O
for	IN	O
a	DT	O
brother	NN	O
with	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
a	DT	O
well-developed	JJ	O
,	,	O
well-nourished	JJ	O
white	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
98.2	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
134/80	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
22	CD	O
,	,	O
pulse	RB	B-TEST
102	CD	O
.	.	O

heent	NN	B-TEST
examination	NN	I-TEST
was	VBD	O
normocephalic	JJ	O
and	CC	O
atraumatic	JJ	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
decreased	VBN	B-PROBLEM
hearing	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

the	DT	O
oropharynx	NN	O
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
with	IN	O
fillings	NNS	O
and	CC	O
a	DT	B-PROBLEM
partial	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
plate	NN	I-PROBLEM
.	.	O

the	DT	O
neck	NN	O
had	VBD	O
a	DT	O
full	JJ	O
range	NN	O
of	IN	O
motion	NN	O
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
chest	JJS	I-TEST
exam	NN	I-TEST
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

cardiac	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
an	DT	O
s1	NN	O
and	CC	O
an	DT	O
s2	NN	O
and	CC	O
a	DT	B-PROBLEM
diffuse	NN	I-PROBLEM
2/6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
and	CC	O
nondistended	VBN	B-PROBLEM
with	IN	O
no	DT	O
guarding	NN	B-PROBLEM
and	CC	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
skin	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
right	JJ	O
breast	NN	O
had	VBD	O
a	DT	B-PROBLEM
dark	JJ	I-PROBLEM
two	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
ecchymosis	NN	I-PROBLEM
and	CC	O
the	DT	O
left	JJ	O
medial	JJ	O
thigh	NN	O
had	VBD	O
two	CD	O
pale	JJ	B-PROBLEM
blue	JJ	I-PROBLEM
two	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
macules	NNS	I-PROBLEM
.	.	O

admitting	VBG	B-TEST
labs	NNS	I-TEST
were	VBD	O
:	:	O

sodium	NN	B-TEST
138	CD	O
,	,	O
potassium	NN	B-TEST
4.2	CD	O
,	,	O
chloride	RB	B-TEST
98	CD	O
,	,	O
bun	NN	B-TEST
21	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	RB	B-TEST
117	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
13,200	CD	O
,	,	O
hematocrit	NN	B-TEST
22.5	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
40,000	CD	O
.	.	O

ast	RB	B-TEST
29	CD	O
,	,	O
alk	RB	B-TEST
151	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.2	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
7.2	CD	O
,	,	O
albumin	RB	B-TEST
4.3	CD	O
,	,	O
globulins	VBZ	B-TEST
2.9	CD	O
,	,	O
calcium	NN	B-TEST
8.9	CD	O
.	.	O

pt	NN	B-TEST
12.8	CD	O
,	,	O
ptt	RB	B-TEST
19.1	CD	O
.	.	O

peripheral	JJ	B-TEST
smear	NN	I-TEST
revealed	VBD	O
blasts	NNS	B-TEST
of	IN	O
62%	CD	O
.	.	O

a	DT	B-TREATMENT
hickman	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
chemotherapy	NN	B-TREATMENT
.	.	O

the	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
included	VBD	O
cyclophosphamide	NN	B-TREATMENT
,	,	O
daunorubicin	NN	B-TREATMENT
,	,	O
prednisone	NN	B-TREATMENT
,	,	O
vincristine	NN	B-TREATMENT
and	CC	O
peg-asparaginase	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
chemotherapy	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
well	RB	O
.	.	O

the	DT	O
patient	NN	O
began	VBD	O
neutropenic	JJ	B-PROBLEM
on	IN	O
day	NN	O
five	CD	O
of	IN	O
induction	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
began	VBD	O
to	TO	O
rise	VB	O
and	CC	O
she	PRP	O
began	VBD	O
to	TO	O
experience	VB	O
pulmonary	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
including	VBG	O
increased	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
began	VBD	O
to	TO	O
spike	VB	O
and	CC	O
a	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
grew	VBD	O
out	RP	O
staphylococcusaureus	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
gentamicin	NN	B-TREATMENT
,	,	O
vancomycin	NN	B-TREATMENT
and	CC	O
piperacillin	NN	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
changed	VBN	O
to	TO	O
gentamicin	VB	B-TREATMENT
and	CC	O
ceftazidime	VB	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
spike	VB	O
and	CC	O
was	VBD	O
enrolled	VBN	O
in	IN	O
a	DT	O
randomized	JJ	O
trial	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
randomized	VBN	O
to	TO	O
ambisome	VB	B-TREATMENT
antifungal	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

an	DT	B-TEST
abdominal	JJ	I-TEST
mri	NN	I-TEST
was	VBD	O
performed	VBN	O
to	TO	O
assess	VB	O
continued	VBN	O
elevated	JJ	B-PROBLEM
liver	NN	I-PROBLEM
enzymes	NNS	I-PROBLEM
;	:	O
however	RB	O
,	,	O
the	DT	B-TEST
mri	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
nafcillin	NNS	B-TREATMENT
due	JJ	O
to	TO	O
continued	JJ	O
spiking	NN	O
.	.	O

the	DT	O
patient	NN	O
began	VBD	O
to	TO	O
experience	VB	O
urinary	JJ	B-PROBLEM
retention	NN	I-PROBLEM
and	CC	O
was	VBD	O
straight	VBN	O
catheterized	VBN	O
.	.	O

thepatient	NN	O
developed	VBD	O
a	DT	O
possible	JJ	O
drug	NN	B-PROBLEM
rash	NN	I-PROBLEM
and	CC	O
nafcillin	NN	B-TREATMENT
was	VBD	O
changed	VBN	O
to	TO	O
ancef	VB	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
became	VBD	O
constipated	VBN	B-PROBLEM
;	:	O
this	DT	O
resolved	VBN	O
with	IN	O
laxatives	NNS	B-TREATMENT
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
discharge	NN	I-TREATMENT
medications	NNS	I-TREATMENT
include	VBP	O
the	DT	O
following	NN	O
:	:	O

1)	CD	O
albuterol	JJ	B-TREATMENT
inhaler	NN	I-TREATMENT
two	CD	O
puffs	NNS	O
q.i.d.	JJ	O
p.r.n.	JJ	O
breathing	NN	B-PROBLEM
difficulties	NNS	I-PROBLEM
.	.	O

2)	CD	O
calcium	NN	B-TREATMENT
gluconate	NN	I-TREATMENT
1000	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

3)	CD	O
cefazolin	NN	B-TREATMENT
one	CD	O
gram	NN	O
iv	NN	O
q.8h.	NN	O
x	VBD	O
13days	CD	O
.	.	O

4)	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

5)	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

6)	CD	O
lactulose	JJ	B-TREATMENT
30	CD	O
milliliters	NNS	O
p.o.	VBP	O
q.2h.	JJ	O
p.r.n.	NN	O
constipation	NN	B-PROBLEM
.	.	O

7)	CD	O
magnesium	NN	B-TREATMENT
hydroxide	NN	I-TREATMENT
30	CD	O
milliliters	NNS	O
p.o.	JJ	O
q	JJ	O
day	NN	O
.	.	O

8)	CD	O
miracle	NN	B-TREATMENT
creamtopical	JJ	I-TREATMENT
q	NN	O
day	NN	O
p.r.n.	VB	O
skin	JJ	B-PROBLEM
irritation	NN	I-PROBLEM
.	.	O

9)	CD	O
sarna	JJ	B-TREATMENT
topical	JJ	I-TREATMENT
b.i.d.	NN	O
p.r.n.	NN	O
itching	NN	B-PROBLEM
.	.	O

10)	CD	O
senna	JJ	B-TREATMENT
tablets	NNS	I-TREATMENT
,	,	O
two	CD	O
tablets	NNS	O
p.o.	VBP	O
b.i.d.	NN	O

11)	CD	O
simethicone	NN	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O
p.r.n.	NN	O
gas	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

12)	CD	O
citrucel	NN	B-TREATMENT
one	CD	O
tablespoon	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

13)	CD	O
k-dur	JJ	B-TREATMENT
10	CD	O
meq	NN	O
x	NNP	O
three	CD	O
,	,	O
p.o.	VBZ	O
b.i.d.	NN	O

14)	CD	O
zoloft	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

15)	CD	O
peridex	NN	B-TREATMENT
30	CD	O
cc	NN	O
p.o.	NN	O
b.i.d.	NN	O
x	$	O
14	CD	O
days	NNS	O
.	.	O

16)	CD	O
robituss	NN	B-TREATMENT
in	IN	I-TREATMENT
ac	JJ	I-TREATMENT
five	CD	O
to	TO	O
ten	VB	O
milliliters	NNS	O
p.o.	VBP	O
q.h.s.	JJ	O
p.r.n.	JJ	O
cough	NN	B-PROBLEM
.	.	O

1.	CD	O
carotid	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

2.	CD	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

3.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
76-year-old	JJ	O
female	NN	O
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
medicine	NN	O
service	NN	O
on	IN	O
04-29-92	JJ	O
with	IN	O
a	DT	O
past	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
who	WP	O
presented	VBD	O
for	IN	O
evaluation	NN	B-TEST
for	IN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replace-ment	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
exertional	JJ	B-PROBLEM
angina	NN	I-PROBLEM
and	CC	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
associated	VBN	O
with	IN	O
light-headedness	NN	B-PROBLEM
for	IN	O
nine	CD	O
years	NNS	O
which	WDT	O
was	VBD	O
noted	VBN	O
to	TO	O
increase	VB	O
in	IN	O
frequency	NN	O
over	IN	O
the	DT	O
past	JJ	O
year	NN	O
,	,	O
then	RB	O
upon	IN	O
admission	NN	O
had	VBD	O
light-headedness	JJ	B-PROBLEM
and	CC	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
dull	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
neck	NN	I-PROBLEM
to	TO	O
her	PRP$	O
substernal	JJ	O
area	NN	O
,	,	O
with	IN	O
only	RB	O
minimal	JJ	O
exertion	NN	O
such	JJ	O
as	IN	O
&quot;	JJ	O
walking	VBG	O
across	IN	O
the	DT	O
room	NN	O
&quot;	NN	O
.	.	O

she	PRP	O
states	VBZ	O
this	DT	O
light-headedness	NN	B-PROBLEM
is	VBZ	O
often	RB	O
associated	VBN	O
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
diaphoresis	NN	B-PROBLEM
occasionally	RB	O
with	IN	O
nausea	NN	B-PROBLEM
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	O
vomiting	NN	B-PROBLEM
,	,	O
states	VBZ	O
that	IN	O
the	DT	B-PROBLEM
episodes	NNS	I-PROBLEM
usually	RB	O
last	JJ	O
about	IN	O
five	CD	O
minutes	NNS	O
and	CC	O
are	VBP	O
relieved	VBN	O
with	IN	O
rest	NN	O
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
light-headedness	NN	B-PROBLEM
is	VBZ	O
now	RB	O
severely	RB	O
lifestyle	JJ	O
limiting	NN	O
and	CC	O
the	DT	O
patient	NN	O
requested	VBD	O
evaluation	NN	B-TEST
for	IN	O
possible	JJ	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

cardiac	JJ	O
risk	NN	O
factors	NNS	O
hypercholesterolemia	VBP	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
no	DT	O
history	NN	O
of	IN	O
tobacco	NN	O
use	NN	O
,	,	O
diabetes	VBZ	B-PROBLEM
or	CC	O
family	NN	O
history	NN	O
.	.	O

past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
as	RB	O
stated	VBN	O
above	IN	O
,	,	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
found	VBN	O
to	TO	O
be	VB	O
critical	JJ	O
on	IN	O
echocardiogram	NN	B-TEST
on	IN	O
4-13-92	JJ	O
,	,	O
done	VBN	O
in	IN	O
otte	NN	O
a	DT	O
,	,	O
new	JJ	O
jersey	NN	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
left	VBN	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
and	CC	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
58%	CD	O
,	,	O
no	DT	O
right	JJ	B-PROBLEM
heart	NN	I-PROBLEM
wall	DT	I-PROBLEM
motion	NN	I-PROBLEM
abnormali-ties	NNS	I-PROBLEM
and	CC	O
an	DT	B-TEST
aortic	JJ	I-TEST
valve	NN	I-TEST
gradient	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
100	CD	O
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
uterine	JJ	B-PROBLEM
fibroids	NNS	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
known	VBN	B-PROBLEM
bilateral	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
stated	VBN	O
to	TO	O
be	VB	O
greater	JJR	O
than	IN	O
70%	CD	O
bilaterally	RB	O
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
glaucoma	NN	B-PROBLEM
and	CC	O
a	DT	O
questionable	JJ	O
history	NN	O
of	IN	O
claudication	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
legs	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
.	.	O

medications	NNS	B-TREATMENT
on	IN	I-TREATMENT
admission	NN	I-TREATMENT
were	VBD	O
only	RB	O
aspirin	JJ	B-TREATMENT
p.r.n.	NN	O
and	CC	O
timoptic	JJ	B-TREATMENT
solution	NN	I-TREATMENT
0.5%	CD	I-TREATMENT
to	TO	O
the	DT	O
left	NN	O
eye	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
with	IN	O
a	DT	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
170/100	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
70	CD	O
.	.	O

heent	JJ	B-TEST
examination	NN	I-TEST
notable	JJ	O
for	IN	O
bilateral	JJ	B-PROBLEM
arcussenilis	NNS	I-PROBLEM
but	CC	O
otherwise	RB	O
unremarkable	JJ	O
.	.	O

her	PRP$	O
neck	NN	O
showed	VBD	O
no	DT	O
jvd	NN	B-PROBLEM
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
slow	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
upstroke	VBD	I-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
there	EX	O
were	VBD	O
bilateral	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
bruits	NNS	I-PROBLEM
versus	VBP	O
transmitted	VBN	B-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

cardiac	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
3/6	CD	O
systolic	JJ	B-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
,	,	O
no	DT	O
gallop	NN	B-PROBLEM
was	VBD	O
detected	VBN	O
.	.	O

her	PRP$	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
with	IN	O
good	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
peripheral	JJ	I-TEST
pulses	NNS	I-TEST
were	VBD	O
trace	JJ	O
palpable	JJ	O
.	.	O

sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
5.0	CD	O
,	,	O
bun	NN	B-TEST
18	CD	O
,	,	O
creatinine	NN	B-TEST
1.0	CD	O
,	,	O
pt	NN	B-TEST
12.3	CD	O
,	,	O
ptt	NN	B-TEST
24	CD	O
,	,	O
wbc	VBD	B-TEST
7.6	CD	O
,	,	O
hematocrit	NN	B-TEST
41	CD	O
,	,	O
platelets	NNS	B-TEST
278,000	CD	O
.	.	O

ekg	NN	B-TEST
revealed	VBD	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
with	IN	O
a	DT	O
rate	NN	O
of	IN	O
69	CD	O
,	,	O
left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
hyper-trophy	NN	I-PROBLEM
with	IN	O
poor	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
progression	NN	I-PROBLEM
of	IN	I-PROBLEM
r-waves	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
and	CC	O
evaluated	VBN	O
by	IN	O
the	DT	O
cardiac	JJ	O
surgery	NN	O
service	NN	O
after	IN	O
having	VBG	O
undergone	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	O
70%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
circumflex	JJ	I-PROBLEM
artery	NN	I-PROBLEM
,	,	O
50%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
and	CC	O
10%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

carotid	NN	B-TEST
angiography	NN	I-TEST
revealed	VBD	O
left	VBD	B-PROBLEM
internal	JJ	I-PROBLEM
carotid	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
90%	CD	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
&quot;	NNP	I-PROBLEM
critical	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
&quot;	NN	I-PROBLEM
.	.	O

on	IN	O
05-01-92	JJ	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	O
#	#	B-TREATMENT
19	CD	I-TREATMENT
st.	JJ	I-TREATMENT
jude	NN	I-TREATMENT
valve	NN	I-TREATMENT
,	,	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
one	CD	O
with	IN	O
saphenous	JJ	B-TREATMENT
vein	NNS	I-TREATMENT
graft	NN	I-TREATMENT
from	IN	O
the	DT	O
posterior	JJ	O
descending	NN	O
artery	NN	O
to	TO	O
the	DT	O
obtuse	NN	O
marginal	JJ	O
and	CC	O
right	JJ	B-TREATMENT
carotid	NN	I-TREATMENT
endarterectomy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
found	VBN	O
postoperatively	RB	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
left	VBN	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
on	IN	O
proximal	NN	O
greater	JJR	O
than	IN	O
distal	JJ	O
musculature	NN	O
.	.	O

she	PRP	O
was	VBD	O
extubated	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
and	CC	O
otherwise	RB	O
had	VBD	O
an	DT	O
unremarkable	JJ	O
postoperative	JJ	O
course	NN	O
with	IN	O
the	DT	O
exception	NN	O
of	IN	O
her	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

on	IN	O
05-04-92	JJ	O
she	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
neurology	NN	O
service	NN	O
,	,	O
who	WP	O
recommended	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
,	,	O
however	RB	O
no	DT	O
evidence	NN	O
of	IN	O
infarction	NN	B-PROBLEM
was	VBD	O
detected	VBN	O
.	.	O

there	EX	O
was	VBD	O
only	RB	O
diffuse	RB	B-PROBLEM
small	JJ	I-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
noted	VBD	O
.	.	O

on	IN	O
05-05-92	JJ	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
convert	VB	O
to	TO	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
which	WDT	O
resolved	VBD	O
spontaneously	RB	O
a	DT	O
few	JJ	O
days	NNS	O
later	RB	O
.	.	O

however	RB	O
,	,	O
on	IN	O
05-07-92	NN	O
there	EX	O
was	VBD	O
a	DT	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
event	NN	I-PROBLEM
with	IN	O
addition	NN	O
to	TO	O
the	DT	B-PROBLEM
left	VBN	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
some	DT	B-PROBLEM
noted	VBD	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
discoordination	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
begun	VBN	O
on	IN	O
a	DT	B-TREATMENT
heparin	NN	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

on	IN	O
5-9-92	JJ	O
the	DT	B-PROBLEM
right-sided	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
worsened	VBD	O
and	CC	O
she	PRP	O
also	RB	O
had	VBD	O
some	DT	B-PROBLEM
elements	NNS	I-PROBLEM
of	IN	I-PROBLEM
aphasia	NN	I-PROBLEM
.	.	O

she	PRP	O
underwent	JJ	O
angiography	NN	B-TEST
on	IN	O
5-9-92	JJ	O
which	WDT	O
showed	VBD	O
the	DT	O
right	JJ	O
internal	JJ	O
carotid	NN	O
artery	NN	O
to	TO	O
be	VB	O
patent	NN	O
,	,	O
however	RB	O
there	EX	O
was	VBD	O
highly	RB	O
significant	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
later	RB	O
that	DT	O
day	NN	O
for	IN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
carotid	NN	I-TREATMENT
endarterectomy	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
taken	VBN	O
postoperatively	RB	O
the	DT	O
icu	NN	O
where	WRB	O
she	PRP	O
was	VBD	O
extubated	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
and	CC	O
by	IN	O
5-11-92	JJ	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
markedly	RB	O
increased	VBN	O
use	NN	O
of	IN	O
her	PRP$	O
right	JJ	O
side	NN	O
,	,	O
resolving	VBG	O
aphasia	NN	B-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
with	IN	O
the	DT	B-PROBLEM
residual	JJ	I-PROBLEM
deficit	NN	I-PROBLEM
only	RB	O
noted	VBD	O
to	TO	O
be	VB	O
some	DT	B-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
worked	VBN	O
up	RP	O
aggressively	RB	O
with	IN	O
the	DT	O
physical	JJ	O
therapy	NN	O
and	CC	O
occupational	JJ	O
services	NNS	O
,	,	O
made	VBD	O
good	JJ	O
progress	NN	O
and	CC	O
began	VBD	O
ambulating	VBG	O
with	IN	O
assistance	NN	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
but	CC	O
with	IN	O
minimal	JJ	O
assistance	NN	O
from	IN	O
an	DT	O
aid	NN	O
.	.	O

she	PRP	O
was	VBD	O
feeding	VBG	O
herself	PRP	O
and	CC	O
was	VBD	O
very	RB	O
enthusiastic	JJ	O
and	CC	O
energetic	JJ	O
in	IN	O
her	PRP$	O
participation	NN	O
in	IN	O
her	PRP$	B-TREATMENT
rehabilitation	NN	I-TREATMENT
activities	NNS	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
initially	RB	O
but	CC	O
this	DT	O
was	VBD	O
quickly	RB	O
switched	VBN	O
over	IN	O
to	TO	O
coumadin	VB	B-TREATMENT
anticoagulation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
which	WDT	O
she	PRP	O
will	MD	O
need	VB	O
to	TO	O
be	VB	O
on	IN	O
long-term	JJ	O
for	IN	O
her	PRP$	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
transferred	VBN	O
to	TO	O
rockdempbanri	VB	O
hospital	NN	O
on	IN	O
05-28-92	NN	O
to	TO	O
continue	VB	O
her	PRP$	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

lopressor	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
;	:	O
nifedipine	CC	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
;	:	O
timoptic	JJ	B-TREATMENT
solution	NN	I-TREATMENT
0.5%	CD	O
os	NN	O
b.i.d.	NN	O
;	:	O
coumadin	CC	B-TREATMENT
1	CD	O
mg	NNS	O
alternating	VBG	O
with	IN	O
1.5	CD	O
mg	NNS	O
q.o.d.	RB	O
at	IN	O
q.h.s.	NN	O
and	CC	O
haldol	$	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
p.r.n.	NN	O
in	IN	O
the	DT	O
evening	NN	O
,	,	O
only	RB	O
for	IN	O
agitation	NN	B-PROBLEM
associated	VBN	O
with	IN	O
confusion	NN	B-PROBLEM
.	.	O

upon	IN	O
discharge	NN	O
it	PRP	O
was	VBD	O
the	DT	O
recommendation	NN	O
of	IN	O
the	DT	O
cardiology	NN	O
team	NN	O
that	IN	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
be	VB	O
monitored	VBN	O
weekly	JJ	O
and	CC	O
be	VB	O
kept	VBN	O
at	IN	O
a	DT	O
ratio	NN	O
of	IN	O
3-4	JJ	O
iu	NN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
ph	VB	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
.	.	O

your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
fong	NN	O
,	,	O
coney	NN	O
n	NN	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
perforation	NN	B-PROBLEM
.	.	O

head	NN	B-PROBLEM
trauma	SYM	I-PROBLEM
-	:	O
mva	NN	O

treatment	NN	B-TREATMENT
rendered	VBD	O
:	:	O

history	NN	O
,	,	O
physical	JJ	B-TEST
,	,	O
neuro	JJ	B-TEST
exam	NN	I-TEST
normal	JJ	O

tylenol	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

refrain	NN	O
from	IN	O
motrin	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

monitor	NN	O
/	JJ	O
return	NN	O
for	IN	O
nausea	NN	B-PROBLEM
/	NNP	O
vomiting	NN	B-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
/	NNP	I-PROBLEM
mental	NN	I-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
concerns	NNS	I-PROBLEM
.	.	O

hyperparathyroidism	NN	B-PROBLEM
.	.	O

hyperparathyroidism	NN	B-PROBLEM
.	.	O

1.	CD	O
status	NN	O
post	NN	O
mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O

2.	CD	O
hypertension	NN	B-PROBLEM
,	,	O

3.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O

4.	CD	O
hypertrophic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O

5.	CD	O
osteoarthritis	NN	B-PROBLEM
,	,	O

6.	CD	O
right	JJ	B-PROBLEM
cheek	NN	I-PROBLEM
basal	NN	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O

7.	CD	O
glaucoma	NN	B-PROBLEM
,	,	O

8.	CD	O
non-insulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O

9.	CD	O
status	NN	O
post	NN	O
laparoscopic	NN	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
,	,	O

10.	CD	O
status	NN	O
post	NN	O
dilation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
,	,	O

11.	CD	O
status	NN	O
post	NN	O
cataract	NN	B-TREATMENT
surgery	NN	I-TREATMENT
,	,	O

12.	CD	O
status	NN	O
post	NN	O
left	VBD	B-TEST
breast	NN	I-TEST
biopsy	NN	I-TEST
.	.	O

parathyroidectomy	NN	B-TREATMENT
on	IN	O
12-27-96	JJ	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
83-year-old	JJ	O
female	NN	O
who	WP	O
presents	VBZ	O
for	IN	O
surgical	JJ	B-TEST
evaluation	NN	I-TEST
for	IN	O
her	PRP$	B-PROBLEM
hyperparathyroidism	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
an	DT	O
83-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertrophic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
1988	CD	O
,	,	O
chronic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
for	IN	O
parathyroidectomy	NN	B-TREATMENT
.	.	O

in	IN	O
august	NN	O
of	IN	O
1996	CD	O
while	IN	O
the	DT	O
patient	NN	O
was	VBD	O
at	IN	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
for	IN	O
replacement	NN	B-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
knees	NNS	I-TREATMENT
bilaterally	RB	I-TREATMENT
,	,	O
and	CC	O
on	IN	O
preoperative	JJ	B-TEST
evaluation	NN	I-TEST
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
calcium	NN	I-PROBLEM
and	CC	O
therefore	RB	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
was	VBD	O
canceled	VBN	O
.	.	O

further	RB	B-TEST
testing	VBG	I-TEST
revealed	VBD	O
hyperparathyroidism	NN	B-PROBLEM
as	IN	O
evidenced	VBN	O
by	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
pth	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
reports	VBZ	O
no	DT	O
masses	NNS	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
noticed	VBN	O
some	DT	O
generalized	JJ	B-PROBLEM
hoarseness	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
voice	NN	I-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
5-6	JJ	O
months	NNS	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
has	VBZ	O
some	DT	B-PROBLEM
dysphagia	NN	I-PROBLEM
,	,	O
particularly	RB	O
has	VBZ	O
had	VBN	O
some	DT	B-PROBLEM
difficulties	NNS	I-PROBLEM
with	IN	I-PROBLEM
swallowing	NN	I-PROBLEM
.	.	O

1.	CD	O
status	NN	O
post	NN	O
mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
1988	CD	O
.	.	O

she	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
st.	JJ	I-TREATMENT
jude	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
mechanical	JJ	I-TREATMENT
valve	NN	I-TREATMENT
and	CC	O
has	VBZ	O
been	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
since	IN	O
then	RB	O
,	,	O

2.	CD	O
hypertension	NN	B-PROBLEM
,	,	O
she	PRP	O
has	VBZ	O
had	VBN	O
hypertension	NN	B-PROBLEM
for	IN	O
15	CD	O
years	NNS	O
,	,	O

3.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
cardioversion	NN	B-TREATMENT
3-25-94	CD	O
,	,	O

4.	CD	O
hypertrophic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O

5.	CD	O
osteoarthritis	NN	B-PROBLEM
;	:	O
she	PRP	O
is	VBZ	O
to	TO	O
receive	VB	O
bilateral	JJ	B-TREATMENT
total	JJ	I-TREATMENT
knee	NN	I-TREATMENT
replacements	NNS	I-TREATMENT
at	IN	O
some	DT	O
time	NN	O
in	IN	O
the	DT	O
near	JJ	O
future	NN	O
,	,	O

6.	CD	O
right	JJ	B-PROBLEM
cheek	NN	I-PROBLEM
basal	NN	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
to	TO	O
be	VB	O
removed	VBN	O
in	IN	O
the	DT	O
future	NN	O
,	,	O

7.	CD	O
history	NN	O
of	IN	O
glaucoma	NN	B-PROBLEM
,	,	O

8.	CD	O
non	JJ	B-PROBLEM
insulin	NN	I-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	CD	I-PROBLEM
which	WDT	O
was	VBD	O
diagnosed	VBN	O
in	IN	O
march	NN	O
,	,	O
1995	CD	O
,	,	O

9.	CD	O
shingles	NNS	B-PROBLEM
.	.	O

1.	CD	O
laparoscopic	JJ	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
03/93	CD	O
by	IN	O
dr.	NN	O
sapmal	NN	O
,	,	O

2.	CD	O
dilation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
in	IN	O
1992	CD	O
for	IN	O
polyps	NNS	B-PROBLEM
,	,	O

3.	CD	O
left	VBD	B-TEST
breast	NN	I-TEST
biopsy	NN	I-TEST
which	WDT	O
was	VBD	O
benign	NN	O
,	,	O

4.	CD	O
cataract	NN	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
lopid	JJ	B-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O

2.	CD	O
k-dur	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O

3.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O

4.	CD	O
coumadin	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
which	WDT	O
was	VBD	O
last	JJ	O
taken	VBN	O
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O

5.	CD	O
norvasc	JJ	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O

6.	CD	O
digoxin	NN	B-TREATMENT
.25	NNP	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O

7.	CD	O
lopressor	NN	B-TREATMENT
50	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O

8.	CD	O
glucotrol	NN	B-TREATMENT
10	CD	O
xl	NN	O
qam	NN	O
,	,	O

9.	CD	O
timoptic	JJ	B-TREATMENT
0.5%	CD	O
b.i.d.	NN	O
to	TO	O
both	DT	O
eyes	NNS	O
,	,	O

10.	CD	O
pilocarpine	NN	B-TREATMENT
gel	NN	I-TREATMENT
qhs	NN	O
to	TO	O
both	DT	O
eyes	NNS	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
parathyroid	NN	B-PROBLEM
or	CC	I-PROBLEM
thyroid	NN	I-PROBLEM
diseases	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
review	NN	I-TEST
of	IN	I-TEST
systems	NNS	I-TEST
is	VBZ	O
significant	JJ	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
dyspnea	NN	B-PROBLEM
on	IN	I-PROBLEM
exertion	NN	I-PROBLEM
.	.	O

at	IN	O
present	JJ	O
,	,	O
she	PRP	O
can	MD	O
walk	VB	O
one	CD	O
to	TO	O
two	CD	O
blocks	NNS	O
before	IN	O
having	VBG	O
to	TO	O
stop	VB	O
because	IN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

when	WRB	O
walking	VBG	O
outside	RB	O
,	,	O
she	PRP	O
stops	VBZ	O
multiple	JJ	O
times	NNS	O
because	IN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

she	PRP	O
gets	VBZ	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
walking	VBG	O
up	RP	O
steps	NNS	O
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
she	PRP	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
pulse	NN	I-TEST
is	VBZ	O
72	CD	O
,	,	O
irregularly	RB	O
irregular	JJ	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
96/60	CD	O
,	,	O
temperature	NN	B-TEST
97.9	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
pupils	NNS	O
which	WDT	O
have	VBP	O
irregular	JJ	B-PROBLEM
border	NN	I-PROBLEM
and	CC	O
are	VBP	O
very	RB	B-PROBLEM
sluggishly	RB	I-PROBLEM
reactive	JJ	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
reports	NNS	O
that	IN	O
she	PRP	O
will	MD	O
have	VB	O
revision	NN	B-TREATMENT
of	IN	I-TREATMENT
cataract	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

cardiovascular	JJ	B-TEST
exam	NN	I-TEST
:	:	O

iii	NN	B-PROBLEM
/	NNP	I-PROBLEM
vi	VBZ	I-PROBLEM
systolic	JJ	I-PROBLEM
click	NN	I-PROBLEM
and	CC	O
irregularly	RB	B-PROBLEM
irregular	JJ	I-PROBLEM
rhythm	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
guaiac	JJ	O
negative	JJ	O
on	IN	O
rectal	JJ	B-TEST
examination	NN	I-TEST
.	.	O

admission	NN	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
4.3	CD	O
,	,	O
hematocrit	NN	B-TEST
31.0	CD	O
,	,	O
electrolytes	NNS	B-TEST
were	VBD	O
all	DT	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
glucose	JJ	B-TEST
218	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
15.1	CD	O
with	IN	O
inr	NN	B-TEST
of	IN	O
1.5	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
23.3	CD	O
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
slow	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
response	NN	I-PROBLEM
and	CC	O
digitalis	JJ	B-PROBLEM
effect	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
left	VBN	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

impression	NN	O
was	VBD	O
that	IN	O
this	DT	O
was	VBD	O
an	DT	O
83-year-old	JJ	O
female	NN	O
with	IN	O
cardiac	JJ	B-PROBLEM
history	NN	I-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
on	IN	I-PROBLEM
exertion	NN	I-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
calcium	NN	I-PROBLEM
and	CC	O
hyperparathyroidism	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
for	IN	O
parathyroidectomy	NN	B-TREATMENT
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
parathyroidectomy	NN	B-TREATMENT
.	.	O

the	DT	O
right	JJ	O
superior	JJ	O
parathyroid	NN	O
gland	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
markedly	RB	B-PROBLEM
enlarged	VBN	I-PROBLEM
and	CC	O
consistent	JJ	O
with	IN	O
an	DT	B-PROBLEM
adenoma	NN	I-PROBLEM
.	.	O

postoperatively	RB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
cough	VB	O
and	CC	O
phonate	VB	O
completely	RB	O
with	IN	O
no	DT	O
changes	NNS	B-PROBLEM
from	IN	O
preoperative	NN	O
.	.	O

the	DT	O
plan	NN	O
was	VBD	O
to	TO	O
start	VB	O
her	PRP$	O
on	IN	O
heparin	NN	B-TREATMENT
and	CC	O
coumadin	NN	B-TREATMENT
and	CC	O
discontinue	VB	O
her	PRP$	B-TREATMENT
heparin	NN	I-TREATMENT
when	WRB	O
her	PRP$	B-TEST
coumadin	NN	I-TEST
levels	NNS	I-TEST
became	VBD	O
therapeutic	JJ	O
as	IN	O
judged	VBN	O
by	IN	O
the	DT	B-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
/	NNP	O
inr	NN	B-TEST
.	.	O

however	RB	O
,	,	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
,	,	O
the	DT	O
patient	NN	O
in	IN	O
the	DT	O
afternoon	NN	O
noticed	VBD	O
some	DT	B-PROBLEM
tingling	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	O
also	RB	O
some	DT	B-PROBLEM
tingling	VBG	I-PROBLEM
hear	JJ	I-PROBLEM
her	PRP$	I-PROBLEM
perioral	JJ	I-PROBLEM
region	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
muscular	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
noted	VBD	O
.	.	O

an	DT	B-TEST
ionized	JJ	I-TEST
calcium	NN	I-TEST
was	VBD	O
drawn	VBN	O
which	WDT	O
was	VBD	O
low	JJ	O
at	IN	O
1.0	CD	O
.	.	O

as	IN	O
a	DT	O
result	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
os-cal	JJ	B-TREATMENT
250	CD	O
mg	NN	O
po	NN	O
q.i.d.	NN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
her	PRP$	B-TEST
ionized	JJ	I-TEST
calcium	NN	I-TEST
was	VBD	O
1.06	CD	O
and	CC	O
her	PRP$	B-TREATMENT
os-cal	JJ	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
500	CD	O
q.i.d.	NNS	O

however	RB	O
,	,	O
her	PRP	B-PROBLEM
ionized	JJ	I-PROBLEM
calcium	NN	I-PROBLEM
decreased	VBD	I-PROBLEM
to	TO	O
0.97	CD	O
and	CC	O
she	PRP	O
was	VBD	O
given	VBN	O
one	CD	O
amp	NN	O
of	IN	O
calcium	NN	B-TREATMENT
gluconate	NN	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
,	,	O
the	DT	O
patient	NN	O
felt	VBD	O
fine	JJ	O
and	CC	O
had	VBD	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
1.9	CD	O
with	IN	O
a	DT	B-TEST
prothrombin	JJ	I-TEST
time	NN	I-TEST
of	IN	O
16.6	CD	O
.	.	O

her	PRP$	B-TEST
calcium	NN	I-TEST
was	VBD	O
8.5	CD	O
,	,	O
albumin	RB	B-TEST
3.6	CD	O
,	,	O
and	CC	O
phosphate	VB	B-TEST
4.5	CD	O
.	.	O

she	PRP	O
had	VBD	O
had	VBN	O
no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
tingling	VBG	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
fingers	NNS	I-PROBLEM
after	IN	O
the	DT	O
initial	JJ	O
episode	NN	O
which	WDT	O
had	VBD	O
prompted	VBN	O
us	PRP	O
originally	RB	O
to	TO	O
draw	VB	O
the	DT	B-TEST
ionized	JJ	I-TEST
calcium	NN	I-TEST
.	.	O

1.	CD	O
coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O
then	RB	O
she	PRP	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
and	CC	O
decide	VB	O
the	DT	O
dosage	NN	O
thereafter	RB	O
,	,	O

2.	CD	O
lopid	JJ	B-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O

3.	CD	O
k-dur	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O

4.	CD	O
os-cal	JJ	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
q.i.d.	NN	O
,	,	O

5.	CD	O
rocaltrol	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O

6.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O

7.	CD	O
norvasc	JJ	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O

8.	CD	O
digoxin	NN	B-TREATMENT
.25	NNP	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O

9.	CD	O
lopressor	NN	B-TREATMENT
50	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O

10.	CD	O
glucotrol	NN	B-TREATMENT
10	CD	O
mg	NN	O
qam	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
is	VBZ	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
to	TO	O
check	VB	O
her	PRP$	B-TEST
prothrombin	JJ	I-TEST
time	NN	I-TEST
/	JJ	O
inr	NN	B-TEST
as	RB	O
well	RB	O
as	IN	O
calcium	NN	B-TEST
,	,	I-TEST
albumin	NN	I-TEST
and	CC	I-TEST
phosphate	NN	I-TEST
levels	NNS	I-TEST
.	.	O

left	NN	B-PROBLEM
sided	VBD	I-PROBLEM
spastic	JJ	I-PROBLEM
hemiparesis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
surgical	JJ	B-TREATMENT
correction	NN	I-TREATMENT
of	IN	I-TREATMENT
c-1	JJ	I-TREATMENT
,	,	I-TREATMENT
c-2	JJ	I-TREATMENT
dural	JJ	I-TREATMENT
avm	NN	I-TREATMENT
.	.	O

ms.	NN	O
breunlinke	NN	O
is	VBZ	O
a	DT	O
69	JJ	O
year-old	JJ	O
right	NN	O
handed	VBN	O
woman	NN	O
,	,	O
status	NN	O
post	NN	O
surgical	JJ	B-TREATMENT
correction	NN	I-TREATMENT
of	IN	I-TREATMENT
a	DT	I-TREATMENT
c-1	JJ	I-TREATMENT
to	TO	I-TREATMENT
c-2	JJ	I-TREATMENT
dural	JJ	I-TREATMENT
avm	NN	I-TREATMENT
in	IN	O
january	NN	O
,	,	O
1998	CD	O
,	,	O
now	RB	O
presenting	VBG	O
with	IN	O
a	DT	O
one	CD	O
month	NN	O
history	NN	O
of	IN	O
increasing	VBG	B-PROBLEM
left	VBN	I-PROBLEM
sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
pain	NN	B-PROBLEM
with	IN	O
spasticity	NN	B-PROBLEM
,	,	O
occasional	JJ	O
difficulty	NN	B-PROBLEM
swallowing	VBG	I-PROBLEM
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
originally	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
verg	NNP	O
medical	JJ	O
center	NN	O
in	IN	O
january	NN	O
,	,	O
1998	CD	O
,	,	O
because	IN	O
of	IN	O
a	DT	O
one	CD	O
year	NN	O
history	NN	O
of	IN	O
left	NN	B-PROBLEM
sided	VBN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
spasticity	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
intermedullary	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
at	IN	I-PROBLEM
c1-2	JJ	I-PROBLEM
level	NN	I-PROBLEM
which	WDT	O
on	IN	O
biopsy	NN	B-TEST
showed	VBD	O
abnormal	JJ	B-PROBLEM
vasculature	NN	I-PROBLEM
,	,	O
hemosiderin	JJ	B-PROBLEM
deposit	NN	I-PROBLEM
,	,	O
leading	VBG	O
in	IN	O
turn	NN	O
to	TO	O
the	DT	O
discovery	NN	O
of	IN	O
a	DT	B-PROBLEM
dural	JJ	I-PROBLEM
arteriovenous	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
at	IN	O
that	DT	O
level	NN	O
which	WDT	O
was	VBD	O
surgically	RB	O
corrected	VBN	O
.	.	O

the	DT	O
postoperative	JJ	O
period	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
transient	NN	B-PROBLEM
swallowing	VBG	I-PROBLEM
difficulty	NN	I-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
left	VBN	I-PROBLEM
sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
urinary	JJ	B-PROBLEM
retention	NN	I-PROBLEM
.	.	O

as	IN	O
of	IN	O
the	DT	O
beginning	NN	O
of	IN	O
september	NN	O
,	,	O
1999	CD	O
,	,	O
she	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
swallow	VB	O
without	IN	O
difficulty	NN	O
,	,	O
urinate	NN	O
without	IN	O
difficulty	NN	O
(	(	O
although	IN	O
bowel	NN	O
movements	NNS	O
have	VBP	O
been	VBN	O
problematic	JJ	B-PROBLEM
)	)	O
.	.	O

functionally	RB	O
,	,	O
she	PRP	O
was	VBD	O
at	IN	O
the	DT	O
level	NN	O
of	IN	O
pre-gait	JJ	B-TREATMENT
training	NN	I-TREATMENT
and	CC	O
able	JJ	O
to	TO	O
stand	VB	O
and	CC	O
take	VB	O
several	JJ	O
steps	NNS	O
with	IN	O
upper	JJ	B-TREATMENT
body	NN	I-TREATMENT
support	NN	I-TREATMENT
.	.	O

over	IN	O
the	DT	O
past	JJ	O
4-5	JJ	O
weeks	NNS	O
her	PRP$	B-PROBLEM
functional	JJ	I-PROBLEM
level	NN	I-PROBLEM
has	VBZ	O
progressively	RB	O
deteriorated	VBN	O
.	.	O

her	PRP$	O
left	JJ	O
arm	NN	O
has	VBZ	O
developed	VBN	O
a	DT	B-PROBLEM
flexure	NN	I-PROBLEM
contraction	NN	I-PROBLEM
and	CC	O
she	PRP	O
reports	VBZ	O
intermitttent	NN	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
which	WDT	O
occurs	VBZ	O
both	DT	O
spontaneously	RB	O
and	CC	O
is	VBZ	O
also	RB	O
triggered	VBN	O
by	IN	O
contact	NN	O
.	.	O

she	PRP	O
has	VBZ	O
developed	VBN	O
some	DT	O
new	JJ	B-PROBLEM
swallowing	VBG	I-PROBLEM
difficulty	NN	I-PROBLEM
and	CC	O
since	IN	O
her	PRP$	O
transfer	NN	O
to	TO	O
a	DT	O
long	JJ	O
term	NN	O
inpatient	NN	O
care	NN	O
facility	NN	O
,	,	O
she	PRP	O
has	VBZ	O
lost	VBN	O
ten	JJ	O
pounds	NNS	O
.	.	O

she	PRP	O
denies	VBZ	O
dysuria	NNS	B-PROBLEM
or	CC	O
excessive	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
frequency	NN	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
past	JJ	O
several	JJ	O
weeks	NNS	O
she	PRP	O
has	VBZ	O
also	RB	O
developed	VBN	O
severe	JJ	B-PROBLEM
intermittent	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
localized	VBN	O
to	TO	O
the	DT	O
suprapubic	JJ	O
area	NN	O
,	,	O
left	VBD	O
greater	JJR	O
than	IN	O
right	RB	O
,	,	O
occurring	VBG	O
intermittently	RB	O
.	.	O

the	DT	O
patient	NN	O
feels	NNS	O
this	DT	O
is	VBZ	O
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
hemorrhoids	NNS	I-PROBLEM
,	,	O
although	IN	O
it	PRP	O
does	VBZ	O
not	RB	O
clearly	RB	O
localize	VB	O
to	TO	O
the	DT	O
rectum	NN	O
.	.	O

this	DT	B-PROBLEM
pain	NN	I-PROBLEM
often	RB	O
follows	VBZ	O
bowel	JJ	O
movement	NN	O
but	CC	O
does	VBZ	O
occur	VB	O
spontaneously	RB	O
.	.	O

significant	JJ	O
for	IN	O
insulin	NN	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	RBS	I-PROBLEM
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
depression	NN	B-PROBLEM
,	,	O
frequent	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
neuropathic	JJ	B-PROBLEM
pain	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
and	CC	O
osteoporosis	NN	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
include	VBP	O
cozaar	JJ	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
coumadin	VBP	B-TREATMENT
2	CD	O
mg/1	NN	O
mg	NN	O
alternate	NN	O
days	NNS	O
,	,	O
synthroid	JJ	B-TREATMENT
175	CD	O
mcg	NN	O
q.d.	NN	O
,	,	O
zoloft	JJ	B-TREATMENT
50	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
zantac	VBZ	B-TREATMENT
150	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
diabeta	VBZ	B-TREATMENT
25	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
proctofoam	VBP	B-TREATMENT
1%	CD	O
q.i.d.	NN	O
,	,	O
demerol	NN	B-TREATMENT
100	CD	O
mg	NN	O
q	NN	O
6	CD	O
p.r.n.	NN	O
,	,	O
oscal	JJ	B-TREATMENT
2	CD	O
tabs	NN	O
t.i.d.	NN	O
,	,	O
multivitamins	NNS	B-TREATMENT
and	CC	O
kcl	NN	B-TREATMENT
supplements	NNS	I-TREATMENT
,	,	O
dulcolax	VBZ	B-TREATMENT
5	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
senokot	VBD	B-TREATMENT
2	CD	O
tabs	NNS	O
q	JJ	O
h.s.	NN	O
,	,	O
metamucil	NN	B-TREATMENT
1	CD	O
tablespoon	NN	O
b.i.d.	NN	O
,	,	O
detrol	NN	B-TREATMENT
2	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
neurontin	RB	B-TREATMENT
200	CD	O
mg	NN	O
t.i.d.	NN	O
,	,	O
hydrodiuril	VBD	B-TREATMENT
12.5	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
valium	NN	B-TREATMENT
10	CD	O
mg	NN	O
q	NN	O
8	CD	O
p.r.n.	NN	O
muscle	NN	B-PROBLEM
spasm	NN	I-PROBLEM
,	,	O
insulin	NN	B-TREATMENT
by	IN	O
sliding	VBG	O
scale	NN	O
and	CC	O
levofloxacin	$	B-TREATMENT
500	CD	O
mg	NN	O
q.d.	NN	O
beginning	VBG	O
october	PRP	O
23	CD	O
,	,	O
1999	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
hydralazine	VB	B-TREATMENT
,	,	O
codeine	NN	B-TREATMENT
,	,	O
ace	NN	B-TREATMENT
inhibitors	NNS	I-TREATMENT
,	,	O
nifedipine	NN	B-TREATMENT
and	CC	O
percocet	NN	B-TREATMENT
.	.	O

on	IN	O
admission	NN	O
,	,	O
heart	NN	O
is	VBZ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
with	IN	O
marked	JJ	B-PROBLEM
suprapubic	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
reduced	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

anal	JJ	O
tone	NN	O
is	VBZ	O
reduced	VBN	B-PROBLEM
.	.	O

rectal	JJ	B-TEST
examination	NN	I-TEST
is	VBZ	O
nontender	JJ	B-PROBLEM
and	CC	O
stool	NN	O
is	VBZ	O
guaiac	JJ	O
negative	JJ	O
.	.	O

pupils	NNS	O
are	VBP	O
4-6	JJ	O
mm	NN	O
bilaterally	RB	O
,	,	O
extraocular	JJ	O
movements	NNS	O
were	VBD	O
full	JJ	O
without	IN	O
nystagmus	NN	B-PROBLEM
.	.	O

the	DT	O
tone	NN	O
is	VBZ	O
markedly	RB	B-PROBLEM
increased	VBN	I-PROBLEM
in	IN	I-PROBLEM
bot	NN	I-PROBLEM
legs	NN	I-PROBLEM
with	IN	O
left	NN	O
greater	JJR	O
than	IN	O
right	NN	O
.	.	O

left	NN	O
arm	NN	O
shows	VBZ	O
a	DT	B-PROBLEM
flexor	JJ	I-PROBLEM
contracture	NN	I-PROBLEM
and	CC	O
markedly	RB	B-PROBLEM
increased	VBD	I-PROBLEM
tone	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
arm	NN	O
shows	NNS	O
moderate	VBP	B-PROBLEM
increased	VBN	I-PROBLEM
tone	NN	I-PROBLEM
.	.	O

the	DT	O
left	JJ	O
upper	JJ	O
extremity	NN	O
shows	NNS	O
reduction	NN	B-PROBLEM
in	IN	I-PROBLEM
motor	NN	I-PROBLEM
power	NN	I-PROBLEM
ranging	VBG	O
from	IN	O
2/5	CD	O
in	IN	O
the	DT	O
triceps	NNS	O
,	,	O
4/5	CD	O
in	IN	O
the	DT	O
biceps	NNS	O
,	,	O
and	CC	O
3-4/5	NNS	O
in	IN	O
the	DT	O
wrists	NNS	O
and	CC	O
hand	NN	O
intrinsics	NNS	O
.	.	O

the	DT	O
right	JJ	O
upper	JJ	O
extremity	NN	O
shows	NNS	O
generalized	VBN	B-PROBLEM
reduction	NN	I-PROBLEM
in	IN	I-PROBLEM
strength	NN	I-PROBLEM
,	,	O
4/5	CD	O
in	IN	O
all	DT	O
joints	NNS	O
.	.	O

upper	JJ	O
extremities	NNS	O
are	VBP	O
very	RB	O
brisk	JJ	O
bilaterally	RB	O
and	CC	O
symmetrical	JJ	O
3+.	CD	O
there	EX	O
is	VBZ	O
positive	JJ	B-PROBLEM
tremor	NN	I-PROBLEM
reflex	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	O
absent	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
.	.	O

lower	JJR	O
extremities	NNS	O
show	VBP	O
patellar	JJ	B-TEST
reflexes	NNS	I-TEST
3+	CD	O
left	VBD	O
,	,	O
4+	CD	O
right	NN	O
,	,	O
no	DT	O
cross	NN	B-TEST
deductor	NN	I-TEST
reflexes	NNS	I-TEST
and	CC	O
absent	JJ	O
ankle	NN	O
jerks	NNS	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
clonus	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
but	CC	O
sustained	VBD	B-PROBLEM
clonus	NNS	I-PROBLEM
(	(	I-PROBLEM
10-12	JJ	I-PROBLEM
beats	NNS	I-PROBLEM
)	)	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
diminished	VBN	B-PROBLEM
vibration	NN	I-PROBLEM
and	CC	I-PROBLEM
propioception	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	NN	I-PROBLEM
and	CC	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	O
decreased	JJ	B-PROBLEM
temperature	NN	I-PROBLEM
,	,	O
light	JJ	B-TEST
touch	NN	I-TEST
and	CC	O
pinprick	JJ	B-TEST
sensation	NN	I-TEST
in	IN	O
the	DT	O
right	JJ	O
upper	NN	O
and	CC	O
lower	JJR	O
extremity	NN	O
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
cervical	JJ	I-PROBLEM
spinal	JJ	I-PROBLEM
sensory	JJ	I-PROBLEM
level	NN	I-PROBLEM
.	.	O

cerebellar	NN	O
;	:	O
the	DT	O
patient	NN	O
demonstrates	VBZ	O
an	DT	B-PROBLEM
intention	NN	I-PROBLEM
tremor	NN	I-PROBLEM
on	IN	O
finger	NN	B-TEST
to	TO	I-TEST
nose	VB	I-TEST
with	IN	O
the	DT	O
left	JJ	O
hand	NN	O
.	.	O

fine	JJ	O
motor	NN	O
movements	NNS	O
are	VBP	O
slow	JJ	B-PROBLEM
but	CC	O
accurate	NN	O
in	IN	O
the	DT	O
left	NN	O
and	CC	O
right	JJ	O
hands	NNS	O
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
3.8	CD	O
,	,	O
chloride	RB	B-TEST
100	CD	O
,	,	O
bicarbonate	NN	B-TEST
of	IN	O
30	CD	O
,	,	O
bun	NN	B-TEST
of	IN	O
13	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
serum	VBD	B-TEST
glucose	JJ	I-TEST
228	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
is	VBZ	O
7,000	CD	O
.	.	O

hematocrit	NN	B-TEST
is	VBZ	O
37.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
is	VBZ	O
148,000	CD	O
.	.	O

prothrombin	JJ	B-TEST
time	NN	I-TEST
is	VBZ	O
15.9	CD	O
with	IN	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
1.7	CD	O
.	.	O

ptt	NN	B-TEST
is	VBZ	O
24	CD	O
.	.	O

urinalysis	NN	B-TEST
from	IN	O
october	$	O
21	CD	O
,	,	O
is	VBZ	O
positive	JJ	O
for	IN	O
citrobacter	NN	B-PROBLEM
susceptible	JJ	O
to	TO	O
ciprofloxacin	VB	B-TREATMENT
,	,	O
gentamycin	NN	B-TREATMENT
,	,	O
nitrofurantoin	RB	B-TREATMENT
,	,	O
tetracycline	NN	B-TREATMENT
and	CC	O
bactrim	NN	B-TREATMENT
.	.	O

electrocardiogram	NN	B-TEST
shows	VBZ	O
no	DT	O
p-waves	NNS	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
with	IN	O
and	CC	O
without	IN	O
contrast	NN	O
was	VBD	O
performed	VBN	O
,	,	O
showing	VBG	O
a	DT	B-PROBLEM
missing	VBG	I-PROBLEM
posterior	JJ	I-PROBLEM
arch	NN	I-PROBLEM
at	IN	I-PROBLEM
c-1	NN	I-PROBLEM
and	CC	O
metallic	JJ	B-TREATMENT
clips	NNS	I-TREATMENT
at	IN	I-TREATMENT
the	DT	I-TREATMENT
craniocervical	JJ	I-TREATMENT
junction	NN	I-TREATMENT
consistent	NN	O
with	IN	O
prior	JJ	B-TREATMENT
surgical	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

no	DT	O
arteriovenous	JJ	B-PROBLEM
malformations	NNS	I-PROBLEM
are	VBP	O
identified	VBN	O
;	:	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
recurrence	NN	B-PROBLEM
of	IN	O
her	PRP$	B-PROBLEM
former	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
.	.	O

no	DT	O
intraspinal	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
are	VBP	O
identified	VBN	O
.	.	O

upon	IN	O
further	JJ	O
review	NN	O
of	IN	O
dr.	NN	O
laymie	NN	O
fields	NNS	O
,	,	O
department	NN	O
of	IN	O
neuroradiology	NN	O
,	,	O
review	NN	O
of	IN	O
the	DT	O
cervical	JJ	O
spine	NN	O
on	IN	O
ct	NN	B-TEST
reveals	NNS	O
no	DT	O
extrinsic	JJ	B-PROBLEM
compressive	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
impacting	VBG	O
the	DT	O
spinal	JJ	O
cord	NN	O
and	CC	O
no	DT	O
enhancing	VBG	B-PROBLEM
lesions	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
spinal	JJ	I-PROBLEM
cord	NN	I-PROBLEM
with	IN	O
contrast	NN	B-TEST
.	.	O

angiography	NN	B-TEST
performed	VBD	O
on	IN	O
october	NN	O
31	CD	O
,	,	O
1999	CD	O
,	,	O
showed	VBD	O
normal	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
distribution	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
head	NN	I-PROBLEM
and	CC	I-PROBLEM
neck	NN	I-PROBLEM
with	IN	O
no	DT	O
recurrence	NN	B-PROBLEM
of	IN	I-PROBLEM
arteriovenous	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
.	.	O

during	IN	O
this	DT	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
baclofen	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
for	IN	O
spasticity	NN	B-PROBLEM
.	.	O

coumadin	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
given	VBN	O
valium	JJ	B-TREATMENT
5-10	JJ	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
for	IN	O
muscle	NN	B-PROBLEM
spasm	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
demerol	NN	B-TREATMENT
50	CD	O
mg	NN	O
q	JJ	O
6-8	JJ	O
hours	NNS	O
p.r.n.	NN	O
for	IN	O
left	JJ	B-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
leg	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

upon	IN	O
further	JJ	O
review	NN	O
of	IN	O
ct	NN	B-TEST
and	CC	O
angiography	NN	B-TEST
results	NNS	O
with	IN	O
neuroradiology	NN	O
and	CC	O
neurology	NN	O
service	NN	O
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
ct	NN	B-TEST
myelography	NN	I-TEST
was	VBD	O
not	RB	O
indicated	VBN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

note	NN	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
not	RB	O
a	DT	O
candidate	NN	O
for	IN	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
secondary	JJ	O
to	TO	O
ferromagnetic	JJ	B-TREATMENT
intracardiac	NN	I-TREATMENT
pacing	VBG	I-TREATMENT
device	NN	I-TREATMENT
.	.	O

we	PRP	O
recommend	VBP	O
daily	JJ	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
maximize	VB	O
functional	JJ	B-PROBLEM
capacity	NN	I-PROBLEM
with	IN	O
optimization	NN	O
of	IN	O
pharmacological	JJ	B-TREATMENT
regimen	NNS	I-TREATMENT
for	IN	O
spasticity	NN	B-PROBLEM
including	VBG	O
baclofen	NN	B-TREATMENT
,	,	O
valium	NN	B-TREATMENT
and	CC	O
adequate	JJ	B-TREATMENT
analgesia	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
epigastric	JJ	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
ro	VB	O
woodma	NN	O
healthcare	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
priesdouet	JJ	O
,	,	O
ch	JJ	O
j	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
cholecystitis	NN	B-PROBLEM
.	.	O

vaginal	JJ	B-TREATMENT
delivery	NN	I-TREATMENT
with	IN	O
second	JJ	B-PROBLEM
degree	NN	I-PROBLEM
laceration	NN	I-PROBLEM

low	JJ	B-PROBLEM
lying	VBG	I-PROBLEM
placenta	NN	I-PROBLEM
;	:	O
past	JJ	O
medical	JJ	O
history	NN	O
,	,	O
history	NN	O
of	IN	O
;	:	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O

spontaneous	JJ	B-TREATMENT
vertex	NNS	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT

routine	JJ	B-TREATMENT
post	NN	I-TREATMENT
partum	NN	I-TREATMENT
care	NN	I-TREATMENT

active	JJ	B-PROBLEM
labor	NN	I-PROBLEM

height	RB	B-TEST
66	CD	O
heent	NN	B-TEST
normal	JJ	O
neck	NN	O
normal	JJ	O
breasts	NNS	O
normal	JJ	O
nipples	NNS	O
normal	JJ	O
chest	JJS	O
normal	JJ	O
cor	NN	O
normal	JJ	O
abdomen	NNS	O
normal	JJ	O
extrem	JJ	O
normal	JJ	O
skin	NN	O
normal	JJ	O
nodes	NNS	O
normal	JJ	O
vulva	NN	O
normal	JJ	O
vagina	NN	O
normal	JJ	O
cervix	NN	O
normal	JJ	O
os	NN	O
normal	JJ	O
adnexae	NN	O
normal	JJ	O
uterus	JJ	O
normal	JJ	O
uterine	JJ	O
size	NN	O
in	IN	O
weeks	NNS	O
normal	JJ	O
12	CD	O

active	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

she	PRP	O
delivered	VBD	O
a	DT	O
3550	CD	O
gram	NN	O
male	NN	O
infant	NN	O
on	IN	O
08/31/2004	CD	O
at	IN	O
09:33	CD	O
pm	NN	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
9	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
41.0	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

chorioamnionitis	NN	B-PROBLEM
.	.	O

nuchal	JJ	B-PROBLEM
cord	NN	I-PROBLEM
.	.	O

multivitamins	NNS	B-TREATMENT
and	CC	O
folate	NN	B-TREATMENT
(	(	I-TREATMENT
fam	JJ	I-TREATMENT
pren	NNS	I-TREATMENT
forte	NN	I-TREATMENT
)	)	I-TREATMENT

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
treated	VBN	O
and	CC	O
released	VBN	O
.	.	O

1)	CD	O
acquired	VBD	B-PROBLEM
immunodeficiency	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

2)	CD	O
pneumocystis	NN	B-PROBLEM
carinii	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

3)	CD	O
adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

mr.	NN	O
breutzfarstxei	NN	O
is	VBZ	O
a	DT	O
30	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
recently	RB	O
diagnosed	VBN	O
acquired	VBN	B-PROBLEM
immunodeficiency	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
and	CC	O
pneumocystis	NN	B-PROBLEM
carinii	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
pneumonia	NN	B-PROBLEM
,	,	O
developed	VBD	O
adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
and	CC	O
died	VBD	O
in	IN	O
the	DT	O
hospital	NN	O
after	IN	O
failed	VBD	O
efforts	NNS	O
of	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

mr.	NN	O
breutzfarstxei	NN	O
was	VBD	O
recently	RB	O
diagnosed	VBN	O
with	IN	O
acquired	JJ	B-PROBLEM
immunodeficiency	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
when	WRB	O
he	PRP	O
had	VBD	O
pneumocystis	NN	B-PROBLEM
carinii	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
on	IN	O
01/17/91	CD	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
at	IN	O
that	DT	O
time	NN	O
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
bactrim	NN	B-TREATMENT
and	CC	O
steroids	NNS	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
actually	RB	O
intubated	VBN	O
and	CC	O
underwent	JJ	O
bronchoscopy	NN	B-TREATMENT
where	WRB	O
the	DT	O
diagnosis	NN	O
was	VBD	O
made	VBN	O
with	IN	O
a	DT	B-PROBLEM
positive	JJ	I-PROBLEM
toluidine	NN	I-PROBLEM
blue	NN	I-PROBLEM
study	NN	I-PROBLEM
.	.	O

he	PRP	O
initially	RB	O
did	VBD	O
well	RB	O
after	IN	O
extubation	NN	B-TREATMENT
and	CC	O
completed	VBD	O
approximately	RB	O
two	CD	O
weeks	NNS	O
of	IN	O
bactrim	NN	B-TREATMENT
and	CC	O
a	DT	B-TREATMENT
steroid	JJ	I-TREATMENT
taper	NN	I-TREATMENT
.	.	O

at	IN	O
discharge	NN	O
after	IN	O
about	IN	O
two	CD	O
weeks	NNS	O
post-extubation	NN	O
,	,	O
he	PRP	O
had	VBD	O
an	DT	O
o2	JJ	B-TEST
saturation	NN	I-TEST
of	IN	O
approximately	RB	O
95%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

on	IN	O
02/06/91	CD	O
,	,	O
he	PRP	O
was	VBD	O
seen	VBN	O
in	IN	O
flfdmc	NN	O
and	CC	O
at	IN	O
that	DT	O
point	NN	O
,	,	O
his	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
101.4	CD	O
and	CC	O
he	PRP	O
had	VBD	O
malaise	NN	B-PROBLEM
and	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
his	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
only	RB	O
90%	CD	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
his	PRP$	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
no	DT	O
change	NN	O
.	.	O

cultures	NNS	B-TEST
were	VBD	O
taken	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
sent	VBN	O
out	RP	O
.	.	O

on	IN	O
02/08/91	CD	O
,	,	O
the	DT	O
patient	NN	O
called	VBD	O
dr.	NN	O
seen	VBN	O
because	IN	O
of	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
malaise	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
in	IN	O
flfdmc	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
jaundice	NN	B-PROBLEM
and	CC	O
newly	RB	B-PROBLEM
palpable	JJ	I-PROBLEM
liver	NN	I-PROBLEM
edge	NN	I-PROBLEM
.	.	O

review	NN	O
of	IN	O
liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
cholestatic	JJ	I-PROBLEM
picture	NN	I-PROBLEM
which	WDT	O
was	VBD	O
not	RB	O
previously	RB	O
found	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
this	DT	O
was	VBD	O
secondary	JJ	O
to	TO	O
the	DT	B-TREATMENT
bactrim	NN	I-TREATMENT
which	WDT	O
had	VBD	O
been	VBN	O
recently	RB	O
stopped	VBD	O
anyway	RB	O
.	.	O

his	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
only	RB	O
86%	CD	O
on	IN	O
room	NN	O
air	NN	O
and	CC	O
he	PRP	O
was	VBD	O
admitted	VBN	O
.	.	O

1)	CD	O
hiv	NNS	B-PROBLEM
positive	JJ	I-PROBLEM
with	IN	O
a	DT	B-TEST
cd4	NN	I-TEST
count	NN	I-TEST
of	IN	O
74	CD	O
.	.	O

2)	CD	O
recent	JJ	B-PROBLEM
pcp	NN	I-PROBLEM
.	.	O

3)	CD	O
status	NN	O
post	NN	O
right	RB	B-TREATMENT
elbow	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

4)	CD	O
venereal	JJ	B-PROBLEM
disease	NN	I-PROBLEM
history	NN	I-PROBLEM
.	.	O

5)	CD	O
ppd	JJ	B-PROBLEM
anergic	NN	I-PROBLEM
.	.	O

on	IN	O
presentation	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
young	JJ	O
appearing	VBG	O
hispanic	JJ	O
male	NN	O
in	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
140/90	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
120	CD	O
,	,	O
respirations	NNS	B-TEST
32	CD	O
,	,	O
and	CC	O
temperature	NN	B-TEST
101	CD	O
.	.	O

revealed	VBN	O
icteric	JJ	B-PROBLEM
sclerae	NN	I-PROBLEM
,	,	O
the	DT	B-PROBLEM
oropharynx	NN	I-PROBLEM
with	IN	I-PROBLEM
extensive	JJ	I-PROBLEM
thrush	NN	I-PROBLEM
,	,	O
and	CC	O
an	DT	B-PROBLEM
ulcer	NN	I-PROBLEM
under	IN	I-PROBLEM
his	PRP$	I-PROBLEM
tongue	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
cervical	JJ	B-PROBLEM
adenopathy	NN	I-PROBLEM
and	CC	O
his	PRP$	O
neck	NN	O
was	VBD	O
supple	NN	O
.	.	O

had	VBD	O
tubular	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
especially	RB	O
in	IN	O
the	DT	O
lower	JJR	O
lung	NN	O
fields	NNS	O
.	.	O

showed	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
costovertebral	JJ	B-PROBLEM
angle	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

soft	JJ	O
with	IN	O
bowel	NN	O
sounds	NNS	O
and	CC	O
there	EX	O
was	VBD	O
mid	JJ	B-PROBLEM
epigastric	JJ	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
.	.	O

his	PRP$	O
penis	NN	O
had	VBD	O
a	DT	O
1/2	CD	B-PROBLEM
cm	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
yellowish	JJ	B-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
7.2	CD	O
with	IN	O
57%	CD	O
neutrophils	NNS	B-TEST
,	,	O
40%	CD	O
lymphocytes	NNS	B-TEST
,	,	O
l	NN	O
mononuclear	NN	B-TEST
cell	NN	I-TEST
,	,	O
and	CC	O
1.6	CD	O
eosinophils	NNS	B-TEST
.	.	O

pt	NN	B-TEST
was	VBD	O
12.6	CD	O
and	CC	O
ptt	NN	B-TEST
was	VBD	O
29	CD	O
.	.	O

sodium	NN	B-TEST
was	VBD	O
133	CD	O
,	,	O
potassium	NN	B-TEST
was	VBD	O
4.2	CD	O
,	,	O
chloride	RB	B-TEST
100	CD	O
,	,	O
co2	NN	B-TEST
19	CD	O
,	,	O
bun	NN	B-TEST
21	CD	O
,	,	O
creatinine	NN	B-TEST
1.2	CD	O
,	,	O
and	CC	O
glucose	RB	B-TEST
122	CD	O
.	.	O

alt	NN	B-TEST
was	VBD	O
181	CD	O
,	,	O
ast	NN	B-TEST
was	VBD	O
156	CD	O
,	,	O
ldh	NN	B-TEST
was	VBD	O
336	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
214	CD	O
,	,	O
and	CC	O
bilirubin	NN	B-TEST
was	VBD	O
12.7	CD	O
total	NN	O
.	.	O

(	(	O
on	IN	O
02/06	CD	O
,	,	O
his	PRP$	B-TEST
bilirubin	NN	I-TEST
had	VBD	O
been	VBN	O
7.2	CD	O
with	IN	O
6	CD	O
direct	JJ	O
)	)	O
.	.	O

his	PRP$	B-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
on	IN	O
50%	CD	O
was	VBD	O
po2	JJ	B-TEST
92	CD	O
,	,	O
pco2	NN	B-TEST
24	CD	O
,	,	O
and	CC	O
ph	RB	B-TEST
7.46	CD	O
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
bilateral	JJ	B-PROBLEM
nodular	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
work-up	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
cholestatic	JJ	I-PROBLEM
jaundice	NN	I-PROBLEM
picture	NN	I-PROBLEM
along	IN	O
with	IN	O
work-up	NN	B-TEST
for	IN	O
his	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
process	NN	I-PROBLEM
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
both	DT	O
.	.	O

in	IN	O
terms	NNS	O
of	IN	O
pulmonary	JJ	O
function	NN	O
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
one	CD	O
possibility	NN	O
was	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	B-PROBLEM
bactrim	JJ	I-PROBLEM
failure	NN	I-PROBLEM
for	IN	O
pcp	NN	B-PROBLEM
although	IN	O
this	DT	O
was	VBD	O
unusual	JJ	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
pentamidine	NN	B-TREATMENT
,	,	O
especially	RB	O
in	IN	O
light	NN	O
of	IN	O
the	DT	O
fact	NN	O
that	IN	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
his	PRP$	B-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
due	JJ	O
possibly	RB	O
to	TO	O
bactrim	VB	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
covered	VBN	O
with	IN	O
erythromycin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
for	IN	O
coverage	NN	O
of	IN	O
community	NN	B-PROBLEM
acquired	VBN	I-PROBLEM
pneumonias	NN	I-PROBLEM
and	CC	O
gram	NN	B-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

in	IN	O
terms	NNS	O
of	IN	O
his	PRP$	B-PROBLEM
liver	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
viral	JJ	B-PROBLEM
hepatitis	NN	I-PROBLEM
was	VBD	O
in	IN	O
the	DT	O
differential	NN	O
as	RB	O
well	RB	O
as	IN	O
several	JJ	B-PROBLEM
opportunistic	JJ	I-PROBLEM
infections	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
but	CC	O
also	RB	O
was	VBD	O
felt	VBN	O
that	IN	O
bactrim	NN	B-TREATMENT
could	MD	O
be	VB	O
a	DT	O
cause	NN	O
of	IN	O
these	DT	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

titers	NNS	B-TEST
for	IN	O
cmv	NN	B-PROBLEM
and	CC	O
epstein-barr	JJ	B-PROBLEM
virus	NN	I-PROBLEM
were	VBD	O
sent	VBN	O
and	CC	O
a	DT	B-TEST
titer	NN	I-TEST
for	IN	O
toxoplasma	NN	B-PROBLEM
was	VBD	O
sent	VBN	O
.	.	O

stool	NN	B-TEST
was	VBD	O
sent	VBN	O
for	IN	O
ova	NN	B-PROBLEM
and	CC	O
parasites	NNS	B-PROBLEM
.	.	O

initially	RB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
in	IN	O
terms	NNS	O
of	IN	O
his	PRP$	O
pre-status	NN	O
and	CC	O
required	VBN	O
less	JJR	O
oxygen	NN	B-TREATMENT
.	.	O

however	RB	O
,	,	O
on	IN	O
02/10/91	CD	O
,	,	O
his	PRP$	B-TEST
respiratory	JJ	I-TEST
rate	NN	I-TEST
increased	VBD	O
and	CC	O
his	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
decreased	VBD	O
.	.	O

actually	RB	O
in	IN	O
reviewing	VBG	O
the	DT	O
records	NNS	O
at	IN	O
this	DT	O
point	NN	O
,	,	O
it	PRP	O
appears	VBZ	O
that	IN	O
pentamidine	NN	B-TREATMENT
was	VBD	O
not	RB	O
started	VBN	O
initially	RB	O
so	RB	O
on	IN	O
the	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
of	IN	O
erythromycin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
respiratory	NN	O
status	NN	O
worsened	VBD	O
and	CC	O
his	PRP$	B-TEST
ldh	NN	I-TEST
climbed	VBD	O
so	RB	O
he	PRP	O
began	VBD	O
pentamidine	VB	B-TREATMENT
on	IN	O
02/10/91	CD	O
.	.	O

on	IN	O
02/11/91	CD	O
,	,	O
the	DT	O
patient	NN	O
again	RB	O
appeared	VBD	O
more	RBR	O
comfortable	JJ	O
this	DT	O
time	NN	O
with	IN	O
50%	CD	B-TREATMENT
facemask	NNS	I-TREATMENT
but	CC	O
then	RB	O
required	VBD	O
more	RBR	O
oxygen	JJ	B-TREATMENT
,	,	O
dropped	VBD	O
his	PRP$	B-TEST
o2	JJ	I-TEST
saturations	NNS	I-TEST
,	,	O
and	CC	O
was	VBD	O
intubated	VBN	O
on	IN	O
02/11/91	CD	O
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
on	IN	O
12/12/90	CD	O
on	IN	O
gentamicin	NN	B-TREATMENT
,	,	O
vancomycin	NN	B-TREATMENT
,	,	O
pentamidine	NN	B-TREATMENT
,	,	O
and	CC	O
prednisone	NN	B-TREATMENT
.	.	O

also	RB	O
of	IN	O
note	NN	O
at	IN	O
that	DT	O
point	NN	O
,	,	O
hepatitis	NN	B-TEST
c	NNS	I-TEST
virus	NN	I-TEST
serologies	NNS	I-TEST
had	VBD	O
come	VBN	O
back	RB	O
positive	JJ	O
.	.	O

however	RB	O
,	,	O
at	IN	O
this	DT	O
point	NN	O
,	,	O
his	PRP$	B-PROBLEM
liver	NN	I-PROBLEM
function	NN	I-PROBLEM
test	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
appeared	VBD	O
more	RBR	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
cholestatic	JJ	I-PROBLEM
picture	NN	I-PROBLEM
with	IN	O
his	PRP$	B-TEST
direct	JJ	I-TEST
bilirubin	NN	I-TEST
being	VBG	O
12.1	CD	O
and	CC	O
total	JJ	B-TEST
being	VBG	O
14.1	CD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
no	DT	O
liver	NN	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
no	DT	O
obstruction	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
appeared	VBD	O
to	TO	O
improve	VB	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
penile	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
cultured	VBN	O
and	CC	O
grew	VBD	O
positive	JJ	B-PROBLEM
herpes	NNS	I-PROBLEM
simplex	JJ	I-PROBLEM
virus	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
acyclovir	NN	B-TREATMENT
.	.	O

on	IN	O
02/13/91	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
bronchoalveolar	JJ	I-TEST
lavage	NN	I-TEST
performed	VBD	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
toluidine	NN	I-PROBLEM
blue	NN	I-PROBLEM
with	IN	O
many	JJ	B-PROBLEM
pneumocysts	NNS	I-PROBLEM
noted	VBD	O
.	.	O

no	DT	O
other	JJ	B-TEST
cultures	NNS	I-TEST
grew	VBD	O
out	RP	O
and	CC	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
clinical	JJ	O
status	NN	O
deteriorated	VBN	O
.	.	O

the	DT	O
patient	NN	O
required	VBD	O
100%	CD	B-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
maintain	VB	O
adequate	JJ	O
oxygen	NN	O
saturations	NNS	O
on	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

he	PRP	O
required	VBD	O
elevated	JJ	B-TREATMENT
ventilatory	NN	I-TREATMENT
pressures	NNS	I-TREATMENT
with	IN	O
pips	NNS	B-TEST
often	RB	O
above	IN	O
60	CD	O
.	.	O

fortunately	RB	O
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
baratroma	NN	B-PROBLEM
was	VBD	O
ever	RB	O
discerned	VBN	O
.	.	O

however	RB	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
respiratory	NN	O
status	NN	O
continued	VBD	O
to	TO	O
decline	VB	O
and	CC	O
we	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
maintain	VB	O
oxygen	JJ	B-TEST
saturations	NNS	I-TEST
above	IN	O
80%	CD	O
even	RB	O
using	VBG	O
reverse	NN	B-TREATMENT
i	NN	I-TREATMENT
to	TO	I-TREATMENT
e	VB	I-TREATMENT
ventilation	NN	I-TREATMENT
,	,	O
paralysis	NN	B-TREATMENT
,	,	O
sedation	NN	B-TREATMENT
,	,	O
and	CC	O
other	JJ	B-TREATMENT
modes	NNS	I-TREATMENT
of	IN	I-TREATMENT
ventilation	NN	I-TREATMENT
.	.	O

patient	JJ	O
underwent	JJ	O
liver	NN	B-TEST
biopsy	NN	I-TEST
on	IN	O
02/16/91	CD	O
and	CC	O
the	DT	O
results	NNS	O
of	IN	O
this	DT	O
were	VBD	O
pending	VBG	O
when	WRB	O
the	DT	O
patient	NN	O
died	VBD	O
.	.	O

the	DT	O
patient	NN	O
actually	RB	O
developed	VBD	O
decreasing	VBG	B-PROBLEM
counts	NNS	I-PROBLEM
with	IN	O
white	JJ	B-TEST
count	NN	I-TEST
as	RB	O
low	JJ	O
as	IN	O
1.75	CD	O
,	,	O
hematocrit	NN	B-TEST
as	RB	O
low	JJ	O
as	IN	O
26	CD	O
,	,	O
and	CC	O
platelets	NNS	B-TEST
as	RB	O
low	JJ	O
as	IN	O
68	CD	O
noted	VBD	O
on	IN	O
02/15/91	CD	O
.	.	O

these	DT	O
were	VBD	O
supported	VBN	O
with	IN	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
and	CC	O
hematology	NN	O
was	VBD	O
consulted	VBN	O
.	.	O

they	PRP	O
felt	VBD	O
that	IN	O
it	PRP	O
was	VBD	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
bactrim	VB	B-TREATMENT
and	CC	O
these	DT	O
actually	RB	O
were	VBD	O
getting	VBG	O
better	RB	O
when	WRB	O
the	DT	O
patient	NN	O
died	VBD	O
.	.	O

bone	NN	B-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
was	VBD	O
not	RB	O
attempted	VBN	O
.	.	O

discussions	NNS	O
were	VBD	O
begun	VBN	O
with	IN	O
the	DT	O
family	NN	O
regarding	VBG	O
limits	NNS	O
of	IN	O
supportive	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

due	JJ	O
to	TO	O
continued	VB	B-PROBLEM
worsening	VBG	I-PROBLEM
pulmonary	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
an	DT	O
overall	JJ	O
grim	JJ	O
prognosis	NN	O
,	,	O
the	DT	O
family	NN	O
decided	VBD	O
,	,	O
in	IN	O
consultation	NN	O
with	IN	O
the	DT	O
medical	JJ	O
team	NN	O
,	,	O
to	TO	O
withdraw	VB	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

patient	NN	O
expired	VBD	O
after	IN	O
the	DT	B-TREATMENT
endotracheal	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
withdrawn	VBN	O
at	IN	O
6:40	CD	O
p.m.	NN	O

an	DT	B-TEST
autopsy	NN	I-TEST
will	MD	O
be	VB	O
performed	VBN	O
.	.	O

an	DT	B-TEST
autopsy	NN	I-TEST
was	VBD	O
performed	VBN	O
as	IN	O
per	IN	O
the	DT	O
family	NN	O
&apos;s	NN	O
wishes	NNS	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
hematuria	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
daughtersvillshamen&apos;s	VB	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
linkethore	RB	O
,	,	O
hansverllen	VBN	O
g	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
hematuria	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
71-year-old	JJ	O
police	NN	O
chief	NN	O
who	WP	O
presents	VBZ	O
with	IN	O
painless	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
x1	NNP	O
day	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
generally	RB	O
in	IN	O
excellent	JJ	O
health	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
only	RB	O
for	IN	O
noninsulin	JJ	B-PROBLEM
dependent	JJ	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NNS	I-PROBLEM
who	WP	O
was	VBD	O
presented	VBN	O
with	IN	O
painless	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
x2	NNP	O
days	NNS	O
.	.	O

he	PRP	O
also	RB	O
noted	VBD	O
a	DT	B-PROBLEM
23	CD	I-PROBLEM
pound	NN	I-PROBLEM
weight	VBD	I-PROBLEM
loss	NN	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
11	CD	O
months	NNS	O
despite	IN	O
having	VBG	O
an	DT	B-PROBLEM
increased	VBN	I-PROBLEM
appetite	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
complained	VBD	O
of	IN	O
fatigue	NN	B-PROBLEM
and	CC	O
&quot;	NN	B-PROBLEM
feeling	VBG	I-PROBLEM
down	RP	I-PROBLEM
&quot;	NNP	I-PROBLEM
.	.	O

his	PRP$	O
wife	NN	O
noted	VBD	O
personality	NN	B-PROBLEM
changes	NNS	I-PROBLEM
with	IN	O
increased	JJ	B-PROBLEM
irritability	NN	I-PROBLEM
.	.	O

patient	JJ	O
denies	NNS	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
month	NN	O
.	.	O

the	DT	O
patient	NN	O
denies	VBZ	O
melena	RBS	B-PROBLEM
,	,	O
hematochezia	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
states	VBZ	O
that	IN	O
he	PRP	O
is	VBZ	O
occasionally	RB	B-PROBLEM
constipated	VBN	I-PROBLEM
.	.	O

also	RB	O
denies	VBZ	O
tenesmus	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
family	NN	O
noted	VBD	O
that	IN	O
&quot;	NN	O
he	PRP	O
looked	VBD	O
yellow	JJ	B-PROBLEM
&quot;	NN	O
and	CC	O
presented	VBN	O
to	TO	O
the	DT	O
lorough	JJ	O
medical	JJ	O
center	NN	O
&apos;s	NNP	O
emergency	NN	O
department	NN	O
this	DT	O
after	IN	O
noon	NN	O
.	.	O

1.	CD	O
type	NN	B-PROBLEM
ii	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
diagnosed	VBD	O
06/94	CD	O
,	,	O
well-controlled	JJ	O
with	IN	O
last	JJ	B-TEST
hemoglobin	NN	I-TEST
a1c	VBD	I-TEST
6.2	CD	O

2.	CD	O
vocal	JJ	B-PROBLEM
cord	NN	I-PROBLEM
polyps	NNS	I-PROBLEM

3.	CD	O
question	NN	O
of	IN	O
history	NN	O
of	IN	O
avn	NN	B-PROBLEM
or	CC	O
osseous	JJ	B-PROBLEM
necrosis	NN	I-PROBLEM

4.	CD	O
history	NN	O
of	IN	O
hyperkalemia	NN	B-PROBLEM
.	.	O

question	NN	O
rta	NN	B-PROBLEM
type	NN	I-PROBLEM
4	CD	I-PROBLEM

glucotrol	NN	B-TREATMENT
10	CD	O
q.a.m.	NN	O
and	CC	O
vitamins	NNS	B-TREATMENT

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
msg	VB	O
from	IN	O
which	WDT	O
he	PRP	O
gets	VBZ	O
hives	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NN	O
father	NN	O
died	VBD	O
at	IN	O
the	DT	O
age	NN	O
of	IN	O
83	CD	O
of	IN	O
chf	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
with	IN	O
a	DT	O
complaint	NN	O
of	IN	O
painless	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
,	,	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
,	,	O
and	CC	O
fatigue	NN	B-PROBLEM
.	.	O

abdominal	JJ	B-TEST
ct	NN	I-TEST
while	IN	O
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
revealed	VBD	O
likely	JJ	O
primary	JJ	B-PROBLEM
colorectal	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
with	IN	O
multiple	JJ	B-PROBLEM
liver	NN	I-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
24	CD	O
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
two	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
and	CC	O
the	DT	B-TEST
hematocrit	NN	I-TEST
rose	VBD	O
to	TO	O
30	CD	O
the	DT	O
following	JJ	O
day	NN	O
.	.	O

biopsy	NN	B-TEST
was	VBD	O
taken	VBN	O
at	IN	O
colonoscopy	NN	B-TEST
on	IN	O
7/5/99	CD	O
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
was	VBD	O
done	VBN	O
with	IN	O
final	JJ	O
results	NNS	O
pending	VBG	O
on	IN	O
discharge	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
to	TO	O
follow-up	JJ	O
with	IN	O
the	DT	O
petersly	JJ	O
hospital	NN	O
and	CC	O
medical	JJ	O
center	NN	O
as	IN	O
an	DT	O
outpatient	NN	O
for	IN	O
further	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

his	PRP$	O
condition	NN	O
is	VBZ	O
stable	JJ	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
with	IN	O
the	DT	B-TREATMENT
following	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
:	:	O

iron	NN	B-TREATMENT
300	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
glucotrol	NN	B-TREATMENT
,	,	O
acel	RB	B-TREATMENT
10	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
and	CC	O
bactrim	JJ	B-TREATMENT
ss	NN	I-TREATMENT
1	CD	O
tablet	NN	O
p.o.	NN	O
b.i.d.	NN	O

ovarian	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
,	,	O
asthma	NN	B-PROBLEM
,	,	O
obesity	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
heart	NN	B-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
hemorrhoids	NNS	B-PROBLEM
,	,	O
whooping	VBG	B-PROBLEM
cough	NN	I-PROBLEM
as	IN	O
a	DT	O
child	NN	O
.	.	O

total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingooophorectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
omentectomy	NN	B-TREATMENT
,	,	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
removal	NN	B-TREATMENT
of	IN	O
mass	NN	B-PROBLEM
from	IN	O
surface	NN	O
of	IN	O
transverse	JJ	O
colon	NN	O
.	.	O

64-year-old	JJ	O
g5p5	NN	O
postmenopausal	NN	O
for	IN	O
10	CD	O
years	NNS	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
two	CD	O
months	NNS	O
of	IN	O
progressive	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
distention	NN	I-PROBLEM
,	,	O
crampy	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
urinary	JJ	B-PROBLEM
frequency	NN	I-PROBLEM
and	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
not	RB	O
obtained	VBN	O
gynecologic	NNS	B-TREATMENT
care	NN	I-TREATMENT
for	IN	O
32	CD	O
years	NNS	O
until	IN	O
april	JJ	O
2004	CD	O
when	WRB	O
an	DT	O
increase	NN	O
in	IN	O
abdominal	JJ	B-PROBLEM
gerd	NN	I-PROBLEM
and	CC	O
urinary	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
lead	VBP	O
her	PRP$	O
to	TO	O
initial	JJ	O
consultation	NN	O
with	IN	O
dr.	JJ	O
lentny	NN	O
farstnappsshee	NN	O
in	IN	O
gobrew	JJ	O
street	NN	O
,	,	O
denlandcobridclevena	NN	O
,	,	O
west	JJ	O
virginia	NN	O
28880	CD	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
a	DT	B-TEST
pelvic	JJ	I-TEST
ultrasound	NN	I-TEST
was	VBD	O
performed	VBN	O
showing	VBG	O
extensive	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
and	CC	O
clear	JJ	B-PROBLEM
mass	NN	I-PROBLEM
within	IN	O
the	DT	O
pelvi-abdominal	JJ	O
cavity	NN	O
.	.	O

mri	NN	B-TEST
showed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
filled	VBN	I-PROBLEM
abdomen	NNS	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
relatively	RB	I-PROBLEM
small	JJ	I-PROBLEM
mass	NN	I-PROBLEM
measuring	VBG	O
about	RB	O
5	CD	O
to	TO	O
6	CD	O
cm	NN	O
in	IN	O
the	DT	O
right	JJ	O
pelvis	NN	O
.	.	O

at	IN	O
this	DT	O
point	NN	O
she	PRP	O
had	VBD	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
ca	MD	I-PROBLEM
125	CD	O
at	IN	O
440	CD	O
and	CC	O
came	VBD	O
to	TO	O
dr.	VB	O
chabechird	NN	O
for	IN	O
further	JJ	O
consultation	NN	O
.	.	O

hypertension	NN	B-PROBLEM
,	,	O
asthma	NN	B-PROBLEM
for	IN	O
10	CD	O
years	NNS	O
,	,	O
no	DT	O
hospitalizations	NNS	B-TREATMENT
,	,	O
obesity	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
heart	NN	B-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
hemorrhoids	NNS	B-PROBLEM
and	CC	O
whooping	JJ	B-PROBLEM
cough	NN	I-PROBLEM
as	IN	O
a	DT	O
child	NN	O
.	.	O

tonsillectomy	NN	B-TREATMENT
in	IN	O
1947	CD	O
,	,	O
removal	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
renal	JJ	I-PROBLEM
calculus	NN	I-PROBLEM
in	IN	O
1979	CD	O
,	,	O
cholecystectomy	NN	B-TREATMENT
in	IN	O
1986	CD	O
.	.	O

g5	NN	O
,	,	O
p5	NN	O
normal	JJ	O
pap	NN	O
smears	NNS	O
,	,	O
sexual	JJ	O
active	JJ	O
without	IN	O
dyspareunia	NN	B-PROBLEM
.	.	O

no	DT	O
regular	JJ	B-TEST
breast	NN	I-TEST
self	NN	I-TEST
examination	NN	I-TEST
,	,	O
has	VBZ	O
not	RB	O
had	VBN	O
a	DT	B-TEST
mammogram	NN	I-TEST
.	.	O

included	VBN	O
prinzide	RB	B-TREATMENT
12.5	CD	O
mg	NNS	O
po	JJ	O
daily	RB	O
,	,	O
albuterol	VB	B-TREATMENT
inhaler	NN	I-TREATMENT
prn	NN	O

demerol	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
ulceration	NN	B-PROBLEM
after	IN	O
im	JJ	B-TREATMENT
injection	NN	I-TREATMENT
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
food	NN	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
raw	VB	O
vegetables	NNS	O
as	RB	O
well	RB	O
as	IN	O
some	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
throat	NN	B-PROBLEM
constriction	NN	I-PROBLEM
with	IN	O
shrimp	NN	O
.	.	O

remarkable	JJ	O
for	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
her	PRP$	O
mother	NN	O
and	CC	O
maternal	JJ	O
grandfather	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
05/16/2004	CD	O
for	IN	O
bowel	NN	B-TREATMENT
preparation	NN	I-TREATMENT
before	IN	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

on	IN	O
05/17/2004	CD	O
the	DT	O
patient	NN	O
underwent	JJ	O
atotal	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingooophorectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
omentectomy	NN	B-TREATMENT
,	,	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
removal	NN	B-TREATMENT
of	IN	O
mass	NN	B-PROBLEM
from	IN	O
surface	NN	O
of	IN	O
transverse	JJ	O
colon	NN	O
.	.	O

the	DT	O
report	NN	O
from	IN	O
the	DT	B-TEST
frozen	JJ	I-TEST
section	NN	I-TEST
sent	VBN	O
in	IN	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
came	VBD	O
back	RB	O
with	IN	O
poorly	RB	B-PROBLEM
differentiated	VBN	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
,	,	O
possibly	RB	O
serous	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
ovary	JJ	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
postoperative	JJ	O
recovery	NN	O
room	NN	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
29.2	CD	O
with	IN	O
low	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
1	CD	O
unit	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cell	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
subsequently	RB	O
increased	VBD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
without	IN	O
any	DT	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
urine	JJ	I-TEST
culture	NN	I-TEST
came	VBD	O
back	RB	O
with	IN	O
moderate	JJ	B-PROBLEM
e.	NN	I-PROBLEM
coli	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
500	CD	O
mg	NN	O
po	JJ	O
daily	RB	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
,	,	O
her	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
port	NN	I-TREATMENT
placed	VBN	O
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
one	CD	O
episode	NN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

achest	RB	B-TEST
x-ray	NN	I-TEST
done	VBN	O
at	IN	O
that	DT	O
time	NN	O
showed	VBD	O
left	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
small	JJ	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
not	RB	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
consolidations	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
her	PRP	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
and	CC	O
she	PRP	O
maintained	VBD	O
a	DT	O
good	JJ	O
urine	NN	B-TEST
output	NN	I-TEST
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
nausea	NN	B-PROBLEM
with	IN	O
some	DT	B-PROBLEM
emesis	NN	I-PROBLEM
,	,	O
after	IN	O
being	VBG	O
treated	VBN	O
with	IN	O
zofran	NN	B-TREATMENT
with	IN	O
no	DT	B-PROBLEM
relief	NN	I-PROBLEM
,	,	O
a	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
which	WDT	O
drained	VBD	O
1200	CD	O
cc	NN	O
of	IN	O
bilious	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
four	CD	O
,	,	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
have	VB	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
done	VBN	O
for	IN	O
dyspnea	NN	B-PROBLEM
showed	VBD	O
persistent	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
with	IN	O
atelectasis	NN	B-PROBLEM
versus	NN	O
pneumonia	NN	B-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
levofloxacin	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
nasogastric	JJ	B-TEST
tube	NN	I-TEST
clamping	VBG	I-TEST
trials	NNS	I-TEST
with	IN	O
high	JJ	B-PROBLEM
residuals	NNS	I-PROBLEM
in	IN	O
the	DT	O
600	CD	O
cc	NN	O
range	NN	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
clear	JJ	O
fluids	NNS	O
with	IN	O
a	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
clamped	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
decadron	NN	B-TREATMENT
in	IN	O
preparation	NN	O
for	IN	O
her	PRP$	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
eight	CD	O
which	WDT	O
is	VBZ	O
memorial	JJ	O
day	NN	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
carboplatin-taxolchemo	NN	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
which	WDT	O
she	PRP	O
tolerated	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
nine	CD	O
,	,	O
her	PRP$	B-TREATMENT
jp	NN	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

dilaudid	RB	B-TREATMENT
2	CD	O
to	TO	O
4	CD	O
mg	NNS	O
po	JJ	O
q3h	JJ	O
prn	NN	O
pain	NN	B-PROBLEM
,	,	O
ativan	RB	B-TREATMENT
1	CD	O
mg	NNS	O
po	JJ	O
q12h	JJ	O
prn	NN	O
anxiety	NN	B-PROBLEM
,	,	O
zofran	VBD	B-TREATMENT
8	CD	O
mg	NN	O
po	NN	O
q8h	NN	O
prn	NN	O
nausea	NN	B-PROBLEM
,	,	O
compazine	NN	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
nausea	NN	B-PROBLEM
,	,	O
decadron	NN	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
q6h	NN	O
x	VBD	O
2	CD	O
doses	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
take	VB	O
20	CD	O
mg	NNS	O
at	IN	O
11	CD	O
pm	NN	O
the	DT	O
night	NN	O
before	IN	O
her	PRP$	B-TREATMENT
next	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
and	CC	O
8	CD	O
am	VBP	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
chemotherapy	NN	B-TREATMENT
.	.	O

colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
,	,	O
albuterol	NN	B-TREATMENT
inhalers	NNS	I-TREATMENT
two	CD	O
puffs	NNS	O
inhaled	VBD	O
qid	JJ	O
prn	NN	O
wheezing	NN	B-PROBLEM
and	CC	O
asthma	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
told	VBN	O
to	TO	O
make	VB	O
an	DT	O
appointment	NN	O
two	CD	O
weeks	NNS	O
after	IN	O
her	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
removal	NN	B-TREATMENT
of	IN	O
her	PRP$	B-TREATMENT
retention	NN	I-TREATMENT
sutures	NNS	I-TREATMENT
.	.	O

pancreatic	JJ	B-PROBLEM
cancer	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
for	IN	O
a	DT	O
second	JJ	O
opinion	NN	O
regarding	VBG	O
workup	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
pancreatic	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
61	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
,	,	O
and	CC	O
asthma	NN	B-PROBLEM
who	WP	O
was	VBD	O
diagnosed	VBN	O
recently	RB	O
with	IN	O
pancreatic	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
after	IN	O
he	PRP	O
presented	VBD	O
to	TO	O
seph&apos;sju	VB	O
memorial	JJ	O
after	IN	O
a	DT	O
motor	NN	O
vehicle	NN	O
accident	NN	O
.	.	O

chest	NN	B-TEST
ct	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

abdominal	JJ	B-TEST
ct	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
3.0	CD	I-PROBLEM
to	TO	I-PROBLEM
4.0	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pancreatic	JJ	I-PROBLEM
head	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
ercp	NN	I-TEST
performed	VBD	O
there	EX	O
showed	VBD	O
a	DT	B-PROBLEM
long	JJ	I-PROBLEM
segment	NN	I-PROBLEM
of	IN	I-PROBLEM
distal	JJ	I-PROBLEM
narrowing	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
common	JJ	I-PROBLEM
bileduct	NN	I-PROBLEM
and	CC	O
a	DT	B-TREATMENT
transhepatic	JJ	I-TREATMENT
biliary	NN	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
there	RB	O
on	IN	O
december	NN	O
29	CD	O
.	.	O

on	IN	O
january	JJ	O
1	CD	O
,	,	O
a	DT	B-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
for	IN	O
a	DT	B-PROBLEM
loculated	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

on	IN	O
january	JJ	O
2	CD	O
,	,	O
pleurodesis	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

on	IN	O
january	JJ	O
4	CD	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
desaturation	NN	I-PROBLEM
.	.	O

vq	NN	B-TEST
was	VBD	O
indeterminate	NN	O
.	.	O

lenis	NN	B-TEST
were	VBD	O
negative	JJ	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

on	IN	O
january	JJ	O
5	CD	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
chest	JJ	I-TEST
xray	NN	I-TEST
with	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
apicalpneumothorax	NN	I-PROBLEM
but	CC	O
was	VBD	O
stable	JJ	O
on	IN	O
chest	JJS	B-TEST
xray	NN	I-TEST
of	IN	O
january	JJ	O
7	CD	O
.	.	O

brain	NN	B-TEST
ct	NN	I-TEST
was	VBD	O
negative	JJ	O
,	,	O
as	IN	O
was	VBD	O
a	DT	B-TEST
bronchoscopy	NN	I-TEST
with	IN	O
lavage	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
ca99	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
reported	VBN	O
an	DT	O
approximately	RB	O
30	CD	B-PROBLEM
pound	NN	I-PROBLEM
weight	VBD	I-PROBLEM
loss	NN	I-PROBLEM
in	IN	I-PROBLEM
six	CD	I-PROBLEM
weeks	NNS	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
experienced	VBN	O
some	DT	B-PROBLEM
constipation	NN	I-PROBLEM
for	IN	O
the	DT	O
few	JJ	O
months	NNS	O
prior	RB	O
with	IN	O
lighter	JJR	B-PROBLEM
colored	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
darkened	VBN	B-PROBLEM
urine	NN	I-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
for	IN	O
months	NNS	O
with	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
orthopnea	NN	B-PROBLEM
and	CC	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

he	PRP	O
denied	VBD	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
or	CC	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
recently	RB	B-PROBLEM
diagnosed	VBN	I-PROBLEM
pancreatic	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

diabetes	NNS	B-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

gout	NN	B-PROBLEM
.	.	O

hypercholesterolemia	NN	B-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

asthma	NN	B-PROBLEM
.	.	O

hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
.	.	O

psoriasis	NN	B-PROBLEM
.	.	O

lasix	NN	B-TREATMENT
,	,	O
80	CD	O
;	:	O
avandia	NN	B-TREATMENT
,	,	O
4	CD	O
b.i.d.	NN	O
;	:	O
glipizide	NN	B-TREATMENT
,	,	O
10	CD	O
b.i.d.;	NN	O
imdur	NN	B-TREATMENT
,	,	O
30	CD	O
;	:	O
allopurinol	NN	B-TREATMENT
;	:	O
zocor	NN	B-TREATMENT
,	,	O
20	CD	O
;	:	O
prilosec	NN	B-TREATMENT
,	,	O
20	CD	O
,	,	O
potassium	NN	B-TREATMENT
,	,	O
40	CD	O
;	:	O
oxycontin	NN	B-TREATMENT
,	,	O
30	CD	O
b.i.d.;	NN	O
subcutaneous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
;	:	O
unasyn	JJ	B-TREATMENT
,	,	O
1.5	CD	O
grams	NNS	O
q	RB	O
6	CD	O
;	:	O
combivent	NN	B-TREATMENT
and	CC	O
morphine	NN	B-TREATMENT
prn	NN	O
.	.	O

mother	NN	O
and	CC	O
father	NN	O
died	VBD	O
of	IN	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

theyalso	NN	O
had	VBD	O
diabetes	NNS	B-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

sister	NN	O
with	IN	O
stomach	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
78	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
98/50	CD	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
32	CD	O
,	,	O
satting	VBG	B-TEST
91%	CD	O
on	IN	O
four	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

in	IN	O
general	JJ	O
,	,	O
this	DT	O
is	VBZ	O
an	DT	O
obese	JJ	O
male	NN	O
in	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

neck	NN	O
was	VBD	O
supple	JJ	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

heent	NN	O
-	:	O
normocephalic	JJ	O
/	NNP	O
atraumatic	NN	B-PROBLEM
,	,	O
extraocular	JJ	O
movements	NNS	O
are	VBP	O
intact	JJ	O
,	,	O
pupils	JJ	O
equal	JJ	O
,	,	O
round	NN	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
.	.	O

chest	NN	O
had	VBD	O
diffuse	NN	B-PROBLEM
crackles	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
halfway	VBP	O
up	RP	O
.	.	O

coronary	JJ	O
-	:	O
irregular	JJ	B-PROBLEM
pvcs	NN	I-PROBLEM
,	,	O
s1	NN	O
,	,	O
s2	NN	O
normal	JJ	O
,	,	O
positive	JJ	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
radiating	VBG	O
throughout	IN	O
.	.	O

abdomen	NNS	O
was	VBD	O
distended	VBN	B-PROBLEM
,	,	O
tympanitic	JJ	B-PROBLEM
,	,	O
mildly	RB	B-PROBLEM
tender	NN	I-PROBLEM
epigastrium	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
quadrant	NN	I-PROBLEM
.	.	O

no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

extremities	NNS	O
had	VBD	O
2+	CD	B-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
knees	NNS	I-PROBLEM
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
or	CC	O
cyanosis	NN	B-PROBLEM
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
-	:	O
alert	NN	O
and	CC	O
oriented	VBD	O
x	NNP	O
3	CD	O
,	,	O
slurred	VBN	B-PROBLEM
and	CC	I-PROBLEM
slow	JJ	I-PROBLEM
speech	NN	I-PROBLEM
,	,	O
distractable	JJ	B-PROBLEM
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
4.36	CD	O
,	,	O
hematocrit	VBD	B-TEST
26.1	CD	O
with	IN	O
platelets	NNS	B-TEST
of	IN	O
107,000	CD	O
,	,	O
mcv	VBD	B-TEST
81	CD	O
.	.	O

sodium	NN	B-TEST
137	CD	O
,	,	O
potassium	NN	B-TEST
4.5	CD	O
,	,	O
chloride97	NN	B-TEST
,	,	O
bicarb	NN	B-TEST
24	CD	O
,	,	O
bun	NN	B-TEST
124	CD	O
,	,	O
creatinine	NN	B-TEST
4.1	CD	O
,	,	O
glucose	RB	B-TEST
144	CD	O
,	,	O
ast	RB	B-TEST
49	CD	O
,	,	O
alt33	NN	B-TEST
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
253	CD	O
,	,	O
total	JJ	B-TEST
bili	NN	I-TEST
1.6	CD	O
,	,	O
calcium	NN	B-TEST
9.2	CD	O
,	,	O
magnesium	NN	B-TEST
2.3	CD	O
,	,	O
albumin	RB	B-TEST
3.4	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
bilirubin	NN	I-PROBLEM
on	IN	O
admission	NN	O
with	IN	O
decreased	JJ	B-PROBLEM
output	NN	I-PROBLEM
of	IN	O
biliary	JJ	B-TREATMENT
drain	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
replaced	VBN	O
over	IN	O
the	DT	O
wire	NN	O
,	,	O
8-10	JJ	O
by	IN	O
ir	NN	O
,	,	O
when	WRB	O
it	PRP	O
was	VBD	O
accidentally	RB	O
removed	VBN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
signs	NNS	B-PROBLEM
and	CC	O
symptoms	NNS	B-PROBLEM
develop	VB	O
of	IN	O
sbp	NN	B-PROBLEM
,	,	O
also	RB	O
with	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
white	JJ	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
broadly	RB	O
with	IN	O
amp	NN	B-TREATMENT
,	,	O
levo	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

cultures	NNS	B-TEST
were	VBD	O
negative	JJ	O
and	CC	O
onlyon	JJ	O
one	CD	B-TEST
gram	NN	I-TEST
stain	NN	I-TEST
did	VBD	O
it	PRP	O
show	VB	O
rare	JJ	B-PROBLEM
gram	NN	I-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
abdominal	JJ	I-TEST
fluid	NN	I-TEST
cell	NN	I-TEST
counts	VBZ	I-TEST
showed	JJ	O
2400	CD	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
,	,	O
500	CD	O
red	JJ	B-TEST
cells	NNS	I-TEST
with	IN	O
82	CD	O
polyps	NNS	B-TEST
,	,	O
11	CD	O
lymphs	NN	B-TEST
,	,	O
7	CD	O
monos	NNS	B-TEST
.	.	O

clinically	RB	O
,	,	O
this	DT	O
was	VBD	O
consistent	JJ	O
with	IN	O
sbp	NN	B-PROBLEM
,	,	O
although	IN	O
unfortunately	RB	O
,	,	O
fluid	NN	O
was	VBD	O
never	RB	O
sent	VBN	O
for	IN	O
cytology	NN	B-TEST
and	CC	O
a	DT	O
lot	NN	O
of	IN	O
those	DT	B-PROBLEM
white	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
are	VBP	O
most	RBS	O
likely	JJ	O
due	JJ	O
to	TO	O
his	PRP$	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

he	PRP	B-TREATMENT
underwent	VBD	I-TREATMENT
abdominal	JJ	I-TREATMENT
paracentesis	NN	I-TREATMENT
approximately	RB	O
two	CD	O
times	NNS	O
a	DT	O
week	NN	O
for	IN	O
therapeutic	JJ	O
.	.	O

this	DT	O
had	VBD	O
to	TO	O
be	VB	O
performed	VBN	O
by	IN	O
ir	NN	O
because	IN	O
the	DT	B-PROBLEM
pocket	NN	I-PROBLEM
was	VBD	O
too	RB	O
deep	JJ	O
to	TO	O
access	NN	O
from	IN	O
the	DT	O
bedside	NN	O
.	.	O

he	PRP	O
received	VBD	O
a	DT	O
two	CD	O
week	NN	O
course	NN	O
of	IN	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
and	CC	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
iv	NN	I-TREATMENT
for	IN	O
prophylaxis	NN	B-TREATMENT
against	IN	O
sbp	NN	B-PROBLEM
.	.	O

from	IN	O
a	DT	O
pulmonary	JJ	O
standpoint	NN	O
,	,	O
he	PRP	O
continued	VBD	O
to	TO	O
complain	VB	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

his	PRP$	B-PROBLEM
apical	JJ	I-PROBLEM
pneumothorax	NN	I-PROBLEM
from	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
had	VBD	O
resolved	VBN	O
.	.	O

chest	JJS	B-TEST
xray	NN	I-TEST
was	VBD	O
consistent	JJ	O
with	IN	O
pleurodesis	NN	B-PROBLEM
.	.	O

however	RB	O
,	,	O
with	IN	O
persistent	JJ	B-PROBLEM
abdomen	NNS	I-PROBLEM
distention	NN	I-PROBLEM
,	,	O
there	EX	O
is	VBZ	O
likely	JJ	O
restrictive	JJ	B-PROBLEM
deficit	NN	I-PROBLEM
and	CC	O
,	,	O
in	IN	O
addition	NN	O
,	,	O
after	IN	O
each	DT	O
tap	NN	B-TEST
,	,	O
he	PRP	O
at	IN	O
times	NNS	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
and	CC	O
with	IN	O
some	DT	B-TREATMENT
mild	JJ	I-TREATMENT
fluid	JJ	I-TREATMENT
resuscitation	NN	I-TREATMENT
decompensated	VBN	O
with	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
,	,	O
requiring	VBG	O
both	DT	O
albumin	NN	B-TREATMENT
and	CC	O
lasix	NN	B-TREATMENT
to	TO	O
try	VB	O
to	TO	O
mobilize	VB	O
third	JJ	B-PROBLEM
space	NN	I-PROBLEM
fluids	NNS	I-PROBLEM
.	.	O

chest	NN	B-TEST
xray	NN	I-TEST
is	VBZ	O
still	RB	O
consistent	JJ	O
with	IN	O
volume	NN	B-PROBLEM
overload	NN	I-PROBLEM
.	.	O

the	DT	O
plan	NN	O
will	MD	O
be	VB	O
to	TO	O
continue	VB	O
to	TO	O
try	VB	O
to	TO	O
alternate	VB	O
albumin	NN	B-TREATMENT
and	CC	O
lasix	NN	B-TREATMENT
to	TO	O
mobilize	VB	O
his	PRP$	B-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
episodes	NNS	O
of	IN	O
bradycardia	NN	B-PROBLEM
without	IN	O
subsequent	JJ	B-PROBLEM
fall	NN	I-PROBLEM
in	IN	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
at	IN	O
the	DT	O
beginning	NN	O
of	IN	O
his	PRP$	O
admission	NN	O
.	.	O

he	PRP	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

echocardiogram	NN	B-TEST
showed	VBD	O
50%	CD	O
ejection	NN	O
fraction	NN	O
with	IN	O
mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

he	PRP	O
did	VBD	O
not	RB	O
show	VB	O
any	DT	O
episodes	NNS	O
of	IN	O
bradycardia	NN	B-PROBLEM
throughout	IN	O
the	DT	O
remainder	NN	O
of	IN	O
his	PRP$	B-TREATMENT
hospital	NN	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

diabetes	NNS	B-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
avandia	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
side	NN	I-PROBLEM
effect	NN	I-PROBLEM
profile	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
on	IN	O
glipizide	NN	B-TREATMENT
and	CC	O
sliding	VBG	B-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
.	.	O

from	IN	O
a	DT	O
heme	NN	O
standpoint	NN	O
,	,	O
he	PRP	O
presented	VBD	O
anemic	JJ	B-PROBLEM
and	CC	O
with	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
pt	NN	I-PROBLEM
inr	NN	I-PROBLEM
.	.	O

he	PRP	O
required	VBD	O
a	DT	B-TREATMENT
few	JJ	I-TREATMENT
transfusions	NNS	I-TREATMENT
during	IN	O
his	PRP$	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

he	PRP	O
also	RB	O
required	VBD	O
ffp	RB	B-TREATMENT
initially	RB	O
to	TO	O
reverse	VB	O
his	PRP$	B-PROBLEM
coagulopathy	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
this	DT	O
resolved	VBN	O
on	IN	O
its	PRP$	O
own	JJ	O
over	IN	O
the	DT	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
inr	NN	I-TEST
normalized	VBN	O
,	,	O
however	RB	O
,	,	O
unfortunately	RB	O
,	,	O
he	PRP	O
developed	VBD	O
bilateral	JJ	B-PROBLEM
deep	RB	I-PROBLEM
venous	JJ	I-PROBLEM
thromboses	NNS	I-PROBLEM
during	IN	O
his	PRP$	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
and	CC	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
lovenox	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
4.0	CD	O
on	IN	O
admission	NN	O
and	CC	O
this	DT	O
decreased	VBD	O
down	RB	O
to	TO	O
the	DT	O
mid	JJ	O
ones	NNS	O
with	IN	O
fluid	NN	B-TREATMENT
,	,	O
currently	RB	O
at	IN	O
1.7	CD	O
on	IN	O
discharge	NN	O
.	.	O

from	IN	O
his	PRP$	B-TEST
urinalysis	NN	I-TEST
,	,	O
he	PRP	O
has	VBZ	O
mostly	RB	O
a	DT	B-PROBLEM
prerenal	JJ	I-PROBLEM
state	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
he	PRP	O
does	VBZ	O
require	VB	O
diuresis	NN	B-TREATMENT
to	TO	O
prevent	VB	O
increased	JJ	B-PROBLEM
volume	NN	I-PROBLEM
overload	NN	I-PROBLEM
in	IN	O
his	PRP$	O
lungs	NNS	O
from	IN	O
his	PRP$	B-PROBLEM
hypoalbunemic	JJ	I-PROBLEM
state	NN	I-PROBLEM
.	.	O

his	PRP$	O
appetite	NN	O
is	VBZ	O
decreasing	VBG	O
somewhat	RB	O
as	IN	O
his	PRP$	B-PROBLEM
disease	NN	I-PROBLEM
process	NN	I-PROBLEM
progresses	VBZ	O
,	,	O
therefore	RB	O
,	,	O
we	PRP	O
have	VBP	O
liberalized	VBN	O
his	PRP$	O
diet	NN	O
for	IN	O
him	PRP	O
to	TO	O
take	VB	O
what	WP	O
he	PRP	O
wishes	VBZ	O
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
for	IN	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
for	IN	O
clinical	JJ	B-PROBLEM
sbp	NN	I-PROBLEM
.	.	O

he	PRP	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
for	IN	O
prophylaxis	NN	B-TREATMENT
against	IN	O
sbp	NN	B-PROBLEM
.	.	O

given	VBN	O
that	IN	O
he	PRP	O
will	MD	O
need	VB	O
continued	JJ	B-TEST
taps,	NN	I-TEST

the	DT	O
patient	NN	O
initially	RB	O
came	VBD	O
for	IN	O
workup	NN	B-TEST
of	IN	O
pancreatic	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
a	DT	O
questions	NNS	O
of	IN	O
palliative	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
given	VBN	O
his	PRP$	B-PROBLEM
rapid	JJ	I-PROBLEM
clinical	JJ	I-PROBLEM
decline	NN	I-PROBLEM
,	,	O
this	DT	O
was	VBD	O
deferred	VBN	O
and	CC	O
i	VB	O
do	VBP	O
not	RB	O
suspect	VB	O
that	IN	O
he	PRP	O
will	MD	O
be	VB	O
a	DT	O
candidate	NN	O
for	IN	O
this	DT	O
,	,	O
as	IN	O
the	DT	O
degree	NN	O
of	IN	O
his	PRP$	B-PROBLEM
decline	NN	I-PROBLEM
bodes	VBZ	O
a	DT	O
poor	JJ	O
prognosis	NN	O
for	IN	O
him	PRP	O
.	.	O

his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
here	RB	O
has	VBZ	O
been	VBN	O
controlled	VBN	O
,	,	O
initially	RB	O
on	IN	O
oxycontin	NN	B-TREATMENT
with	IN	O
morphine	NN	B-TREATMENT
for	IN	O
breakthrough	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

as	IN	O
he	PRP	O
becomes	VBZ	O
progressively	RB	B-PROBLEM
more	RBR	I-PROBLEM
somnolent	JJ	I-PROBLEM
,	,	O
this	DT	O
will	MD	O
likely	RB	O
need	VB	O
to	TO	O
be	VB	O
switched	VBN	O
to	TO	O
iv	VB	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
only	RB	O
.	.	O

discussion	NN	O
,	,	O
at	IN	O
that	DT	O
point	NN	O
in	IN	O
time	NN	O
,	,	O
should	MD	O
occur	VB	O
with	IN	O
the	DT	O
family	NN	O
about	IN	O
comfort	NN	B-TREATMENT
measures	NNS	I-TREATMENT
and	CC	O
about	IN	O
weaning	VBG	O
him	PRP	O
from	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
to	TO	O
make	VB	O
him	PRP	O
more	RBR	O
comfortable	JJ	O
.	.	O

tylenol	NN	B-TREATMENT
,	,	O
650	CD	O
mg	NN	O
p.o.	NN	O
q	VBD	O
4	CD	O
prn	NN	O
;	:	O
allopurinol	CC	B-TREATMENT
,	,	O
100	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
;	:	O
peridex	NN	B-TREATMENT
mouthwash	NN	I-TREATMENT
,	,	O
10	CD	O
ml	NN	O
b.i.d.;	NN	O
cholysteramineresin	NN	B-TREATMENT
,	,	O
4	CD	O
grams	NNS	O
p.o.	JJ	O
q.d.	NN	O
;	:	O
clotrimazole	NN	B-TREATMENT
,	,	O
one	CD	O
troche	NN	O
p.o.	NN	O
q.i.d.	NN	O
;	:	O
fentanyl	JJ	B-TREATMENT
patch	NN	I-TREATMENT
,	,	O
100	CD	O
mcg	NN	O
per	IN	O
hour	NN	O
topical	JJ	O
q	NN	O
72	CD	O
hours	NNS	O
;	:	O
glipizide	VB	B-TREATMENT
,	,	O
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.;	NN	O
atarax	NN	B-TREATMENT
,	,	O
25	CD	O
operating	NN	O
table	NN	O
50	CD	O
mg	NN	O
p.o.	NN	O
q	$	O
6	CD	O
to	TO	O
8	CD	O
hours	NNS	O
prn	JJ	O
itching	NN	B-PROBLEM
;	:	O
regular	JJ	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
;	:	O
kbl	CC	B-TREATMENT
mouthwash	NN	I-TREATMENT
,	,	O
15	CD	O
ccp	NN	O
.o.	NNP	O
q.d.	NN	O
prn	NN	O
mouth	NN	B-PROBLEM
discomfort	NN	I-PROBLEM
;	:	O
lactulose	CC	B-TREATMENT
,	,	O
30	CD	O
ml	NN	O
p.o.	NN	O
q.i.d.	NN	O
that	WDT	O
was	VBD	O
started	VBN	O
on	IN	O
january	JJ	O
30	CD	O
,	,	O
for	IN	O
no	DT	O
bowel	NN	B-PROBLEM
movements	NNS	I-PROBLEM
with	IN	O
instructions	NNS	O
to	TO	O
continue	VB	O
until	IN	O
bowel	JJ	O
movement	NN	O
and	CC	O
then	RB	O
decrease	VB	O
to	TO	O
b.i.d.	VB	O
or	CC	O
q.d.	VB	O
;	:	O
lidocaine	NN	B-TREATMENT
,	,	O
2%	CD	O
,	,	O
10	CD	O
ml	NN	O
ur	JJ	O
q	RB	O
3	CD	O
to	TO	O
4	CD	O
hours	NNS	O
prn	NN	O
for	IN	O
pain	NN	B-PROBLEM
around	IN	I-PROBLEM
foley	JJ	I-PROBLEM
site	NN	I-PROBLEM
;	:	O
ativan	CC	B-TREATMENT
,	,	O
0.25	CD	O
to	TO	O
0.5	CD	O
mg	NNS	O
iv	JJ	O
q	RB	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
prn	JJ	O
anxiety	NN	B-PROBLEM
with	IN	O
instructions	NNS	O
to	TO	O
use	VB	O
caution	NN	O
.	.	O

the	DT	O
patient	JJ	O
gets	VBZ	O
very	RB	B-PROBLEM
somnolent	JJ	I-PROBLEM
with	IN	O
ativan	NN	B-TREATMENT
.	.	O

maalox	NN	B-TREATMENT
plus	CC	I-TREATMENT
,	,	I-TREATMENT
extra	JJ	I-TREATMENT
strength	NN	I-TREATMENT
,	,	O
15	CD	O
cc	NN	O
p.o.	NN	O
q	VBD	O
6	CD	O
hours	NNS	O
prn	JJ	O
indigestion	NN	B-PROBLEM
;	:	O
magnesium	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
;	:	O
sliding	VBG	O
scale	NN	O
iv	NN	O
and	CC	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
,	,	O
sliding	VBG	O
scale	JJ	O
iv	NN	O
.	.	O

he	PRP	O
is	VBZ	O
also	RB	O
on	IN	O
reglan	NN	B-TREATMENT
,	,	O
10	CD	O
mg	NN	O
p.o.	NN	O
q	NN	O
h	NN	O
;	:	O
miracle	CC	B-TREATMENT
topical	JJ	I-TREATMENT
cream	NN	I-TREATMENT
to	TO	O
affected	JJ	B-PROBLEM
area	NN	I-PROBLEM
;	:	O
also	RB	O
sarna	VBP	B-TREATMENT
,	,	I-TREATMENT
topical	JJ	I-TREATMENT
cream	NN	I-TREATMENT
,	,	O
b.i.d.	NN	O

he	PRP	O
has	VBZ	O
nystatin	VBN	B-TREATMENT
suspension	NN	I-TREATMENT
mouthwash	NN	I-TREATMENT
,	,	O
10	CD	O
cc	NN	O
swish	NN	O
and	CC	O
swallow	JJ	O
q.i.d.	NN	O
he	PRP	O
gets	VBZ	O
serax	RB	B-TREATMENT
,	,	O
15	CD	O
to	TO	O
30	CD	O
mg	NNS	O
p.o.	JJ	O
q	JJ	O
h.s.	NN	O
prni	NN	O
nsomnia	NN	B-PROBLEM
.	.	O

ocean	JJ	B-TREATMENT
spray	NN	I-TREATMENT
q.i.d.	NN	O
to	TO	O
nares	NNS	O
prn	VB	O
nasal	JJ	B-PROBLEM
dryness	NN	I-PROBLEM
.	.	O

multivitamin	NN	B-TREATMENT
,	,	O
one	CD	O
tab	NN	O
q.d.	NN	O
morphine	NN	B-TREATMENT
immediate	JJ	I-TREATMENT
release	NN	I-TREATMENT
,	,	O
msir	NN	B-TREATMENT
,	,	O
15	CD	O
to	TO	O
30	CD	O
mg	NNS	O
p.o.	JJ	O
q	RB	O
2	CD	O
to	TO	O
3	CD	O
hours	NNS	O
prn	JJ	O
pain	NN	B-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
also	RB	O
on	IN	O
a	DT	B-TREATMENT
fentanyl	JJ	I-TREATMENT
patch	NN	I-TREATMENT
,	,	O
100	CD	O
mcg	NN	O
q	NN	O
72	CD	O
hours	NNS	O
.	.	O

the	DT	B-TREATMENT
morphine	NN	I-TREATMENT
is	VBZ	O
for	IN	O
breakthrough	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

hydrocortisone	NN	B-TREATMENT
,	,	O
1%	CD	O
topical	JJ	O
cream	NN	O
q	RB	O
6	CD	O
to	TO	O
8	CD	O
hours	NNS	O
prn	JJ	O
itching	NN	B-PROBLEM
.	.	O

levofloxacin	NN	B-TREATMENT
,	,	O
250	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
;	:	O
albuterol	NN	B-TREATMENT
and	CC	I-TREATMENT
atrovent	JJ	I-TREATMENT
nebs	NN	I-TREATMENT
q	VBD	O
4	CD	O
to6	NN	O
hours	NNS	O
as	IN	O
needed	VBN	O
prn	NN	O
wheeze	NN	B-PROBLEM
.	.	O

gastritis	NN	B-PROBLEM

amoxicillin	RB	B-TREATMENT
1,000	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
x	VBZ	O
28	CD	O
doses	NNS	O

for	IN	O
h.pylori	NN	B-PROBLEM
.	.	O

clarithromycin	NN	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
bid	NN	O
x	VBZ	O
28	CD	O
doses	NNS	O

h.pylori	NN	B-TREATMENT
tx	NN	I-TREATMENT
.	.	O

simvastatin	NN	B-TREATMENT
and	CC	O
clarithromycin	NN	B-TREATMENT

simvastatin	NN	B-TREATMENT
and	CC	O
clarithromycin	NN	B-TREATMENT

hydrochlorothiazide	RB	B-TREATMENT
25	CD	O
mg	NNS	O
po	JJ	O
qd	JJ	O
zocor	NN	B-TREATMENT
(	(	I-TREATMENT
simvastatin	NN	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

override	RB	O
added	VBD	O
on	IN	O
01/23/05	CD	O
by	IN	O
dainsaylesnoort	NN	O
,	,	O
ager	NN	O
,	,	O
m.d.	NN	O
,	,	O
ph.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
clarithromycin	NN	B-TREATMENT
po	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
99052380	CD	O
)	)	O

simvastatin	NN	B-TREATMENT
and	CC	O
clarithromycin	NN	B-TREATMENT

simvastatin	NN	B-TREATMENT
and	CC	O
clarithromycin	NN	B-TREATMENT

potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
slow	JJ	I-TREATMENT
rel.	NN	I-TREATMENT
(	(	I-TREATMENT
kcl	JJ	I-TREATMENT
slow	VB	I-TREATMENT
release	NN	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
meq	NN	O
po	NN	O
qd	NN	O
as	IN	O
per	IN	O
sc	NN	O

each	DT	O
20	CD	O
meq	NNS	O
dose	VB	O
to	TO	O
be	VB	O
given	VBN	O
with	IN	O
4	CD	O
oz	NNS	O
of	IN	O
fluid	NN	O
cozaar	NN	B-TREATMENT
(	(	I-TREATMENT
losartan	JJ	I-TREATMENT
)	)	I-TREATMENT
50	CD	O
mg	NN	O
po	NN	O
qd	NN	O

lamictal	NN	B-TREATMENT
(	(	I-TREATMENT
lamotrigine	NN	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

wellbutrin	NN	B-TREATMENT
sr	NN	I-TREATMENT
(	(	I-TREATMENT
bupropion	NN	I-TREATMENT
hcl	NN	I-TREATMENT
sustained	VBD	I-TREATMENT
release	NN	I-TREATMENT
)	)	I-TREATMENT
200	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

esomeprazole	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
x	VBZ	O
28	CD	O
doses	NNS	O

h.	NN	B-TREATMENT
pylori	NN	I-TREATMENT
tx	NN	I-TREATMENT
.	.	O

percocet	NN	B-TREATMENT
,	,	O
iv	JJ	B-TREATMENT
contrast	NN	I-TREATMENT
,	,	O
lisinopril	NN	B-TREATMENT
,	,	O
atenolol	NN	B-TREATMENT

gastritis	NN	B-PROBLEM

principal	JJ	O
discharge	NN	O
diagnosis	NN	O
;	:	O
responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
gastritis	NN	B-PROBLEM

other	JJ	O
diagnosis	NN	O
;	:	O
conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
obesity	NN	B-PROBLEM
htn	VBP	B-PROBLEM
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
tobacco	NN	O
fhx	NN	O
of	IN	O
cad	NN	B-PROBLEM
ett	NN	B-TREATMENT
12/94	CD	O
(	(	O
-	:	O
)	)	O
ischemia	NN	B-PROBLEM
echo	$	B-TEST
02/89	CD	O
nl	JJ	B-TEST
ett	RB	I-TEST
03/89	CD	O
,	,	O
07/90	CD	O
c	NN	O
/	NNP	O
w	NN	O
nd	NN	B-PROBLEM
ische	NN	I-PROBLEM

takes	VBZ	O
hubby	NN	O
&apos;s	NNP	O
sl	NN	B-TREATMENT
ntg	NN	I-TREATMENT
barium	NN	B-TEST
swallow	NN	I-TEST
04/89	CD	O
(	(	O
-	:	O
)	)	O
ugi	VBP	B-TEST
06/91	CD	O
(	(	O
-	:	O
)	)	O

mri	NN	B-TEST
hida	NN	B-TEST
ct	NN	B-TEST

the	DT	O
pt	NN	O
is	VBZ	O
a	DT	O
55yo	JJ	O
f	NN	O
s	NN	O
/	NNP	O
p	NN	O
roux	NN	B-TREATMENT
en	IN	I-TREATMENT
y	NN	I-TREATMENT
gbp	NN	I-TREATMENT
in	IN	O
12/20	CD	O
presenting	NN	O
to	TO	O
the	DT	O
ed	NN	O
this	DT	O
am	VBP	O
c	JJ	O
/	NNP	O
o	MD	O
mod	VB	B-PROBLEM
severe	JJ	I-PROBLEM
midepigastric	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
notes	VBZ	O
that	IN	O
she	PRP	O
has	VBZ	O
had	VBD	O
this	DT	B-PROBLEM
pain	NN	I-PROBLEM
since	IN	O
thursday	NN	O
,	,	O
and	CC	O
that	IN	O
it	PRP	O
becomes	VBZ	O
much	JJ	O
worse	JJR	O
within	IN	O
15	CD	O
min	NN	O
of	IN	O
consuming	VBG	O
a	DT	O
meal	NN	O
.	.	O

she	PRP	O
has	VBZ	O
also	RB	O
had	VBN	O
intermittent	JJ	B-PROBLEM
post-prandial	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
/	NNP	I-PROBLEM
satiety	NN	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
had	VBD	O
been	VBN	O
scheduled	VBN	O
for	IN	O
an	DT	B-TEST
outpt	JJ	I-TEST
egd	NN	I-TEST
with	IN	O
gi	NN	B-TEST
on	IN	O
2/8	CD	O
.	.	O

she	PRP	O
describes	VBZ	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
as	IN	O
band-like	JJ	O
/	NN	O
radiating	NN	O
to	TO	O
both	DT	O
sides	NNS	O
but	CC	O
not	RB	O
the	DT	O
back	NN	O
.	.	O

her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
currently	RB	O
is	VBZ	O
5/10	CD	O
.	.	O

ros	NN	O
(	(	O
-	:	O
)	)	O
emesis	NN	B-PROBLEM
/	JJ	O
brbpr/melena	NN	B-PROBLEM
/	NNP	O
fever/chills	VBZ	B-PROBLEM
/	JJ	O
sob	NN	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
gi	NN	O
on	IN	O
13	CD	O
egd	NN	B-TEST
was	VBD	O
performed	VBN	O
hd2	NN	O
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
gastritis	NN	B-PROBLEM
,	,	O
stricture	NN	B-PROBLEM
or	CC	O
ulcer	NN	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
h.	JJ	B-PROBLEM
pylori	JJ	I-PROBLEM
positive	JJ	I-PROBLEM
and	CC	O
therefore	NN	O
was	VBD	O
started	VBN	O
on	IN	O
empiric	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

afferent	JJ	O
limb	NN	O
of	IN	O
the	DT	O
roux	NN	B-TREATMENT
en	FW	I-TREATMENT
y	FW	I-TREATMENT
anastamosis	NN	I-TREATMENT
was	VBD	O
visualized	VBN	O
however	RB	O
the	DT	O
efferent	NN	O
limb	NN	O
could	MD	O
not	RB	O
be	VB	O
explored	VBN	O
.	.	O

pt	NN	O
had	VBD	O
hida	VBN	B-TEST
scan	JJ	I-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
obstruction	NN	B-PROBLEM
,	,	O
and	CC	O
ct	NN	B-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

pt	NN	O
was	VBD	O
tolerating	VBG	O
regular	JJ	O
diet	JJ	O
by	IN	O
hd4	NN	O
,	,	O
and	CC	O
gi	NN	O
felt	VBD	O
that	IN	O
further	JJ	B-TEST
workup	NN	I-TEST
could	MD	O
be	VB	O
continued	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

plans	NNS	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
outpatient	JJ	B-TEST
mra	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
ischemic	JJ	O
causes	NNS	O
of	IN	O
post	NN	B-PROBLEM
prandial	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
hida	NN	B-TEST
with	IN	I-TEST
ck	JJ	I-TEST
challenge	NN	I-TEST
to	TO	O
evaluate	VB	O
for	IN	O
biliary	JJ	B-PROBLEM
dyskinesia	NN	I-PROBLEM
without	IN	O
stasis	NN	O
.	.	O

pt	NN	O
will	MD	O
finish	VB	O
course	NN	O
of	IN	O
h.	JJ	B-TREATMENT
pylori	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
as	RB	O
well	RB	O
.	.	O

if	IN	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	I-PROBLEM
food	NN	I-PROBLEM
please	NN	O
call	NN	O
dr.	NN	O
gaetzfreierm	NN	O
&apos;s	NNP	O
office	NN	O
or	CC	O
pcp	NN	O
.	.	O

if	IN	O
severe	JJ	O
,	,	O
then	RB	O
proceed	VB	O
to	TO	O
er	VB	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

will	MD	O
need	VB	O
to	TO	O
call	VB	O
for	IN	O
outpatient	JJ	O
mra	NN	B-TEST
and	CC	O
hida	NN	B-TEST
with	IN	I-TEST
cck	JJ	I-TEST
challenge	NN	I-TEST
to	TO	O
evaluate	VB	O
biliary	JJ	O
system	NN	O
and	CC	O
mesenteric	JJ	O
vasculature	NN	O
.	.	O

please	NN	O
continue	VB	O
taking	VBG	O
the	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
for	IN	O
h.	NN	B-PROBLEM
pylori	NN	I-PROBLEM
for	IN	O
full	JJ	O
course	NN	O
(	(	O
26	CD	O
more	JJR	O
days	NNS	O
)	)	O
.	.	O

non-toxic	JJ	B-PROBLEM
multinodular	JJ	I-PROBLEM
goiter	NN	I-PROBLEM
.	.	O

left	VBN	B-PROBLEM
thyroid	JJ	I-PROBLEM
occult	NN	I-PROBLEM
papillary	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
lymphocytic	JJ	I-PROBLEM
thyroiditis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
right	JJ	B-TREATMENT
total	NN	I-TREATMENT
and	CC	I-TREATMENT
left	VBD	I-TREATMENT
subtotal	JJ	I-TREATMENT
oophorectomy	NN	I-TREATMENT
,	,	O
asthma	NN	B-PROBLEM
,	,	O
migraine	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
droperidol	NN	B-PROBLEM
allergy	NN	I-PROBLEM
.	.	O

thyroidectomy	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
51	CD	O
year-old	JJ	O
female	NN	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
non-toxic	JJ	I-PROBLEM
multinodular	JJ	I-PROBLEM
goiter	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
developed	VBN	O
symptoms	NNS	B-PROBLEM
from	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
dominant	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
with	IN	O
pressure	NN	B-PROBLEM
discomfort	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
dyspnea	NN	B-PROBLEM
or	CC	O
dysphagia	NN	B-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
thyroid	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
received	VBN	O
prior	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
exposure	NN	I-TREATMENT
.	.	O

on	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
,	,	O
she	PRP	O
is	VBZ	O
a	DT	O
healthy-appearing	JJ	O
female	NN	O
with	IN	O
a	DT	O
normal	JJ	O
voice	NN	O
and	CC	O
no	DT	O
exophthalmos	NN	B-PROBLEM
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
:	:	O

include	VBP	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
174/84	CD	O
,	,	O
respirations	NNS	B-TEST
14	CD	O
,	,	O
pulse	RB	B-TEST
89	CD	O
,	,	O
temperature	NN	B-TEST
98.9	CD	O
,	,	O
o2	PRP	B-TEST
sat	VBD	I-TEST
98%	CD	O
.	.	O

palpation	NN	B-TEST
of	IN	O
the	DT	O
neck	NN	O
discloses	VBZ	O
a	DT	B-PROBLEM
multinodular	JJ	I-PROBLEM
goiter	NN	I-PROBLEM
,	,	O
larger	JJR	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
,	,	O
with	IN	O
no	DT	O
associated	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

carotid	NN	O
pulsations	NNS	O
are	VBP	O
normal	JJ	O
without	IN	O
bruit	NN	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

bilaterally	RB	O
without	IN	O
stridor	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
heart	NN	I-TEST
rhythm	NN	I-TEST
is	VBZ	O
regular	JJ	O
with	IN	O
a	DT	O
normal	JJ	O
s1-s2	NN	O
,	,	O
and	CC	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
with	IN	O
no	DT	O
organomegaly	NN	B-PROBLEM
or	CC	O
masses	NNS	B-PROBLEM
.	.	O

her	PRP$	B-TEST
deep	JJ	I-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
are	VBP	O
symmetric	JJ	O
.	.	O

on	IN	O
5-29-00	JJ	O
,	,	O
she	PRP	O
underwent	JJ	O
thyroidectomy	NN	B-TREATMENT
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
3.3	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
right	RB	I-PROBLEM
lobe	VBZ	I-PROBLEM
microfollicular	JJ	I-PROBLEM
adenoma	NN	I-PROBLEM
and	CC	O
left	VBD	O
lobe	NN	O
6	CD	O
mm	NN	O
.	.	O

papillary	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
any	DT	B-PROBLEM
middle	JJ	I-PROBLEM
compartment	NN	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
or	CC	O
spread	NN	O
of	IN	O
the	DT	B-PROBLEM
tumor	NN	I-PROBLEM
outside	IN	O
the	DT	O
thyroid	NN	O
.	.	O

her	PRP$	B-TREATMENT
sutures	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
one	CD	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
went	VBD	O
home	NN	O
in	IN	O
satisfactory	JJ	O
condition	NN	O
.	.	O

1.	CD	O
synthroid	JJ	B-TREATMENT
0.125	CD	O
mg.	JJ	O
daily	RB	O
.	.	O

3.	CD	O
she	PRP	O
will	MD	O
remove	VB	O
the	DT	B-TREATMENT
neck	NN	I-TREATMENT
suture	NN	I-TREATMENT
lines	NNS	I-TREATMENT
steri-strips	NNS	I-TREATMENT
in	IN	O
10	CD	O
days	NNS	O
.	.	O

vaginal	JJ	B-TREATMENT
delivery	NN	I-TREATMENT
with	IN	O
second	JJ	B-PROBLEM
degree	NN	I-PROBLEM
laceration	NN	I-PROBLEM

abnormal	JJ	B-PROBLEM
pap	NN	I-PROBLEM
test	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
;	:	O
bacterial	JJ	B-PROBLEM
vaginitis	NN	I-PROBLEM
;	:	O
contraception	NN	B-TREATMENT
management	NN	I-TREATMENT
;	:	O
hiv	NN	O
counseled	VBD	O

spontaneous	JJ	B-TREATMENT
vertex	NNS	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT

antimicrobial	JJ	B-TREATMENT
therapy	NN	I-TREATMENT

srom	NN	B-PROBLEM
in	IN	O
labor	NN	B-PROBLEM

mouth	NN	O
normal	JJ	O
neck	NN	O
normal	JJ	O
thyroid	NN	O
wnl	NN	O
breasts	NNS	O
normal	JJ	O
no	DT	O
distinct	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
nipples	NNS	O
normal	JJ	O
inverted	JJ	B-PROBLEM
[	NN	O
b	NN	O
]	NN	O
,	,	O
evert	JJ	B-TREATMENT
w	NN	I-TREATMENT
/	NNP	I-TREATMENT
stimulation	NN	I-TREATMENT
chest	NN	O
normal	JJ	O
lcta	JJ	O
cor	NN	O
normal	JJ	O
rrr	JJ	O
abdomen	NNS	O
normal	JJ	O
gravid	JJ	O
extrem	NN	O
normal	JJ	O
skin	NN	O
normal	JJ	O
nodes	NNS	O
normal	JJ	O
vulva	NNS	O
normal	JJ	O
no	DT	O
lesions	NNS	B-PROBLEM
,	,	O
white	JJ	B-PROBLEM
d	NN	I-PROBLEM
/	NN	I-PROBLEM
c	NN	I-PROBLEM
at	IN	I-PROBLEM
introitus	JJ	I-PROBLEM
vagina	FW	O
normal	JJ	O
sml	NN	B-PROBLEM
amt	NN	I-PROBLEM
thin	JJ	I-PROBLEM
white	JJ	I-PROBLEM
d	NN	I-PROBLEM
/	NNP	I-PROBLEM
c	VBZ	I-PROBLEM
ph	JJ	B-TEST
4.5	CD	O
,	,	O
koh	FW	B-TEST
+amine	NN	O
,	,	O
ns	JJ	B-TEST
+clue	NNP	O
,	,	O
neg	NN	O
trich	JJ	O
cervix	NN	O
normal	JJ	O
1/100/0	CD	O
srom	NN	B-PROBLEM
clear	JJ	O
os	IN	O
normal	JJ	O
closed	VBD	O
adnexae	NN	O
normal	JJ	O
no	DT	O
palp	NN	B-PROBLEM
masses	VBZ	I-PROBLEM
,	,	O
nt	JJ	O
uterus	NN	O
normal	JJ	O
gravid	JJ	O
uterine	JJ	O
size	NN	O
in	IN	O
weeks	NNS	O
normal	JJ	O
term	NN	O
rectum	NN	O
normal	JJ	O
no	DT	O
ext	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM

srom	NN	B-PROBLEM
in	IN	O
labor	NN	B-PROBLEM
.	.	O

she	PRP	O
delivered	VBD	O
a	DT	O
3680	CD	O
gram	NN	O
male	NN	O
infant	NN	O
on	IN	O
10/12/2004	CD	O
at	IN	O
10:17	CD	O
pm	NN	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
9	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
40.0	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

srom	NN	B-PROBLEM
.	.	O

metronidazole	JJ	B-TREATMENT
tablets	NNS	I-TREATMENT
(	(	I-TREATMENT
flagyl	NN	I-TREATMENT
)	)	I-TREATMENT
;	:	O
multivitamins	NNS	B-TREATMENT
and	CC	I-TREATMENT
folate	NN	I-TREATMENT
capsules	NNS	I-TREATMENT
(	(	I-TREATMENT
stuart	JJ	I-TREATMENT
prenatal	NN	I-TREATMENT
with	IN	I-TREATMENT
folate	NN	I-TREATMENT
)	)	I-TREATMENT

tca	NN	B-PROBLEM
overdose	NN	I-PROBLEM

rehabilitation	NN	B-TREATMENT

folate	NN	B-TREATMENT
(	(	I-TREATMENT
folic	JJ	I-TREATMENT
acid	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
qd	NN	O
zantac	NN	B-TREATMENT
(	(	I-TREATMENT
ranitidine	JJ	I-TREATMENT
hcl	NN	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
mvi	VBZ	B-TREATMENT
therapeutic	JJ	I-TREATMENT
w	NN	I-TREATMENT
/	NN	I-TREATMENT
minerals	NNS	I-TREATMENT
(	(	I-TREATMENT
therap	VB	I-TREATMENT
vits	NNS	I-TREATMENT
/	NNP	I-TREATMENT
minerals	NNS	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
qd	NN	O
thiamine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
qd	NN	O

dr.	NN	O
ee	NN	O
,	,	O
patient	NN	O
to	TO	O
arrange	VB	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

tca	NN	B-PROBLEM
overdose	NN	I-PROBLEM

principal	JJ	O
discharge	NN	O
diagnosis	NN	O
;	:	O
responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
tca	NN	B-PROBLEM
overdose	NN	I-PROBLEM

other	JJ	O
diagnosis	NN	O
;	:	O
conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
depression	NN	B-PROBLEM
(	(	I-PROBLEM
depression	NN	I-PROBLEM
)	)	I-PROBLEM

32	CD	O
y	JJ	O
/	NNP	O
o	MD	O
woman	NN	O
with	IN	O
h	JJ	O
/	JJ	O
o	NN	O
anxiety	NN	B-PROBLEM
and	CC	O
depression	NN	B-PROBLEM
and	CC	O
prior	JJ	B-PROBLEM
suicide	NN	I-PROBLEM
attempt	NN	I-PROBLEM
presents	NNS	O
with	IN	O
tca	NN	B-PROBLEM
and	CC	I-PROBLEM
celexa	NN	I-PROBLEM
overdose	RB	I-PROBLEM
,	,	O
tremulous	JJ	B-PROBLEM
/	CD	O
light-headed	JJ	B-PROBLEM
,	,	O
felt	VBD	O
better	RBR	O
post	NN	O
charcoal	NN	B-TREATMENT
.	.	O

no	DT	O
ekg	NN	O
changes	NNS	O
,	,	O
marijuana	NN	B-TEST
in	IN	I-TEST
urine	NN	I-TEST
,	,	O
hco3	VBD	B-TEST
22	CD	O
.	.	O

transferred	VBN	O
to	TO	O
floor	NN	O
on	IN	O
day	NN	O
of	IN	O
admission	NN	O
with	IN	O
no	DT	O
acute	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
;	:	O
awaiting	VBG	O
psych	NN	B-TEST
eval	NN	I-TEST
.	.	O

not	RB	O
actively	RB	B-PROBLEM
suicidal	JJ	I-PROBLEM
.	.	O

3/7	CD	O
--	:	O
repeat	NN	B-TEST
hco3	JJ	I-TEST
24	CD	O
and	CC	O
26	CD	O
without	IN	O
bicarb	NN	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

ekg	NN	B-TEST
without	IN	O
changes	NNS	O
.	.	O

best	JJS	B-TEST
team	NN	I-TEST
eval	NN	I-TEST
found	VBD	O
bed	NN	O
at	IN	O
psych	NN	O
rehab	NN	O
facility	NN	O
.	.	O

of	IN	O
note	NN	O
,	,	O
nortriptyline	JJ	B-TEST
level	NN	I-TEST
came	VBD	O
back	RB	O
as	IN	O
43	CD	O
(	(	O
subtherapeutic	JJ	O
--	:	O
normal	JJ	O
50-150	JJ	O
)	)	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
wheezes	NNS	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
heaonboburg	VB	O
linpack	NN	O
grant	JJ	O
medical	JJ	O
center	NN	O
.	.	O

your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
sapsclyss	NN	O
,	,	O
leo	JJ	O
r	NN	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
,	,	O
.	.	O

1.	CD	O
right	RB	B-TREATMENT
sided	VBN	I-TREATMENT
sciatica	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
:	:	O

right	JJ	B-TREATMENT
laminectomy	NN	I-TREATMENT
and	CC	O
discectomy	NN	B-TREATMENT
by	IN	O
dr.	NN	O
small	JJ	O
,	,	O
neurosurgery	RB	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
42	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
who	WP	O
suffered	VBD	O
lower	JJR	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
during	IN	O
an	DT	O
accident	NN	O
at	IN	O
work	NN	O
in	IN	O
1990	CD	O
.	.	O

this	DT	O
gradually	RB	O
increased	VBN	O
until	IN	O
june	NN	O
1992	CD	O
where	WRB	O
he	PRP	O
had	VBD	O
recurrent	NN	B-PROBLEM
severe	RB	I-PROBLEM
right	RB	I-PROBLEM
sided	VBN	I-PROBLEM
sciatica	NN	I-PROBLEM
.	.	O

in	IN	O
september	JJ	O
1992	CD	O
ct	NN	B-TEST
myelogram	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
lateral	JJ	I-PROBLEM
l-1	JJ	I-PROBLEM
s-1	JJ	I-PROBLEM
disc	NN	I-PROBLEM
bulge	NN	I-PROBLEM
and	CC	O
small	JJ	B-PROBLEM
l-4-4	JJ	I-PROBLEM
bulge	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
change	NN	O
in	IN	O
pain	NN	B-PROBLEM
in	IN	O
the	DT	O
last	JJ	O
few	JJ	O
months	NNS	O
.	.	O

his	PRP$	B-TEST
examination	NN	I-TEST
was	VBD	O
completely	RB	O
unremarkable	JJ	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
,	,	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
he	PRP	O
underwent	VBD	O
l5-s1	JJ	B-TREATMENT
right	JJ	I-TREATMENT
hemilaminectomy	NN	I-TREATMENT
and	CC	O
discectomy	NN	B-TREATMENT
.	.	O

over	IN	O
the	DT	O
next	JJ	O
three	CD	O
days	NNS	O
he	PRP	O
increased	VBD	O
his	PRP$	O
activity	NN	O
gradually	RB	O
,	,	O
was	VBD	O
able	JJ	O
to	TO	O
do	VB	O
stairs	NNS	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
had	VBD	O
pain	NN	B-PROBLEM
which	WDT	O
could	MD	O
be	VB	O
controlled	VBN	O
with	IN	O
oral	JJ	B-TREATMENT
analgesics	NNS	I-TREATMENT
.	.	O

he	PRP	O
is	VBZ	O
discharged	VBN	O
on	IN	O
percocet	NN	B-TREATMENT
,	,	O
colace	NN	B-TREATMENT
and	CC	O
motrin	NN	B-TREATMENT
.	.	O

normal	JJ	B-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT

current	JJ	O
smoker	NN	O
,	,	O
history	NN	O
of	IN	O
;	:	O
depression	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
;	:	O
isoimmunization	NN	B-PROBLEM
,	,	I-PROBLEM
rh	NN	I-PROBLEM
;	:	O
undesired	JJ	B-PROBLEM
fertility	NN	I-PROBLEM

spontaneous	JJ	B-TREATMENT
vertex	NNS	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT

pp	NN	B-TREATMENT
sterilization	NN	I-TREATMENT

early	RB	B-PROBLEM
labor	NN	I-PROBLEM
/	NNP	O
rule	NN	O
out	IN	O
labor	NN	B-PROBLEM

this	DT	O
22	CD	O
year	NN	O
old	JJ	O
gravida	NN	O
4	CD	O
para	NN	O
2012	CD	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
naliheall	JJ	O
county	NN	O
memorial	JJ	O
hospital	JJ	O
obstetrical	JJ	O
service	NN	O
on	IN	O
10/29/2003	CD	O
at	IN	O
11:14	CD	O
pm	NN	O
for	IN	O
the	DT	O
indication	NN	O
(	(	O
s	JJ	O
)	)	O
:	:	O
early	JJ	B-PROBLEM
labor	NN	I-PROBLEM
/	NNP	O
rule	NN	O
out	IN	O
labor	NN	B-PROBLEM
.	.	O

she	PRP	O
delivered	VBD	O
a	DT	O
3263	CD	O
gram	NN	O
female	JJ	O
infant	NN	O
on	IN	O
10/30/2003	CD	O
at	IN	O
05:03	CD	O
am	VBP	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
8	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
40.1	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

nuchal	JJ	B-PROBLEM
cord	NN	I-PROBLEM
,	,	O
x	JJ	O
1-	JJ	O
reduced	VBN	O
prior	JJ	O
to	TO	O
delivery	NN	B-TREATMENT
.	.	O

discharge	NN	O
orders	NNS	O
(	(	O
medications	NNS	B-TREATMENT
instructions	NNS	O
to	TO	O
patient	VB	O
,	,	O
follow-up	JJ	O
care	NN	O
)	)	O
:	:	O

home	NN	O
with	IN	O
self-care	JJ	B-TREATMENT
(	(	O
routine	JJ	O
discharge	NN	O
)	)	O

multivitamins	NNS	B-TREATMENT
and	CC	O
folate	NN	B-TREATMENT

severe	JJ	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

right	RB	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

atonic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
with	IN	O
suprapubic	JJ	B-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

anxiety	NN	B-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
status	NN	O
post	NN	O
hemicolectomy	NN	B-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
76	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
severe	JJ	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
who	WP	O
has	VBZ	O
had	VBN	O
several	JJ	O
recent	JJ	O
admissions	NNS	O
to	TO	O
oaksgekesser/	VB	O
memorial	JJ	O
hospital	NN	O
for	IN	O
respiratory	NN	B-PROBLEM
insuffiencey	NN	I-PROBLEM
most	RBS	O
often	RB	O
secondary	JJ	O
to	TO	O
pneumonia	VB	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
doing	VBG	O
relatively	RB	O
at	IN	O
home	NN	O
until	IN	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
he	PRP	O
complained	VBD	O
discomfort	NN	B-PROBLEM
over	IN	O
a	DT	B-TREATMENT
suprapubic	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
area	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
missed	VBN	O
his	PRP$	O
usual	JJ	O
monthly	JJ	O
change	NN	O
of	IN	O
his	PRP$	B-TREATMENT
suprapubic	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
felt	VBD	O
discomfort	NN	B-PROBLEM
and	CC	O
noticed	VBD	O
some	DT	B-PROBLEM
blood	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
site	NN	I-PROBLEM
of	IN	O
the	DT	O
catheter	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
urology	NN	O
and	CC	O
had	VBD	O
his	PRP$	B-TREATMENT
catheter	NN	I-TREATMENT
changed	VBD	O
.	.	O

the	DT	O
patient	NN	O
at	IN	O
that	DT	O
time	NN	O
noted	VBD	O
slight	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
but	CC	O
was	VBD	O
sent	VBN	O
home	NN	O
anyway	RB	O
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
the	DT	O
patient	NN	O
noticed	VBD	O
increasing	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
confused	VBN	B-PROBLEM
and	CC	O
to	TO	O
be	VB	O
disoriented	VBN	B-PROBLEM
toward	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
day	NN	O
after	IN	O
complaining	VBG	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
for	IN	O
most	JJS	O
of	IN	O
the	DT	O
day	NN	O
.	.	O

the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	O
recent	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
no	DT	O
fevers	NNS	B-PROBLEM
,	,	O
no	DT	O
chills	NNS	B-PROBLEM
,	,	O
no	DT	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
cough	NN	I-PROBLEM
,	,	O
sputum	NN	B-PROBLEM
.	.	O

he	PRP	O
also	RB	O
denies	VBZ	O
any	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

no	DT	O
orthopnea	NN	B-PROBLEM
.	.	O

no	DT	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
taking	VBG	O
his	PRP$	B-TREATMENT
usual	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
using	VBG	O
his	PRP$	B-TREATMENT
nasal	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
at	IN	I-TREATMENT
home	NN	I-TREATMENT
.	.	O

by	IN	O
the	DT	O
time	NN	O
the	DT	O
patient	NN	O
arrived	VBD	O
at	IN	O
the	DT	O
oaksgekesser/	JJ	O
memorial	JJ	O
hospital	NN	O
emergency	NN	O
room	NN	O
he	PRP	O
was	VBD	O
in	IN	O
moderate	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
initial	JJ	I-TEST
blood	NN	I-TEST
gases	NNS	I-TEST
on	IN	O
40%	CD	B-TREATMENT
02	CD	I-TREATMENT
was	VBD	O
p02	JJ	B-TEST
102	CD	O
,	,	O
pc02	NN	B-TEST
115	CD	O
,	,	O
ph	RB	B-TEST
7.11	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
respiratory	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
way	NN	O
of	IN	O
nebulizer	NN	B-TREATMENT
treatments	NNS	I-TREATMENT
in	IN	O
the	DT	O
oaksgekesser/	JJ	O
memorial	JJ	O
hospital	NN	O
emergency	NN	O
room	NN	O
because	IN	O
of	IN	O
a	DT	O
longstanding	JJ	O
desire	NN	O
by	IN	O
patient	NN	O
and	CC	O
family	NN	O
to	TO	O
refrain	VB	O
from	IN	O
intubation	NN	B-TREATMENT
to	TO	O
be	VB	O
considered	VBN	O
do	VBP	O
not	RB	O
resuscitate	VB	O
.	.	O

however	RB	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
where	WRB	O
he	PRP	O
received	VBD	O
continuous	JJ	B-TREATMENT
respiratory	NN	I-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
theway	NN	O
of	IN	O
albuterol	NN	B-TREATMENT
nebulizers	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
nasal	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
,	,	O
intravenous	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
in	IN	O
the	DT	O
oaksgekesser/	JJ	O
memorial	JJ	O
hospital	NN	O
emergency	NN	O
room	NN	O
showed	VBD	O
new	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
on	IN	O
his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
on	IN	O
top	NN	O
of	IN	O
his	PRP$	B-PROBLEM
usual	JJ	I-PROBLEM
severe	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
emphysema_____	NN	I-PROBLEM
with	IN	O
scarring	NN	B-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
lungs	NNS	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
new	JJ	B-PROBLEM
air	NN	I-PROBLEM
space	NN	I-PROBLEM
opacifications	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
apex	NN	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

these	DT	O
were	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
consistent	JJ	O
either	CC	O
with	IN	O
pneumonia	NN	B-PROBLEM
or	CC	O
asymmetric	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

associated	VBN	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
include	VBP	O
:	:	O

1.	CD	O
atonic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
with	IN	O
a	DT	B-TREATMENT
suprapubic	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

2.	CD	O
anxiety	NN	B-PROBLEM
.	.	O

3.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
a	DT	O
history	NN	O
of	IN	O
angina	NN	B-PROBLEM
in	IN	O
the	DT	O
distant	JJ	O
past	NN	O
.	.	O

4.	CD	O
history	NN	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
a	DT	B-TREATMENT
colectomy	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O
.	.	O

1.	CD	O
ativan	JJ	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

2.	CD	O
trusopt	JJ	B-TREATMENT
1	CD	O
gtt	NN	O
left	VBD	O
eye	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
xalatan	JJ	B-TREATMENT
0.005%	CD	O
one	CD	O
gtt	NN	O
left	VBD	O
eye	NN	O
qhs	NN	O
.	.	O

4.	CD	O
brimonidine	NN	B-TREATMENT
1	CD	O
gtt	NN	O
left	VBD	O
eye	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

5.	CD	O
combivent	JJ	B-TREATMENT
3	CD	O
puffs	NNS	O
four	CD	O
times	NNS	O
per	IN	O
day	NN	O
.	.	O

6.	CD	O
aerobid	JJ	B-TREATMENT
three	CD	O
puffs	NNS	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
sorbitol	JJ	B-TREATMENT
30	CD	O
cc	NN	O
every	DT	O
other	JJ	O
day	NN	O
.	.	O

he	PRP	O
was	VBD	O
an	DT	O
elderly	JJ	O
frail	NN	O
gentleman	NN	O
in	IN	O
moderate	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
110/70	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
110	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
and	CC	O
regular	JJ	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
25	CD	O
.	.	O

he	PRP	O
was	VBD	O
in	IN	O
moderate	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
98f	CD	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	VB	I-TEST
exam	NN	I-TEST
.	.	O

neck	NN	B-TEST
exam	NN	I-TEST
revealed	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
and	CC	O
no	DT	O
masses	NNS	B-PROBLEM
.	.	O

lung	NN	B-TEST
exam	NN	I-TEST
revealed	VBD	O
decreased	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
crackles	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
wheezes	NN	B-PROBLEM
or	CC	O
rhonchi	NN	B-PROBLEM
.	.	O

heart	NN	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	O
soft	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
was	VBD	O
heard	VBN	O
,	,	O
no	DT	O
s3	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	FW	B-PROBLEM
with	IN	O
no	DT	O
masses	NNS	B-PROBLEM
palpable	RB	I-PROBLEM
.	.	O

rectal	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
with	IN	O
stool	JJ	B-TEST
heme	NN	I-TEST
negative	JJ	O
.	.	O

neurological	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
an	DT	O
alert	NN	O
and	CC	O
oriented	VBD	O
x	$	O
3	CD	O
elderly	JJ	O
male	NN	O
.	.	O

deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
symmetrical	JJ	O
in	IN	O
all	DT	O
extremities	NNS	O
.	.	O

sodium	NN	B-TEST
148	CD	O
,	,	O
potassium	NN	B-TEST
3.4	CD	O
,	,	O
glucose	RB	B-TEST
174	CD	O
,	,	O
p02	NN	B-TEST
102	CD	O
,	,	O
pc02	NN	B-TEST
115	CD	O
,	,	O
ph	RB	B-TEST
7.11	CD	O
on	IN	O
40%	CD	B-TREATMENT
02	CD	I-TREATMENT
.	.	O

blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
11	CD	O
,	,	O
creatinine	NN	B-TEST
.6	NN	O
,	,	O
uric	JJ	B-TEST
acid	NN	I-TEST
3.0	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
78	CD	O
,	,	O
creatinine	NN	B-PROBLEM
phosphokinase	NN	I-PROBLEM
isoenzymes	VBZ	I-PROBLEM
too	RB	I-PROBLEM
low	JJ	I-PROBLEM
,	,	O
hematocrit	JJ	B-TEST
41	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11.6	CD	O
.	.	O

urine	JJ	B-TEST
analysis	NN	I-TEST
showed	VBD	O
20-50	JJ	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
and	CC	O
3-5	JJ	O
red	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
.	.	O

electrocardiogram	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
a	DT	O
rate	NN	O
of	IN	O
123	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
compared	VBN	O
to	TO	O
previous	JJ	B-TEST
electrocardiogram	NN	I-TEST
of	IN	O
1/29	CD	O
there	EX	O
were	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

during	IN	O
that	DT	O
period	NN	O
of	IN	O
time	NN	O
he	PRP	O
received	VBD	O
nebulizer	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
with	IN	O
albuterol	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
ticarcillin	NN	I-TREATMENT
for	IN	O
possible	JJ	O
gram	NN	B-PROBLEM
negative	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
diuresed	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
lasix	NNS	I-TREATMENT
to	TO	O
which	WDT	O
he	PRP	O
responded	VBD	O
with	IN	O
at	IN	O
lease	NN	O
a	DT	O
2l	CD	O
urine	JJ	B-TEST
output	NN	I-TEST
on	IN	O
the	DT	O
first	JJ	O
day	NN	O
and	CC	O
1.5l	CD	O
the	DT	O
second	JJ	O
day	NN	O
.	.	O

after	IN	O
one	CD	O
day	NN	O
in	IN	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
enough	RB	O
to	TO	O
go	VB	O
to	TO	O
the	DT	O
floor	NN	O
where	WRB	O
he	PRP	O
continued	VBD	O
the	DT	O
rest	NN	O
of	IN	O
his	PRP$	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

this	DT	O
consisted	VBD	O
of	IN	O
continued	JJ	O
nebulizer	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
solu-medrol	NN	I-TREATMENT
.	.	O

as	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NN	I-TREATMENT
diuresis	NN	I-TREATMENT
continued	VBD	O
his	PRP$	B-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
improved	VBN	O
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
clearing	NN	O
of	IN	O
the	DT	B-PROBLEM
opacities	NNS	I-PROBLEM
in	IN	O
the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
that	WDT	O
were	VBD	O
consistent	JJ	O
with	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
because	IN	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
abnormality	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
for	IN	O
possible	JJ	O
pneumonia	NN	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
chosen	NN	O
was	VBD	O
levaquin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
1	CD	O
tab	NN	O
per	IN	O
day	NN	O
.	.	O

the	DT	B-TREATMENT
ticarcillin	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
after	IN	O
two	CD	O
days	NNS	O
when	WRB	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
he	PRP	O
did	VBD	O
not	RB	O
have	VB	O
a	DT	B-PROBLEM
serious	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
continued	VBD	O
to	TO	O
improve	VB	O
but	CC	O
towards	IN	O
the	DT	O
last	JJ	O
2-3	JJ	O
days	NNS	O
of	IN	O
his	PRP$	O
hospitalization	NN	O
the	DT	O
amount	NN	O
of	IN	O
improvement	NN	O
was	VBD	O
minimal	JJ	O
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
his	PRP$	B-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
maximally	RB	O
treated	VBN	O
by	IN	O
then	RB	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
major	JJ	O
improvement	NN	O
came	VBD	O
after	IN	O
the	DT	O
first	JJ	O
two	CD	O
days	NNS	O
with	IN	O
brisk	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
with	IN	O
lasix	NN	B-TREATMENT
.	.	O

while	IN	O
in	IN	O
the	DT	O
oaksgekesser/	JJ	O
memorial	JJ	O
hospital	NN	O
the	DT	O
patient	NN	O
on	IN	O
4/4/99	CD	O
complained	NNS	O
of	IN	O
mild	JJ	B-PROBLEM
epigastric	JJ	I-PROBLEM
discomfort	NN	I-PROBLEM
because	IN	O
he	PRP	O
was	VBD	O
put	VBN	O
in	IN	O
cimetidine	NN	B-TREATMENT
while	IN	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
prophylaxis	NN	B-TREATMENT
against	IN	O
peptic	JJ	B-PROBLEM
ulcer	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
upgraded	VBN	O
to	TO	O
prilosec	VB	B-TREATMENT
20	CD	O
mg	NNS	O
per	IN	O
day	NN	O
for	IN	O
possible	JJ	O
treatment	NN	O
of	IN	O
gastritis	NN	B-PROBLEM
or	CC	O
gastroesophageal	NN	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
any	DT	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
evidence	NN	O
of	IN	O
gastrointestinal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
should	MD	O
be	VB	O
followed	VBN	O
over	IN	O
the	DT	O
next	JJ	O
week	NN	O
or	CC	O
so	RB	O
in	IN	O
case	NN	O
it	PRP	O
does	VBZ	O
not	RB	O
respond	VB	O
to	TO	O
prilosec	VB	B-TREATMENT
.	.	O

it	PRP	O
is	VBZ	O
hoped	VBN	O
that	IN	O
when	WRB	O
he	PRP	O
is	VBZ	O
transferred	VBN	O
to	TO	O
a	DT	O
rehab	NN	O
facility	NN	O
that	IN	O
he	PRP	O
will	MD	O
continue	VB	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
regain	VB	O
his	PRP$	O
strength	NN	O
and	CC	O
regain	NN	O
independence	NN	O
in	IN	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
.	.	O

they	PRP	O
wanted	VBD	O
the	DT	O
patient	NN	O
to	TO	O
return	VB	O
to	TO	O
his	PRP$	O
home	NN	O
after	IN	O
a	DT	O
stay	NN	O
at	IN	O
a	DT	B-TREATMENT
rehab	NN	I-TREATMENT
facility	NN	I-TREATMENT
.	.	O

i	NN	O
think	VBP	O
his	PRP$	O
breathing	NN	O
was	VBD	O
as	RB	O
good	JJ	O
as	IN	O
to	TO	O
be	VB	O
expected	VBN	O
with	IN	O
the	DT	O
amount	NN	O
of	IN	O
severe	JJ	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
he	PRP	O
had	VBD	O
.	.	O

he	PRP	O
needed	VBD	O
to	TO	O
go	VB	O
to	TO	O
a	DT	B-TREATMENT
rehab	NN	I-TREATMENT
facility	NN	I-TREATMENT
for	IN	O
continued	JJ	B-TREATMENT
respiratory	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
for	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
increase	VB	O
his	PRP$	O
muscle	NN	O
strength	NN	O
.	.	O

1.	CD	O
albuterol	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
in	IN	O
2.5	CD	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
q4h	NN	O
.	.	O

2.	CD	O
heparin	JJ	B-TREATMENT
5000	CD	O
units	NNS	O
subcutaneously	RB	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
ativan	JJ	B-TREATMENT
.5	NNP	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
nasal	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
3l	CD	O
per	IN	O
minute	NN	O
.	.	O

5.	CD	O
levaquin	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
per	IN	O
day	NN	O
to	TO	O
be	VB	O
continued	VBN	O
until	IN	O
4/12/99	CD	O
.	.	O

6.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
per	IN	O
day	NN	O
.	.	O

7.	CD	O
prednisone	NN	B-TREATMENT
40	CD	O
mg	NN	O
per	IN	O
day	NN	O
to	TO	O
be	VB	O
tapered	VBN	O
over	IN	O
two	CD	O
weeks	NNS	O
.	.	O

8.	CD	O
xalatan	JJ	B-TREATMENT
eyedrops	NNS	I-TREATMENT
1	CD	O
gtt	NN	O
in	IN	O
left	JJ	O
eye	NN	O
per	IN	O
day	NN	O
.	.	O

9.	CD	O
alphagan	JJ	B-TREATMENT
1	CD	O
gtt	NN	O
in	IN	O
left	NN	O
eye	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

10.	CD	O
trusopt	JJ	B-TREATMENT
1gtt	CD	O
in	IN	O
left	NN	O
eye	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

11.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
per	IN	O
day	NN	O
.	.	O

cp	NN	B-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

noncardiac	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM

labs	RBR	B-TEST
stable	JJ	O
,	,	O
ntg	JJ	B-TREATMENT
sublingual	JJ	I-TREATMENT
,	,	O
stress	JJ	B-TEST
mibi	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
ischemia	NN	B-PROBLEM
.	.	O

continue	VB	O
current	JJ	B-TREATMENT
medication	NN	I-TREATMENT

return	NN	O
to	TO	O
the	DT	O
ed	NN	O
for	IN	O
worsening	VBG	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
/	NNP	O
vomiting	NN	B-PROBLEM
,	,	O
fever	RB	B-PROBLEM
/	NNP	O
chills	NNS	B-PROBLEM
,	,	O
weakness	NN	B-PROBLEM
/	NNP	O
dizziness/numbness	NN	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

anxiety	NN	B-PROBLEM
nos	NNS	I-PROBLEM

psychological	JJ	B-TEST
assessment	NN	I-TEST
,	,	O
past	JJ	O
medication	NN	O
responses	NNS	O
discussed	VBN	O
.	.	O

no	DT	O
new	JJ	B-TREATMENT
meds	NNS	I-TREATMENT
for	IN	O
now	RB	O

continuing	VBG	O
taking	VBG	O
meds	NNS	B-TREATMENT
she	PRP	O
prescribed	VBD	O
.	.	O

copd	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
with	IN	O
nstemi	NN	B-PROBLEM

attending	VBG	B-TEST
evaluation	NN	I-TEST

vitamin	NN	B-TREATMENT
c	NN	I-TREATMENT
(	(	I-TREATMENT
ascorbic	JJ	I-TREATMENT
acid	NN	I-TREATMENT
)	)	I-TREATMENT
1,000	CD	O
mg	NN	O
po	NN	O
qd	NN	O
ecasa	NN	B-TREATMENT
(	(	I-TREATMENT
aspirin	JJ	I-TREATMENT
enteric	RB	I-TREATMENT
coated	VBN	I-TREATMENT
)	)	I-TREATMENT
81	CD	O
mg	NN	O
po	NN	O
qd	NN	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
(	(	I-TREATMENT
500	CD	I-TREATMENT
mg	NN	I-TREATMENT
elemental	JJ	I-TREATMENT
ca++	NN	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
prednisone	NN	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qam	NN	O
starting	VBG	O
today	NN	O
(	(	O
12/09	CD	O
)	)	O

taper	NN	O
over	IN	O
2	CD	O
weeks	NNS	O
multivitamin	RB	B-TREATMENT
therapeutic	JJ	I-TREATMENT
(	(	I-TREATMENT
therapeutic	JJ	I-TREATMENT
multivi	NN	I-TREATMENT
...	:	I-TREATMENT
)	)	I-TREATMENT
5	CD	O
milliliters	NNS	O
po	VBP	O
qd	NN	O

override	RB	O
added	VBD	O
on	IN	O
12/07/05	CD	O
by	IN	O
belb	NN	O
,	,	O
britherl	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
atorvastatin	NN	B-TREATMENT
po	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
33823759	CD	O
)	)	O

niacin	RB	B-TREATMENT
,	,	O
vit	NN	B-TREATMENT
.	.	O

b-3	NN	B-TREATMENT
and	CC	O
atorvastatin	NN	B-TREATMENT
calcium	NN	I-TREATMENT

override	RB	O
added	VBD	O
on	IN	O
12/06/05	CD	O
by	IN	O
belb	NN	O
,	,	O
britherl	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
zocor	NN	B-TREATMENT
po	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
33033281	CD	O
)	)	O

niacin	RB	B-TREATMENT
,	,	O
vit	NN	B-TREATMENT
.	.	O

b-3	NN	B-TREATMENT
and	CC	O
simvastatin	NN	B-TREATMENT

flovent	NN	B-TREATMENT
(	(	I-TREATMENT
fluticasone	JJ	I-TREATMENT
propionate	NN	I-TREATMENT
)	)	I-TREATMENT
44	CD	O
mcg	JJ	O
inh	NN	O
bid	NN	O
starting	VBG	O
today	NN	O
(	(	O
12/09	CD	O
)	)	O
levaquin	NN	B-TREATMENT
(	(	I-TREATMENT
levofloxacin	NN	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
qd	NN	O

administer	RB	O
iron	NN	B-TREATMENT
products	NNS	I-TREATMENT
a	DT	O
minimum	NN	O
of	IN	O
2	CD	O
hours	NNS	O
before	IN	O
or	CC	O
after	IN	O
a	DT	O
levofloxacin	NN	B-TREATMENT
or	CC	O
ciprofloxacin	NN	B-TREATMENT
dose	VBP	O
dose	NN	O

if	IN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
,	,	O
please	VB	O
cycle	NN	O
(	(	O
hold	VB	O
1	CD	O
hr	NN	O
before	IN	O
to	TO	O
2	CD	O
hr	NNS	O
after	IN	O
)	)	O

salmeterol	NN	B-TREATMENT
xinafoate	NN	I-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT

serevent	NN	B-TREATMENT
diskus	NN	I-TREATMENT
(	(	I-TREATMENT
salmeterol	JJ	I-TREATMENT
diskus	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
puff	JJ	O
inh	NN	O
bid	NN	O

override	RB	O
added	VBD	O
on	IN	O
12/06/05	CD	O
by	IN	O
belb	NN	O
,	,	O
britherl	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
levaquin	NN	B-TREATMENT
po	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
57095042	CD	O
)	)	O

salmeterol	NN	B-TREATMENT
xinafoate	NN	I-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT

lisinopril	RB	B-TREATMENT
5	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O

potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
and	CC	O
lisinopril	NN	B-TREATMENT

toprol	NN	B-TREATMENT
xl	NNP	I-TREATMENT
(	(	I-TREATMENT
metoprolol	JJ	I-TREATMENT
succinate	NN	I-TREATMENT
extended	VBD	I-TREATMENT
release	NN	I-TREATMENT
)	)	I-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
qd	NN	O
starting	VBG	O
today	NN	O
(	(	O
12/09	CD	O
)	)	O

alendronate	NN	B-TREATMENT
70	CD	O
mg	NN	O
po	NN	O
qweek	NN	O

take	VB	O
with	IN	O
8	CD	O
oz	NN	O
of	IN	O
plain	JJ	O
water	NN	O
albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
2	CD	O
puff	NN	O
inh	NN	O
qid	NN	O
starting	VBG	O
today	NN	O
(	(	O
12/09	CD	O
)	)	O
atrovent	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
(	(	I-TREATMENT
ipratropium	JJ	I-TREATMENT
inhaler	NN	I-TREATMENT
)	)	I-TREATMENT
2	CD	O
puff	NN	O
inh	NN	O
qid	NN	O
starting	VBG	O
today	NN	O
(	(	O
12/09	CD	O
)	)	O

nka	JJ	B-PROBLEM
admit	NN	O
diagnosis	NN	O
:	:	O

copd	NN	B-PROBLEM
exacerbation	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
copd	NN	B-PROBLEM
exacerbation	NN	I-PROBLEM
with	IN	O
nstemi	NN	B-PROBLEM

severe	JJ	B-PROBLEM
copd	NN	I-PROBLEM
pneumonia	NN	B-PROBLEM
recovering	VBG	O
alcoholic	JJ	O
recovering	VBG	O
barbituate	NN	O
abuse	NN	O
unexplained	VBD	B-PROBLEM
hct	JJ	I-PROBLEM
drop	NN	I-PROBLEM
poor	JJ	B-PROBLEM
appetite	JJ	I-PROBLEM
x	NN	O
1	CD	O
week	NN	O

steroid	JJ	B-PROBLEM
psychosis	NN	I-PROBLEM
no	DT	O
benzos	NN	B-TREATMENT

heparin	NN	B-TREATMENT
while	IN	O
having	VBG	O
a	DT	B-PROBLEM
demand	NN	I-PROBLEM
ischemic	JJ	I-PROBLEM
episode	NN	I-PROBLEM

82f	CD	O
with	IN	O
copd	NN	B-PROBLEM
exacerpation	NN	I-PROBLEM

copd	JJ	B-PROBLEM
exacerpation	NN	I-PROBLEM
with	IN	O
troponin	NN	B-PROBLEM
leak	NN	I-PROBLEM
likely	JJ	O
nstemi	JJ	B-PROBLEM
secondary	JJ	O
to	TO	O
demand	VB	B-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

4	CD	O
days	NNS	O
of	IN	O
worsening	VBG	B-PROBLEM
sob	NN	I-PROBLEM
with	IN	O
sore	NN	B-PROBLEM
throat	NN	I-PROBLEM
and	CC	O
cough	JJ	B-PROBLEM
productive	NN	I-PROBLEM
of	IN	I-PROBLEM
yellow	JJ	I-PROBLEM
/	NNP	I-PROBLEM
green	JJ	I-PROBLEM
sputum	NN	I-PROBLEM
.	.	O

fatigue	NN	B-PROBLEM
secondary	JJ	O
to	TO	O
worsening	VBG	B-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

took	VBD	O
prednisone	NN	B-TREATMENT
40	CD	I-TREATMENT
at	IN	O
home	NN	O
and	CC	O
presented	VBN	O
to	TO	O
ed	VB	O
where	WRB	O
found	VBN	O
to	TO	O
have	VB	O
1mm	CD	B-PROBLEM
lateral	JJ	I-PROBLEM
st	NN	I-PROBLEM
depressions	NNS	I-PROBLEM
and	CC	O
slight	JJ	B-PROBLEM
troponin	NN	I-PROBLEM
and	CC	I-PROBLEM
mb	NN	I-PROBLEM
leak	NN	I-PROBLEM
.	.	O

no	DT	O
n	JJ	B-PROBLEM
/	NNP	O
v/ha	NN	B-PROBLEM
/	NNP	O
d	VBZ	B-PROBLEM
no	DT	O
sweats	NNS	B-PROBLEM
,	,	O
no	DT	O
chills	NNS	B-PROBLEM
,	,	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
pleuricy	NN	B-PROBLEM
,	,	O
no	DT	O
lee	NN	B-PROBLEM
,	,	O
no	DT	O
paresthesias	NN	B-PROBLEM
,	,	O
no	DT	O
numbness	NN	B-PROBLEM
,	,	O
no	DT	O
shoulder	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
jaw	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

copd	NN	B-PROBLEM
(	(	O
s	JJ	O
/	NN	O
p	NN	O
lung	NN	B-TREATMENT
resection	NN	I-TREATMENT
fev1	RB	B-TEST
25%	CD	O
)	)	O
,	,	O
chronic	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
pvd	NN	B-PROBLEM
,	,	O
r	VBP	B-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
osteoporosis	NN	B-PROBLEM
,	,	O
presbylaryngis	NN	B-PROBLEM

98.4	CD	O
,	,	O
94	CD	O
,	,	O
22	CD	O
,	,	O
120/96	CD	O
,	,	O
98%	CD	O
on	IN	O
2l.	CD	O
nad	NNS	B-PROBLEM
,	,	O
using	VBG	O
scalenes	NNS	B-TEST
,	,	O
at	IN	O
/	NNP	O
nc	NN	O
,	,	O
no	DT	O
oral	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
bibasilar	JJ	B-PROBLEM
rales	NNS	I-PROBLEM
otherwise	RB	O
clear	JJ	O
,	,	O
good	JJ	O
air	NN	O
movement	NN	O
,	,	O
rrr	NN	O
,	,	O
no	DT	O
mrg	NN	O
,	,	O
ntnd	JJ	O
+bs	NNP	O
,	,	O
no	DT	O
cce	NN	O
,	,	O
2+	CD	O
dps	NN	O
.	.	O

wbc	NN	B-TEST
12.91	CD	O

small	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
flat	JJ	O
diaphrams	VBZ	O
no	DT	O
acute	NN	B-PROBLEM
changes	NNS	I-PROBLEM

echo	LS	B-TEST
-	:	O

likely	RB	O
having	VBG	O
a	DT	B-PROBLEM
nstemi	JJ	I-PROBLEM
secondary	JJ	O
to	TO	O
demand	VB	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
trending	VBG	O
down	RB	O
on	IN	O
12.7.05	CD	O
,	,	O
anticoagulated	VBN	O
while	IN	O
having	VBG	O
leak	NN	B-TEST
.	.	O

i	SYM	O
-	:	O
heparin	NN	B-TREATMENT
for	IN	O
ptt	JJ	B-PROBLEM
50-70	JJ	O
durin	NN	O
enzyme	NN	B-PROBLEM
leak	NN	I-PROBLEM
.	.	O
metoprolol	CC	B-TREATMENT
12	CD	O
qid	NN	O
.	.	O

cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
bid	VBP	O
while	IN	O
actively	RB	O
having	VBG	O
leak	NN	B-PROBLEM
,	,	O
asa	NN	B-TREATMENT

r	LS	O
-	:	O
monitor	NN	O
on	IN	O
telemetry	NN	B-TREATMENT

p	SYM	O
-	:	O
no	DT	O
evidence	NN	B-PROBLEM
of	IN	I-PROBLEM
failure	NN	I-PROBLEM

likely	JJ	O
exacerbation	NN	B-PROBLEM
possibly	RB	O
from	IN	O
uri	JJ	B-PROBLEM
/	NNP	O
pneumonia	NN	B-PROBLEM
.	.	O

aputum	NN	B-TEST
cultures	NNS	I-TEST
pending	VBG	O
.	.	O

atrovent	NN	B-TREATMENT
neb	NN	I-TREATMENT
qid	NN	O
,	,	O
albuterol	NN	B-TREATMENT
neb	NN	I-TREATMENT
qid	NN	O
,	,	O
ipratropium	JJ	B-TREATMENT
neb	NN	I-TREATMENT
bid	NN	O
,	,	O
flovent	JJ	B-TREATMENT
inh	NN	I-TREATMENT
bid	NN	O
,	,	O
serevent	JJ	B-TREATMENT
inh	NN	I-TREATMENT
bid	NN	O
,	,	O
and	CC	O
prednisone	RB	B-TREATMENT
30	CD	O
qd	JJ	O
taper	NN	O
.	.	O

levaquin	RB	B-TREATMENT
500	CD	O
qd	NNS	O
empirically	RB	O

ppi	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT

mvi	NN	B-PROBLEM
,	,	O
cardiac	JJ	O
diet	NN	O

please	VB	O
taper	JJR	O
off	IN	O
your	PRP$	O
prednisone	NN	B-TREATMENT
within	IN	O
2	CD	O
weeks	NNS	O

please	VB	O
evaluate	JJ	O
ambutlation	NN	O
ability	NN	O
and	CC	O
o2	JJ	B-TEST
requirement	NN	I-TEST

please	VB	O
evaluate	JJ	O
resolution	NN	O
of	IN	O
cardiac	JJ	B-PROBLEM
troponin	NN	I-PROBLEM
leak	NN	I-PROBLEM
and	CC	O
stable	JJ	O
ekg	NN	O
.	.	O

please	VB	O
evaluate	JJ	O
resolution	NN	O
of	IN	O
copd	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
and	CC	O
need	NN	O
for	IN	O
any	DT	B-TREATMENT
further	JJ	I-TREATMENT
antibiocis	NN	I-TREATMENT

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
known	VBN	O
history	NN	O
of	IN	O
pancreatic	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
admitted	VBN	O
at	IN	O
this	DT	O
time	NN	O
because	IN	O
of	IN	O
significant	JJ	B-PROBLEM
gi	NN	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
fatigue	NN	B-PROBLEM
and	CC	O
increased	VBD	B-PROBLEM
abdominal	JJ	I-PROBLEM
discomfort	NN	I-PROBLEM
.	.	O

insulin	NN	B-TREATMENT
,	,	O
celexa	NN	B-TREATMENT
,	,	O
protonix	NN	B-TREATMENT
,	,	O
ambien	NN	B-TREATMENT
and	CC	O
pancreas	NNS	B-TREATMENT
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
showed	VBD	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
to	TO	O
be	VB	O
slightly	RB	B-PROBLEM
decreased	VBN	I-PROBLEM
at	IN	O
120/60	CD	O
,	,	O
pulse	RB	B-TEST
64	CD	O
,	,	O
respirations	NNS	B-TEST
16	CD	O
,	,	O
temperature	NN	B-TEST
98.8	CD	O
,	,	O
o2	PRP	B-TEST
sat	VBD	I-TEST
95	CD	O
.	.	O

evidence	NN	B-PROBLEM
of	IN	I-PROBLEM
anemia	NN	I-PROBLEM
with	IN	O
being	VBG	B-PROBLEM
pale	JJ	I-PROBLEM
,	,	O
but	CC	O
anicteric	RB	O
,	,	O
no	DT	O
oral	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

back	RB	O
without	IN	O
cva	NN	B-PROBLEM
or	CC	I-PROBLEM
spinal	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

bowel	NN	O
sounds	VBZ	O
positive	JJ	O
,	,	O
soft	JJ	O
,	,	O
mildly	RB	B-PROBLEM
tender	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
epigastrium	NN	I-PROBLEM
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
mass	NN	B-PROBLEM
or	CC	O
tenderness	NN	B-PROBLEM
.	.	O

trace	NN	B-PROBLEM
edema	NN	I-PROBLEM
without	IN	O
cyanosis	NN	B-PROBLEM
or	CC	O
clubbing	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
was	VBD	O
20.5	CD	O
,	,	O
after	IN	O
having	VBG	O
been	VBN	O
32	CD	O
one	CD	O
week	NN	O
earlier	RBR	O
.	.	O

the	DT	B-TEST
assessment	NN	I-TEST
was	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
gi	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

endoscopy	NN	B-TEST
showed	VBD	O
multiple	JJ	B-PROBLEM
angio	NN	I-PROBLEM
ectasias	NN	I-PROBLEM
throughout	IN	I-PROBLEM
the	DT	I-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

he	PRP	O
received	VBD	O
multiple	JJ	B-TREATMENT
treatments	NNS	I-TREATMENT
for	IN	O
this	DT	O
over	IN	O
the	DT	O
succeeding	JJ	O
weeks	NNS	O
.	.	O

his	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
was	VBD	O
maintained	VBN	O
with	IN	O
platelet	NN	B-TREATMENT
transfusion	NN	I-TREATMENT
as	IN	O
necessary	JJ	O
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
octreotide	NN	B-TREATMENT
to	TO	O
try	VB	O
to	TO	O
slow	VB	O
down	RP	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

despite	IN	O
all	PDT	O
these	DT	O
measures	NNS	O
,	,	O
his	PRP$	B-PROBLEM
bleeding	NN	I-PROBLEM
was	VBD	O
never	RB	O
totally	RB	O
controlled	VBN	O
.	.	O

he	PRP	O
then	RB	O
had	VBD	O
an	DT	B-TREATMENT
angiogram	NN	I-TREATMENT
with	IN	I-TREATMENT
gel	NN	I-TREATMENT
foam	NN	I-TREATMENT
to	TO	O
try	VB	O
to	TO	O
control	VB	O
his	PRP$	B-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

at	IN	O
that	DT	O
point	NN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
was	VBD	O
no	RB	B-PROBLEM
longer	RB	I-PROBLEM
responsive	VB	I-PROBLEM
.	.	O

the	DT	O
cause	NN	O
of	IN	O
death	NN	B-PROBLEM
was	VBD	O
a	DT	O
combination	NN	O
of	IN	O
gi	NN	B-PROBLEM
bleeding	VBG	I-PROBLEM
felt	VBD	O
to	TO	O
be	VB	O
ultimately	RB	O
related	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
known	VBN	I-PROBLEM
metastatic	JJ	I-PROBLEM
pancreatic	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

r	NN	B-PROBLEM
elbow	VBZ	I-PROBLEM
injury	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
sprains	NNS	B-PROBLEM
,	,	O
fractures	NNS	B-PROBLEM
and	CC	O
bruises	NNS	B-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

r	NN	B-PROBLEM
elbow	NN	I-PROBLEM
strain	NN	I-PROBLEM

xray	SYM	B-TEST
-	:	O
no	DT	O
evidence	NN	O
of	IN	O
effusion	NN	B-PROBLEM
or	CC	O
fracture	NN	B-PROBLEM

motrin	JJ	B-TREATMENT
400-600	JJ	O
mg	NN	O
every	DT	O
8	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM

it	PRP	O
is	VBZ	O
recommended	VBN	O
that	IN	O
you	PRP	O
receive	VBP	O
follow-up	JJ	O
care	NN	O
with	IN	O
the	DT	O
department	NN	O
of	IN	O
orthopaedics	NNS	O
if	IN	O
your	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
are	VBP	O
not	RB	O
improved	VBN	O
in	IN	O
5-7	JJ	O
days	NNS	O
.	.	O

use	NN	O
ice	NN	B-TREATMENT
to	TO	O
sore	VB	B-PROBLEM
areas	NNS	I-PROBLEM
for	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
.	.	O

do	VB	O
no	DT	O
strenuous	JJ	O
activity	NN	O
until	IN	O
your	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
are	VBP	O
improved	VBN	O
.	.	O

do	VB	O
gentle	JJ	B-TREATMENT
range	NN	I-TREATMENT
of	IN	I-TREATMENT
motion	NN	I-TREATMENT
exercises	NNS	I-TREATMENT
for	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
.	.	O

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O
hypertension	NN	B-PROBLEM
;	:	O
hyperlipidemia	NN	B-PROBLEM
;	:	O
sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
;	:	O
diabetes	VBZ	B-PROBLEM
type	IN	I-PROBLEM
2	CD	I-PROBLEM
.	.	O

adenosine	JJ	B-TEST
stress	NN	I-TEST
test	NN	I-TEST
.	.	O

part	NN	B-TEST
1	CD	I-TEST
of	IN	I-TEST
a	DT	I-TEST
sleep	NN	I-TEST
study	NN	I-TEST
.	.	O

coronary	JJ	B-TEST
angiogram	NN	I-TEST
.	.	O

chest	NN	B-TEST
ct	NN	I-TEST
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
55-year-old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
cad	NN	B-PROBLEM
status	NN	O
post	NN	O
non	NN	B-PROBLEM
st	NN	I-PROBLEM
elevation	NN	I-PROBLEM
mi	NN	I-PROBLEM
in	IN	O
11/17	CD	O
who	WP	O
presents	VBZ	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
x	VBD	O
48	CD	O
hours	NNS	O
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
,	,	O
and	CC	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

in	IN	O
2003	CD	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
non	JJ	I-PROBLEM
st	NN	I-PROBLEM
elevation	NN	I-PROBLEM
mi	NN	I-PROBLEM
,	,	O
came	VBD	O
to	TO	O
the	DT	O
rwh	NN	O
,	,	O
and	CC	O
had	VBD	O
a	DT	B-TEST
cath	NN	I-TEST
done	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
40%	CD	I-PROBLEM
rca	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
hazy	NN	B-PROBLEM
.	.	O

an	DT	B-TEST
ivus	NN	I-TEST
was	VBD	O
done	VBN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
it	PRP	O
was	VBD	O
more	RBR	O
severe	JJ	O
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
ptc	JJ	I-TREATMENT
stenting	NN	I-TREATMENT
of	IN	I-TREATMENT
an	DT	I-TREATMENT
rca	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
vision	NN	I-TREATMENT
stent	NN	I-TREATMENT
,	,	O
3	CD	O
x	NN	O
18	CD	O
.	.	O

diagonal	JJ	O
1	CD	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
99%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
other	JJ	B-PROBLEM
noted	VBD	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

since	IN	O
then	RB	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
occasional	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
emotional	JJ	B-PROBLEM
stress	NN	I-PROBLEM
,	,	O
when	WRB	O
he	PRP	O
is	VBZ	O
angry	JJ	O
or	CC	O
upset	JJ	O
.	.	O

yesterday	NN	O
morning	NN	O
,	,	O
he	PRP	O
developed	VBD	O
intermittent	JJ	B-PROBLEM
substernal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
shoulder	NN	I-PROBLEM
that	WDT	O
worsened	VBD	O
with	IN	O
any	DT	O
activity	NN	O
and	CC	O
any	DT	O
motion	NN	O
of	IN	O
his	PRP$	O
shoulders	NNS	O
.	.	O

he	PRP	O
also	RB	O
became	VBD	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
climbing	VBG	O
a	DT	O
flight	NN	O
of	IN	O
stairs	NNS	O
.	.	O

he	PRP	O
denies	VBZ	O
diaphoresis	NN	B-PROBLEM
or	CC	O
nausea	NN	B-PROBLEM
.	.	O

he	PRP	O
went	VBD	O
to	TO	O
the	DT	O
padrugmoff	NN	O
hospital	NN	O
emergency	NN	O
room	NN	O
after	IN	O
trying	VBG	O
nitroglycerin	NN	B-TREATMENT
at	IN	O
home	NN	O
.	.	O

however	RB	O
,	,	O
his	PRP$	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
was	VBD	O
old	JJ	O
and	CC	O
the	DT	B-TREATMENT
script	NN	I-TREATMENT
was	VBD	O
expired	VBN	O
.	.	O

in	IN	O
the	DT	O
er	NN	O
,	,	O
he	PRP	O
received	VBD	O
3	CD	B-TREATMENT
sublingual	JJ	I-TREATMENT
nitroglycerins	NNS	I-TREATMENT
and	CC	O
1	CD	O
mg	NN	O
of	IN	O
dilaudid	NN	B-TREATMENT
.	.	O

after	IN	O
that	DT	O
,	,	O
he	PRP	O
was	VBD	O
pain-free	JJ	B-PROBLEM
.	.	O

lopressor	NN	B-TREATMENT
iv	NN	I-TREATMENT
was	VBD	O
given	VBN	O
to	TO	O
control	VB	O
his	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
.	.	O

he	PRP	O
also	RB	O
received	VBD	O
lipitor	JJ	B-TREATMENT
80	CD	O
mg	NN	O
,	,	O
plavix	NN	B-TREATMENT
300	CD	O
,	,	O
heparin	NN	B-TREATMENT
iv	NN	I-TREATMENT
,	,	O
integrelin	NN	B-TREATMENT
double	JJ	I-TREATMENT
bolus	NN	I-TREATMENT
,	,	O
followed	VBN	O
by	IN	O
a	DT	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

apparently	RB	O
once	RB	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
free	JJ	O
,	,	O
his	PRP$	B-TEST
ekg	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
hyperacute	JJ	B-PROBLEM
t-wave	JJ	I-PROBLEM
anteriorly	RB	I-PROBLEM
without	IN	O
progression	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
ro	NN	O
woodma	NN	O
healthcare	NN	O
for	IN	O
further	JJ	B-TREATMENT
cardiac	JJ	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

diabetes	NNS	B-PROBLEM
;	:	O
hypertension	NN	B-PROBLEM
;	:	O
hyperlipidemia	NN	B-PROBLEM
.	.	O

include	VBP	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
nitroglycerin	CC	B-TREATMENT
sublingual	JJ	I-TREATMENT
p.r.n.;	NN	O
toprol	NN	B-TREATMENT
xl	VBZ	I-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
plavix	CC	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
avandia	CC	B-TREATMENT
4	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
lipitor	CC	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
;	:	O
tricor	CC	B-TREATMENT
145	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

he	PRP	O
does	VBZ	O
have	VB	O
a	DT	O
lot	NN	O
of	IN	O
anxiety	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
ruled	VBD	O
out	RP	O
for	IN	O
an	DT	B-PROBLEM
mi	NN	I-PROBLEM
with	IN	O
negative	JJ	O
ck	NN	O
x4	NN	O
and	CC	O
negative	JJ	O
troponin	NN	O
x4	NN	O
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
catheterization	NN	O
lab	NN	O
where	WRB	O
cath	NN	B-TEST
showed	VBD	O
top-normal	JJ	O
lvedp	NN	O
at	IN	O
12	CD	O
;	:	O
no	DT	O
af	NN	B-PROBLEM
;	:	O
widely	RB	B-PROBLEM
patent	NN	I-PROBLEM
rca	NN	I-PROBLEM
stent	NN	I-PROBLEM
;	:	O
mild	JJ	B-PROBLEM
cad	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
symptom	NN	I-PROBLEM
;	:	O
widely	RB	B-PROBLEM
patent	VBP	I-PROBLEM
diagonal	JJ	I-PROBLEM
1	CD	I-PROBLEM
at	IN	O
the	DT	O
site	NN	O
of	IN	O
prior	JJ	B-TREATMENT
ptca	NN	I-TREATMENT
.	.	O

he	PRP	O
received	VBD	O
an	DT	B-TREATMENT
angio-seal	JJ	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
common	JJ	I-TREATMENT
femoral	JJ	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

he	PRP	O
then	RB	O
underwent	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
pe	NN	I-PROBLEM
.	.	O

he	PRP	O
underwent	VBD	O
lower	JJR	B-TEST
extremity	NN	I-TEST
study	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
dvt	NN	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
legs	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	O
episode	NN	O
of	IN	O
desaturation	NN	B-PROBLEM
into	IN	I-PROBLEM
the	DT	I-PROBLEM
80%	CD	I-PROBLEM
range	NN	I-PROBLEM
while	IN	O
sleeping	VBG	O
.	.	O

pulmonary	JJ	B-TEST
consult	NN	I-TEST
was	VBD	O
done	VBN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
should	MD	O
undergo	VB	O
a	DT	B-TEST
formal	JJ	I-TEST
sleep	NN	I-TEST
study	NN	I-TEST
,	,	O
full	JJ	B-TEST
pfts	NN	I-TEST
,	,	O
and	CC	O
a	DT	B-TEST
repeat	NN	I-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
in	IN	O
1	CD	O
year	NN	O
to	TO	O
assess	VB	O
for	IN	O
pulmonary	JJ	B-PROBLEM
nodule	NN	I-PROBLEM
that	WDT	O
was	VBD	O
seen	VBN	O
.	.	O

however	RB	O
,	,	O
please	VB	O
note	NN	O
that	IN	O
this	DT	B-PROBLEM
nodule	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
stable	JJ	O
over	IN	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
complained	VBD	O
of	IN	O
intermittent	NN	B-PROBLEM
right	NN	I-PROBLEM
neck	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
,	,	O
and	CC	O
recommendations	NNS	O
are	VBP	O
to	TO	O
consider	VB	O
a	DT	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
with	IN	I-TEST
contrast	NN	I-TEST
to	TO	O
evaluate	VB	O
nodes	NNS	B-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

on	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
today	NN	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
swelling	NN	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
states	VBZ	O
that	IN	O
he	PRP	O
did	VBD	O
not	RB	O
feel	VB	O
the	DT	B-PROBLEM
swelling	NN	I-PROBLEM
was	VBD	O
present	JJ	O
.	.	O

the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
adenosine	JJ	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
,	,	O
where	WRB	O
he	PRP	O
exercised	VBD	O
for	IN	O
4	CD	O
minutes	NNS	O
,	,	O
reaching	VBG	O
65%	CD	O
of	IN	O
predicted	JJ	O
heart	NN	O
rate	NN	O
.	.	O

he	PRP	O
did	VBD	O
not	RB	O
have	VB	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

ekg	NN	B-TEST
was	VBD	O
negative	JJ	O
for	IN	O
ischemia	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
myocardial	JJ	I-TEST
perfusion	NN	I-TEST
images	NNS	I-TEST
show	VBP	O
no	DT	O
definite	JJ	O
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
lv	NN	I-TEST
contractile	NN	I-TEST
function	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

there	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
vasal	NN	I-PROBLEM
thinning	NN	I-PROBLEM
.	.	O

he	PRP	O
underwent	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
an	DT	B-TEST
ef	NN	I-TEST
of	IN	O
60%	CD	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
mvp	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
trace	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
la	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
trace	NN	B-PROBLEM
aortic	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
lv	JJ	B-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
obvious	JJ	O
segmental	JJ	B-PROBLEM
wall-motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
ventricle	NN	O
was	VBD	O
not	RB	O
dilated	VBN	B-PROBLEM
.	.	O

the	DT	B-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

the	DT	O
patient	NN	O
underwent	VBD	O
a	DT	B-TEST
sleep	NN	I-TEST
study	NN	I-TEST
,	,	O
the	DT	O
first	JJ	O
part	NN	O
,	,	O
which	WDT	O
showed	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
75	CD	B-PROBLEM
respiratory	JJ	I-PROBLEM
events	NNS	I-PROBLEM
observed	VBN	O
with	IN	O
apnea	NN	B-PROBLEM
,	,	O
hypopnea	NN	B-TEST
index	NN	I-TEST
of	IN	O
11	CD	O
an	DT	O
hour	NN	O
.	.	O

the	DT	B-TEST
mean	JJ	I-TEST
heart	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
68	CD	O
.	.	O

they	PRP	O
felt	VBD	O
that	IN	O
there	EX	O
was	VBD	O
obstruction	NN	B-PROBLEM
and	CC	O
possible	JJ	O
obstruction	NN	B-PROBLEM
to	TO	I-PROBLEM
airflow	VB	I-PROBLEM
generating	VBG	O
some	DT	B-PROBLEM
obstructive	JJ	I-PROBLEM
apnea	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
partial	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
events	NNS	I-PROBLEM
.	.	O

they	PRP	O
recommended	VBD	O
that	IN	O
the	DT	O
patient	NN	O
may	MD	O
benefit	VB	O
from	IN	O
a	DT	O
trial	NN	O
of	IN	O
continuous	JJ	B-TREATMENT
positive	JJ	I-TREATMENT
pressure	NN	I-TREATMENT
at	IN	I-TREATMENT
the	DT	I-TREATMENT
bedside	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
scheduled	VBN	O
to	TO	O
have	VB	O
the	DT	O
second	JJ	O
part	NN	O
of	IN	O
the	DT	B-TEST
sleep	NN	I-TEST
study	NN	I-TEST
done	VBN	O
on	IN	O
june	NN	O
18	CD	O
,	,	O
2006	CD	O
,	,	O
at	IN	O
8:30	CD	O
p.m.	NN	O
at	IN	O
rwh	NN	O
in	IN	O
the	DT	O
esley	NN	O
community	NN	O
hospital	NN	O
,	,	O
10th	CD	O
floor	NN	O
sleep	NN	O
lab	NN	O
,	,	O
phone	NN	O
number	NN	O
133-225-1257	JJ	O
.	.	O

prior	RB	O
to	TO	O
discharge	VB	O
today	NN	O
,	,	O
he	PRP	O
underwent	JJ	O
pfts	NNS	B-TEST
.	.	O

the	DT	O
results	NNS	O
of	IN	O
the	DT	B-TEST
pfts	NNS	I-TEST
are	VBP	O
unavailable	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
.	.	O

based	VBN	O
on	IN	O
all	PDT	B-TEST
the	DT	I-TEST
tests	NNS	I-TEST
above	IN	I-TEST
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
for	IN	O
discharge	NN	O
home	NN	O
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
114	CD	O
to	TO	O
123/62	CD	O
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
69	CD	O
to	TO	O
80	CD	O
.	.	O

room	NN	B-TEST
air	NN	I-TEST
saturation	NN	I-TEST
96%	CD	O
.	.	O

temperature	NN	B-TEST
97.9	CD	O
.	.	O

lung	NN	B-TEST
sounds	VBZ	I-TEST
clear	JJ	O
bilaterally	RB	O
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
;	:	O
s1-s2	JJ	O
;	:	O
positive	JJ	O
s4	NN	O
;	:	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

soft	JJ	O
,	,	O
nontender	NN	O
,	,	O
nondistended	VBD	O
;	:	O
no	DT	O
guarding	NN	B-PROBLEM
;	:	O
no	DT	O
masses	NNS	B-PROBLEM
;	:	O
positive	JJ	O
bowel	NN	B-TEST
sounds	VBZ	I-TEST
x4	JJ	O
.	.	O

right	RB	O
groin	NN	O
status	NN	B-PROBLEM
post	NN	I-PROBLEM
catheterization	NN	I-PROBLEM
showed	VBD	O
no	DT	O
hematoma	NN	B-PROBLEM
or	CC	O
bruit	NN	B-PROBLEM
.	.	O

lower	JJR	B-TEST
extremity	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
intact	JJ	O
without	IN	O
any	DT	O
edema	NN	B-PROBLEM
.	.	O

sodium	NN	B-TEST
139	CD	O
;	:	O
potassium	NN	B-TEST
4.1	CD	O
;	:	O
bun	CC	B-TEST
15	CD	O
;	:	O
creatinine	NN	B-TEST
1.1	CD	O
;	:	O
magnesium	NN	B-TEST
1.6	CD	O
;	:	O
sgpt	JJ	B-TEST
19	CD	O
;	:	O
sgot	VBD	B-TEST
20	CD	O
;	:	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
66	CD	O
;	:	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.6	CD	O
;	:	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
0.2	CD	O
;	:	O
total	JJ	B-TEST
cholesterol	NN	I-TEST
234	CD	O
;	:	O
triglycerides	NNS	B-TEST
274	CD	O
;	:	O
hdl	JJ	B-TEST
44	CD	O
;	:	O
ldl	CC	B-TEST
135	CD	O
;	:	O
hemoglobin	NN	B-TEST
a1c	VBZ	B-TEST
6.7	CD	O
;	:	O
white	JJ	B-TEST
cell	NN	I-TEST
count	NN	I-TEST
6.1	CD	O
;	:	O
hematocrit	NN	B-TEST
36.4	CD	O
;	:	O
platelet	NN	B-TEST
count	NN	I-TEST
201	CD	O
.	.	O

during	IN	O
the	DT	O
hospital	NN	O
course	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
ppi	NN	I-TREATMENT
,	,	O
nexium	NN	B-TREATMENT
,	,	O
for	IN	O
concerns	NNS	O
of	IN	O
acid	NN	B-PROBLEM
reflux	NN	I-PROBLEM
.	.	O

also	RB	O
,	,	O
a	DT	O
long	JJ	O
discussion	NN	O
was	VBD	O
taken	VBN	O
with	IN	O
the	DT	O
patient	NN	O
as	IN	O
most	JJS	O
of	IN	O
his	PRP$	B-PROBLEM
chest	JJS	I-PROBLEM
discomfort	NN	I-PROBLEM
happens	VBZ	O
when	WRB	O
he	PRP	O
is	VBZ	O
quite	RB	O
anxious	JJ	B-PROBLEM
.	.	O

he	PRP	O
used	VBD	O
ativan	NN	B-TREATMENT
in	IN	O
the	DT	O
hospital	NN	O
,	,	O
which	WDT	O
helped	VBD	O
him	PRP	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
advised	VBN	O
that	IN	O
he	PRP	O
needs	VBZ	O
to	TO	O
speak	VB	O
with	IN	O
his	PRP$	O
pcp	NN	O
about	IN	O
medication	NN	B-TREATMENT
for	IN	I-TREATMENT
antianxiety	NN	I-TREATMENT
and	CC	O
/	NN	O
or	CC	O
further	JJ	B-TEST
testing	NN	I-TEST
or	CC	O
counseling	NN	B-TREATMENT
to	TO	O
help	VB	O
control	VB	O
his	PRP$	B-PROBLEM
anxiety	NN	I-PROBLEM
level	NN	I-PROBLEM
.	.	O

nitroglycerin	RB	B-TREATMENT
1	CD	O
tablet	NN	O
sublingual	JJ	O
q.	NN	O
5	CD	O
minutes	NNS	O
x3	JJ	O
p.r.n.	JJ	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

tricor	NN	B-TREATMENT
145	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

lipitor	NN	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

plavix	NN	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
p.o.	JJ	O
every	DT	O
day	NN	O
.	.	O

lisinopril	RB	B-TREATMENT
5	CD	O
mg	NNS	O
p.o.	JJ	O
every	DT	O
day	NN	O
.	.	O

avandia	RB	B-TREATMENT
4	CD	O
mg	NNS	O
p.o.	JJ	O
every	DT	O
day	NN	O
.	.	O

toprol	NN	B-TREATMENT
xl	VBZ	I-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

prilosec	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
every	DT	O
day	NN	O
.	.	O

ativan	RB	B-TREATMENT
0.5	CD	O
mg	NNS	O
p.o.	JJ	O
b.i.d.	JJ	O
p.r.n.	NN	O
anxiety	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
told	VBN	O
that	IN	O
he	PRP	O
should	MD	O
discus	VB	O
with	IN	O
his	PRP$	O
pcp	NN	O
further	RBR	B-TEST
gi	NN	I-TEST
testing	VBG	I-TEST
,	,	O
as	RB	O
well	RB	O
as	IN	O
medications	NNS	B-TREATMENT
for	IN	O
anxiety	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
will	MD	O
need	VB	O
to	TO	O
have	VB	O
a	DT	B-TEST
followup	JJ	I-TEST
sleep	NN	I-TEST
study	NN	I-TEST
done	VBN	O
as	IN	O
above	IN	O
per	IN	O
the	DT	O
recommendations	NNS	O
based	VBN	O
on	IN	O
the	DT	O
results	NNS	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
cp	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
ro	VB	O
woodma	NN	O
healthcare	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
kotedaizreke	VBN	O
,	,	O
lila	RBR	O
and	CC	O
the	DT	O
preliminary	JJ	O
admitting	NN	O
diagnosis	NN	O
is	VBZ	O
cp	JJ	B-PROBLEM
.	.	O

acute	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

acute	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O

2.	CD	O
unstable	JJ	B-PROBLEM
angina	NN	I-PROBLEM
(	(	I-PROBLEM
postmyocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
angina	NN	I-PROBLEM
)	)	I-PROBLEM
,	,	O

3.	CD	O
parkinson	NN	B-PROBLEM
&apos;s	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
and	CC	O
coronary	JJ	B-TREATMENT
atherectomy	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
,	,	O
8-17-93	CD	O
,	,	O

2.	CD	O
relook	NN	O
coronary	JJ	B-TEST
angiogram	NN	I-TEST
,	,	O
08-18-93	NN	O
.	.	O

ecotrin	RB	B-TREATMENT
1	CD	O
tablet	NN	O
po	NN	O
qd	NN	O
,	,	O
captopril	VBP	B-TREATMENT
6.25	CD	O
mg	NN	O
po	NN	O
tid	NN	O
,	,	O
k-dur	JJ	B-TREATMENT
20	CD	O
meq.	NN	O
po	NN	O
qd	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O
,	,	O
isordil	JJ	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
tid	NN	O
,	,	O
sinemet	VBD	B-TREATMENT
1/2	CD	O
tablet	NN	O
po	NN	O
bid	NN	O
,	,	O
symmetrel	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
,	,	O
parloder	NN	B-TREATMENT
2.5mg	CD	O
po	NN	O
qd	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
58	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
parkinson	NN	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
for	IN	O
more	JJR	O
than	IN	O
twenty	CD	O
years	NNS	O
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
gemenadentoolpai	JJ	O
medical	JJ	O
center	NN	O
with	IN	O
a	DT	B-PROBLEM
revolving	VBG	I-PROBLEM
anterolateral	JJ	I-PROBLEM
wall	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
on	IN	O
08-01-93	NN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
dr.	NN	O
aalv	NN	O
manual	JJ	O
and	CC	O
was	VBD	O
referred	VBN	O
here	RB	O
for	IN	O
further	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
prior	JJ	O
significant	JJ	O
cardiac	JJ	O
history	NN	O
and	CC	O
presented	VBD	O
to	TO	O
her	PRP$	O
local	JJ	O
medical	JJ	O
doctor	NN	O
&apos;s	NNP	O
office	NN	O
with	IN	O
an	DT	O
episode	NN	O
of	IN	O
severe	JJ	B-PROBLEM
retrosternal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
right	NN	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
anterior	JJ	I-PROBLEM
hemiblock	NN	I-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
hospital	JJ	I-TREATMENT
course	NN	I-TREATMENT
was	VBD	O
remarkable	JJ	O
for	IN	O
ruling	VBG	O
in	IN	O
for	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
cpk	NN	I-TEST
of	IN	O
9,379	CD	O
units	NNS	O
with	IN	O
a	DT	O
5.9%	CD	O
mb	NN	O
fraction	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
on	IN	O
telemetry	NN	B-TEST
she	PRP	O
developed	VBD	O
complete	JJ	B-PROBLEM
heart	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
requiring	VBG	O
temporary	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
wire	NN	I-TREATMENT
and	CC	O
then	RB	O
a	DT	B-TREATMENT
permanent	JJ	I-TREATMENT
pacemaker	NN	I-TREATMENT
implantation	NN	I-TREATMENT
on	IN	O
08-03-93	NN	O
.	.	O

she	PRP	O
developed	VBD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
required	VBD	O
pressor	NN	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

she	PRP	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
on	IN	O
8-15-93	JJ	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
end	NN	I-TEST
diastolic	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
28	CD	O
millimeters	NNS	O
of	IN	O
mercury	NN	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
dominant	JJ	I-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
with	IN	O
minor	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
main	JJ	O
left	VBD	O
coronary	JJ	O
artery	NN	O
had	VBD	O
a	DT	B-PROBLEM
20%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

the	DT	O
left	JJ	O
anterior	JJ	O
descending	NN	O
had	VBD	O
a	DT	B-PROBLEM
severe	JJ	I-PROBLEM
80%	CD	I-PROBLEM
proximal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
filling	VBG	I-PROBLEM
defect	JJ	I-PROBLEM
consistent	NN	O
with	IN	O
intraluminal	JJ	B-PROBLEM
thrombus	NN	I-PROBLEM
.	.	O

the	DT	O
circumflex	JJ	O
artery	NN	O
had	VBD	O
a	DT	B-PROBLEM
minor	JJ	I-PROBLEM
40%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

cine	NN	B-TEST
left	VBD	I-TEST
ventriculogram	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
left	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
with	IN	O
an	DT	B-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
anterolateral	JJ	I-PROBLEM
,	,	I-PROBLEM
apical	JJ	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
septal	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
was	VBD	O
estimated	VBN	O
to	TO	O
38%	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
heaonboburg	NN	O
linpack	NN	O
grant	NN	O
medical	JJ	O
center	NN	O
for	IN	O
consideration	NN	O
of	IN	O
coronary	JJ	B-TREATMENT
angioplasty	NN	I-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
included	VBD	O
a	DT	B-PROBLEM
positive	JJ	I-PROBLEM
family	NN	I-PROBLEM
history	NN	I-PROBLEM
and	CC	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
cholesterol	NN	I-PROBLEM
level	NN	I-PROBLEM
.	.	O

her	PRP$	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
remarkable	JJ	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
parkinson	NN	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
revealed	VBD	O
a	DT	O
pleasant	JJ	O
lady	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
120/70	CD	O
millimeters	NNS	O
of	IN	O
mercury	NN	O
.	.	O

her	PRP$	B-TEST
pulse	NN	I-TEST
was	VBD	O
regular	JJ	O
at	IN	O
80	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

the	DT	B-TEST
jugular	JJ	I-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
elevated	VBN	O
at	IN	O
6	CD	O
cm	NNS	O
above	IN	O
the	DT	O
sternal	JJ	O
angle	NN	O
.	.	O

the	DT	B-TEST
cardiac	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
anapical	JJ	B-PROBLEM
impulse	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
fifth	NN	I-PROBLEM
left	VBD	I-PROBLEM
intercostal	JJ	I-PROBLEM
space	NN	I-PROBLEM
,	,	O
left	VBD	O
to	TO	O
mid	VB	O
clavicular	JJ	O
line	NN	O
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
murmurs	NNS	B-PROBLEM
and	CC	O
no	DT	O
gallops	NNS	B-PROBLEM
.	.	O

the	DT	B-TEST
examination	NN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
was	VBD	O
benign	JJ	O
.	.	O

the	DT	B-TEST
examination	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
extremities	NNS	I-TEST
showed	VBD	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
revealed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
,	,	O
left	VBD	B-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
poor	JJ	B-PROBLEM
r-wave	JJ	I-PROBLEM
progression	NN	I-PROBLEM
in	IN	O
v1	NN	O
through	IN	O
v4	NN	O
,	,	O
consistent	JJ	O
with	IN	O
marked	JJ	O
clockwise	NN	O
rotation	NN	O
,	,	O
cannot	NN	O
rule	NN	O
out	IN	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
anteroseptal	NN	I-PROBLEM
wall	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
prominent	JJ	B-PROBLEM
q-waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
avl	NN	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
lateral	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
non-specific	JJ	B-PROBLEM
st-t	JJ	I-PROBLEM
wave	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
neurology	NN	O
department	NN	O
because	IN	O
of	IN	O
the	DT	O
history	NN	O
of	IN	O
parkinson	NN	B-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
.	.	O

on	IN	O
8-17-93	JJ	O
,	,	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
catheterization	NN	O
laboratory	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
proximal	JJ	I-TREATMENT
left	VBD	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
.	.	O

following	VBG	O
balloon	NN	B-TREATMENT
angioplasty	RB	I-TREATMENT
,	,	O
there	EX	O
was	VBD	O
a	DT	B-TREATMENT
local	JJ	I-TREATMENT
dissection	NN	I-TREATMENT
with	IN	O
evidence	NN	O
of	IN	O
intraluminal	JJ	B-PROBLEM
thrombus	NN	I-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
10%	CD	I-PROBLEM
loss	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
initial	JJ	I-PROBLEM
gain	NN	I-PROBLEM
following	VBG	O
coronary	JJ	B-TREATMENT
angioplasty	NN	I-TREATMENT
.	.	O

therefore	RB	O
,	,	O
directional	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
atherectomy	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
with	IN	O
an	DT	O
excellent	JJ	O
angiographic	JJ	O
outcome	NN	O
,	,	O
and	CC	O
a	DT	B-PROBLEM
less	JJR	I-PROBLEM
than	IN	I-PROBLEM
10%	CD	I-PROBLEM
residual	JJ	I-PROBLEM
narrowing	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
and	CC	O
was	VBD	O
brought	VBN	O
back	RB	O
to	TO	O
the	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
laboratory	NN	I-TEST
on	IN	O
08-18-93	NN	O
for	IN	O
a	DT	B-TEST
relook	NN	I-TEST
coronary	JJ	I-TEST
angiography	NN	I-TEST
.	.	O

coronary	JJ	B-TEST
angiography	NN	I-TEST
demonstrated	VBD	O
ongoing	JJ	O
benefit	NN	O
of	IN	O
the	DT	B-TREATMENT
initial	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
atherectomy	NN	I-TREATMENT
.	.	O

specifically	RB	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
decrease	NN	O
in	IN	O
the	DT	O
initial	JJ	O
gain	NN	O
that	IN	O
she	PRP	O
achieved	VBD	O
after	IN	O
directional	JJ	B-TREATMENT
atherectomy	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
in	IN	O
stable	JJ	O
condition	NN	O
to	TO	O
the	DT	O
pasi	NN	O
for	IN	O
further	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

1)	CD	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
pseudomonas	NNS	I-PROBLEM
cellulitis	NN	I-PROBLEM
.	.	O

2)	CD	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

3)	CD	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
.	.	O

4)	CD	O
steroid	NN	B-PROBLEM
induced	VBN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

5)	CD	O
plasmacytoma	NN	B-PROBLEM
.	.	O

6)	CD	O
poor	JJ	B-PROBLEM
nutritional	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

7)	CD	O
thrombocytopenia	NN	B-PROBLEM
status	NN	O
post	NN	O
bone	NN	B-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

8)	CD	O
multiple	JJ	B-PROBLEM
myeloma	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
multiple	VBN	B-PROBLEM
myeloma	NNS	I-PROBLEM
since	IN	O
1990	CD	O
.	.	O

he	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
autologous	JJ	I-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
10/92	CD	O
at	IN	O
petersly	RB	O
hospital	JJ	O
and	CC	O
medical	JJ	O
center	NN	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
he	PRP	O
received	VBD	O
total	JJ	B-TREATMENT
body	NN	I-TREATMENT
irradiation	NN	I-TREATMENT
of	IN	O
1400	CD	O
cgy	NN	O
.	.	O

this	DT	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
did	VBD	O
not	RB	O
produce	VB	O
remission	NN	O
and	CC	O
then	RB	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
three	CD	B-TREATMENT
cycles	NNS	I-TREATMENT
of	IN	I-TREATMENT
vad	NN	I-TREATMENT
subsequently	RB	O
.	.	O

in	IN	O
08/94	CD	O
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
lower	JJR	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
workup	NN	I-TEST
done	VBN	O
in	IN	O
de	NN	O
is	VBZ	O
not	RB	O
available	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
.	.	O

according	VBG	O
to	TO	O
her	PRP$	O
scanty	NN	O
records	NNS	O
,	,	O
an	DT	B-TEST
mri	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
spine	NN	I-TEST
showed	VBD	O
diffuse	IN	B-PROBLEM
spinal	JJ	I-PROBLEM
column	NN	I-PROBLEM
involvement	NN	I-PROBLEM
with	IN	O
lesions	NNS	B-PROBLEM
in	IN	I-PROBLEM
t4	NN	I-PROBLEM
and	CC	I-PROBLEM
t8	NN	I-PROBLEM
with	IN	O
no	DT	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

he	PRP	O
was	VBD	O
then	RB	O
treated	VBN	O
with	IN	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
from	IN	O
t3	NN	O
to	TO	O
t9	VB	O
receiving	VBG	O
2500	CD	O
cgy	NN	O
from	IN	O
08/94	CD	O
to	TO	O
09/94	CD	O
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
decadron	NN	B-TREATMENT
since	IN	O
08/94	CD	O
.	.	O

about	RB	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	VB	O
the	DT	O
patient	NN	O
developed	VBD	O
mid	VB	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
burning	VBG	O
in	IN	O
nature	NN	O
with	IN	O
radiation	NN	O
around	IN	O
the	DT	O
right	NN	O
lower	JJR	O
ribs	NN	O
.	.	O

he	PRP	O
also	RB	O
began	VBD	O
to	TO	O
develop	VB	O
noticeably	RB	B-PROBLEM
increasing	VBG	I-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
possibly	RB	O
numbness	RB	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

he	PRP	O
stated	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
difficulty	NN	B-PROBLEM
rising	VBG	I-PROBLEM
from	IN	I-PROBLEM
a	DT	I-PROBLEM
chair	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
mri	NN	I-TEST
without	IN	I-TEST
gadolinium	NN	I-TEST
done	VBN	O
on	IN	O
11/20/94	CD	O
of	IN	O
the	DT	O
spine	NN	O
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
posterior	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
epidural	JJ	I-PROBLEM
mass	NN	I-PROBLEM
extending	VBG	O
from	IN	O
t9	NN	O
to	TO	O
t12	VB	O
.	.	O

there	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
cord	NN	B-PROBLEM
compression	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
decadron	NN	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
12	CD	O
mg	NNS	O
q	JJ	O
day	NN	O
and	CC	O
he	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
and	CC	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
being	VBG	O
planned	VBN	O
and	CC	O
arranged	VBN	O
at	IN	O
the	DT	O
petersly	JJ	O
hospital	NN	O
and	CC	O
medical	JJ	O
center	NN	O
.	.	O

however	RB	O
,	,	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	VB	O
the	DT	O
patient	NN	O
developed	VBD	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
could	MD	O
not	RB	O
walk	VB	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
next	JJ	O
12	CD	O
hours	NNS	O
while	IN	O
in	IN	O
transit	NN	O
to	TO	O
the	DT	O
hospital	NN	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NN	O
right	RB	O
lower	JJR	O
extremity	NN	O
became	VBD	O
red	JJ	B-PROBLEM
,	,	O
swollen	VBN	B-PROBLEM
,	,	O
and	CC	O
increasingly	RB	B-PROBLEM
painful	JJ	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
chronic	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
since	IN	O
his	PRP$	B-TREATMENT
transplant	NN	I-TREATMENT
but	CC	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
swelling	NN	I-PROBLEM
was	VBD	O
noticeably	RB	O
increased	VBN	O
.	.	O

he	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
some	DT	B-PROBLEM
fecal	JJ	I-PROBLEM
incontinence	NN	I-PROBLEM
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
without	IN	O
urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
presentation	NN	O
the	DT	O
patient	NN	O
denied	VBD	O
headache	NN	B-PROBLEM
,	,	O
arm	NN	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
changes	NNS	B-PROBLEM
in	IN	I-PROBLEM
vision	NN	I-PROBLEM
,	,	O
dysarthria	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
chest	VBP	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
huyychestleme	VB	O
health	NN	O
of	IN	O
in	IN	O
scoo	NN	O
,	,	O
utah	NN	O
where	WRB	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
99.9	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
90/50	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
128	CD	O
,	,	O
and	CC	O
o2	JJ	B-TEST
sat	NN	I-TEST
of	IN	O
91%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
,	,	O
urine	JJ	B-TEST
culture	NN	I-TEST
,	,	O
and	CC	O
ua	NNS	B-TEST
were	VBD	O
all	DT	O
done	VBN	O
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
drawn	VBN	O
on	IN	O
admission	NN	O
subsequently	RB	O
grew	VBD	O
pseudomonas	JJ	B-PROBLEM
aeruginosa	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
ceftazidime	NN	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
vancomycin	NN	B-TREATMENT
and	CC	O
also	RB	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
dopamine	NN	I-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
treatment	NN	O
of	IN	O
his	PRP$	B-PROBLEM
sepsis	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
swan	NN	I-TEST
was	VBD	O
placed	VBN	O
and	CC	O
initial	JJ	O
readings	NNS	O
were	VBD	O
cvp	NNS	B-TEST
of	IN	O
6	CD	O
,	,	O
wedge	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
10	CD	O
to	TO	O
12	CD	O
,	,	O
cardiac	JJ	B-TEST
index	NN	I-TEST
of	IN	O
4.7	CD	O
,	,	O
and	CC	O
svr	NN	B-TEST
of	IN	O
438	CD	O
all	DT	O
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
pseudomonas	JJ	I-PROBLEM
sepsis	NN	I-PROBLEM
picture	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
stress	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
and	CC	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
lorough	VB	O
medical	JJ	O
center	NN	O
&apos;s	NNP	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

1)	CD	O
multiple	JJ	B-PROBLEM
myeloma	NN	I-PROBLEM
.	.	O

2)	CD	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

3)	CD	O
plasmacytoma	NN	B-PROBLEM
of	IN	I-PROBLEM
t9	NN	I-PROBLEM
through	IN	I-PROBLEM
t12	NN	I-PROBLEM
.	.	O

4)	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

5)	CD	O
chronically	RB	B-PROBLEM
low	JJ	I-PROBLEM
platelet	NN	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

6)	CD	O
failed	VBD	B-TREATMENT
autologous	JJ	I-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
10/92	CD	O
.	.	O

7)	CD	O
hypothyroidism	NN	B-PROBLEM
.	.	O

positive	JJ	O
for	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

question	NN	O
of	IN	O
penicillin	NN	B-TREATMENT
and	CC	O
sulfa	NN	B-TREATMENT
drugs	NNS	I-TREATMENT
leading	VBG	O
to	TO	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

on	IN	O
transfer	NN	O
include	VBP	O
vancomycin	NN	B-TREATMENT
,	,	O
ceftazidime	NN	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
solu	JJ	B-TREATMENT
cortef	NN	I-TREATMENT
100	CD	O
mg	NN	O
q8h	NN	O
,	,	O
lasix	NN	B-TREATMENT
,	,	O
synthroid	NN	B-TREATMENT
,	,	O
insulin	NN	B-TREATMENT
,	,	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
60	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
mso4	FW	B-TREATMENT
2	CD	O
mg	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
iv	NN	O
,	,	O
dopamine	VB	B-TREATMENT
12	CD	O
mcg	NNS	O
per	IN	O
minute	NN	O
.	.	O

on	IN	O
admission	NN	O
showed	VBD	O
a	DT	O
non-toxic	JJ	O
appearing	VBG	O
male	NN	O
with	IN	O
temperature	NN	B-TEST
99.5	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
82/50	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
118	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
15	CD	O
.	.	O

heent	NN	B-TEST
exam	NN	I-TEST
atraumatic	JJ	B-PROBLEM
,	,	O
no	DT	O
oral	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

neck	NN	O
supple	NN	O
,	,	O
carotids	NNS	O
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
regular	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

chest	NN	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
with	IN	O
a	DT	B-PROBLEM
few	JJ	I-PROBLEM
fine	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

abdomen	NNS	O
non-distended	JJ	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
or	CC	O
masses	NNS	B-PROBLEM
.	.	O

rectal	JJ	O
normal	JJ	O
tone	NN	O
,	,	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
brown	NN	I-PROBLEM
stool	NN	I-PROBLEM
,	,	O
no	DT	O
perirectal	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
or	CC	O
erythema	NN	B-PROBLEM
.	.	O

extremities	NNS	O
reveal	VBP	O
the	DT	O
right	NN	O
lower	JJR	O
extremity	NN	O
was	VBD	O
tense	JJ	B-PROBLEM
,	,	O
purple-red	JJ	B-PROBLEM
,	,	O
swollen	JJ	B-PROBLEM
,	,	O
and	CC	O
was	VBD	O
warm	VBN	O
from	IN	O
the	DT	O
knee	NN	O
to	TO	O
the	DT	O
ankle	NN	O
and	CC	O
extremely	RB	B-PROBLEM
tender	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
pitting	VBG	B-PROBLEM
edema	NN	I-PROBLEM
of	IN	I-PROBLEM
both	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
cellulitis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

neurological	JJ	B-TEST
exam	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
revealed	VBD	O
he	PRP	O
was	VBD	O
drowsy	RB	B-PROBLEM
but	CC	O
easily	RB	O
arousable	JJ	O
to	TO	O
voice	NN	O
,	,	O
oriented	VBN	O
to	TO	O
person	NN	O
,	,	O
retelk	VB	O
county	RB	O
medical	JJ	O
center	NN	O
,	,	O
and	CC	O
date	NN	O
,	,	O
able	JJ	O
to	TO	O
say	VB	O
no	DT	O
but	CC	O
mildly	RB	B-PROBLEM
inattentive	JJ	I-PROBLEM
during	IN	O
examination	NN	B-TEST
.	.	O

motor	NN	B-TEST
exam	NN	I-TEST
normal	JJ	O
tone	NN	O
,	,	O
positive	JJ	B-PROBLEM
asterixis	NN	I-PROBLEM
,	,	O
no	DT	O
drift	NN	O
.	.	O

deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
2+	CD	O
in	IN	O
the	DT	O
upper	JJ	O
extremities	NNS	O
,	,	O
1+	CD	O
in	IN	O
the	DT	O
patella	NN	B-TEST
reflexes	NNS	I-TEST
,	,	O
no	DT	B-PROBLEM
reflexes	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
ankles	NNS	I-PROBLEM
,	,	O
upgoing	VBG	O
babinski	NN	O
toes	NNS	O
bilaterally	RB	O
.	.	O

on	IN	O
admission	NN	O
revealed	VBN	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
4.2	CD	O
,	,	O
hct	NN	B-TEST
27	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
28	CD	O
.	.	O

glucose	RB	B-TEST
191	CD	O
.	.	O

pt	NN	B-TEST
17.6	CD	O
,	,	O
ptt	NN	B-TEST
48.7	CD	O
,	,	O
fibrinogen	NN	B-TEST
686	CD	O
,	,	O
tt	VBD	B-TEST
39.2	CD	O
.	.	O

magnesium	NN	B-TEST
1.7	CD	O
.	.	O

ua	NN	B-TEST
showed	VBD	O
no	DT	O
white	JJ	O
blood	NN	O
cells	NNS	O
,	,	O
positive	JJ	B-PROBLEM
granular	JJ	I-PROBLEM
casts	NNS	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
without	IN	O
infiltrates	NNS	B-PROBLEM
,	,	O
wand	NN	O
in	IN	O
good	JJ	O
position	NN	O
.	.	O

an	DT	B-TEST
mri	NN	I-TEST
was	VBD	O
performed	VBN	O
upon	IN	O
admission	NN	O
and	CC	O
showed	VBD	O
an	DT	B-PROBLEM
epidural	JJ	I-PROBLEM
mass	NN	I-PROBLEM
at	IN	O
the	DT	O
right	JJ	O
posterior	JJ	O
lateral	JJ	O
t9	NN	O
to	TO	O
t12	VB	O
area	NN	O
invading	VBG	O
the	DT	O
neural	JJ	O
foramina	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
csf	JJ	B-PROBLEM
density	NN	I-PROBLEM
.	.	O

these	DT	B-PROBLEM
findings	NNS	I-PROBLEM
were	VBD	O
consistent	JJ	O
with	IN	O
the	DT	B-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
clinical	JJ	I-PROBLEM
situation	NN	I-PROBLEM
was	VBD	O
most	RBS	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
pseudomonas	JJ	I-PROBLEM
cellulitis	NN	I-PROBLEM
and	CC	O
subsequent	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
drawn	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
grew	VBD	O
out	RP	O
pseudomonas	NNS	B-PROBLEM
that	WDT	O
was	VBD	O
sensitive	JJ	O
to	TO	O
imipenem	VB	B-TREATMENT
and	CC	O
tobramycin	VB	B-TREATMENT
.	.	O

there	EX	O
were	VBD	O
cultures	NNS	B-TEST
obtained	VBN	O
seeping	VBG	O
from	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
at	IN	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
and	CC	O
those	DT	O
also	RB	O
grew	VBD	O
out	RP	O
pseudomonas	JJ	B-PROBLEM
aeruginosa	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
organism	NN	I-PROBLEM
grown	VBN	O
at	IN	O
this	DT	O
institution	NN	O
was	VBD	O
sensitive	JJ	O
to	TO	O
imipenem	VB	B-TREATMENT
,	,	O
ceftazidime	NN	B-TREATMENT
,	,	O
amikacin	NN	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
ciprofloxacin	NN	B-TREATMENT
,	,	O
tobramycin	NN	B-TREATMENT
but	CC	O
was	VBD	O
resistant	JJ	O
to	TO	O
cefotetan	VB	B-TREATMENT
,	,	O
ceftriaxone	NN	B-TREATMENT
,	,	O
mezlocillin	NN	B-TREATMENT
,	,	O
bactrim	NN	B-TREATMENT
,	,	O
ampicillin	NN	B-TREATMENT
,	,	O
chloramphenicol	NN	B-TREATMENT
,	,	O
and	CC	O
sulbactam	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
initially	RB	O
with	IN	O
ceftazidime	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
but	CC	O
there	EX	O
was	VBD	O
a	DT	O
question	NN	O
about	IN	O
the	DT	B-PROBLEM
organism	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
susceptibility	NN	I-PROBLEM
from	IN	O
lab	NN	B-TEST
studies	NNS	I-TEST
done	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

he	PRP	O
was	VBD	O
subsequently	RB	O
switched	VBN	O
to	TO	O
imipenem	VB	B-TREATMENT
and	CC	O
tobramycin	VB	B-TREATMENT
and	CC	O
was	VBD	O
maintained	VBN	O
on	IN	O
those	DT	B-TREATMENT
medications	NNS	I-TREATMENT
throughout	IN	O
the	DT	O
hospital	NN	O
course	NN	O
.	.	O

the	DT	B-TREATMENT
tobramycin	NN	I-TREATMENT
and	CC	O
imipenem	NN	B-TREATMENT
were	VBD	O
started	VBN	O
on	IN	O
11/25/94	CD	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
a	DT	O
five	CD	O
day	NN	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
igg	NN	I-TREATMENT
to	TO	O
improve	VB	O
infection	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

vancomycin	NN	B-TREATMENT
was	VBD	O
also	RB	O
added	VBN	O
to	TO	O
his	PRP$	B-TREATMENT
regimen	NNS	I-TREATMENT
on	IN	O
11/28/94	CD	O
and	CC	O
this	DT	O
was	VBD	O
primarily	RB	O
to	TO	O
provide	VB	O
improved	JJ	B-TREATMENT
mrsa	NN	I-TREATMENT
coverage	NN	I-TREATMENT
as	IN	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
erythema	VBN	B-PROBLEM
along	IN	I-PROBLEM
the	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
surgery	NN	O
department	NN	O
and	CC	O
it	PRP	O
is	VBZ	O
there	RB	O
feeling	VBG	O
that	IN	O
there	EX	O
is	VBZ	O
no	DT	O
indication	NN	O
for	IN	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
/	POS	O
amputation	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

he	PRP	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
with	IN	O
twice	JJ	O
daily	JJ	O
xeroform	NN	B-TREATMENT
with	IN	O
betadine	NN	B-TREATMENT
changes	NNS	O
.	.	O

these	DT	B-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
are	VBP	O
applied	VBN	O
by	IN	O
applying	VBG	O
the	DT	O
xeroform	NN	B-TREATMENT
on	IN	O
betadine	NN	B-TREATMENT
initially	RB	O
and	CC	O
then	RB	O
changing	VBG	O
it	PRP	O
with	IN	O
sterile	JJ	B-TREATMENT
dry	JJ	I-TREATMENT
bandages	NNS	I-TREATMENT
.	.	O

of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
extreme	JJ	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
these	DT	B-TREATMENT
dressing	VBG	I-TREATMENT
changes	NNS	I-TREATMENT
and	CC	O
requires	VBZ	O
parenteral	JJ	B-TREATMENT
morphine	NN	I-TREATMENT
sulfate	NN	I-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
control	NN	I-PROBLEM
during	IN	I-PROBLEM
dressing	VBG	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

the	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
complete	VB	O
a	DT	O
full	JJ	O
course	NN	O
of	IN	O
imipenem	NN	B-TREATMENT
and	CC	O
tobramycin	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
pseudomonas	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
.	.	O

as	IN	O
mentioned	VBN	O
earlier	RBR	O
he	PRP	O
continues	VBZ	O
to	TO	O
have	VB	O
erythema	NN	B-PROBLEM
tracking	VBG	O
up	RP	O
his	PRP$	O
leg	NN	O
and	CC	O
up	RB	O
to	TO	O
his	PRP$	O
lateral	JJ	O
thigh	NN	O
.	.	O

the	DT	O
cause	NN	O
of	IN	O
this	DT	B-PROBLEM
erythema	NN	I-PROBLEM
is	VBZ	O
not	RB	O
know	VBN	O
at	IN	O
this	DT	O
time	NN	O
but	CC	O
has	VBZ	O
not	RB	O
shown	VBN	O
extensive	JJ	O
progression	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
dopamine	NN	B-TREATMENT
which	WDT	O
was	VBD	O
subsequently	RB	O
weaned	VBN	O
off	RP	O
after	IN	O
his	PRP$	B-PROBLEM
sepsis	NN	I-PROBLEM
improved	VBD	O
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
rapid	JJ	B-PROBLEM
af	NN	I-PROBLEM
on	IN	O
several	JJ	O
episodes	NNS	O
receiving	VBG	O
5	CD	B-TREATMENT
mg	JJ	I-TREATMENT
iv	NN	I-TREATMENT
lopressor	IN	I-TREATMENT
each	DT	O
time	NN	O
with	IN	O
improvement	NN	O
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
in	IN	O
and	CC	O
out	IN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
performed	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
while	IN	O
he	PRP	O
was	VBD	O
septic	JJ	B-PROBLEM
showed	VBD	O
decreased	JJ	B-PROBLEM
global	JJ	I-PROBLEM
ef	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
on	IN	O
digoxin	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
paroxysmal	JJ	I-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
significant	JJ	O
episode	NN	O
of	IN	O
tachycardia	NN	B-PROBLEM
or	CC	O
blood	NN	B-PROBLEM
pressure	NN	I-PROBLEM
alteration	NN	I-PROBLEM
during	IN	O
the	DT	O
final	JJ	O
days	NNS	O
of	IN	O
hospitalization	NN	O
.	.	O

the	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
continue	VB	O
the	DT	B-TREATMENT
digoxin	NN	I-TREATMENT
and	CC	O
to	TO	O
recheck	VB	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
to	TO	O
assess	VB	O
his	PRP$	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
when	WRB	O
he	PRP	O
is	VBZ	O
clinically	RB	O
better	RBR	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
plasmacytoma	NN	I-PROBLEM
affecting	VBG	O
the	DT	O
spine	NN	O
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
receiving	VBG	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
that	DT	O
area	NN	O
during	IN	O
the	DT	O
hospital	NN	O
stay	NN	O
.	.	O

the	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
complete	VB	O
a	DT	O
full	JJ	O
course	NN	O
of	IN	O
xrt	NN	B-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
spinal	JJ	I-TREATMENT
region	NN	I-TREATMENT
for	IN	O
the	DT	B-PROBLEM
plasmacytoma	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
lesion	NN	I-PROBLEM
compressing	VBG	O
his	PRP$	O
thoracic	NN	O
spine	NN	O
was	VBD	O
never	RB	O
biopsied	VBN	O
,	,	O
however	RB	O
,	,	O
the	DT	B-TEST
mri	JJ	I-TEST
appearance	NN	O
does	VBZ	O
not	RB	O
seem	VB	O
to	TO	O
be	VB	O
infectious	JJ	B-PROBLEM
and	CC	O
is	VBZ	O
most	RBS	O
consistent	JJ	O
with	IN	O
plasmacytoma	NN	B-PROBLEM
for	IN	O
which	WDT	O
he	PRP	O
is	VBZ	O
receiving	VBG	O
the	DT	B-TREATMENT
radiation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

as	IN	O
mentioned	VBN	O
above	IN	O
he	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
and	CC	O
is	VBZ	O
on	IN	O
steroids	NNS	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
decadron	NN	I-TREATMENT
10	CD	O
mg	NN	O
up	RB	O
front	RB	O
and	CC	O
then	RB	O
6	CD	O
mg	NNS	O
q6h.	NN	O

his	PRP$	B-TEST
neurological	JJ	I-TEST
exam	NN	I-TEST
remained	VBD	O
stable	JJ	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
increasing	VBG	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
decadron	NN	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
titrated	VBN	O
down	RB	O
to	TO	O
5	CD	O
mg	NNS	O
iv	JJ	O
q6h	NN	O
on	IN	O
12/3/94	CD	O
.	.	O

his	PRP$	B-TREATMENT
decadron	NN	I-TREATMENT
dose	NN	I-TREATMENT
will	MD	O
be	VB	O
slowly	RB	O
titrated	VBN	O
down	RP	O
over	IN	O
time	NN	O
following	VBG	O
his	PRP$	B-TEST
neurological	JJ	I-TEST
exam	NN	I-TEST
closely	RB	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
steroid	VBN	B-PROBLEM
induced	VBN	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	RBR	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
increasing	VBG	B-TREATMENT
doses	NNS	I-TREATMENT
of	IN	I-TREATMENT
insulin	NN	I-TREATMENT
receiving	VBG	O
nph	NN	B-TREATMENT
in	IN	O
the	DT	O
morning	NN	O
and	CC	O
night	NN	O
in	IN	O
addition	NN	O
to	TO	O
a	DT	B-TREATMENT
czi	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
on	IN	O
a	DT	O
q6h	JJ	O
basis	NN	O
.	.	O

the	DT	O
plan	NN	O
is	VBZ	O
to	TO	O
continue	VB	O
the	DT	B-TREATMENT
supplemental	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
while	IN	O
he	PRP	O
is	VBZ	O
on	IN	O
steroids	NNS	B-TREATMENT
and	CC	O
while	IN	O
his	PRP$	B-TEST
sugars	NNS	I-TEST
remain	VBP	O
high	JJ	O
.	.	O

he	PRP	O
initially	RB	O
required	VBD	O
a	DT	B-TREATMENT
face	NN	I-TREATMENT
mask	NN	I-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
saturation	NN	I-TEST
above	IN	O
90%	CD	O
.	.	O

however	RB	O
,	,	O
with	IN	O
increasing	VBG	B-TREATMENT
diuresis	NN	I-TREATMENT
and	CC	O
improving	VBG	B-PROBLEM
septic	JJ	I-PROBLEM
pictures	NNS	I-PROBLEM
his	PRP$	B-TEST
o2	JJ	I-TEST
saturations	NNS	I-TEST
have	VBP	O
improved	VBN	O
and	CC	O
he	PRP	O
is	VBZ	O
now	RB	O
on	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
sat	NN	I-TEST
above	IN	O
93%	CD	O
.	.	O

he	PRP	O
can	MD	O
be	VB	O
given	VBN	O
intravenous	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
as	IN	O
needed	VBN	O
for	IN	O
any	DT	O
evidence	NN	O
of	IN	O
respiratory	JJ	B-PROBLEM
compromise	NN	I-PROBLEM
or	CC	O
increasing	VBG	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
poor	JJ	I-PROBLEM
nutritional	JJ	I-PROBLEM
status	NN	I-PROBLEM
with	IN	O
hypoalbuminemia	NN	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
maintained	VBN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
and	CC	O
that	DT	O
should	MD	O
be	VB	O
continued	VBN	O
.	.	O

he	PRP	O
should	MD	O
also	RB	O
be	VB	O
encouraged	VBN	O
to	TO	O
eat	VB	O
as	RB	O
much	JJ	O
as	IN	O
possible	JJ	O
orally	RB	O
in	IN	O
addition	NN	O
to	TO	O
this	DT	B-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
and	CC	O
aspiration	NN	B-TREATMENT
precaution	NN	I-TREATMENT
should	MD	O
be	VB	O
maintained	VBN	O
.	.	O

8)	CD	O
elevated	JJ	B-PROBLEM
pt	NN	I-PROBLEM
and	CC	I-PROBLEM
ptt	NN	I-PROBLEM
:	:	O

both	DT	O
of	IN	O
these	DT	O
responded	VBN	O
to	TO	O
three	CD	O
day	NN	O
course	NN	O
of	IN	O
vitamin	JJ	B-TREATMENT
k	NN	I-TREATMENT
10	CD	O
mg	JJ	O
each	DT	O
day	NN	O
.	.	O

his	PRP$	B-TEST
pt	NN	I-TEST
and	CC	O
ptt	NN	B-TEST
are	VBP	O
now	RB	O
normal	JJ	O
,	,	O
however	RB	O
,	,	O
he	PRP	O
continues	VBZ	O
to	TO	O
run	VB	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
platelet	NN	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

this	DT	O
has	VBZ	O
been	VBN	O
evident	JJ	O
since	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

we	PRP	O
have	VBP	O
been	VBN	O
transfusing	VBG	O
him	PRP	O
with	IN	O
platelets	NNS	B-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
counts	NNS	I-TEST
above	IN	O
20,000	CD	O
to	TO	O
reduce	VB	O
his	PRP$	B-PROBLEM
bleeding	NN	I-PROBLEM
risk	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
received	VBD	O
several	JJ	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
while	IN	O
here	RB	O
to	TO	O
maintain	VB	O
his	PRP$	B-TEST
hct	NN	I-TEST
around	IN	O
30	CD	O
.	.	O

thrombocytopenic	JJ	B-TREATMENT
inducing	VBG	I-TREATMENT
drugs	NNS	I-TREATMENT
should	MD	O
be	VB	O
avoided	VBN	O
if	IN	O
possible	JJ	O
on	IN	O
this	DT	O
patient	NN	O
.	.	O

tylenol	RB	B-TREATMENT
650	CD	O
mg	NNS	O
po	JJ	O
q4h	JJ	O
p.r.n.	NN	O
,	,	O
dulcolax	VBZ	B-TREATMENT
10	CD	O
mg	NN	O
per	IN	O
rectum	NN	O
b.i.d.	NN	O
p.r.n.	NN	O
,	,	O
decadron	VBZ	B-TREATMENT
5	CD	O
mg	NN	O
iv	NN	O
q6h	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
florinef	VBP	B-TREATMENT
0.1	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
for	IN	O
presumed	JJ	O
adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
imipenem	JJ	B-TREATMENT
500	CD	O
mg	NN	O
iv	NN	O
q6h	NN	O
,	,	O
insulin	NN	B-TREATMENT
nph	RB	I-TREATMENT
60	CD	O
units	NNS	O
subcu	VBP	O
q	JJ	O
a.m.	NN	O
,	,	O
insulin	NN	B-TREATMENT
nph	RB	I-TREATMENT
20	CD	O
units	NNS	O
subcu	VBP	O
q	JJ	O
p.m.	NN	O
,	,	O
insulin	NN	B-TREATMENT
czi	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
regular	JJ	I-TREATMENT
,	,	O
synthroid	JJ	B-TREATMENT
125	CD	O
mcg	NN	O
po	NN	O
q	JJ	O
day	NN	O
,	,	O
magnesium	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
,	,	O
potassium	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
today	NN	O
,	,	O
morphine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
iv	NN	I-TREATMENT
p.r.n.	NN	O
dressing	VBG	B-TREATMENT
changes	NNS	I-TREATMENT
and	CC	O
breakthrough	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
carafate	NN	B-TREATMENT
1	CD	O
gm	NN	O
po	NN	O
q.i.d.	NN	O
,	,	O
tobramycin	VBZ	B-TREATMENT
200	CD	O
mg	NN	O
iv	NN	O
q30h	NN	O
,	,	O
vancomyin	FW	B-TREATMENT
1	CD	O
mg	NN	O
iv	NN	O
q18h.	NN	O

obstructive	JJ	B-PROBLEM
sleep	NN	I-PROBLEM
apnea	NN	I-PROBLEM

wellbutrin	NN	B-TREATMENT
(	(	I-TREATMENT
bupropion	NN	I-TREATMENT
hcl	NN	I-TREATMENT
)	)	I-TREATMENT
150	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
folate	NN	B-TREATMENT
(	(	I-TREATMENT
folic	JJ	I-TREATMENT
acid	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
qd	NN	O
ativan	NN	B-TREATMENT
(	(	I-TREATMENT
lorazepam	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
q12h	NN	O
x	$	O
1	CD	O
days	NNS	O
ativan	RB	B-TREATMENT
(	(	I-TREATMENT
lorazepam	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
qhs	NN	O
x	$	O
7	CD	O
days	NNS	O
starting	VBG	O
on	IN	O
11/5	CD	O
mvi	NNS	B-TREATMENT
therapeutic	JJ	I-TREATMENT
w	NN	I-TREATMENT
/	NN	I-TREATMENT
minerals	NNS	I-TREATMENT
(	(	I-TREATMENT
therap	VB	I-TREATMENT
vits	NNS	I-TREATMENT
/	NNP	I-TREATMENT
minerals	NNS	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
qd	NN	O

simvastatin	NN	B-TREATMENT
and	CC	O
niacin	NN	B-TREATMENT
,	,	O
vit.	NN	B-TREATMENT

b-3	JJ	B-TREATMENT
reason	NN	O
for	IN	O
override	NN	O
:	:	O

indicated	VBN	O
thiamine	NN	B-TREATMENT
(	(	I-TREATMENT
thiamine	JJ	I-TREATMENT
hcl	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
qd	NN	O
simvastatin	VBD	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

override	RB	O
added	VBD	O
on	IN	O
11/03/00	CD	O
by	IN	O
twada	NN	O
,	,	O
stasterl	NN	O
etheshi	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
mvi	NN	B-TREATMENT
therapeutic	JJ	I-TREATMENT
w	NN	I-TREATMENT
/	NN	I-TREATMENT
minerals	NNS	I-TREATMENT
po	VBP	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
90299469	CD	O
)	)	O

simvastatin	NN	B-TREATMENT
and	CC	O
niacin	NN	B-TREATMENT
,	,	O
vit.	JJ	B-TREATMENT
b-3	NN	I-TREATMENT

indicated	VBN	O
lisinopril	JJ	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
qd	NN	O
nicotine	JJ	B-TREATMENT
patch	NN	I-TREATMENT
(	(	I-TREATMENT
nicotine	JJ	I-TREATMENT
)	)	I-TREATMENT
21	CD	O
mg/day	JJ	O
tp	NN	O
q24h	NN	O

firmert	JJ	O
hospital	NN	O
11/6	CD	O
at	IN	O
9am	CD	O
scheduled	JJ	O
,	,	O
cialneinsisters	NNS	O
hospital	VBP	O
and	CC	O
medical	JJ	O
center	NN	O
11/16	CD	O
at	IN	O
8:15pm	CD	O
scheduled	JJ	O
,	,	O
dr.	JJ	O
condnort	NN	O
12/04	CD	O
at	IN	O
2pm	CD	O
scheduled	JJ	O
,	,	O
dr.	JJ	O
lila	NN	O
spielbjaque	VBD	O
12/01	CD	O
at	IN	O
1:50pm	CD	O
scheduled	VBN	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

r	NN	O
/	''	O
o	JJ	O
mi	NN	B-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
obstructive	JJ	B-PROBLEM
sleep	NN	I-PROBLEM
apnea	NN	I-PROBLEM

conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
htn	RB	B-PROBLEM
tobacco	NN	O
etoh	NN	O
abuse	IN	O
sinus	NN	B-PROBLEM
bradycardia	NN	I-PROBLEM

50	CD	O
yo	JJ	O
m	NN	O
from	IN	O
taheimpromong	JJ	O
admitted	VBN	O
w	NN	O
/	NNP	O
cp	NN	B-PROBLEM
for	IN	O
r	NN	O
/	NNP	O
o	NN	O
mi	NN	B-PROBLEM
.	.	O

has	VBZ	O
significant	JJ	B-PROBLEM
cardiac	NNS	I-PROBLEM

fh	NN	O
,	,	O
htn	NN	B-PROBLEM
,	,	O
tobacco	NN	O
.	.	O

presented	VBN	O
w	JJ	O
/	NNP	O
epigastric	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
sob	NN	B-PROBLEM
at	IN	O
work	NN	O
.	.	O

ett	NN	B-TEST
was	VBD	O
negative	JJ	O
for	IN	O
ischemia	NN	B-PROBLEM
.	.	O

echo	NN	B-TEST
showed	VBD	O
ef	JJ	B-TEST
45-50%	JJ	O
,	,	O
with	IN	O
mild	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
and	CC	O
no	DT	O
significant	JJ	B-PROBLEM
valvular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
nl	JJ	O
pap	NN	O
.	.	O

during	IN	O
this	DT	O
hospitalization	NN	O
,	,	O
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
sinus	VBN	B-PROBLEM
bradycardia	NN	I-PROBLEM
and	CC	O
pauses	NNS	B-PROBLEM
,	,	O
associated	VBN	O
with	IN	O
desaturations	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
70	CD	I-PROBLEM
&apos;s	NN	I-PROBLEM
.	.	O

cpap	NN	B-TREATMENT
at	IN	O
5	CD	O
was	VBD	O
attempted	VBN	O
,	,	O
but	CC	O
pt	RB	O
did	VBD	O
not	RB	O
tolerate	VB	O
this	DT	O
.	.	O

he	PRP	O
will	MD	O
have	VB	O
outpt	JJ	B-TREATMENT
fitting	NN	I-TREATMENT
at	IN	O
the	DT	O
sleep	NN	O
center	NN	O
in	IN	O
sabo	NN	O
.	.	O

migraines	NNS	B-PROBLEM
for	IN	O
10	CD	O
days	NNS	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
headache	NN	B-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

headache	NN	B-PROBLEM

md	JJ	B-TREATMENT
evaluation	NN	I-TREATMENT
,	,	O
head	NN	B-TEST
ct	NN	I-TEST

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
sob	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
oaksgekesser/	VB	O
memorial	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
brittsfyfeast	VBN	O
,	,	O
sher	JJR	O
t	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
s	JJ	O
/	NNP	O
sob	NN	B-PROBLEM
.	.	O

tylenol	NN	B-TREATMENT
(	(	I-TREATMENT
acetaminophen	NN	I-TREATMENT
)	)	I-TREATMENT
650	CD	O
mg	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

acetaminophen	NN	B-TREATMENT
and	CC	O
acetaminophen	NN	B-TREATMENT

colace	NN	B-TREATMENT
(	(	I-TREATMENT
docusate	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
ibuprofen	VBZ	B-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

take	VB	O
with	IN	O
food	NN	O
milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
(	(	I-TREATMENT
magnesium	JJ	I-TREATMENT
hydroxide	NN	I-TREATMENT
)	)	I-TREATMENT
30	CD	O
milliliters	NNS	O
po	VBP	O
bid	NN	O
prn	NN	O
constipation	NN	B-PROBLEM
percocet	IN	B-TREATMENT
1-2	JJ	O
tab	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

override	RB	O
added	VBD	O
on	IN	O
10/01/03	CD	O
by	IN	O
kotejoasthoreuphkays	NNS	O
,	,	O
gai	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
tylenol	NN	B-TREATMENT
po	NN	O
650	CD	O
mg	NN	O
q4h	NN	O
(	(	O
ref	JJ	O
#	#	O
85225311	CD	O
)	)	O

acetaminophen	NN	B-TREATMENT
and	CC	O
acetaminophen	NN	B-TREATMENT

sulfa	NN	B-TREATMENT
,	,	O
bactrim	NN	B-TREATMENT

pregnancy	NN	B-PROBLEM

undelivered	JJ	B-PROBLEM

breech	NN	B-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
gestation	NN	I-PROBLEM
,	,	O

no	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

apgars	NNS	B-TEST
8,9	CD	O

weight	NN	B-TEST
:	:	O

apgars	NNS	B-TEST
8,8	CD	O

weight	NN	B-TEST
:	:	O

pneumonia	NN	B-PROBLEM

shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
38-year-old	JJ	O
gentleman	NN	O
,	,	O
spanish-speaking	JJ	O
,	,	O
from	IN	O
the	DT	O
taheimpromong	NN	O
,	,	O
with	IN	O
no	DT	O
significant	JJ	O
past	JJ	O
medical	JJ	O
history	NN	O
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
x	$	O
2	CD	O
months	NNS	O
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
dry	JJ	I-PROBLEM
cough	NN	I-PROBLEM
x	RB	O
1	CD	O
month	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
his	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
two	CD	O
months	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
he	PRP	O
began	VBD	O
to	TO	O
notice	VB	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
on	IN	O
climbing	VBG	O
flights	NNS	O
of	IN	O
stairs	NNS	O
.	.	O

he	PRP	O
stated	VBD	O
that	IN	O
this	DT	O
became	VBD	O
worse	JJR	O
over	IN	O
the	DT	O
last	JJ	O
month	NN	O
until	IN	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
at	IN	O
rest	NN	O
.	.	O

he	PRP	O
also	RB	O
states	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
had	VBD	O
a	DT	B-PROBLEM
dry	JJ	I-PROBLEM
and	CC	I-PROBLEM
nonproductive	JJ	I-PROBLEM
cough	NN	I-PROBLEM
for	IN	O
one	CD	O
month	NN	O
.	.	O

he	PRP	O
denied	VBD	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
or	CC	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
.	.	O

no	DT	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
or	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

he	PRP	O
did	VBD	O
note	VB	O
some	DT	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
several	JJ	O
months	NNS	O
,	,	O
though	IN	O
the	DT	O
amount	NN	O
was	VBD	O
unknown	JJ	O
.	.	O

he	PRP	O
did	VBD	O
drink	VB	O
alcohol	NN	O
three	CD	O
drinks	NNS	O
per	IN	O
day	NN	O
,	,	O
no	DT	O
withdrawal	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

in	IN	O
emergency	NN	O
room	NN	O
,	,	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
afebrile	JJ	O
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
,	,	O
was	VBD	O
treated	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
azithromycin	NN	B-TREATMENT
,	,	O
and	CC	O
cefuroxime	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

sister	NN	O
with	IN	O
bone	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
97.4	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
100	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
142/89	CD	O
,	,	O
and	CC	O
o2	JJ	B-TEST
saturation	NN	I-TEST
94%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

general	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	O
well-developed	JJ	O
,	,	O
well-nourished	JJ	O
gentleman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

heent	NN	B-TEST
exam	NN	I-TEST
revealed	VBD	O
sclerae	NN	B-PROBLEM
to	TO	O
be	VB	O
injected	VBN	O
.	.	O

no	DT	O
lymphadenopathy	NN	B-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
neck	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
right	JJ	B-PROBLEM
axillary	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

chest	NN	B-TEST
exam	NN	I-TEST
reveals	NNS	O
coarse	VBP	B-PROBLEM
rhonchi	NN	I-PROBLEM
with	IN	O
some	DT	B-PROBLEM
bibasilar	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

abdominal	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
soft	JJ	O
,	,	O
nontender	NN	O
,	,	O
and	CC	O
nondistended	VBD	O
abdomen	NNS	O
.	.	O

heart	NN	B-TEST
exam	NN	I-TEST
was	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
tachycardic	JJ	B-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
flat	JJ	I-PROBLEM
jugular	NN	I-PROBLEM
venous	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
.	.	O

his	PRP$	O
extremities	NNS	O
were	VBD	O
without	IN	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
.	.	O

his	PRP$	O
skin	NN	O
was	VBD	O
clear	JJ	O
,	,	O
without	IN	O
rashes	NNS	B-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
noted	VBD	O
on	IN	O
abdominal	JJ	B-TEST
exam	NN	I-TEST
.	.	O

neuro	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
x	$	O
3	CD	O
.	.	O

sodium	NN	B-TEST
139	CD	O
,	,	O
potassium	NN	B-TEST
3.5	CD	O
,	,	O
chloride	RB	B-TEST
103	CD	O
,	,	O
bicarbonate	NN	B-TEST
25	CD	O
,	,	O
bun	NN	B-TEST
9	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
,	,	O
and	CC	O
glucose	RB	B-TEST
83	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11.2	CD	O
,	,	O
hematocrit	NN	B-TEST
43.2	CD	O
,	,	O
and	CC	O
platelets	VBZ	B-TEST
447,000	CD	O
.	.	O

sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
100	CD	O
.	.	O

diffuse	NN	B-PROBLEM
interstitial	JJ	I-PROBLEM
process	NN	I-PROBLEM
/	NNP	O
consolidation	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
differential	JJ	O
diagnosis	NN	O
included	VBD	O
initially	RB	O
a	DT	O
question	NN	O
of	IN	O
an	DT	B-PROBLEM
atypical	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
or	CC	O
pcp	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
ppd	NN	I-TEST
has	VBZ	O
been	VBN	O
negative	JJ	O
one	CD	O
year	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
ppd	NN	B-TEST
was	VBD	O
rechecked	VBN	O
during	IN	O
this	DT	O
admission	NN	O
and	CC	O
was	VBD	O
negative	JJ	O
.	.	O

he	PRP	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
tuberculosis	NN	B-PROBLEM
with	IN	O
an	DT	B-TEST
induced	JJ	I-TEST
sputum	NN	I-TEST
x	VBD	O
3	CD	O
,	,	O
which	WDT	O
showed	VBD	O
no	DT	O
afb	NN	B-PROBLEM
.	.	O

chest	NN	B-TEST
ct	NN	I-TEST
showed	VBD	O
bibasilar	JJ	B-PROBLEM
diffuse	NN	I-PROBLEM
infiltrates	NNS	I-PROBLEM
,	,	O
pcp	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

thus	RB	O
initially	RB	O
he	PRP	O
had	VBD	O
been	VBN	O
started	VBN	O
on	IN	O
prednisone	NN	B-TREATMENT
and	CC	O
bactrim	NN	B-TREATMENT
,	,	O
this	DT	O
was	VBD	O
discontinued	VBN	O
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
azithromycin	NN	B-TREATMENT
and	CC	O
cefuroxime	NN	B-TREATMENT
until	IN	O
bronchoscopy	JJ	O
results	NNS	O
were	VBD	O
known	VBN	O
,	,	O
negative	JJ	O
.	.	O

he	PRP	O
initially	RB	O
had	VBD	O
refused	VBN	O
hiv	NN	B-TEST
testing	NN	I-TEST
,	,	O
however	RB	O
,	,	O
was	VBD	O
finally	RB	O
consented	VBN	O
,	,	O
hiv	NN	B-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

pulmonary	JJ	O
consult	NN	O
was	VBD	O
invited	VBN	O
,	,	O
initially	RB	O
the	DT	O
patient	NN	O
refused	VBD	O
bronchoscopy	NN	B-TEST
,	,	O
however	RB	O
,	,	O
did	VBD	O
agree	VB	O
to	TO	O
it	PRP	O
during	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

the	DT	O
results	NNS	O
were	VBD	O
negative	JJ	O
for	IN	O
micro	NN	B-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
diagnosis	NN	O
as	IN	O
per	IN	O
review	NN	B-TEST
of	IN	I-TEST
pathology	NN	I-TEST
is	VBZ	O
organizing	VBG	B-PROBLEM
pneumonia	NN	I-PROBLEM
with	IN	O
possible	JJ	O
diagnosis	NN	O
of	IN	O
boop	NN	B-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
inhalational	JJ	I-PROBLEM
injury	NN	I-PROBLEM
was	VBD	O
a	DT	O
possibility	NN	O
.	.	O

the	DT	O
patient	NN	O
required	VBN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
greater	JJR	O
than	IN	O
93%	CD	O
.	.	O

ambulatory	JJ	B-TEST
saturation	NN	I-TEST
was	VBD	O
82%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
supportive	JJ	B-TREATMENT
medical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
cough	NN	I-PROBLEM
.	.	O

echocardiogram	NN	B-TEST
was	VBD	O
checked	VBN	O
to	TO	O
rule	VB	O
out	IN	O
chf	NN	B-PROBLEM
,	,	O
showed	VBD	O
lvh	NN	B-PROBLEM
and	CC	O
trace	NN	B-PROBLEM
tr	NN	I-PROBLEM
,	,	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
60%	CD	O
without	IN	O
any	DT	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

hepatitis	NN	B-TEST
serologies	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

his	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
repeated	VBN	O
p.r.n.	NN	O

lovenox	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
in	IN	O
satisfactory	JJ	O
condition	NN	O
with	IN	O
home	NN	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

multiple	JJ	O
conversations	NNS	O
were	VBD	O
had	VBN	O
with	IN	O
the	DT	O
patient	NN	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
interpreter	NN	O
stating	VBG	O
the	DT	O
importance	NN	O
of	IN	O
not	RB	O
smoking	VBG	O
and	CC	O
keeping	VBG	O
flames	NNS	O
away	RB	O
from	IN	O
his	PRP$	B-TREATMENT
oxygen	NN	I-TREATMENT
tank	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
sent	VBN	O
home	NN	O
with	IN	O
ldamc	JJ	O
services	NNS	O
to	TO	O
help	VB	O
with	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
oxygen	NN	O
education	NN	O
.	.	O

he	PRP	O
was	VBD	O
told	VBN	O
to	TO	O
call	VB	O
a	DT	O
doctor	NN	O
or	CC	O
come	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
should	MD	O
he	PRP	O
have	VB	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
troubles	NNS	I-PROBLEM
,	,	O
breathing	NN	O
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
fevers	NNS	B-PROBLEM
.	.	O

1.	CD	O
prednisone	NN	B-TREATMENT
60	CD	O
mg	NN	O
p.o.	NN	O
q.a.m.	NN	O

2.	CD	O
bactrim	JJ	B-TREATMENT
double	JJ	I-TREATMENT
strength	NN	I-TREATMENT
one	CD	O
tablet	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
pcp	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
during	IN	O
his	PRP$	B-TREATMENT
steroid	JJ	I-TREATMENT
course	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
cp	NN	B-PROBLEM
sob	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
ro	VB	O
woodma	NN	O
healthcare	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
dreissneigh	JJ	O
,	,	O
liru	JJ	O
and	CC	O
the	DT	O
preliminary	JJ	O
admitting	NN	O
diagnosis	NN	O
is	VBZ	O
cp	JJ	B-PROBLEM
,	,	O
r	JJ	O
/	NNP	O
o	NN	O
mi	NN	B-PROBLEM
.	.	O

r	NN	O
/	''	O
o	JJ	O
hemmoroids	NNS	B-PROBLEM

perianal	JJ	B-PROBLEM
and	CC	I-PROBLEM
perivaginal	JJ	I-PROBLEM
pruritis	NN	I-PROBLEM

pelvic	JJ	B-TEST
exam	NN	I-TEST

please	VB	O
call	NN	O
(	(	O
994	CD	O
)	)	O
944-4238	CD	O
in	IN	O
2-3	JJ	O
days	NNS	O
to	TO	O
obtain	VB	O
results	NNS	O
of	IN	O
the	DT	B-TEST
lab	NN	I-TEST
tests	NNS	I-TEST
that	WDT	O
were	VBD	O
ordered	VBN	O
.	.	O

if	IN	O
tests	NNS	O
are	VBP	O
positive	JJ	B-PROBLEM
,	,	O
follow	VB	O
up	RP	O
with	IN	O
your	PRP$	O
primary	JJ	O
care	NN	O
doctor	NN	O
of	IN	O
gynecologist	NN	O
.	.	O

metastatic	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
unknown	JJ	I-PROBLEM
primary	NN	I-PROBLEM
.	.	O

intrauterine	JJ	B-PROBLEM
pregnancy	NN	I-PROBLEM
at	IN	I-PROBLEM
23	CD	I-PROBLEM
weeks	NNS	I-PROBLEM
.	.	O

hypercalcemia	NN	B-PROBLEM
.	.	O

inferior	JJ	B-PROBLEM
vena	NN	I-PROBLEM
cava	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

impending	VBG	B-PROBLEM
spinal	JJ	I-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
34-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	B-PROBLEM
22	CD	I-PROBLEM
week	NN	I-PROBLEM
intrauterine	JJ	I-PROBLEM
pregnancy	NN	I-PROBLEM
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
bri	JJ	O
health	NN	O
with	IN	O
diffuse	NN	B-PROBLEM
metastatic	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
unknown	JJ	I-PROBLEM
primary	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
excellent	JJ	O
health	NN	O
until	IN	O
july	NN	O
of	IN	O
1991	CD	O
when	WRB	O
she	PRP	O
first	RB	O
noted	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
clavicular	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

subsequently	RB	O
,	,	O
the	DT	B-PROBLEM
mass	NN	I-PROBLEM
continued	VBD	O
to	TO	O
increase	VB	O
in	IN	O
size	NN	O
.	.	O

on	IN	O
12/23	CD	O
,	,	O
she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
dr.	JJ	O
stonge	NN	O
at	IN	O
bri	NN	O
health	NN	O
where	WRB	O
a	DT	B-PROBLEM
3	CD	I-PROBLEM
x	NN	I-PROBLEM
7	CD	I-PROBLEM
cm	NN	I-PROBLEM
left	VBD	I-PROBLEM
mid	JJ	I-PROBLEM
clavicular	JJ	I-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

a	DT	B-TEST
fine	JJ	I-TEST
needle	JJ	I-TEST
aspirate	NN	I-TEST
of	IN	O
this	DT	B-PROBLEM
mass	NN	I-PROBLEM
reportedly	RB	O
revealed	VBD	O
giant	JJ	B-PROBLEM
cell	NN	I-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
told	VBD	O
that	IN	O
this	DT	O
was	VBD	O
a	DT	B-PROBLEM
benign	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
and	CC	O
that	IN	O
it	PRP	O
could	MD	O
simply	RB	O
be	VB	O
watched	VBN	O
and	CC	O
definitively	RB	O
treated	VBN	O
after	IN	O
the	DT	B-TREATMENT
delivery	NN	I-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
baby	NN	I-TREATMENT
.	.	O

subsequently	RB	O
,	,	O
the	DT	B-PROBLEM
mass	NN	I-PROBLEM
progressively	RB	O
increased	VBN	O
in	IN	O
size	NN	O
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
developed	VBN	O
significant	JJ	B-PROBLEM
discomfort	NN	I-PROBLEM
in	IN	I-PROBLEM
this	DT	I-PROBLEM
region	NN	I-PROBLEM
.	.	O

on	IN	O
1/5	CD	O
,	,	O
the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TREATMENT
local	JJ	I-TREATMENT
tumor	NN	I-TREATMENT
debulking	VBG	I-TREATMENT
at	IN	O
bri	JJ	O
health	NN	O
under	IN	O
local	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
pathology	NN	I-TEST
,	,	O
unfortunately	RB	O
,	,	O
revealed	VBD	O
an	DT	B-PROBLEM
aggressive	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
(	(	O
micropapillary	JJ	O
type	NN	O
;	:	O
mucin	CC	O
producing	VBG	O
)	)	O
.	.	O

this	DT	O
prompted	VBD	O
further	JJ	B-TEST
staging	VBG	I-TEST
work-up	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
subsequently	RB	O
had	VBD	O
a	DT	B-TEST
limited	JJ	I-TEST
chest	NN	I-TEST
ct	NN	I-TEST
at	IN	O
bri	NN	O
health	NN	O
which	WDT	O
showed	VBD	O
diffuse	IN	B-PROBLEM
bilateral	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
,	,	O
metastases	NNS	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
sternum	NN	I-PROBLEM
,	,	I-PROBLEM
rib	NN	I-PROBLEM
,	,	I-PROBLEM
multiple	JJ	I-PROBLEM
spinal	JJ	I-PROBLEM
levels	NNS	I-PROBLEM
;	:	O
internal	JJ	B-PROBLEM
mammary	NN	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

the	DT	O
poor	JJ	O
prognosis	NN	O
for	IN	O
the	DT	O
patient	NN	O
and	CC	O
child	NN	O
were	VBD	O
discussed	VBN	O
and	CC	O
after	IN	O
the	DT	O
patient	NN	O
decided	VBD	O
to	TO	O
have	VB	O
an	DT	B-TREATMENT
elective	JJ	I-TREATMENT
abortion	NN	I-TREATMENT
,	,	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
revealed	VBD	O
diffuse	NN	B-PROBLEM
metastatic	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liverspine	NN	I-PROBLEM
,	,	I-PROBLEM
ribs	NN	I-PROBLEM
and	CC	I-PROBLEM
most	JJS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lymph	NN	I-PROBLEM
nodes	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
obvious	JJ	B-PROBLEM
gior	JJ	I-PROBLEM
pancreatic	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
identified	VBD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
firm	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
at	IN	O
the	DT	O
vertex	NN	O
of	IN	O
her	PRP$	O
calvarium	NN	O
.	.	O

a	DT	O
specimen	NN	O
was	VBD	O
obtained	VBN	O
by	IN	O
fine	JJ	B-TEST
needle	JJ	I-TEST
aspiration	NN	I-TEST
and	CC	O
the	DT	B-TEST
pathology	NN	I-TEST
of	IN	O
this	DT	O
was	VBD	O
consistent	JJ	O
with	IN	O
adenocarcinoma	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
nimaconwood	VB	O
valley	JJ	O
hospital	NN	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
termination	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
pregnancy	NN	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
past	JJ	O
four	CD	O
weeks	NNS	O
,	,	O
the	DT	O
patient	NN	O
reported	VBD	O
progressive	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
mid	NN	B-PROBLEM
thoracic	NN	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
motor	NN	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
abnormal	JJ	B-PROBLEM
sensation	NN	I-PROBLEM
,	,	O
numbness	RB	B-PROBLEM
,	,	O
tingling	VBG	B-PROBLEM
or	CC	O
incontinence	NN	B-PROBLEM
of	IN	I-PROBLEM
bowel	NN	I-PROBLEM
or	CC	I-PROBLEM
bladder	NN	I-PROBLEM
.	.	O

she	PRP	O
denied	VBD	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
or	CC	O
sweats	NNS	B-PROBLEM
.	.	O

there	EX	O
has	VBZ	O
been	VBN	O
no	DT	O
gi	NN	B-PROBLEM
or	CC	I-PROBLEM
gu	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
except	IN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
included	VBD	O
percocet	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
multivitamins	NNS	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NN	O
father	NN	O
died	VBD	O
at	IN	O
age	NN	O
69	CD	O
with	IN	O
metastatic	JJ	B-PROBLEM
prostate	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NN	O
sister	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
cervical	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
any	DT	O
alcoholic	JJ	O
beverages	NNS	O
during	IN	O
this	DT	B-PROBLEM
pregnancy	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
98/64	CD	O
.	.	O

pulse	RB	B-TEST
82	CD	O
.	.	O

respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
.	.	O

skin	NN	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
parietal	JJ	I-PROBLEM
scalp	NN	I-PROBLEM
nodle	JJ	I-PROBLEM
measuring	VBG	O
2	CD	O
x	JJ	O
3	CD	O
cm	NN	O
which	WDT	O
was	VBD	O
very	RB	O
firm	JJ	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
1	CD	I-PROBLEM
cm	NN	I-PROBLEM
firm	NN	I-PROBLEM
nodule	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
thoracic	JJ	I-PROBLEM
region	NN	I-PROBLEM
of	IN	O
the	DT	O
back	NN	O
between	IN	O
the	DT	O
midline	NN	O
and	CC	O
the	DT	O
scapula	NN	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
1	CD	I-PROBLEM
cm	NN	I-PROBLEM
firm	NN	I-PROBLEM
nodule	NN	I-PROBLEM
in	IN	O
the	DT	O
right	JJ	O
upper	JJ	O
quadrant	NN	O
of	IN	O
the	DT	O
abdomen	NNS	O
.	.	O

heent	NN	B-TEST
exam	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

back	RB	O
was	VBD	O
without	IN	O
cva	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
scapular	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
thoracic	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

there	EX	O
were	VBD	O
no	DT	O
rales	NNS	B-PROBLEM
or	CC	O
wheezes	NNS	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
egophony	NN	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
tachycardic	JJ	B-PROBLEM
and	CC	O
regular	JJ	O
,	,	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
ii	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
loudest	NN	O
at	IN	O
the	DT	O
left	JJ	O
upper	JJ	O
sternal	JJ	O
border	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
heave	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
was	VBD	O
gravid	NN	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
tympanitic	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

the	DT	O
liver	NN	O
was	VBD	O
11	CD	O
cm	NN	O
by	IN	O
percussion	NN	B-TEST
.	.	O

extremities	NNS	O
revealed	VBD	O
1+	CD	B-PROBLEM
bipedal	JJ	I-PROBLEM
edema	NN	I-PROBLEM
on	IN	O
admission	NN	O
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
patient	NN	O
to	TO	O
be	VB	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
.	.	O

sensation	NN	O
was	VBD	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
.	.	O

deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
1-2+	JJ	O
and	CC	O
symmetric	JJ	O
bilaterally	RB	O
.	.	O

on	IN	O
admission	NN	O
included	VBD	O
an	DT	B-TEST
alt	NN	I-TEST
of	IN	O
108	CD	O
,	,	O
ast	NN	B-TEST
of	IN	O
286	CD	O
.	.	O

total	JJ	B-TEST
bilirubin	NN	I-TEST
3.0	CD	O
,	,	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
of	IN	O
2.0	CD	O
.	.	O

alkaline	NN	B-TEST
phosphatase	NN	I-TEST
1148	CD	O
.	.	O

ldh	RB	B-TEST
806	CD	O
.	.	O

calcium	NN	B-TEST
11.8	CD	O
.	.	O

albumin	RB	B-TEST
2.3	CD	O
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
30.6	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
11.14	CD	O
.	.	O

pt	NN	B-TEST
was	VBD	O
13.2	CD	O
.	.	O

ptt	NN	B-TEST
was	VBD	O
29.8	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TREATMENT
elective	JJ	I-TREATMENT
termination	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
pregnancy	NN	I-PROBLEM
on	IN	O
1/13/91	CD	O
.	.	O

the	DT	B-TEST
work-up	NN	I-TEST
for	IN	O
the	DT	O
extent	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
disease	NN	I-PROBLEM
included	VBD	O
mri	JJ	B-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
cervical	JJ	I-TEST
and	CC	I-TEST
thoracic	JJ	I-TEST
spine	NN	I-TEST
which	WDT	O
revealed	VBD	O
multiple	JJ	B-PROBLEM
metastatic	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
vertebral	JJ	I-PROBLEM
bodies	NNS	I-PROBLEM
;	:	O
a	DT	B-PROBLEM
t3	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
extending	VBG	O
from	IN	O
the	DT	O
body	NN	O
to	TO	O
the	DT	O
right	JJ	O
neural	NN	O
for	IN	O
amina	NN	O
with	IN	O
foraminal	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

an	DT	B-PROBLEM
epidural	JJ	I-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
present	JJ	O
at	IN	O
t10	NN	O
which	WDT	O
was	VBD	O
extending	VBG	O
from	IN	O
the	DT	O
lamina	NN	O
or	CC	O
spinous	JJ	O
process	NN	O
anteriorly	RB	O
and	CC	O
almost	RB	O
compressing	VBG	O
the	DT	O
spinal	JJ	O
cord	NN	O
.	.	O

an	DT	B-TEST
abdominal	JJ	I-TEST
and	CC	I-TEST
pelvic	JJ	I-TEST
ct	NNS	I-TEST
scan	JJ	I-TEST
with	IN	I-TEST
iv	JJ	I-TEST
contrast	NN	I-TEST
revealed	VBD	O
bilateral	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
nodules	NNS	I-PROBLEM
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
extensive	JJ	B-PROBLEM
liver	NN	I-PROBLEM
metastases	NNS	I-PROBLEM
,	,	O
narrowing	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
intra	JJ	I-PROBLEM
hepatic	JJ	I-PROBLEM
ivc	NN	I-PROBLEM
and	CC	O
distention	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
azygous	JJ	I-PROBLEM
system	NN	I-PROBLEM
suggestive	NN	O
of	IN	O
ivc	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
by	IN	O
liver	NN	B-PROBLEM
metastases	NNS	I-PROBLEM
;	:	O
ascites	NNS	B-PROBLEM
;	:	O
multiple	JJ	B-PROBLEM
bony	NN	I-PROBLEM
metastases	NNS	I-PROBLEM
;	:	O
and	CC	O
an	DT	B-PROBLEM
isolated	JJ	I-PROBLEM
splenic	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

a	DT	B-TEST
bone	NN	I-TEST
scan	JJ	I-TEST
revealed	VBD	O
increased	JJ	B-PROBLEM
uptake	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
chest	NN	I-PROBLEM
wall	NN	I-PROBLEM
,	,	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
ribs	NNS	I-PROBLEM
four	CD	I-PROBLEM
to	TO	I-PROBLEM
six	CD	I-PROBLEM
,	,	O
and	CC	O
increased	VBD	B-PROBLEM
uptake	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
skull	NN	I-PROBLEM
in	IN	O
the	DT	O
area	NN	O
of	IN	O
the	DT	O
parotids	NNS	O
.	.	O

ahead	RB	B-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
metastatic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	O
the	DT	O
right	JJ	O
vertex	NN	O
of	IN	O
the	DT	O
calvarium	NN	O
but	CC	O
no	DT	O
intracranial	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

work-up	NN	B-TEST
for	IN	O
the	DT	O
source	NN	O
of	IN	O
the	DT	B-PROBLEM
primary	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
still	RB	O
unknown	JJ	O
included	VBD	O
a	DT	B-TEST
mammogram	NN	I-TEST
which	WDT	O
identified	VBD	O
no	DT	O
suspicious	JJ	B-PROBLEM
microcalcifications	NNS	I-PROBLEM
and	CC	O
no	DT	O
dominant	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
abdominal	JJ	I-TEST
and	CC	I-TEST
pelvic	JJ	I-TEST
ct	NN	I-TEST
scans	NNS	I-TEST
showed	VBD	O
no	DT	O
suspicious	JJ	B-PROBLEM
gi	NN	I-PROBLEM
masses	NNS	I-PROBLEM
,	,	O
no	DT	O
pancreatic	JJ	B-PROBLEM
mass	NN	I-PROBLEM
;	:	O
a	DT	B-PROBLEM
2	CD	I-PROBLEM
cm	NN	I-PROBLEM
ovarian	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
.	.	O

the	DT	O
review	NN	O
of	IN	O
the	DT	B-TEST
pathology	NN	I-TEST
from	IN	O
bri	JJ	O
health	NN	O
confirmed	VBD	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
grade	NN	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
.	.	O

erica	NN	B-TEST
and	CC	I-TEST
basic	JJ	I-TEST
cystic	JJ	I-TEST
protein	NN	I-TEST
stains	NNS	I-TEST
are	VBP	O
still	RB	O
pending	VBG	O
.	.	O

serum	NN	B-TEST
markers	NNS	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

the	DT	B-TEST
cea	NN	I-TEST
was	VBD	O
less	JJR	O
than	IN	O
0.7	CD	O
.	.	O

the	DT	B-TEST
hcg	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
was	VBD	O
30,710	CD	O
and	CC	O
on	IN	O
1/19	CD	O
was	VBD	O
805	CD	O
.	.	O

the	DT	B-TEST
ca-125	NN	I-TEST
was	VBD	O
still	RB	O
pending	VBG	O
and	CC	O
alphafeto	JJ	B-TEST
protein	NN	I-TEST
is	VBZ	O
still	RB	O
pending	VBG	O
.	.	O

hypercalcemia	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	B-TEST
serum	JJ	I-TEST
calcium	NN	I-TEST
of	IN	O
11.8	CD	O
and	CC	O
an	DT	B-TEST
albumin	NN	I-TEST
of	IN	O
2.3	CD	O
on	IN	O
admission	NN	O
.	.	O

she	PRP	O
received	VBD	O
three	CD	O
days	NNS	O
of	IN	O
intravenous	JJ	B-TREATMENT
etidronate	NN	I-TREATMENT
with	IN	O
normal	JJ	B-TREATMENT
saline	JJ	I-TREATMENT
diuresis	NN	I-TREATMENT
and	CC	O
the	DT	B-TEST
serum	NN	I-TEST
calcium	NN	I-TEST
subsequently	RB	O
decreased	VBD	O
to	TO	O
9.0	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
switched	VBN	O
to	TO	O
po	VB	B-TREATMENT
etidronate	NN	I-TREATMENT
.	.	O

ivc	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
has	VBZ	O
extensive	JJ	B-PROBLEM
hepatic	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
and	CC	O
by	IN	O
ct	JJ	B-TEST
scan	JJ	I-TEST
there	EX	O
is	VBZ	O
obstruction	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
intrahepatic	JJ	I-PROBLEM
ivc	NN	I-PROBLEM
.	.	O

this	DT	O
has	VBZ	O
resulted	VBN	O
in	IN	O
marked	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	I-PROBLEM
presacral	JJ	I-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
ascites	NNS	B-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
low	JJ	I-PROBLEM
serum	NN	I-PROBLEM
albumin	NN	I-PROBLEM
is	VBZ	O
also	RB	O
contributing	VBG	O
to	TO	O
her	PRP$	B-PROBLEM
extensive	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

hypoxia	NN	B-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
:	:	O

although	IN	O
the	DT	B-TEST
patient	JJ	I-TEST
&apos;s	NN	I-TEST
room	NN	I-TEST
air	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
96%	CD	O
during	IN	O
this	DT	O
admission	NN	O
,	,	O
she	PRP	O
subjectively	RB	O
complained	VBD	O
of	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
extensive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
resulted	VBD	O
in	IN	O
increased	JJ	B-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
respiration	NN	I-PROBLEM
and	CC	O
a	DT	O
sensation	NN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

impending	VBG	B-PROBLEM
spinal	JJ	I-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
had	VBD	O
back	RP	B-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
admission	NN	O
without	IN	O
any	DT	B-PROBLEM
focal	JJ	I-PROBLEM
neurological	JJ	I-PROBLEM
signs	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
mri	JJ	I-TEST
scan	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
revealed	VBD	O
an	DT	B-PROBLEM
impending	JJ	I-PROBLEM
cord	NN	I-PROBLEM
compression	NN	I-PROBLEM
at	IN	O
the	DT	O
level	NN	O
of	IN	O
t10	NN	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
decadron	NN	B-TREATMENT
and	CC	O
on	IN	O
1/17	CD	O
began	VBD	O
the	DT	O
first	JJ	O
of	IN	O
ten	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
to	TO	O
two	CD	O
fields	NNS	O
(	(	O
t2	NN	O
to	TO	O
t5	VB	O
and	CC	O
t9	VB	O
to	TO	O
t11	VB	O
)	)	O
.	.	O

per	IN	O
the	DT	O
patient	NN	O
&apos;s	NN	O
wishes	NNS	O
,	,	O
dr.	NN	O
dalywoo	NN	O
droreite	VBP	O
the	DT	O
windgo	JJ	O
hospital	NN	O
was	VBD	O
consulted	VBN	O
for	IN	O
a	DT	O
second	JJ	O
opinion	NN	O
regarding	VBG	O
the	DT	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
malignancy	NN	I-PROBLEM
.	.	O

dr.	NN	O
linke	NN	O
recommended	VBD	O
chemotherapy	NN	B-TREATMENT
with	IN	I-TREATMENT
pfl	NN	I-TREATMENT
.	.	O

per	IN	O
the	DT	O
patient	NN	O
&apos;s	NN	O
wishes	NNS	O
,	,	O
she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
windgo	JJ	O
hospital	NN	O
for	IN	O
chemotherapy	NN	B-TREATMENT
.	.	O

alt	NN	B-TEST
was	VBD	O
53	CD	O
.	.	O

ast	NN	B-TEST
was	VBD	O
89	CD	O
.	.	O

her	PRP$	B-TEST
ldh	NN	I-TEST
was	VBD	O
394	CD	O
.	.	O

her	PRP$	B-TEST
alkaline	JJ	I-TEST
phosphatase	NN	I-TEST
was	VBD	O
1514	CD	O
.	.	O

total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
2.1	CD	O
.	.	O

direct	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
1.4	CD	O
.	.	O

albumin	NN	B-TEST
was	VBD	O
2.3	CD	O
.	.	O

calcium	NN	B-TEST
9.1	CD	O
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
32.5	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
16.89	CD	O
.	.	O

pt	NN	B-TEST
was	VBD	O
12.9	CD	O
.	.	O

ptt	NN	B-TEST
was	VBD	O
27.3	CD	O
.	.	O

on	IN	O
discharge	NN	O
included	VBD	O
etidronate	NN	B-TREATMENT
,	,	O
475	CD	O
mg	NN	O
iv	JJ	O
q	JJ	O
day	NN	O
;	:	O
heparin	NN	B-TREATMENT
,	,	O
5000	CD	O
units	NNS	O
subcutaneously	RB	O
b.i.d.	VBP	O
;	:	O
decadron	NN	B-TREATMENT
,	,	O
4	CD	O
mg	NN	O
po	NN	O
q	NN	O
six	CD	O
hours	NNS	O
;	:	O
ms	CC	B-TREATMENT
contin	NN	I-TREATMENT
,	,	O
45	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
;	:	O
pepcid	NN	B-TREATMENT
,	,	O
20	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
;	:	O
senekot	CC	B-TREATMENT
,	,	O
one	CD	O
tablet	NN	O
po	NN	O
t.i.d.	NN	O
;	:	O
bronkosol	NN	B-TREATMENT
,	,	O
0.25	CD	O
cc	NN	O
q	RB	O
four	CD	O
hours	NNS	O
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
have	VB	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
medical	JJ	I-PROBLEM
and	CC	I-PROBLEM
oncological	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
managed	VBN	O
at	IN	O
windgo	JJ	O
hospital	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
electrolytes	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

1.	CD	O
undesired	JJ	B-PROBLEM
fertility	NN	I-PROBLEM
.	.	O

2.	CD	O
undesired	JJ	B-PROBLEM
adiposity	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
30	CD	O
-year-old	JJ	O
gravida	NN	O
iii	NN	O
,	,	O
para	NN	O
ii	NN	O
who	WP	O
presented	VBD	O
desiring	VBG	O
definitive	JJ	B-TREATMENT
surgical	JJ	I-TREATMENT
sterilization	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
extensively	RB	O
counseled	VBN	O
regarding	VBG	O
other	JJ	O
methods	NNS	O
of	IN	O
birth	NN	B-TREATMENT
control	NN	I-TREATMENT
and	CC	O
desired	VBD	O
to	TO	O
proceed	VB	O
with	IN	O
definitive	JJ	B-TREATMENT
surgical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
desired	VBD	O
liposuction	NN	B-TREATMENT
of	IN	I-TREATMENT
varying	VBG	I-TREATMENT
areas	NNS	I-TREATMENT
as	RB	O
well	RB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
consented	VBN	O
for	IN	O
both	DT	B-TREATMENT
procedures	NNS	I-TREATMENT
and	CC	O
brought	VBD	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
.	.	O

appendectomy	NN	B-TREATMENT
at	IN	O
the	DT	O
age	NN	O
of	IN	O
14	CD	O
,	,	O
open	JJ	O
.	.	O

spontaneous	JJ	B-PROBLEM
vaginal	JJ	I-PROBLEM
delivery	NN	I-PROBLEM
x	NN	O
2	CD	O
.	.	O

regular	JJ	O
menses	NNS	O
,	,	O
on	IN	O
ortho-tri-cyclen	NN	B-TREATMENT
.	.	O

no	DT	O
history	NN	O
of	IN	O
sexually	RB	B-PROBLEM
transmitted	VBN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
no	DT	O
history	NN	O
of	IN	O
domestic	JJ	O
violence	NN	O
.	.	O

1.	CD	O
ortho	JJ	B-TREATMENT
tri-cyclen	NN	I-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

height	RB	B-TEST
5	CD	O
&apos;	JJ	O
1	CD	O
&quot;	NN	O
,	,	O
weight	VBD	B-TEST
138	CD	O
lb.	NN	O

blood	NN	B-TEST
pressure	NN	I-TEST
:	:	O

130/82	CD	O
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
bilaterally	RB	O
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

pelvic	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
normal	JJ	O
vulva	NN	O
,	,	O
vagina	FW	O
normal	JJ	O
,	,	O
cervix	JJ	O
normal	JJ	O
,	,	O
uterus	JJ	O
anteverted	VBD	O
,	,	O
small	JJ	O
,	,	O
nontender	NN	B-PROBLEM
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
tenderness	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
unremarkable	JJ	I-TREATMENT
laparoscopic	NN	I-TREATMENT
tubal	JJ	I-TREATMENT
ligation	NN	I-TREATMENT
.	.	O

this	DT	O
was	VBD	O
done	VBN	O
with	IN	O
falope	NN	B-TREATMENT
rings	NNS	I-TREATMENT
.	.	O

the	DT	B-PROBLEM
estimated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
was	VBD	O
minimal	JJ	O
and	CC	O
the	DT	O
patient	NN	O
received	VBD	O
600	CD	O
cc.	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
.	.	O

of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
negative	JJ	O
urine	JJ	O
pregnancy	NN	O
test	NN	O
prior	RB	O
to	TO	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
then	RB	O
underwent	JJ	O
liposuction	NN	B-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
abdomen	NNS	I-TREATMENT
,	,	I-TREATMENT
inner	JJ	I-TREATMENT
thighs	NNS	I-TREATMENT
,	,	I-TREATMENT
hips	NNS	I-TREATMENT
,	,	I-TREATMENT
flanks	NNS	I-TREATMENT
,	,	I-TREATMENT
chest	NN	I-TREATMENT
and	CC	I-TREATMENT
arms	NNS	I-TREATMENT
with	IN	O
dr.	NN	O
chain	NN	O
.	.	O

she	PRP	O
did	VBD	O
well	RB	O
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
gyn	NN	O
service	NN	O
postoperatively	RB	O
because	IN	O
the	DT	O
patient	NN	O
had	VBD	O
persistent	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#one	NN	O
,	,	O
she	PRP	O
was	VBD	O
then	RB	O
stable	JJ	O
with	IN	O
no	DT	O
complaints	NNS	B-PROBLEM
.	.	O

she	PRP	O
remained	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

motrin	NN	B-TREATMENT
and	CC	O
percocet	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

eval	NN	B-TEST

ptsd	NN	B-PROBLEM

.5	NNS	B-TREATMENT
risperdal	VBP	I-TREATMENT

continue	NN	O
w/	WRB	O
risperdal	NN	B-TREATMENT
per	IN	O
new	JJ	O
psychiatrist	NN	O

b	NN	B-TREATMENT
and	CC	I-TREATMENT
w	NN	I-TREATMENT
and	CC	O
work	NN	O
w/	NNS	O
therapist	VBP	O
re:	JJ	O
historical	JJ	O
issues	NNS	O
.	.	O

if	IN	O
symptoms	NNS	B-PROBLEM
continue	VBP	O
to	TO	O
be	VB	O
overwhelming	VBG	B-PROBLEM
return	NN	O
to	TO	O
v	VB	O
or	CC	O
call	VB	O
1-903-263-5797	JJ	O

prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM

acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

significant	JJ	B-PROBLEM
problems	NNS	I-PROBLEM
:	:	O

1.	CD	O
metastatic	JJ	B-PROBLEM
prostate	NN	I-PROBLEM
ca	MD	I-PROBLEM
.	.	O

2.	CD	O
obstructive	JJ	B-PROBLEM
uropathy	NN	I-PROBLEM
,	,	O
status	NN	B-PROBLEM
post	NN	I-PROBLEM
left	VBD	I-PROBLEM
nephrostomy	NN	I-PROBLEM
.	.	O

3.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

4.	CD	O
anemia	NN	B-PROBLEM
.	.	O

5.	CD	O
gastroesophageal	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

this	DT	O
88-year-old	JJ	O
male	NN	O
with	IN	O
history	NN	O
of	IN	O
prostate	NN	B-PROBLEM
ca	MD	I-PROBLEM
was	VBD	O
admitted	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
secondary	JJ	O
to	TO	O
persistent	JJ	B-PROBLEM
hematuria	NN	I-PROBLEM
status	NN	O
post	NN	O
nephrostomy	JJ	B-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
transferred	VBD	O
to	TO	O
retelk	VB	O
county	RB	O
medical	JJ	O
center	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

history	NN	O
of	IN	O
present	JJ	B-PROBLEM
illness	NN	I-PROBLEM
:	:	O

mr.	JJ	O
prehekote	NN	O
is	VBZ	O
an	DT	O
88-year-old	JJ	O
portuguese	NN	O
speaking	VBG	O
only	RB	O
male	NN	O
who	WP	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
adenocarcinoma	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
prostate	NN	I-PROBLEM
in	IN	O
1998	CD	O
.	.	O

he	PRP	O
received	VBD	O
transurethral	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
prostate	NN	I-TREATMENT
one	CD	O
year	NN	O
ago	RB	O
because	IN	O
of	IN	O
persistent	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
retention	NN	I-PROBLEM
.	.	O

after	IN	O
that	DT	O
,	,	O
he	PRP	O
was	VBD	O
on	IN	O
lupron	NN	B-TREATMENT
and	CC	O
nilandron	NN	B-TREATMENT
hormone	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
february	JJ	O
23	CD	O
,	,	O
1999	CD	O
to	TO	O
eifro	VB	O
medical	JJ	O
center	NN	O
because	IN	O
of	IN	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
thrive	VB	I-PROBLEM
and	CC	O
decreased	JJ	B-PROBLEM
hematocrit	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
elevated	VBN	B-PROBLEM
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
.	.	O

bun	NN	B-TEST
was	VBD	O
34	CD	O
and	CC	O
creatinine	NN	B-TEST
was	VBD	O
2.6	CD	O
,	,	O
up	RB	O
from	IN	O
his	PRP$	O
baseline	NN	O
of	IN	O
1.0	CD	O
.	.	O

prostate	NN	B-TEST
specific	JJ	I-TEST
antigen	NN	I-TEST
increased	VBD	O
from	IN	O
77.9	CD	O
to	TO	O
88	CD	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
and	CC	O
body	NN	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

further	JJ	B-TEST
evaluation	NN	I-TEST
of	IN	O
his	PRP$	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
showed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
has	VBZ	O
bilateral	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
,	,	O
most	RBS	O
likely	JJ	O
obstructive	JJ	B-PROBLEM
uropathy	JJ	I-PROBLEM
due	JJ	O
to	TO	O
prostate	VB	B-PROBLEM
ca	MD	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pelvic	JJ	I-PROBLEM
area	NN	I-PROBLEM
.	.	O

because	IN	O
of	IN	O
the	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
creatinine	NN	I-PROBLEM
to	TO	O
8.0	CD	O
on	IN	O
february	JJ	O
28	CD	O
,	,	O
1999	CD	O
,	,	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
nephrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

however	RB	O
after	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
hematocrit	NN	I-PROBLEM
dropped	VBD	I-PROBLEM
to	TO	O
24	CD	O
and	CC	O
he	PRP	O
was	VBD	O
transfused	VBN	O
two	CD	B-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
increased	VBD	O
to	TO	O
about	IN	O
30	CD	O
,	,	O
but	CC	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
hematuria	NNS	B-PROBLEM
and	CC	O
his	PRP$	B-TEST
renal	JJ	I-TEST
function	NN	I-TEST
only	RB	O
improved	VBD	O
very	RB	O
slowly	RB	O
.	.	O

he	PRP	O
also	RB	O
received	VBD	O
kayexalate	NN	B-TREATMENT
for	IN	O
hyperkalemia	NN	B-PROBLEM
.	.	O

due	JJ	O
to	TO	O
the	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
from	IN	O
eifro	JJ	O
medical	JJ	O
center	NN	O
to	TO	O
the	DT	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
for	IN	O
angiographic	JJ	B-TEST
studies	NNS	I-TEST
to	TO	O
rule	VB	O
out	RP	O
any	DT	O
vascular	JJ	B-PROBLEM
injuries	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
constipation	NN	B-PROBLEM
with	IN	O
dysuria	NN	B-PROBLEM
,	,	O
but	CC	O
no	DT	O
fever	NN	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

no	DT	O
cough	NN	B-PROBLEM
.	.	O

no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

no	DT	O
palpitations	NNS	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
epigastric	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
body	NN	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

no	DT	O
headache	NN	B-PROBLEM
.	.	O

no	DT	O
bone	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

1)	CD	O
hypertension	NN	B-PROBLEM
.	.	O

2)	CD	O
gastroesophageal	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

3)	CD	O
anemia	NN	B-PROBLEM
.	.	O

4)	CD	O
prostate	NN	B-PROBLEM
ca	MD	I-PROBLEM
.	.	O

allergies	NNS	B-PROBLEM
:	:	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

clonidine	NN	B-TREATMENT
2.5	CD	O
milligrams	NNS	O
topical	JJ	O
q.	NN	O
week	NN	O
,	,	O
nitropaste	RB	B-TREATMENT
2	CD	O
inches	NNS	O
q.4h.	RB	O
,	,	O
nilandron	RB	B-TREATMENT
50	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
lupron	NN	B-TREATMENT
,	,	O
dulcolax	JJ	B-TREATMENT
p.r.n.	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
milligrams	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
300	CD	O
milligrams	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
lansopiacole	JJ	B-TREATMENT
15	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
bethanechol	NN	B-TREATMENT
25	CD	O
milligrams	NNS	O
p.o.	VBP	O
t.i.d.	NN	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
frail	NN	O
looking	VBG	O
elderly	JJ	O
male	NN	O
lying	VBG	O
in	IN	O
bed	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
95.4	CD	O
,	,	O
pulse	RB	B-TEST
120	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
150/80	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
24	CD	O
,	,	O
95%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

isocoric	JJ	B-PROBLEM
cataract	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

mucous	JJ	B-PROBLEM
membranes	NNS	I-PROBLEM
slightly	RB	I-PROBLEM
dry	VBP	I-PROBLEM
.	.	O

no	DT	O
oral	JJ	B-PROBLEM
ulcers	NNS	I-PROBLEM
.	.	O

no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

chest	JJS	B-TEST
examination	NN	I-TEST
showed	VBD	O
some	DT	B-PROBLEM
basilar	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lung	NN	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

heart	NN	O
initially	RB	O
tachycardia	RB	B-PROBLEM
,	,	O
grade	VBD	B-PROBLEM
ii	JJ	I-PROBLEM
/	NNP	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

traced	VBN	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

no	DT	O
cyanosis	NN	B-PROBLEM
and	CC	O
no	DT	O
clubbing	NN	B-PROBLEM
.	.	O

peripheral	JJ	B-TEST
pulses	NNS	I-TEST
were	VBD	O
very	RB	O
strong	JJ	O
and	CC	O
bounding	NN	O
.	.	O

no	DT	O
calf	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

homan	NN	B-TEST
&apos;s	CC	I-TEST
sign	NN	I-TEST
negative	JJ	O
.	.	O

examination	NN	B-TEST
was	VBD	O
limited	VBN	O
because	IN	O
the	DT	O
patient	NN	O
speaks	VBZ	O
only	RB	O
portuguese	JJ	O
.	.	O

on	IN	O
admission	NN	O
the	DT	O
patient	NN	O
&apos;s	NN	O
biochemistry	NN	O
showed	VBD	O
sodium	NN	B-TEST
of	IN	O
140	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
107	CD	O
,	,	O
bicarb	NN	B-TEST
14	CD	O
,	,	O
bun	NN	B-TEST
63	CD	O
,	,	O
creatinine	NN	B-TEST
5.8	CD	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
133	CD	O
.	.	O

liver	NN	B-TEST
function	NN	I-TEST
test	NN	I-TEST
showed	VBD	O
ast	IN	B-TEST
21	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
70	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.3	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
6.5	CD	O
,	,	O
albumin	RB	B-TEST
3.9	CD	O
,	,	O
globulin	NN	B-TEST
2.6	CD	O
.	.	O

cbc	NN	B-TEST
:	:	O

wbc	NN	B-TEST
8.4	CD	O
,	,	O
hematocrit	NN	B-TEST
32.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
194,000	CD	O
.	.	O

pt	NN	B-TEST
11.9	CD	O
,	,	O
inr	NN	B-TEST
1.0	CD	O
,	,	O
ptt	RB	B-TEST
28.4	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
cardiomegaly	NN	B-PROBLEM
.	.	O

no	DT	O
lung	NN	B-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
renal	JJ	I-TEST
area	NN	I-TEST
showed	VBD	O
right	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
which	WDT	O
extends	VBZ	O
to	TO	O
an	DT	B-PROBLEM
asymmetrically	RB	I-PROBLEM
thickened	JJ	I-PROBLEM
urinary	JJ	I-PROBLEM
bladder	NN	I-PROBLEM
wall	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
mass	NN	I-PROBLEM
like	IN	I-PROBLEM
thickening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
urinary	JJ	I-PROBLEM
bladder	NN	I-PROBLEM
suggestive	NN	O
of	IN	O
either	DT	O
detrusor	NN	B-PROBLEM
hypertrophy	NN	I-PROBLEM
or	CC	O
possibly	RB	O
tumor	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
cavitary	JJ	I-PROBLEM
lung	NN	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
compatible	JJ	O
with	IN	O
metastatic	JJ	O
or	CC	O
septic	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
.	.	O

ekg	NN	B-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
lvh	NN	B-PROBLEM
,	,	O
nonspecific	JJ	B-PROBLEM
st-t	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
either	CC	O
due	JJ	O
to	TO	O
digitalis	VB	B-PROBLEM
affect	NN	I-PROBLEM
.	.	O

ck	NN	B-TEST
enzymes	VBZ	I-TEST
146	CD	O
.	.	O

troponin	NN	B-TEST
i	NN	I-TEST
on	IN	O
the	DT	O
second	JJ	O
day	NN	O
of	IN	O
admission	NN	O
was	VBD	O
1.18	CD	O
.	.	O

the	DT	O
specialist	NN	O
concluded	VBD	O
that	IN	O
because	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
hematuria	NN	I-PROBLEM
seemed	VBD	O
to	TO	O
be	VB	O
stable	JJ	O
and	CC	O
hematocrit	NN	B-TEST
to	TO	O
maintain	VB	O
at	IN	O
about	RB	O
29-30	JJ	O
,	,	O
there	EX	O
is	VBZ	O
no	DT	O
urgent	JJ	O
need	NN	O
to	TO	O
do	VB	O
an	DT	B-TEST
arteriogram	NN	I-TEST
which	WDT	O
may	MD	O
cause	VB	O
further	JJ	B-PROBLEM
damage	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
kidney	NN	I-PROBLEM
.	.	O

urology	JJ	B-TEST
consultation	NN	I-TEST
thinks	VBZ	O
that	IN	O
cystoscopy	NN	B-TREATMENT
would	MD	O
not	RB	O
add	VB	O
any	DT	O
benefit	NN	O
to	TO	O
the	DT	O
management	NN	O
and	CC	O
only	RB	O
would	MD	O
consider	VB	O
a	DT	B-TREATMENT
right	NN	I-TREATMENT
nephrostomy	NN	I-TREATMENT
if	IN	O
renal	JJ	B-PROBLEM
function	NN	I-PROBLEM
failed	VBD	O
to	TO	O
improve	VB	O
.	.	O

after	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
conservatively	RB	O
to	TO	O
correct	VB	O
his	PRP$	B-PROBLEM
electrolyte	NN	I-PROBLEM
and	CC	I-PROBLEM
metabolic	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
blood	NN	B-TREATMENT
transfusion	NN	I-TREATMENT
,	,	O
two	CD	O
units	NNS	O
when	WRB	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
dropped	VBD	O
to	TO	O
29.4	CD	O
.	.	O

after	IN	O
transfusion	NN	B-TREATMENT
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
hematocrit	NN	I-TEST
rose	VBD	O
to	TO	O
37.7	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
given	VBN	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
to	TO	O
correct	VB	O
his	PRP$	B-PROBLEM
metabolic	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
pass	VB	O
about	IN	O
1500-2000	CD	O
cc	NN	O
of	IN	O
urine	JJ	O
a	DT	O
day	NN	O
and	CC	O
his	PRP$	B-TEST
renal	JJ	I-TEST
function	NN	I-TEST
improved	VBD	O
slowly	RB	O
with	IN	O
creatinine	NN	B-TEST
decreased	VBN	O
to	TO	O
4.2	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

during	IN	O
this	DT	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
also	RB	O
developed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
ventricular	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
about	IN	O
70-80	NNP	O
.	.	O

cpk	NN	B-TEST
was	VBD	O
tracked	VBN	O
,	,	O
but	CC	O
was	VBD	O
totally	RB	O
normal	JJ	O
.	.	O

no	DT	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
were	VBD	O
given	VBN	O
.	.	O

a	DT	O
long	JJ	O
discussion	NN	O
amongst	IN	O
the	DT	O
specialist	NN	O
,	,	O
nephrology	NN	O
,	,	O
urology	NN	O
,	,	O
interventional	JJ	O
radiology	NN	O
,	,	O
primary	JJ	O
oncology	NN	O
as	RB	O
well	RB	O
with	IN	O
the	DT	O
family	NN	O
lead	NN	O
to	TO	O
the	DT	O
conclusion	NN	O
that	WDT	O
conservative	JJ	B-TREATMENT
management	NN	I-TREATMENT
may	MD	O
give	VB	O
the	DT	O
patient	NN	O
more	JJR	O
comfort	NN	O
than	IN	O
crisis	NN	B-TREATMENT
treatment	NN	I-TREATMENT
in	IN	O
this	DT	B-PROBLEM
well	NN	I-PROBLEM
advanced	VBD	I-PROBLEM
prostate	NN	I-PROBLEM
ca	MD	I-PROBLEM
.	.	O

dr.	NN	O
lucreamull	NN	O
discussed	VBD	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
clinical	JJ	O
status	NN	O
and	CC	O
overall	JJ	O
situation	NN	O
with	IN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
family	NN	O
and	CC	O
the	DT	O
family	NN	O
decided	VBD	O
that	IN	O
mr.	JJ	O
prehekote	NN	O
could	MD	O
return	VB	O
home	NN	O
with	IN	O
hospice	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	NN	O
tomedankell	NN	O
flowayles	NNS	O
will	MD	O
manage	VB	O
the	DT	B-TREATMENT
hospice	NN	I-TREATMENT
issues	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
for	IN	O
hospice	NN	B-TREATMENT
on	IN	O
march	NN	O
8	CD	O
,	,	O
1999	CD	O
.	.	O

bethanechol	NN	B-TREATMENT
25	CD	O
milligrams	NNS	O
p.o.	JJ	O
t.i.d.	NN	O
,	,	O
clonidine	VBP	B-TREATMENT
2.5	CD	O
milligrams	NNS	O
topical	JJ	O
q.	NN	O
week	NN	O
,	,	O
apply	VB	O
every	DT	O
sunday	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
milligrams	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
haldol	JJ	B-TREATMENT
0.5-1	JJ	O
milligrams	NNS	O
p.o.	VBP	O
q.6-8h.	JJ	O
p.r.n.	NN	O
agitation	NN	B-PROBLEM
,	,	O
niferex	RB	B-TREATMENT
150	CD	O
milligrams	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
nitroglycerin	JJ	B-TREATMENT
paste	NN	I-TREATMENT
2%	CD	O
,	,	O
2	CD	O
inches	NNS	O
topical	JJ	O
q.8h.	NN	O
,	,	O
prilosec	VBP	B-TREATMENT
20	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
senna	JJ	B-TREATMENT
tablets	NNS	I-TREATMENT
2	CD	O
tablets	NNS	O
b.i.d.	RB	O
,	,	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
650	CD	O
milligrams	NNS	O
p.o.	VBP	O
t.i.d.	NN	O
for	IN	O
five	CD	O
days	NNS	O
,	,	O
proscar	NN	B-TREATMENT
5	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
casodex	NN	B-TREATMENT
50	CD	O
milligrams	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
nephrocaps	RB	B-TREATMENT
1	CD	O
tablets	NNS	O
p.o.	VBP	O
q.d.	NN	O

home	NN	O
with	IN	O
hospice	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
af-resolved	JJ	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
treated	VBN	O
and	CC	O
released	VBN	O
.	.	O

external	JJ	B-PROBLEM
wound	NN	I-PROBLEM
infections	NNS	I-PROBLEM

sternal	JJ	B-PROBLEM
wound	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
74-year-old	JJ	O
woman	NN	O
,	,	O
well	RB	O
known	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
surgery	NN	O
service	NN	O
,	,	O
readmitted	VBN	O
from	IN	O
glasmif/putdi	NN	O
health	NN	O
network	NN	O
with	IN	O
sternal	JJ	B-PROBLEM
wound	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
previously	RB	O
hospitalized	VBN	O
on	IN	O
12	CD	O
april	NN	O
1998	CD	O
for	IN	O
the	DT	B-PROBLEM
same	JJ	I-PROBLEM
diagnosis	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
now	RB	O
coming	VBG	O
for	IN	O
surgical	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
,	,	O
wound	NN	B-TREATMENT
debridement	NN	I-TREATMENT
,	,	O
and	CC	O
possible	JJ	O
wound	NN	B-TREATMENT
closure	NN	I-TREATMENT
with	IN	I-TREATMENT
bilateral	JJ	I-TREATMENT
pectoralis	NNS	I-TREATMENT
flap	NN	I-TREATMENT
.	.	O

she	PRP	O
underwent	JJ	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
two	CD	O
with	IN	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
on	IN	O
29	CD	O
march	NN	O
1998	CD	O
.	.	O

of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
status	NN	B-PROBLEM
post	NN	I-PROBLEM
lymphoma	NN	I-PROBLEM
with	IN	O
treatment	NN	O
of	IN	O
chemotherapy	NN	B-TREATMENT
and	CC	O
radiation	NN	B-TREATMENT
six	CD	O
years	NNS	O
ago	RB	O
,	,	O
and	CC	O
is	VBZ	O
an	DT	B-PROBLEM
insulin-dependent	JJ	I-PROBLEM
diabetic	NN	I-PROBLEM
.	.	O

insulin-dependent	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
lymphoma	NN	B-PROBLEM
as	IN	O
above	IN	O
,	,	O
ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
,	,	O
melanoma	NN	B-PROBLEM
status	NN	O
post	NN	O
excision	NN	B-TREATMENT
in	IN	I-TREATMENT
right	JJ	I-TREATMENT
upper	JJ	I-TREATMENT
extremity	NN	I-TREATMENT
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
and	CC	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
bypass	NN	B-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
knee	JJ	I-TREATMENT
replacement	NN	I-TREATMENT
and	CC	O
status	NN	O
post	NN	O
multiple	JJ	B-TREATMENT
prior	JJ	I-TREATMENT
surgeries	NNS	I-TREATMENT
and	CC	O
reconstruction	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
knee	NN	I-TREATMENT
.	.	O

status	NN	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
,	,	O
lumbar	NN	B-TREATMENT
diskectomy	NN	I-TREATMENT
,	,	O
and	CC	O
tonsillectomy	NN	B-TREATMENT
with	IN	O
adenoidectomy	NN	B-TREATMENT
.	.	O

erythromycin	NN	B-TREATMENT
,	,	O
vancomycin	NN	B-TREATMENT
,	,	O
and	CC	O
bacitracin	NN	B-TREATMENT
.	.	O

elavil	RB	B-TREATMENT
50	CD	O
mg	NNS	O
p.o.	JJ	O
q.h.s.	NN	O
,	,	O
coated	VBD	B-TREATMENT
aspirin	RB	I-TREATMENT
325	CD	O
mg	NNS	O
p.o.	JJ	O
p.day	NN	O
,	,	O
tegretol	VBZ	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
ancef	RB	B-TREATMENT
1	CD	O
gm	NNS	O
iv	JJ	O
q.12h.	JJ	O
times	NNS	O
seven	CD	O
days	NNS	O
,	,	O
vasotec	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
synthroid	JJ	B-TREATMENT
0.025	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
asacol	RB	B-TREATMENT
400	CD	O
mg	NNS	O
q.a.m.	RB	O
and	CC	O
800	CD	O
mg	NN	O
q.p.m.	NN	O
,	,	O
lopressor	VBZ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
prilosec	VBP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
and	CC	O
insulin	VBZ	B-TREATMENT
70/30	CD	O
26	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
and	CC	O
12	CD	O
units	NNS	O
at	IN	O
night	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
140/80	CD	O
,	,	O
temperature	NN	B-TEST
101.3	CD	O
,	,	O
pulse	RB	B-TEST
84	CD	O
,	,	O
and	CC	O
respiratory	NN	B-TEST
rate	NN	I-TEST
22	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
obese	JJ	B-PROBLEM
with	IN	O
unremarkable	JJ	O
physical	JJ	O
examination	NN	O
except	IN	O
for	IN	O
a	DT	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
i	JJ	B-PROBLEM
/	VBP	I-PROBLEM
vi	NN	I-PROBLEM
and	CC	I-PROBLEM
erythema	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
sternal	JJ	I-PROBLEM
wound	NN	I-PROBLEM
and	CC	O
upper	JJ	O
third	NN	O
.	.	O

the	DT	B-PROBLEM
wound	NN	I-PROBLEM
had	VBD	O
a	DT	B-PROBLEM
beefy	NN	I-PROBLEM
red	JJ	I-PROBLEM
cellulitic	JJ	I-PROBLEM
area	NN	I-PROBLEM
surrounding	VBG	O
an	DT	O
open	JJ	O
area	NN	O
,	,	O
blanching	VBG	O
to	TO	O
touch	VB	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
purulence	NN	B-PROBLEM
or	CC	O
discharge	NN	B-PROBLEM
noted	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
iv	NN	B-TREATMENT
antibiotics	NNS	I-TREATMENT
,	,	O
ancef	RB	B-TREATMENT
1	CD	O
gm	NNS	O
q.8h.	NN	O

on	IN	O
10	CD	O
may	MD	O
1998	CD	O
,	,	O
she	PRP	O
underwent	VBD	O
sternal	JJ	B-TREATMENT
wound	NN	I-TREATMENT
debridement	NN	I-TREATMENT
and	CC	I-TREATMENT
closure	NN	I-TREATMENT
,	,	O
performed	VBN	O
by	IN	O
dr.	NN	O
falccouette	NN	O
and	CC	O
dr.	NN	O
shuffzeln	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
switched	VBN	O
to	TO	O
ampicillin	VB	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
clindamycin	NN	B-TREATMENT
,	,	O
according	VBG	O
to	TO	O
the	DT	B-TEST
culture	NN	I-TEST
,	,	O
enterococci	NN	B-PROBLEM
and	CC	O
staphylococcus	NN	B-PROBLEM
in	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
.	.	O

due	JJ	O
to	TO	O
the	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
the	DT	O
patient	JJ	O
underwent	JJ	O
vancomycin	NN	B-TREATMENT
desensitization	NN	I-TREATMENT
in	IN	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
followed	VBN	O
by	IN	O
a	DT	B-TREATMENT
change	NN	I-TREATMENT
of	IN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
to	TO	O
vancomycin	VB	B-TREATMENT
and	CC	O
levofloxacin	VB	B-TREATMENT
.	.	O

further	JJ	B-TEST
cultures	NNS	I-TEST
from	IN	I-TEST
sputum	NN	I-TEST
and	CC	I-TEST
urine	NN	I-TEST
revealed	VBN	O
yeast	RB	B-PROBLEM
sensitive	JJ	O
to	TO	O
diflucan	VB	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
administered	VBN	O
shortly	RB	O
after	IN	O
.	.	O

because	IN	O
of	IN	O
expected	VBN	B-TREATMENT
long	JJ	I-TREATMENT
term	NN	I-TREATMENT
antibiotic	JJ	I-TREATMENT
administration	NN	I-TREATMENT
,	,	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
prepared	VBN	O
for	IN	O
transfer	NN	O
back	RB	O
to	TO	O
fo	VB	O
hospital	NN	O
.	.	O

as	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
complication	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
opened	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
ankle	NN	I-PROBLEM
wound	IN	I-PROBLEM
post	NN	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
harvest	NN	I-TREATMENT
,	,	O
which	WDT	O
persists	VBZ	O
up	RP	O
until	IN	O
now	RB	O
and	CC	O
is	VBZ	O
of	IN	O
a	DT	O
size	NN	O
2	CD	O
x	NN	O
1	CD	O
cm	NN	O
.	.	O

due	JJ	O
to	TO	O
difficult	JJ	B-PROBLEM
ambulation	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
sacral	JJ	I-PROBLEM
area	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
treated	VBN	O
with	IN	O
duoderm	JJ	B-TREATMENT
dressing	NN	I-TREATMENT
.	.	O

elavil	NN	B-TREATMENT
by	IN	O
mouth	NN	O
15	CD	O
mg	NN	O
every	DT	O
night	NN	O
,	,	O
dulcolax	VB	B-TREATMENT
rectally	RB	O
10	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
tegretol	NN	B-TREATMENT
by	IN	O
mouth	NN	O
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
benadryl	NN	B-TREATMENT
by	IN	O
mouth	NN	O
25	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
colace	NN	B-TREATMENT
by	IN	O
mouth	NN	O
200	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
vasotec	NN	B-TREATMENT
by	IN	O
mouth	NN	O
10	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
eoc	FW	B-TREATMENT
/	JJ	I-TREATMENT
loc	NN	I-TREATMENT
p.r./p.o.	NN	O
one	CD	O
each	DT	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
,	,	O
lasix	NN	B-TREATMENT
by	IN	O
mouth	NN	O
80	CD	O
mg	NN	O
every	DT	O
morning	NN	O
,	,	O
insulin	NN	B-TREATMENT
regular	JJ	O
according	VBG	O
to	TO	O
insulin	VB	O
scale	NN	O
,	,	O
synthroid	NN	B-TREATMENT
by	IN	O
mouth	NN	O
25	CD	O
mcg	NN	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
maalox	NN	B-TREATMENT
plus	CC	I-TREATMENT
extra	JJ	I-TREATMENT
strength	NN	I-TREATMENT
by	IN	O
mouth	NN	O
15	CD	O
ml	NN	O
every	DT	O
six	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
indigestion	NN	B-PROBLEM
,	,	O
milk	NN	O
of	IN	O
magnesia	NN	B-TREATMENT
by	IN	O
mouth	NN	O
30	CD	O
ml	NN	O
once	RB	O
a	DT	O
day	NN	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
,	,	O
asacol	NN	B-TREATMENT
by	IN	O
mouth	NN	O
400	CD	O
mg	NN	O
every	DT	O
morning	NN	O
,	,	O
asacol	RB	B-TREATMENT
800	CD	O
mg	NN	O
every	DT	O
night	NN	O
,	,	O
lopressor	NN	B-TREATMENT
by	IN	O
mouth	NN	O
25	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
miracle	NN	B-TREATMENT
cream	NN	I-TREATMENT
topically	RB	O
on	IN	O
skin	NN	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
nystatin	JJ	B-TREATMENT
swish	JJ	I-TREATMENT
and	CC	I-TREATMENT
swallow	JJ	I-TREATMENT
by	IN	O
mouth	NN	O
5	CD	O
ml	NN	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
percocet	NN	B-TREATMENT
by	IN	O
mouth	NN	O
one	CD	O
tab	NN	O
every	DT	O
four	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
,	,	O
and	CC	O
vancomycin	NN	B-TREATMENT
by	IN	O
infusion	NN	O
1	CD	O
gm	NN	O
every	DT	O
18	CD	O
hours	NNS	O
;	:	O
instructions	NNS	O
in	IN	O
250	CD	O
ml	NNS	O
slow	JJ	B-TREATMENT
iv	NN	I-TREATMENT
infusion	NN	I-TREATMENT
over	IN	O
one	CD	O
hour	NN	O
.	.	O

note	NN	O
,	,	O
please	VB	O
draw	JJ	O
blood	NN	O
for	IN	O
vancomycin	NN	B-TEST
levels	NNS	I-TEST
on	IN	O
25	CD	O
may	MD	O
1998	CD	O
,	,	O
before	IN	O
the	DT	O
next	JJ	O
dose	NN	O
,	,	O
to	TO	O
get	VB	O
the	DT	B-TEST
trough	JJ	I-TEST
level	NN	I-TEST
.	.	O

keep	VB	O
vancomycin	NN	B-TEST
trough	IN	I-TEST
between	IN	O
10-20	JJ	O
,	,	O
but	CC	O
not	RB	O
less	JJR	O
due	JJ	O
to	TO	O
desensitization	NN	B-PROBLEM
.	.	O

vancomycin	NN	B-TEST
levels	NNS	I-TEST
should	MD	O
be	VB	O
checked	VBN	O
every	DT	O
third	JJ	O
day	NN	O
for	IN	O
four	CD	O
to	TO	O
six	CD	O
weeks	NNS	O
,	,	O
according	VBG	O
to	TO	O
imd	NN	O
.	.	O

nizatidine	NN	B-TREATMENT
by	IN	O
mouth	NN	O
150	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
insulin	NN	B-TREATMENT
70/30	CD	O
human	JJ	O
injection	NN	O
under	IN	O
skin	JJ	O
12	CD	O
units	NNS	O
every	DT	O
night	NN	O
,	,	O
insulin	NN	B-TREATMENT
70/30	CD	O
human	JJ	O
injection	NN	O
subcutaneous	JJ	O
26	CD	O
units	NNS	O
every	DT	O
morning	NN	O
,	,	O
lovenox	NN	B-TREATMENT
injection	NN	O
under	IN	O
skin	NN	O
40	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
and	CC	O
levofloxacin	NN	B-TREATMENT
by	IN	O
mouth	NN	O
250	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

non-healing	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

right	RB	B-TREATMENT
fem	NN	I-TREATMENT
to	TO	I-TREATMENT
below	IN	I-TREATMENT
knee	NNS	I-TREATMENT
pop	VBP	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

this	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
seventy	NN	O
eight	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
history	NN	O
of	IN	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
who	WP	O
is	VBZ	O
status	NN	O
post	NN	O
above	IN	B-TREATMENT
knee	NN	I-TREATMENT
to	TO	I-TREATMENT
fem	VB	I-TREATMENT
pop	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
with	IN	O
6	CD	B-TREATMENT
millimeter	NN	I-TREATMENT
ptfe	NN	I-TREATMENT
.	.	O

this	DT	B-TREATMENT
operation	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
for	IN	O
two	CD	O
months	NNS	O
of	IN	O
increased	JJ	B-PROBLEM
rest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
resolved	VBD	O
after	IN	O
surgery	NN	B-TREATMENT
and	CC	O
she	PRP	O
has	VBZ	O
been	VBN	O
doing	VBG	O
well	RB	O
since	IN	O
,	,	O
although	IN	O
at	IN	O
baseline	NN	O
now	RB	O
she	PRP	O
is	VBZ	O
minimally	RB	B-PROBLEM
ambulatory	JJ	I-PROBLEM
from	IN	O
bed	NN	O
to	TO	O
commode	VB	O
.	.	O

for	IN	O
the	DT	O
past	JJ	O
couple	NN	O
of	IN	O
months	NNS	O
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
a	DT	B-PROBLEM
non-healing	JJ	I-PROBLEM
right	NN	I-PROBLEM
dorsal	NN	I-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
been	VBN	O
increasing	VBG	O
in	IN	O
size	NN	O
and	CC	O
started	VBD	O
as	IN	O
a	DT	B-PROBLEM
pin	NN	I-PROBLEM
hole	NN	I-PROBLEM
and	CC	O
she	PRP	O
does	VBZ	O
not	RB	O
recollect	VB	O
any	DT	B-PROBLEM
trauma	NN	I-PROBLEM
,	,	O
as	IN	O
similar	JJ	B-PROBLEM
small	JJ	I-PROBLEM
ulcers	NNS	I-PROBLEM
developed	VBN	O
on	IN	O
the	DT	O
left	JJ	O
foot	NN	O
as	IN	O
well	RB	O
around	IN	O
the	DT	O
same	JJ	O
time	NN	O
,	,	O
but	CC	O
that	DT	O
has	VBZ	O
subsequently	RB	O
healed	VBN	O
.	.	O

the	DT	B-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
managed	VBN	O
conservatively	RB	O
at	IN	O
har	JJ	O
hospital	NN	O
by	IN	O
dr.	NN	O
holes	NNS	O
with	IN	O
silvadene	NN	B-TREATMENT
b.i.d.	NNS	O
lower	JJR	B-TEST
extremity	NN	I-TEST
non-invasive	JJ	I-TEST
study	NN	I-TEST
obtained	VBN	O
at	IN	O
that	DT	O
time	NN	O
showed	VBD	O
poor	JJ	B-PROBLEM
distal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
perfusion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
back	RB	O
to	TO	O
dr.	VB	O
pop	NN	O
for	IN	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	B-TREATMENT
revascularization	NN	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
angiography	NN	B-TEST
today	NN	O
.	.	O

she	PRP	O
has	VBZ	O
just	RB	O
finished	VBN	O
a	DT	O
ten	JJ	O
day	NN	O
course	NN	O
of	IN	O
ciprofloxacin	NN	B-TREATMENT
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	O
fevers	NNS	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

she	PRP	O
does	VBZ	O
have	VB	O
rest	VBN	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
foot	NN	I-PROBLEM
and	CC	I-PROBLEM
ankle	NN	I-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
guillain-barr	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
lupus	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
multiple	NN	B-PROBLEM
decubiti	NN	I-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
right	RB	B-TREATMENT
total	JJ	I-TREATMENT
knee	JJ	I-TREATMENT
replacement	NN	I-TREATMENT
and	CC	O
status	NN	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
hysterectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
goiter	NN	B-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
lung	NN	I-PROBLEM
fibrosis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
methicillin	NN	B-PROBLEM
resistant	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
aureus	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

prednisone	NN	B-TREATMENT
5	CD	O
every	DT	O
other	JJ	O
day	NN	O
,	,	O
alternating	VBG	O
with	IN	O
ten	JJ	O
every	DT	O
other	JJ	O
day	NN	O
.	.	O

trental	JJ	B-TREATMENT
400	CD	O
milligrams	NNS	O
t.i.d.	RB	O
,	,	O
cytotec	JJ	B-TREATMENT
100	CD	O
milligrams	NNS	O
t.i.d.	RB	O
,	,	O
ativan	VBZ	B-TREATMENT
2	CD	O
milligrams	NNS	O
q.h.s.	VBP	O
darvon	JJ	B-TREATMENT
65	CD	O
milligrams	NNS	O
two	CD	O
q.i.d	NNS	O
,	,	O
relafen	VBP	B-TREATMENT
500	CD	O
milligrams	NNS	O
b.i.d	RB	O
,	,	O
vitamin	FW	B-TREATMENT
e	NN	I-TREATMENT
,	,	O
prilosec	VBP	B-TREATMENT
20	CD	O
milligrams	NNS	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
zantac	$	B-TREATMENT
150	CD	O
milligrams	NNS	O
b.i.d	RB	O
,	,	O
lasix	VBD	B-TREATMENT
120	CD	O
milligrams	NNS	O
every	DT	O
other	JJ	O
day	NN	O
prn	IN	O
edema	NN	B-PROBLEM
.	.	O

didronel	NNS	B-TREATMENT
1	CD	O
q	NNS	O
day	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
on	IN	O
hold	NN	O
.	.	O

proventil	JJ	B-TREATMENT
inhaler	NN	I-TREATMENT
via	IN	I-TREATMENT
nebulizers	NNS	I-TREATMENT
0.5	CD	O
milligrams	NNS	O
with	IN	O
atrovent	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
ampicillin	NN	B-TREATMENT
,	,	O
tylenol	NN	B-TREATMENT
,	,	O
clinoril	NN	B-TREATMENT
,	,	O
biaxin	NN	B-TREATMENT
,	,	O
codeine	NN	B-TREATMENT
,	,	O
sulfa	NN	B-TREATMENT
and	CC	O
aminophylline	NN	B-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
afebrile	JJ	O
,	,	O
her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
are	VBP	O
stable	JJ	O
.	.	O

neck	NN	O
,	,	O
she	PRP	O
has	VBZ	O
ii+	JJ	O
bilateral	JJ	O
carotids	NNS	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
,	,	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

lungs	NNS	O
decreased	VBD	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
at	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
bases	NNS	I-PROBLEM
with	IN	O
minimal	JJ	B-PROBLEM
expiratory	NN	I-PROBLEM
crackles	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
.	.	O

abdomen	NNS	O
,	,	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

extremities	NNS	O
on	IN	O
the	DT	O
right	NN	O
,	,	O
she	PRP	O
has	VBZ	O
a	DT	O
ii+	JJ	O
femoral	JJ	O
,	,	O
no	DT	O
distal	JJ	B-PROBLEM
pulses	VBZ	I-PROBLEM
beyond	IN	O
that	DT	O
.	.	O

on	IN	O
the	DT	O
left	NN	O
she	PRP	O
has	VBZ	O
a	DT	O
ii+	JJ	O
femoral	JJ	O
and	CC	O
ii+	JJ	O
popliteal	NN	O
,	,	O
no	DT	O
distal	JJ	B-PROBLEM
pulses	VBZ	I-PROBLEM
beyond	IN	O
that	DT	O
.	.	O

she	PRP	O
has	VBZ	O
on	IN	O
her	PRP$	O
right	JJ	O
ankle	NN	O
anteriorly	RB	O
a	DT	B-PROBLEM
four	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	I-PROBLEM
necrotic	JJ	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

minimal	JJ	B-PROBLEM
surrounding	VBG	I-PROBLEM
erythema	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
angiography	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
proximal	NN	I-PROBLEM
popliteal	NN	I-PROBLEM
occlusion	NN	I-PROBLEM
,	,	O
anterior	JJ	B-PROBLEM
tibial	JJ	I-PROBLEM
dominant	JJ	I-PROBLEM
foot	NN	I-PROBLEM
vessel	NN	I-PROBLEM
.	.	O

small	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
tibial	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
calf	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
peroneal	NN	I-PROBLEM
goes	VBZ	O
down	RB	O
to	TO	O
the	DT	O
ankle	NN	O
.	.	O

on	IN	O
a	DT	B-TEST
rectal	JJ	I-TEST
examination	NN	I-TEST
she	PRP	O
is	VBZ	O
guaiac	JJ	O
negative	JJ	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
and	CC	O
no	DT	O
gluteal	JJ	B-PROBLEM
ulcers	NNS	I-PROBLEM
or	CC	O
decubiti	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
the	DT	O
following	JJ	O
day	NN	O
and	CC	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
fem	NN	I-TREATMENT
to	TO	I-TREATMENT
below	IN	I-TREATMENT
knee	NNS	I-TREATMENT
popliteal	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
using	VBG	O
a	DT	B-TREATMENT
six	CD	I-TREATMENT
millimeter	NN	I-TREATMENT
ring	VBG	I-TREATMENT
ptfe	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
afebrile	RB	O
,	,	O
her	PRP	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
26.8	CD	O
and	CC	O
she	PRP	O
was	VBD	O
transfused	VBN	O
1	CD	O
unit	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
swelling	VBG	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	O
this	DT	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
her	PRP$	B-TEST
pvr	NN	I-TEST
cuff	NN	I-TEST
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	O
amount	NN	O
of	IN	O
surrounding	VBG	B-PROBLEM
erythema	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
ancef	NN	B-TREATMENT
at	IN	O
that	DT	O
time	NN	O
.	.	O

the	DT	O
area	NN	O
of	IN	O
erythema	NN	B-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
leg	NN	I-PROBLEM
enlarged	VBD	O
slightly	RB	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
for	IN	O
several	JJ	O
days	NNS	O
after	IN	O
which	WDT	O
time	NN	O
her	PRP$	B-PROBLEM
erythema	NN	I-PROBLEM
again	RB	O
began	VBD	O
to	TO	O
decrease	VB	O
.	.	O

she	PRP	O
had	VBD	O
wounds	NNS	B-PROBLEM
which	WDT	O
were	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
from	IN	O
a	DT	O
respiratory	NN	O
standpoint	NN	O
using	VBG	O
her	PRP$	B-TREATMENT
respirator	NN	I-TREATMENT
at	IN	O
night	NN	O
.	.	O

the	DT	O
patient	NN	O
required	VBD	O
an	DT	B-TREATMENT
additional	JJ	I-TREATMENT
blood	NN	I-TREATMENT
transfusion	NN	I-TREATMENT
during	IN	O
her	PRP$	O
hospital	JJ	O
stay	NN	O
as	IN	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
had	VBD	O
decreased	VBN	O
to	TO	O
27	CD	O
on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
with	IN	O
po	NN	B-TREATMENT
keflex	NN	I-TREATMENT
that	IN	O
she	PRP	O
was	VBD	O
to	TO	O
take	VB	O
for	IN	O
the	DT	O
next	JJ	O
ten	JJ	O
days	NNS	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
sob	NN	B-PROBLEM
.	.	O

following	VBG	O
triage	NN	B-TEST
,	,	O
the	DT	O
patient	NN	O
left	VBD	O
without	IN	O
being	VBG	O
seen	VBN	O
.	.	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
multinodular	JJ	B-PROBLEM
goiter	NN	I-PROBLEM
;	:	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
;	:	O
history	NN	O
of	IN	O
subtotal	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
.	.	O

electrical	JJ	B-TREATMENT
cardioversion	NN	I-TREATMENT
.	.	O

ms.	NN	O
lenkpruskihkooglekih	NN	O
is	VBZ	O
a	DT	O
63-year-old	JJ	O
lady	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
frequent	JJ	B-PROBLEM
premature	NN	I-PROBLEM
ventricular	JJ	I-PROBLEM
contractions	NNS	I-PROBLEM
and	CC	O
infrequent	JJ	B-PROBLEM
short	JJ	I-PROBLEM
runs	NNS	I-PROBLEM
of	IN	I-PROBLEM
non-sustained	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM
(	(	O
one	CD	O
four-beat	NN	O
run	NN	O
)	)	O
in	IN	O
1991	CD	O
,	,	O
for	IN	O
which	WDT	O
several	JJ	O
antiarrhythmic	JJ	O
agents	NNS	O
including	VBG	O
propranolol	NN	B-TREATMENT
,	,	O
quinidine	NN	B-TREATMENT
,	,	O
procainamide	NN	B-TREATMENT
,	,	O
tenormin	NN	B-TREATMENT
,	,	O
norpace	NN	B-TREATMENT
,	,	O
corgard	NN	B-TREATMENT
,	,	O
and	CC	O
flecainide	NN	B-TREATMENT
were	VBD	O
used	VBN	O
,	,	O
but	CC	O
were	VBD	O
stopped	VBN	O
because	IN	O
of	IN	O
intolerance	NN	B-PROBLEM
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
had	VBD	O
clear	JJ	O
coronary	JJ	O
arteries	NNS	O
on	IN	O
coronary	JJ	B-TEST
angiography	NN	I-TEST
and	CC	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
greater	JJR	O
than	IN	O
50%	CD	O
.	.	O

she	PRP	O
did	VBD	O
well	RB	O
off	IN	O
antiarrhythmic	JJ	B-TREATMENT
agents	NNS	I-TREATMENT
until	IN	O
october	NNP	O
of	IN	O
this	DT	O
year	NN	O
when	WRB	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
rapid	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
rate	NN	I-PROBLEM
after	IN	O
several	JJ	O
days	NNS	O
of	IN	O
decreased	JJ	B-PROBLEM
exercise	NN	I-PROBLEM
tolerance	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
and	CC	O
had	VBD	O
a	DT	O
failed	JJ	O
attempt	NN	O
at	IN	O
dc	JJ	B-TREATMENT
electrical	JJ	I-TREATMENT
cardioversion	NN	I-TREATMENT
on	IN	O
11/16/96	CD	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
since	IN	O
and	CC	O
has	VBZ	O
continued	VBN	O
to	TO	O
have	VB	O
occasional	JJ	B-PROBLEM
palpitations	NNS	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

includes	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
;	:	O
multinodular	JJ	B-PROBLEM
goiter	NN	I-PROBLEM
;	:	O
subtotal	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
.	.	O

include	VBP	O
cardizem	JJ	B-TREATMENT
cd	NN	I-TREATMENT
180	CD	O
mg	JJ	O
daily	RB	O
;	:	O
monopril	CC	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
;	:	O
digoxin	NN	B-TREATMENT
.25	FW	O
mg	JJ	O
daily	JJ	O
;	:	O
and	CC	O
lasix	$	B-TREATMENT
40	CD	O
mg	NN	O
every	DT	O
other	JJ	O
day	NN	O
.	.	O

to	TO	O
quinidine	VB	B-TREATMENT
,	,	O
procardia	NN	B-TREATMENT
,	,	O
and	CC	O
sulfa	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

on	IN	O
examination	NN	B-TEST
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
200/100	CD	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
120	CD	O
per	IN	O
minute	NN	O
(	(	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
)	)	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
anxious	JJ	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
neck	NN	B-PROBLEM
vein	VBZ	I-PROBLEM
distension	NN	I-PROBLEM
or	CC	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
abdominal	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
benign	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
12-lead	JJ	I-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
a	DT	O
qt	JJ	O
interval	NN	O
of	IN	O
.46	JJ	O
seconds	NNS	O
.	.	O

there	EX	O
were	VBD	O
diffuse	NN	B-PROBLEM
st	NN	I-PROBLEM
segment	NN	I-PROBLEM
and	CC	I-PROBLEM
t-wave	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
,	,	O
which	WDT	O
were	VBD	O
nonspecific	NNS	O
.	.	O

a	DT	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
,	,	O
electrolytes	VBZ	B-TEST
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

inr	NN	B-TEST
was	VBD	O
elevated	VBN	O
at	IN	O
2.5	CD	O
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
performed	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
completely	RB	O
normal	JJ	O
left	VBD	O
ventricular	JJ	O
systolic	JJ	O
function	NN	O
with	IN	O
an	DT	O
ejection	NN	O
fraction	NN	O
calculated	VBD	O
at	IN	O
.74	NNP	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
or	CC	O
asymmetric	JJ	B-PROBLEM
septal	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
an	DT	O
issue	NN	O
that	WDT	O
had	VBD	O
been	VBN	O
raised	VBN	O
on	IN	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
in	IN	O
ownra	JJ	O
cin	NN	O
,	,	O
new	JJ	O
mexico	NN	O
on	IN	O
12/06/96	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
propafenone	NN	B-TREATMENT
300	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
and	CC	O
underwent	NN	O
an	DT	O
attempt	NN	O
at	IN	O
electrical	JJ	B-TREATMENT
cardioversion	NN	I-TREATMENT
after	IN	O
seven	CD	O
doses	NNS	O
of	IN	O
this	DT	O
.	.	O

the	DT	O
propafenone	NN	B-TREATMENT
was	VBD	O
stopped	VBN	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
changed	VBN	O
to	TO	O
amiodarone	VB	B-TREATMENT
400	CD	O
mg	NN	O
t.i.d.	NN	O
,	,	O
which	WDT	O
was	VBD	O
continued	VBN	O
for	IN	O
two	CD	O
days	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
on	IN	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	JJ	O
daily	RB	O
on	IN	O
12/29/96	CD	O
.	.	O

an	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
qt	JJ	B-PROBLEM
prolongation	NN	I-PROBLEM
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
and	CC	O
pulmonary	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
will	MD	O
be	VB	O
performed	VBN	O
before	IN	O
the	DT	O
patient	NN	O
goes	VBZ	O
home	RB	O
today	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
will	MD	O
return	VB	O
to	TO	O
this	DT	O
hospital	NN	O
in	IN	O
early	JJ	O
february	NN	O
for	IN	O
repeat	NN	O
attempt	NN	O
at	IN	O
electrical	JJ	B-TREATMENT
cardioversion	NN	I-TREATMENT
on	IN	O
amiodarone	NN	B-TREATMENT
.	.	O

she	PRP	O
will	MD	O
continue	VB	O
her	PRP$	O
coumadin	NN	B-TREATMENT
until	IN	O
then	RB	O
and	CC	O
arrangements	NNS	O
for	IN	O
her	PRP$	O
readmission	NN	O
can	MD	O
be	VB	O
made	VBN	O
through	IN	O
dr.	JJ	O
iceca	NN	O
rhaltkaaispehbreun	NN	O
's	POS	O
office	NN	O
here	RB	O
.	.	O

other	JJ	O
than	IN	O
the	DT	O
addition	NN	O
of	IN	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	JJ	O
daily	JJ	O
,	,	O
will	MD	O
be	VB	O
the	DT	O
same	JJ	O
as	IN	O
her	PRP$	B-TREATMENT
admission	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

body	NN	B-PROBLEM
shaking	VBG	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

back	RB	B-PROBLEM
pain/	JJ	I-PROBLEM
mechanical	JJ	B-PROBLEM
fall	NN	I-PROBLEM

pt	NN	B-TEST
&apos;s	NN	I-TEST
labs	NNS	I-TEST
were	VBD	O
checked	VBN	O
,	,	O
he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
neurology	NN	O
,	,	O
and	CC	O
he	PRP	O
received	VBD	O
a	DT	B-TEST
spine	NN	I-TEST
mri	NN	I-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

he	PRP	O
received	VBD	O
rx	NN	B-TREATMENT
for	IN	O
potassium	NN	B-TREATMENT
to	TO	O
help	VB	O
with	IN	O
cramps	NNS	B-PROBLEM
.	.	O

advised	VBN	O
to	TO	O
contact	VB	O
pain	NN	O
service	NN	O
for	IN	O
repeat	NN	B-TREATMENT
injections	NNS	I-TREATMENT
,	,	O
f	JJ	O
/	NNP	O
u	NN	O
with	IN	O
neurology	NN	O
,	,	O
explore	RB	O
pt	NN	B-TREATMENT
,	,	O
massage	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

k-dur	JJ	B-TREATMENT
20meq	CD	O
po	NN	O
qd	NN	O

colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
diverticulitis	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
,	,	O
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

transverse	NN	B-TREATMENT
colectomy	NN	I-TREATMENT
for	IN	O
tumor	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
84-year-old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diverticulitis	NN	B-PROBLEM
who	WP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
on	IN	O
colonoscopy	NN	B-TEST
,	,	O
which	WDT	O
was	VBD	O
performed	VBN	O
in	IN	O
march	NN	O
of	IN	O
2004	CD	O
.	.	O

an	DT	B-PROBLEM
invasive	JJ	I-PROBLEM
moderately	RB	I-PROBLEM
differentiated	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
transverse	NN	O
colon	NN	O
at	IN	O
80	CD	O
cm	NN	O
.	.	O

the	DT	O
patient	NN	O
reports	VBZ	O
a	DT	O
history	NN	O
of	IN	O
bloating	NN	B-PROBLEM
and	CC	O
flatulence	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
increased	VBN	B-PROBLEM
fatigue	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
also	RB	O
had	VBD	O
some	DT	B-PROBLEM
discomfort	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
abdomen	NNS	I-PROBLEM
and	CC	O
notes	NNS	O
diarrhea	VBP	B-PROBLEM
every	DT	O
4-5	JJ	O
days	NNS	O
.	.	O

she	PRP	O
says	VBZ	O
that	IN	O
her	PRP$	O
appetite	NN	O
is	VBZ	O
good	JJ	O
and	CC	O
has	VBZ	O
noted	VBN	O
no	DT	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
.	.	O

cholecystectomy	NN	B-TREATMENT
in	IN	O
1994	CD	O
,	,	O
colonoscopy	NN	B-TREATMENT
2004	CD	O
,	,	O
status	NN	O
post	NN	O
tonsillectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
orif	NN	B-TREATMENT
of	IN	I-TREATMENT
left	JJ	I-TREATMENT
wrist	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
ear	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
nsvd	JJ	B-TREATMENT
x5	NN	O
,	,	O
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

premarin	JJ	B-TREATMENT
vaginal	JJ	I-TREATMENT
once	RB	O
a	DT	O
month	NN	O
,	,	O
enalapril	NN	B-TREATMENT
,	,	O
tylenol	NN	B-TREATMENT
,	,	O
vitamins	NNS	B-TREATMENT
,	,	O
and	CC	O
halcion	NN	B-TREATMENT
at	IN	O
night	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

on	IN	O
exam	NN	B-TEST
she	PRP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
.	.	O

her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
are	VBP	O
stable	JJ	O
.	.	O

baseline	NN	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
144/61	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
73	CD	O
,	,	O
and	CC	O
oxygen	JJ	B-TEST
saturation	NN	I-TEST
of	IN	O
96%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

she	PRP	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
well	NN	O
appearing	VBG	O
elderly	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

heart	NN	O
is	VBZ	O
regular	JJ	O
without	IN	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

her	PRP$	O
extremities	NNS	O
are	VBP	O
without	IN	O
edema	NN	B-PROBLEM
and	CC	O
are	VBP	O
warm	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
consented	VBN	O
for	IN	O
surgery	NN	B-TREATMENT
and	CC	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
transverse	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
for	IN	O
tumor	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
there	EX	O
are	VBP	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
an	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
and	CC	O
pca	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
control	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
kept	VBN	O
npo	RB	B-TREATMENT
initially	RB	O
and	CC	O
her	PRP$	O
diet	NN	O
was	VBD	O
slowly	RB	O
advanced	JJ	O
as	IN	O
tolerated	VBN	O
.	.	O

when	WRB	O
she	PRP	O
was	VBD	O
taking	VBG	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
,	,	O
her	PRP$	B-TREATMENT
pain	NN	I-TREATMENT
medication	NN	I-TREATMENT
was	VBD	O
switched	VBN	O
to	TO	O
p.o.	VB	B-TREATMENT
pain	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
with	IN	O
good	JJ	O
affect	NN	O
.	.	O

for	IN	O
blood	NN	B-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
metoprolol	NN	B-TREATMENT
at	IN	O
the	DT	O
request	NN	O
of	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
and	CC	O
enalapril	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

with	IN	O
the	DT	O
help	NN	O
of	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
the	DT	O
patient	NN	O
was	VBD	O
ambulated	VBN	O
and	CC	O
on	IN	O
postoperative	JJ	O
seven	CD	O
,	,	O
with	IN	O
the	DT	O
patient	NN	O
tolerating	VBG	O
a	DT	B-TREATMENT
post	NN	I-TREATMENT
surgical	JJ	I-TREATMENT
soft	JJ	I-TREATMENT
diet	NNS	I-TREATMENT
and	CC	O
with	IN	O
pain	NN	B-PROBLEM
well	RB	O
controlled	VBN	O
on	IN	O
oral	JJ	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
rehabilitation	VB	O
facility	NN	O
.	.	O

1.	CD	O
tylenol	JJ	B-TREATMENT
650	CD	O
mg	NN	O
p.o.	NN	O
q.4.h.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

2.	CD	O
metoprolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

3.	CD	O
motrin	JJ	B-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

4.	CD	O
halcion	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
p.o.	NN	O
at	IN	O
night	NN	O
.	.	O

5.	CD	O
dulcolax	JJ	B-TREATMENT
10	CD	O
to	TO	O
20	CD	O
mg	NNS	O
pr	JJ	O
b.i.d.	JJ	O
p.r.n.	NN	O
constipation	NN	B-PROBLEM
.	.	O

6.	CD	O
senna	JJ	B-TREATMENT
2	CD	O
tablets	NNS	O
p.o.	VBP	O
b.i.d.	NN	O

she	PRP	O
is	VBZ	O
to	TO	O
also	RB	O
call	VB	O
the	DT	O
office	NN	O
if	IN	O
she	PRP	O
has	VBZ	O
any	DT	O
fever	RB	B-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
101	CD	I-PROBLEM
,	,	O
bleeding	VBG	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
surgical	JJ	I-PROBLEM
wounds	NNS	I-PROBLEM
,	,	O
or	CC	O
pus	NN	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
wounds	NNS	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
to	TO	O
be	VB	O
maintained	VBN	O
on	IN	O
metoprolol	NN	B-TREATMENT
for	IN	O
blood	NN	B-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
and	CC	O
the	DT	O
restarting	NN	O
of	IN	O
her	PRP$	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
is	VBZ	O
to	TO	O
be	VB	O
decided	VBN	O
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
.	.	O

